clarithromycin has been researched along with Infections, Helicobacter in 2722 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 468 (17.19) | 18.2507 |
| 2000's | 1054 (38.72) | 29.6817 |
| 2010's | 808 (29.68) | 24.3611 |
| 2020's | 392 (14.40) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, F; Ikeda, Y; Kawakita, T; Kuroda, T; Moriguchi, A; Sakurai, N; Sano, M; Uemori, S; Yamamoto, K | 1 |
| Choi, KI; Kang, TW; Nam, G; Shin, JH | 1 |
| Chowdhury, A; De, R; Kundu, P; Mukhopadhyay, AK; Nair, GB; Ramamurthy, T; Swarnakar, S | 1 |
| Alvarez, A; Corredor, LF; Moncayo, JI; Reinosa, E; Santacoloma, M; Santacruz, JJ | 1 |
| Fang, SH; Lai, CH; Rao, YK; Sing, YT; Tzeng, YM | 1 |
| Chang, CS; Chen, LY; Kao, MC; Kuo, SC; Lai, CH; Lin, CD; Lin, HJ; Liu, JF; Lu, DY; Sing, YT; Tang, CH | 1 |
| Cheng, WC; Hsu, TL; Liou, JM; Tseng, YY; Wong, CH; Wu, MS | 1 |
| Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
| Chen, Q; Chen, Y; Huang, X; Ji, X; Lin, Z; Liu, Y; Lu, Y; Nong, G; Suo, B; Wei, J; Wu, B; Zhou, X | 1 |
| Choi, YI; Chung, JW; Kim, JH; Kim, KO; Kim, YJ; Kwon, KA; Park, DK; Seo, JY | 1 |
| El Shahawy, MS; Gaafar, A; Shady, ZM | 1 |
| Cha, JM; Jeon, JW; Kwak, MS; Yoon, JY | 1 |
| George, SA; González, M; Huerta, N; Lagomarcino, AJ; Lucero, Y; Mamani, N; O'Ryan G, M; Roessler, P; Torres, JP | 1 |
| Cheung, KS; Guo, CG; Jiang, F; Leung, WK | 1 |
| Ang, D; Ang, TL; Lim, KW; Tan, M; Wong, YJ; Yih Wong, AS | 1 |
| Cauchi, S; Debono, S; Gauci, J; Gerada, J | 1 |
| Chan, FKL; Lui, RN | 1 |
| Alcedo, J; Amador, J; Bujanda, L; Calvet, X; Castro-Fernández, M; Fernández-Salazar, L; Gené, E; Gisbert, JP; Lanas, Á; Lucendo, AJ; Molina-Infante, J; Nyssen, OP; Pérez-Aisa, A; Puig, I | 2 |
| Bunchorntavakul, C; Buranathawornsom, A | 1 |
| Bénéjat, L; Bessède, E; Blosse, A; Domingues-Martins, C; Ducournau, A; Lecoeur, M; Lehours, P; Mégraud, F | 1 |
| Akkus, S; Bahar-Tokman, H; Bal, K; Demirci, M; Demiryas, S; Ergin, S; Erzin, Y; Gareayaghi, N; Kocazeybek, B; Ozbey, D; Saribas, S; Tasci, I; Tufan-Kocak, B; Yuksel-Mayda, P; Ziver-Sarp, T | 1 |
| Horii, T; Ichijima, R; Ikehara, H; Kusano, C; Suzuki, S | 1 |
| Fujita, Y; Sugaya, T; Tanaka, T; Tominaga, K; Yoshihara, S | 1 |
| Arcidiacono, PG; Armuzzi, A; Bazzoli, F; Biagi, F; Cannizzaro, R; Cavestro, GM; Ciacci, C; Dajti, E; Frazzoni, L; Marasco, G; Monica, F; Peralta, S; Radaelli, F; Romano, M; Zagari, RM | 1 |
| Biswas, DP; Tk, DS | 1 |
| Askari, P; Ghazvini, K; Karbalaei, M; Keikha, M | 1 |
| Barrio Merino, A; Botija, G; Campelo Gutiérrez, C; García Rodríguez, C; Pérez-Fernández, E; Recio Linares, A | 1 |
| Chu, NS; Hsieh, MS; Hsu, PI; Kuo, CH; Kuo, FC; Liu, CJ; Tsai, PY; Wang, JW; Wu, DC; Wu, IC; Wu, JY; Wu, MC; Yu, FJ | 1 |
| Alizadeh-Tabari, S; Derakhshan, MH; Shokri-Shirvani, J; Zamani, M; Zamani, V | 1 |
| Almenoff, JS; Chey, WD; Howden, CW; Sheldon, KL | 1 |
| Bryant, RV; Costello, S; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS | 1 |
| Hu, M; Pang, X; Wang, L; Zhang, J | 1 |
| Cho, JH; Jin, SY; Park, S | 1 |
| He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X | 1 |
| Li, Y; Luan, Z; Ma, C; Shi, C; Yang, L; Zhang, W; Zhao, Y | 1 |
| Katelaris, P | 1 |
| Areia, M; Barrio, J; Beglinger, C; Bordin, D; Boyanova, L; Bujanda, L; Buzas, GM; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernandez, M; Doulberis, M; Fernandez-Salazar, L; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Jurecic, NB; Kunovský, L; Kupčinskas, J; Lamy, V; Lanas, A; Lasala, JP; Leja, M; Lerang, F; Lucendo, AJ; Marcos-Pinto, R; Marlicz, W; Megraud, F; Milivojevic, V; Molina-Infante, J; Morain, CO; Niv, Y; Nyssen, OP; Ortuño, J; Pérez Aísa, Á; Phull, P; Puig, I; Rodrigo, L; Rokkas, T; Sarsenbaeva, AS; Shvets, O; Simsek, I; Smith, S; Tepes, B; Tonkić, A; Vaira, D; Venerito, M; Vologzhanina, L; Voynovan, I | 1 |
| Aw, MM; Huang, JG; Lim, SYS; Quak, SH | 1 |
| Chen, M; Kuang, S; Lu, X; Shi, F; Xu, J; Zhang, Y | 1 |
| Ho, JWK; Lau, K; Leung, SY; Leung, WK; Tong, T; Wang, L; Yao, H | 1 |
| Adamski, R; Dworniczek, E; Krzyżek, P; Spiegel, M; Sroka, Z | 1 |
| Dai, W; Fu, R; Lou, D; Ma, Z; Wang, K | 1 |
| Graham, DY; Moss, SF | 1 |
| Dore, MP; Graham, DY; Lee, YC | 1 |
| Abd El-Fadeal, NM; Abdalla, MO; Kishk, RM; Nemr, N; Salem, A; Soliman, NM | 1 |
| Chen, H; Chen, J; Chen, M; Ding, Y; Huang, Z; Li, Y; Pang, R; Shang, Y; Wang, J; Wang, Z; Wu, Q; Xie, X; Xue, L; Yang, R; Zhang, J | 1 |
| Baik, GH; Bang, CS; Jang, HJ; Kae, SH; Kim, HY; Kim, J; Lee, SP; Lim, H; Seo, SI; Shin, WG; Yang, YJ | 1 |
| Benghezal, M; Hu, R; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X | 1 |
| Chua, D; Dang, LP; Graham, DY; Moss, SF; Sobrado, J; Zhou, Y | 1 |
| Arrua, EC; Hidalgo, A; Morales, JO; Quest, AFG; Sanchez, SV; Trincado, V | 1 |
| Fischbach, W; Malfertheiner, P; Schulz, C; Schütte, K; Sigal, M; Suerbaum, S | 1 |
| An, H; He, Y; Huang, T; Jiang, Z; Li, S; Lin, H; Yang, C; Yuan, J | 1 |
| Hayashi, S; Kamiya, S; Kato, M; Murakami, K; Ojima, H; Osaki, T; Rimbara, E; Sato, T; Shibayama, K; Sugiyama, T; Takeuchi, H; Tokunaga, K; Yokota, K; Yokota, SI; Yonezawa, H | 1 |
| Chou, YP; Chuah, SK; Huang, TH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Tai, WC; Wu, CK; Wu, KL; Yang, SC; Yao, CC | 1 |
| Chen, LL; Hu, SW; Li, WX; Xu, JJ; Ye, WM; Zhang, XR; Zhao, W | 1 |
| Bryant, RV; Costello, SP; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS; Woodman, RJ | 1 |
| Hubscher, E; Jacob, R; Pelletier, C; Shah, S; Vinals, L; Yadlapati, R | 1 |
| Continisio, A; D'Abramo, FS; Di Leo, A; Ierardi, E; Losurdo, G; Piazzolla, M; Pricci, M; Rima, R | 1 |
| Chiu, CT; Chong, CF; Chung, WC; Gu, L; Hou, X; Kudou, K; Meng, F; Sha, W; Wang, J; Zhang, S | 1 |
| Chen, J; Dai, H; Rong, C; Yan, C; Yang, W; Yu, L; Zhang, J | 1 |
| Gościniak, G; Grande, R; Krzyżek, P; Migdał, P | 1 |
| Cheung, KS; Guo, CG; Jiang, F; Law, SYK; Leung, WK; Li, B | 1 |
| Chen, J; Ding, Z; Huang, Y; Liang, X; Lu, H | 1 |
| Altman, E; Chandan, V; Gilbert, M; Goneau, MF; Harrison, BA; Li, J; Schur, M | 1 |
| Florholmen, JR; Goll, R; Halvorsen, FA; Johnsen, KM; Melby, KK; Moayeri, B; Nestegard, O; Paulssen, E; Sørbye, SW; Tønnesen, T | 1 |
| Bénéjat, L; Bessède, E; Bonnac, J; Ducournau, A; Giese, A; Lehours, P; Lescaudron, Z | 1 |
| An, Z; Kang, L; Li, J; Ru, C; Tian, L; Wang, L; Yao, Y; Yin, L | 1 |
| He, C; Hu, Y; Li, NS; Lu, NH; Ouyang, YB; Peng, C; Shu, X; Xie, C; Xie, Y; Xu, X; Zhu, Y; Zhu, ZH | 3 |
| Geng, T; Li, ZY; Liu, B; Yu, ZS; Zhang, HH; Zhou, XX | 1 |
| Daugule, I; Leja, M; Lielause, A; Park, JY; Paršutins, S; Poļaka, I; Rūdule, A; Sjomina, O; Stonāns, I; Vangravs, R | 1 |
| Blackstone, S; Farrar, E; Hauck, FR; Jensen, N; Saif, N | 1 |
| Li, J; Li, P; Ma, F; Wang, J; Wang, Y; Yang, R; Zhai, R | 1 |
| Abouwarda, AM; Abu El-Wafa, WM; Faraag, AHI; Ismail, TA | 1 |
| Cao, LJ; Cao, WL; Che, Y; Ding, CJ; Huang, H; Wang, Y; Wu, JW; Xu, WF; Zhang, Q | 1 |
| de Boer, MGJ; Kuijper, EJ; Molendijk, I; Schoffelen, AF; van den Brink, G; Veenendaal, RA; Woudt, SHS | 1 |
| Elfanagely, Y; Ho, JJC; Moss, SF; Navarro, M; Sawyer, K | 1 |
| Fujimoto, K; Kakiuchi, T; Matsuo, M; Okuda, M | 1 |
| Abd-Elsalam, SM; Bahaa, MM; Baiomy, N; Elnaggar, MH; Elsawy, AA; Gamal, RM; Habba, E; Salamah, AM; Shawky, D | 1 |
| Amiriani, T; Ghafourian, S; Khadiv, A; Kouhsari, E; Krutova, M; Sadeghifard, N; Sayadi, H; Valadbeigi, H | 1 |
| Ahmad, A; Alamri, AS; Basheeruddin Asdaq, SM; Di Cerbo, A; Farid, A; Ghazanfar, S; Israr, M; Khan, KA; Muzammal, M; Pugliese, N | 1 |
| Harada, Y; Hirata, K; Inokuchi, K; Kanai, T; Masaoka, T; Matsuzaki, J; Mori, H; Saito, Y; Suzuki, H | 1 |
| Bai, F; Bo, Y; Chen, X; Deng, Y; Hao, Q; Hu, S; Li, X; Liu, J; Sang, T; Tang, Y; Wang, J; Zhong, Z; Zhou, Y | 1 |
| Fu, Y; Liu, D; Wang, L; Wang, Y; Wu, S; Xie, Y | 1 |
| Ang, D; Ang, TL; Chan, YH; Koo, SH; Krishnasamy-Balasubramanian, JK; Kumar, R; Kwek, AB; Li, JW; Lin, KW; Ong, PJ; R, R; Soon, GH; Tan, CK; Tan, TY; Tan, Y; Tan, YJ; Wong, YJ | 1 |
| Chey, WD; Howden, CW; Hunt, BJ; Laine, L; López, LJ; Mégraud, F | 1 |
| Gao, HJ; Shen, W; Yan, XY; Zhang, WX; Zhong, LJ | 1 |
| Hu, Y; Lu, NH; Ouyang, Y; Wang, M; Xu, YL; Zhu, Y | 1 |
| Calado, CRC; Sousa Sampaio, PN | 1 |
| Karbalaei, M; Keikha, M; Talebi Bezmin Abadi, A | 1 |
| Luan, Z; Ma, C; Shi, C; Wang, Y; Zhao, Y | 1 |
| Buran, T; Gazi, H; Kurutepe, S; Sürücüoğlu, S | 1 |
| Fallone, CA | 2 |
| Baik, GH; Choi, YJ; Chun, HJ; Chung, H; Jang, JY; Jung, HK; Kim, BW; Kim, JH; Kim, JI; Kim, JM; Kim, KO; Kim, N; Kim, SG; Ko, KH; Lee, H; Lee, HL; Lee, YC; Lim, YJ; Moon, JS; Shim, KN; Son, BK | 1 |
| Mladenova, I | 1 |
| Jung, YS; Kim, HY; Kim, S; Noh, SJ; Park, CH; Park, JH | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Hadzhiyski, P; Kandilarov, N; Markovska, R | 1 |
| Lee, J | 1 |
| Ahn, JY; Choi, J; Choi, KD; Jung, HY; Jung, KW; Kim, DH; Kim, JM; Lee, GH; Lee, JH; Na, HK; Noh, JH; Park, YS; Song, HJ | 1 |
| Azevedo, OGR; Benigno, TGDS; Braga, LLBC; Maciel, FS; Oliveira, EL; Oliveira, RTG; Pinheiro, RF; Queiroz, DMM; Ribeiro Junior, HL | 1 |
| Cheng, H; Gao, W; Li, Y; Teng, G; Wang, C; Xu, Y | 1 |
| Hu, Y; Lu, NH | 1 |
| Ang, D | 1 |
| Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G | 1 |
| Gou, LZ; Han, TY; Li, XL; Lin, YM; Wang, C; Xu, HM; Yi, GR; Yu, Y; Yun, JW; Zhang, DK | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Wang, Z | 1 |
| Karbalaei, M; Keikha, M | 1 |
| Jang, JS; Jee, SR; Jung, K; Kim, GH; Kim, SJ; Koh, M; Lee, J; Lee, MW; Park, MI | 1 |
| Badre, W; Benomar, H; Bounder, G; Boura, H; Elyounsi, I; Essaidi, I; Jouimyi, RM; Kheir, FZ; Maachi, F; Zerouali, K | 1 |
| Bakshi, S; Banerjee, S; Chandra Karmakar, B; Chaudhuri, S; Chawla, M; Das, B; Kumar, S; Kumari Pragasam, A; Kumari, S; Mehrotra, T; Mukhopadyay, AK; Mutreja, A; Paul, S; Porey Karmakar, S; Purohit, A; Ramamurthy, T; Ray, A; Talukdar, D; Verma, J | 1 |
| Agay-Shay, K; Azrad, M; On, A; Paritski, M; Peretz, A; Rohana, H; Roshrosh, H; Vazana, D | 1 |
| Chan, MTV; Chen, H; Liu, X; Wu, WKK; Xie, C; Zeng, J; Zhang, L | 1 |
| Chen, CL; Chen, KY; Chuah, SK; Chuah, YY; Hsu, PI; Lee, CL; Liu, YH; Shie, CB; Shih, CA; Shiu, SI; Tsay, FW; Wu, DC; Yang, JC | 1 |
| Choe, Y; Kim, BW; Kim, JS; Kim, MJ; Na, SY | 1 |
| Chey, WD; Graham, DY; Howden, CW; Hunt, B; Leifke, E; Mégraud, F; Smith, N; Trevino, E; Weissfeld, A | 1 |
| Bai, G; Du, H; Yi, J; Yu, Y | 1 |
| Abdalshafy, H; Abdelazeem, B; Abuelazm, M; Ahmed, AAS; Brašić, JR; Mahmoud, A | 1 |
| Higashino, M; Itoh, F; Kato, M; Kubo, K; Oikawa, R; Tsuda, M; Watanabe, R; Watanabe, Y; Yamamoto, H | 1 |
| Hu, C; Jiang, M; Li, H; Peng, K; Shu, X; Ye, D; Zhao, H | 1 |
| Esmaeili, S; Maghami, AA; Mobarez, AM; Nikkhah, M; Sadeghi, A; Yadegar, A | 1 |
| Iakovenko, AV; Ivanov, AN; Soluyanova, IP; Strokova, TV; Vasilyev, NN; Yakovenko, EP | 1 |
| Celiberto, F; D'attoma, B; De Bellis, M; Di Leo, A; Iannone, A; Ierardi, E; Losurdo, G; Pricci, M; Rendina, M; Riezzo, G; Russo, F | 1 |
| Barrio, J; Bontems, P; Cabral, J; Cilleruelo Pascual, ML; Homan, M; Kalach, N; Koletzko, S; Kori, M; Kotilea, K; Le Thi, TG; Lima, R; Misak, Z; Tavares, M; Urbonas, V; Urruzuno, P; Werkstetter, K | 1 |
| Avery, A; Coupland, CAC; Crooks, C; Dumbleton, J; Hawkey, C; Hobbs, FDR; Kendrick, D; Moore, M; Morris, C; Rubin, G; Smith, M; Stevenson, D | 1 |
| Kountouras, J | 2 |
| Fan, J; Han, Y; Liu, J; Meng, F; Sun, BB; Tao, H; Wang, G; Zhou, Y | 1 |
| Kim, GH; Lee, MW | 1 |
| He, XJ; Huang, XY; Li, DL; Li, DZ; Liu, G; Wang, W; Wang, XL | 1 |
| Bontems, P; Burette, A; Delhaye, M; Gossum, MV; Kahegeshe, NL; Kotilea, K; Louis, H; Miendje Deyi, VY; Nkuize, M; Ntounda, R | 1 |
| Choi, SI; Jang, JY; Kim, N; Lee, DH; Lee, JW; Nam, RH; Song, CH | 1 |
| Jung, YS; Kim, HY; Kim, S; Noh, SJ; Park, CH; Park, JH; Sohn, CI | 1 |
| Chen, J; Ding, S; Li, T; Liu, Y; Shao, F; Wang, L; Xie, L; Zhang, Z; Zhou, C; Zhou, S; Zhu, B; Zhu, J | 1 |
| Hu, W; Sun, Y; Yue, L | 1 |
| Endo, H; Esaki, M; Fujimoto, K; Fujioka, Y; Fukuda, K; Hanada, K; Hashiguchi, K; Imamura, I; Kajiwara, T; Kakiuchi, T; Kawakubo, H; Matsunaga, K; Matsunaga, T; Matsuo, M; Muro, E; Noda, T; Ogata, S; Sakata, Y; Sumino, M; Watanabe, A; Yamaguchi, D; Yamamoto, K; Yoshimura, M | 1 |
| Borraccino, AV; Celiberto, F; Di Leo, A; Girardi, B; Iannone, A; Ierardi, E; Losurdo, G; Pricci, M; Rendina, M | 1 |
| Bair, MJ; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chiu, MC; Chou, CK; El-Omar, EM; Fang, YJ; Hsu, YC; Hu, WH; Jiang, XT; Kuo, CC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tsai, MH; Tseng, CH; Wu, MS; Yang, TH; Yu, CC | 1 |
| Abraham, P; Desai, D; Dhoble, P; Doctor, S; Gupta, T; Joshi, A | 1 |
| Cummings, LC; Hojat, LS; Nguyen, DC; Rhoads, DD; Sadri, N; Stempak, LM | 1 |
| Córdova, A; Núñez, P; Quera, R; von Muhlenbrock, C | 1 |
| Graham, DY; Rokkas, T | 2 |
| Adachi, K; Ebi, M; Funaki, Y; Izawa, S; Kasugai, K; Kato, S; Koshino, A; Nagao, K; Ogasawara, N; Ohashi, W; Sasaki, M; Sugiyama, T; Yamaguchi, Y; Yoshimine, T | 1 |
| Gotoda, T; Ishibashi, F; Suzuki, S | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Kandilarov, N; Markovska, R; Yordanov, D | 1 |
| Niu, Z; Ren, X; Song, Z; Suo, B; Tian, X; Xue, Y; Zhou, L | 1 |
| Cheng, H; Dong, J; Dong, X; Gao, W; Ge, C; Liu, B; Liu, J; Teng, G; Wang, X; Xu, Y; Ye, H; Zhang, X | 1 |
| Braendli, T; Braun, DL; Hente, JM; Murray, FR; Pohl, D; Schindler, V | 1 |
| Ellakany, WI; Ghazy, RM; Ismail, A; Kamal, A; Sherief, D | 1 |
| Hoang, VT; Tran, TNQ; Tran, TQA; Vu, DL; Vu, TB | 1 |
| Liu, L; Nahata, MC | 1 |
| Love, BL; Yunusa, I | 1 |
| Bonafede, M; Cappell, K; Jacob, R; Pelletier, C; Sedgley, R; Shah, S; Yadlapati, R | 1 |
| Chen, JN; Ding, ZH; Huang, Y; Liang, X; Lu, H; Luo, LS; Zhang, W | 1 |
| Ayaş, M; Gürol, Y | 1 |
| Graham, DY; He, C; Hu, Y; Li, NS; Liu, XS; Lu, NH; Ouyang, YB; Peng, C; Shu, X; Xie, C; Xie, Y; Xu, X; Zhu, Y; Zhu, ZH | 1 |
| Dang, YN; Gao, X; Li, LR; Li, WJ; Li, X; Qian, HS; Xu, XB; Yang, Z; Yuan, L; Zhang, GX; Zhang, M; Zhang, WF | 1 |
| Dong, RN; Feng, LN; Guan, JL; Han, YY; Li, JY; Li, PY; Liao, JZ; Wang, MR; Xia, SH; Zhang, MY; Zhang, Y; Zhao, K | 1 |
| Kakiuchi, T | 1 |
| Akyön, Y; Örsten, S; Yılmaz, E | 1 |
| Alfaro Almajano, E; Ariño-Pérez, I; Carrera-Lasfuentes, P; Lanas, Á; Martínez-Domínguez, SJ | 1 |
| Li, C; Lu, H; Ren, X; Shi, Y; Song, Z; Suo, B; Tian, X; Yao, X; Zhang, Y; Zhou, L | 1 |
| Ishibashi, F; Mochida, K; Morishita, T; Nagai, M; Suzuki, S | 1 |
| Graham, DY | 4 |
| Bonilla, S; Bousvaros, A; Dannheim, K; Herzlinger, M; Liu, E; Riaz, M | 1 |
| Antunes, R; Lopes, AI; Nogueira, JP; Oleastro, M | 1 |
| Beets, C; Boussageon, R; Collin, A; Jaafari, N; Kefleyesus, A; Mion, F | 1 |
| Bénéjat, L; Bessède, E; Ducournau, A; Lehours, P; Martins, CD | 1 |
| Ding, YM; Duan, M; Han, ZX; Kong, QZ; Li, YQ; Li, YY; Lin, BS; Lin, MJ; Liu, J; Mu, YJ; Wan, M; Wang, J; Wang, ST; Zhang, WL; Zuo, XL | 1 |
| Chen, C; Cheung, KS; Deng, Z; Leung, WK; Lyu, T; Ni, L; Seto, WK; Wu, J | 1 |
| Kim, SJ; Kwon, YM; Lee, JG; Lee, SP | 1 |
| Ding, YM; Han, ZX; Ji, R; Li, YY; Lin, BS; Zhang, WL | 1 |
| Kajihara, Y | 1 |
| Azimi, T; Hashemian, M; Heidarizadeh, H; Heidary, M; Karamollahi, S; Kaviar, VH; Khoshnood, S; Mohamadi, J; Sadeghifard, N; Saki, M; Sholeh, M | 1 |
| Bo, Y; Cao, Y; Cao, Z; Chen, X; Cui, T; Deng, Y; Fu, L; Gao, H; Gao, R; Guo, J; Hao, Q; Hou, Z; Hu, J; Hu, S; Jin, L; Li, F; Li, H; Li, X; Li, Y; Liu, J; Ma, B; Ma, L; Ma, S; Ma, Z; Mu, R; Niu, M; Qi, H; Shi, R; Su, X; Tang, N; Tang, Y; Wang, P; Wang, X; Xin, R; Yang, B; Yang, W; Yao, L; Yong, H; You, Y; Yu, X; Yu, Y; Zhang, X; Zhao, W; Zhou, Y | 1 |
| Chua, EG; Gao, X; Han, X; Lai, B; Marshall, BJ; Tay, CY; Wang, X; Wei, X; Yu, X; Zhang, X | 1 |
| Ai, Q; Chen, Y; Hu, L; Li, GQ; Liu, C; Liu, L; Zeng, X; Zhang, X | 1 |
| Lin, Y; Shao, Y; Yan, J; Ye, G | 1 |
| Düzenli, T; Kaya, M; Köseoğlu, H; Sezikli, M | 1 |
| Huang, J; Lin, Y | 1 |
| Chen, HW; Liu, JJ; Lu, Y; Peng, X; Su, PZ; Wan, Y; Yao, JY; Yu, J; Zhang, M; Zhi, M | 1 |
| Feuerstein, JD; Flynn, DJ | 1 |
| Fan, LL; Guo, Y; He, P; Hu, J; Lan, CH; Liu, YX; Mei, H; Pan, J; Su, NY; Sun, WJ; Wang, XW; Zhang, DK; Zou, PY | 1 |
| Bair, MJ; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chiu, MC; Chou, CK; El-Omar, EM; Fang, YJ; Hsu, YC; Hu, WH; Kuo, CC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tsai, MH; Wu, MS; Yang, TH; Yu, CC | 1 |
| Chen, M; Dong, Y; Gong, Y; Li, Y; Sun, J; Wang, Y | 1 |
| Koliada, AK; Kovalova, AV; Nikulina, LM; Solovyova, GA; Svintsitskyi, IA | 1 |
| Cheung, DY; Kim, BW; Kim, I; Kim, JI; Kim, JS; Maeng, LS; Park, SH | 1 |
| Babic, I; Gisbert, J; Kekic, D; Krstic, M; Mégraud, F; Milivojevic, V; Milosavljevic, T; Moreira, L; Nyssen, OP; O' Morain, C; Panic, N; Rankovic, I; Sagdati, S; Spasic, IS | 1 |
| Abdallah, H; Abdel-Samiee, M; Abdelfattah, A; Abdelsameea, E; Ansari, S; Asaad, AM; Awad, SM; El-Azab, G; El-Refaie, A; Elbahr, O; Ghanem, SE; Kamal, A; Maher, D | 1 |
| Bodunova, N; Bordin, D; Dekhnich, N; Khatkov, I; Medakina, I; Nikolaev, S; Polyakova, V; Tsapkova, L; Yanova, T | 1 |
| Ding, YM; Li, YY | 1 |
| Chen, J; Du, J; Fu, K; Jin, C; Mei, T; Pang, T; Qian, Q; Wang, Y; Wang, Z; Zhang, D | 1 |
| Feng, Q; Lang, C; Liu, L; Lu, K; Mu, Y; Sang, W; Xu, C; Zang, L; Zhao, J; Zou, X | 1 |
| Botão, E; Carrilho, C; Cumbana, R; Ismail, M; Loforte, M; Majaliwa, ND; Mondlane, L; Muchongo, A; Nassone, E; Sacarlal, J; Sumbana, JJ; Taviani, E; Vale, FF; Vítor, JMB | 1 |
| Cerezo, C; Herzlinger, M; Moss, SF; Riaz, MS; Shapiro, JM | 1 |
| Bae, HJ; Jeon, SW; Kwon, YH; Lee, DW; Nam, SY; Park, JH | 1 |
| Bontems, P; Iliadis, E; Kotilea, K; Mahler, T; Miendje Deyi, VY; Nguyen, J; Salame, A | 1 |
| Alavifard, H; Baghaei, K; Nabavi-Rad, A; Sadeghi, A; Yadegar, A; Zali, MR | 1 |
| Chan, P; Cheung, K; Deng, Z; Han, S; Li, K; Li, Y; Luo, X; Lyu, T; Ni, L | 1 |
| Bujanda, L; Cilla, G; Gómez-Ruiz de Arbulo, M; Mendibil, L; Mendiola, J; Montes, M; Tamayo, E | 1 |
| Abdi, M; Hashemian, M; Heidarizadeh, H; Heidary, M; Karamollahi, S; Kaviar, VH; Khoshnood, S; Maleki, A; Moradi, M; Pakzad, R; Sadeghifard, N | 1 |
| Baltzis, D; Blemur, L; Le-Tien, C | 1 |
| Chen, Q; Chen, Y; Huang, X; Ji, X; Lin, Z; Suo, B; Wu, B; Zheng, X; Zhou, X | 1 |
| Chen, S; Dong, Q; Liu, Y; Shen, W; Shi, Y | 1 |
| Couturier, MR; Shakir, FA; Shakir, SM | 1 |
| Du, Q; Li, Y; Liao, O; Liu, X; Lou, G; Wang, Y; Wu, H; Wu, Y; Ye, J | 1 |
| Li, M; Li, R; Li, T; Liang, N; Shao, F; Sun, J; Wang, G; Zhang, Z; Zhao, T; Zhou, S | 1 |
| Bontems, P; Che, TH; Le, GKN; Nguyen, HT; Nguyen, LTH; Nguyen, PNV; Nguyen, TC; Pham, BV; Pham, DTH; Robert, A; Truong, DQ | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Yang, T | 1 |
| Cheung, KS; Leung, WK; Ng, HY | 1 |
| Du, RC; Hu, Y; Lu, NH; Ouyang, YB | 1 |
| Bonilla, S; Bousvaros, A; Goldsmith, J; Mitchell, P | 1 |
| Guo, Y; Hu, J; Lan, CH; Liu, HN; Liu, HQ; Liu, YX; Mei, H; Shi, Q; Su, NY; Wang, XW | 1 |
| Cui, XX; Gu, B; Lai, JX; Li, GH; Li, ZK; Marshall, BJ; Ru, XJ; Si, YT; Tay, ACY; Umar, Z; Wang, L; Zhang, XY | 1 |
| Abay, S; Akar, M; Anuk, T; Aydin, F; Buyuk, F; Celebi, O; Karakaya, E; Kayman, T; Otlu, S; Ozcan, HE; Saticioglu, IB; Tarhane, S | 1 |
| Cao, M; Chen, Q; He, Z; Huang, M; Qing, L; Wu, C; Yan, X; Yu, Z; Zhang, X; Zhao, J; Zhao, Q | 1 |
| Ang, TL; Aye, TT; Basir, DN; Lee, YY; Luu, MN; Mahachai, V; Miftahussurur, M; Quach, DT; Sollano, JD; Vannarath, S; Vilaichone, RK; Vutha, K | 1 |
| Bucki, R; Daniluk, T; Daniluk, U; Kucharska, M; Lebensztejn, DM; Zdanowicz, K | 1 |
| Bryant, RV; Costello, SP; Ingram, PR; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS | 1 |
| Eiamsitrakoon, T; Graham, DY; Mahachai, V; Ratana-Amornpin, S; Sanglutong, L; Siramolpiwat, S | 1 |
| Bendary, MM; El-Batal, AI; Elshimy, R; Mosallam, FM | 1 |
| Chen, J; Chen, Y; Ding, XW; Han, YY; Hu, YL; Li, PY; Li, SL; Lin, Y; Liu, F; Long, H; Su, CX; Wang, QY; Xu, M; Zhang, ZY; Zhou, L | 1 |
| Dai, X; Qin, L; Yang, F; Yu, B | 1 |
| Dadić, B; Dželalija, M; Kalinić, H; Maravić, A; Šamanić, I; Sanader Maršić, Ž; Šundov, Ž; Tonkić, A; Tonkić, M; Vrebalov Cindro, P; Vuković, J | 1 |
| Cho, KB; Jung, HR; Kim, SW; Lee, JW; Lee, JY; Lee, YJ; Park, M | 1 |
| Bruno, MJ; Fuhler, GM; Kuipers, EJ; Mommersteeg, MC; Nieuwenburg, SAV; Peppelenbosch, MP; Roovers, BHCM; Spaander, MCW; van Vuuren, HAJ; Verhaar, AP; Wolters, LMM | 1 |
| Lee, TH; Liao, PC; Lin, CK; Lin, CL | 1 |
| Atherton, J; Bakshi, N; Garvey, E; Letley, D; Mahmood, F; Rhead, J; Robinson, K; Suffian, S; Whiley, D; White, J; Winter, JA | 1 |
| Berdinstein, R; Melzer, E; Shmuely, H; Shvartsman, Y; Yahav, J | 1 |
| Abd-Elhafeez, HH; Mohamed, HMA; Mubarak, AG | 1 |
| Aumpan, N; Graham, D; Issariyakulkarn, N; Mahachai, V; Vilaichone, RK; Yamaoka, Y | 1 |
| Cerqueira, R | 1 |
| Dohi, O; Hara, T; Inada, Y; Inoue, K; Itoh, Y; Iwai, N; Kagawa, K; Komaki, T; Konishi, H; Naito, Y; Oka, K; Okuda, T; Tsuji, T | 1 |
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Furuta, T; Hamaya, Y; Higuchi, T; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Tani, S; Umemura, K; Uotani, T; Yamade, M | 1 |
| Fernández Salazar, L; Valle Muñoz, J | 1 |
| Huang, K; Lu, Z; Peng, L; Sun, G; Wang, Z; Wu, L; Yan, B; Yang, Y | 1 |
| Baik, GH; Choi, IJ; Jeon, SW; Kim, BJ; Kim, GH; Kim, HS; Kim, HU; Kim, J; Kim, JG; Kim, JI; Kim, JJ; Kim, SG; Kim, SW; Lee, DH; Lee, H; Lee, J; Lee, JY; Lee, YC; Park, MI; Sung, JK; Yoon, SM | 1 |
| In Choi, S; Kim, N; Lee, DH; Lee, JW; Lee, JY; Nam, RH | 1 |
| Jha, P; Jha, SK; Mishra, MK; Purkayastha, S; Ranjan, R; Saharawat, K | 1 |
| Castaño, R; Navas, MC; Roldán, IJ | 1 |
| Arévalo, A; Otero, WA; Trespalacios, AA | 1 |
| Fan, X; Sun, YJ; Wang, JT; Xian, HP; Xue, Q; Zhao, XT | 1 |
| Liu, W; Liu, Y; Wang, X; Wang, Y; Zhu, J | 1 |
| Bair, MJ; Chang, CM; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; Chuang, EY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Lu, TP; Luo, JC; Wu, JY; Wu, MS; Yang, TH | 1 |
| Desai, T; Edhi, AI; Hakim, S | 1 |
| Frossard, JL; Gressot, P; Grosgurin, O; Marti, C | 1 |
| Alebouyeh, M; Amirmozafari, N; Bayati, S; Ebrahimi Daryani, N; Talebi, M; Zali, MR | 1 |
| Bossuyt, P; Bourgain, C; Carton, S; Christiaens, P; Cuyle, PJ; Frans, J; Gils, S; Micalessi, I; Moons, V; Smismans, A; Van den Poel, B; Van Olmen, G | 1 |
| Bair, MJ; Chen, CL; Chen, HH; Chia, SL; Chiang, TH; Chu, CH; Chuang, SL; Chung Lo, YT; Jou, YY; Lee, YC; Lei, WY; Lin, CC; Su, WW; Tian, HW; Wang, YW; Wu, CY; Wu, MS | 1 |
| Bergonzi, M; Corazza, GR; Di Sabatino, A; Di Stefano, M; Figura, N; Pagani, E; Pesatori, EV | 1 |
| Apostolopoulos, P; Doulberis, M; Galanopoulos, M; Georgopoulos, SD; Giakoumis, M; Katsinelos, P; Kountouras, J; Kyriakos, N; Liatsos, C; Papadomichelakis, M; Papaefthymiou, A; Rokkas, T | 1 |
| Buzás, GM; Fassan, M; Hritz, I; Kiss, A; Kocsmár, É; Kocsmár, I; Lotz, G; Rugge, M; Schaff, Z; Szirtes, I; Takáts, A; Wacha, J | 1 |
| Broutin, L; Burucoa, C; Cremniter, J; Faure, JP; Olivier, R; Pichon, M; Plouzeau, C; Touroult-Jupin, P | 1 |
| Engidawork, E; Gebeyehu, E; Nigatu, D | 2 |
| Aung, NM; Cooper, D; Danta, M; Hanson, J; Kyi, MM; Myint, NPST; Sain, K; Waiyan, S; Zaw, TT | 1 |
| Adachi, K; Ebi, M; Funaki, Y; Hijikata, Y; Izawa, S; Kasugai, K; Ogasawara, N; Sasaki, M; Shinmura, T; Yamaguchi, Y | 1 |
| Chang, YW; Cho, JH; Jang, JY; Kim, JW; Oh, CH; Oh, SJ; Park, YM | 1 |
| Beckman, E; Clines, N | 1 |
| Pellicano, R | 1 |
| Li, CL; Song, ZQ; Suo, BJ; Tian, XL | 1 |
| Ang, D; Ang, TL | 1 |
| Deretzi, G; Doulberis, M; Katsinelos, P; Kazakos, E; Koffas, A; Kountouras, J; Liatsos, C; Papaefthymiou, A; Polyzos, SA; Srivastava, DS | 1 |
| Arenas, A; Camargo, MC; Echeverría, A; Fuentes-López, E; Harris, P; Jorquera, A; Lavanderos, M; Maquilón, S; Pizarro, M; Quiñones, L; Ríos, C; Riquelme, A; Rojas, L; Sandoval, M; Sepúlveda, R; Serrano, C | 1 |
| Ezzat, SE; Farhoud, NS; Ibrahim, OM | 1 |
| Jin, Z; Li, Y; Lin, D; Lin, L; Meng, F; Pan, J; Shi, Z; Wu, J; Yang, N; Zhang, J; Zhou, Q | 1 |
| Asahina, A; Kikuchi, S; Nobeyama, Y; Saeki, H | 1 |
| Hayashi, Y; Kobayashi, Y; Lefor, AK; Osawa, H; Sakamoto, H; Shinozaki, S; Yamamoto, H | 1 |
| Chu, A; Gong, Y; Guo, Q; Lv, Z; Wang, D; Yuan, Y | 1 |
| Mayderry, DW | 1 |
| Bie, S; Botchway, BOA; Chen, B; Fang, M; Gu, H; Jiang, M; Li, F; Peng, K; Shu, X; Yin, G; Zhao, H; Zheng, W | 1 |
| Bernardino, JI; Martín Carbonero, L; Montejano, R; Moreno, V; Serrano, L; Valencia, ME | 1 |
| Chen, WC; Chen, YH; Hsu, PI; Kao, SS; Lin, TF; Peng, NJ; Tsai, KW; Tsai, TJ; Tsay, FW; Wu, DC | 1 |
| Chowdhary, TS; Gayam, S; Shah-Khan, SM | 1 |
| Huang, Y; Jiang, Y; Tang, Z; Wang, Y; Yan, W; Ye, Z; Zhang, Y; Zhou, Y | 1 |
| Jeon, SW; Kwon, YH; Lee, HS; Lee, SW; Nam, SY | 1 |
| Choi, IJ; Joo, J; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Park, B | 1 |
| Alexandrakis, G; Apostolopoulos, P; Chounta, E; Ekmektzoglou, K; Georgopoulos, S; Kalantzis, C; Theofanopoulou, A; Tsibouris, P; Vlachou, E | 1 |
| Marques, AT; Oleastro, M; Santos, A; Vale, FF; Vítor, JMB | 1 |
| Beheshtirouy, S; Eyvazi, S; Tarhriz, V | 1 |
| Chen, YH; Hsu, PI; Kao, JY; Kao, SS; Kuo, CH; Peng, NJ; Shie, CB; Tsai, KW; Tsai, TJ; Tsay, FW; Wang, HM; Wu, DC | 1 |
| Cogdill, AG; Guevara, B | 1 |
| Alcaide, N; Areia, M; Ariño, I; Axon, T; Barrio, J; Bordin, D; Boyanova, L; Brglez Jurecic, N; Bujanda, L; Buzas, G; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernández, M; Dominguez-Cajal, M; Garre, A; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Kunovský, L; Kupcinskas, L; Lamy, V; Leja, M; Lerang, F; Lucendo, A; Marcos Pinto, R; María Botargues Bote, J; Mégraud, F; Milosavljevic, T; Modolell, I; Niv, Y; Nyssen, OP; O'Morain, C; Ortuño, J; Pérez Lasala, J; Pérez-Aisa, Á; Perona, M; Phull, P; Przytulski, K; Rodrigo-Sáez, L; Rokkas, T; Romero, PM; Shvets, O; Simsek, I; Tepes, B; Tonkic, A; Venerito, M; Voynovan, I | 1 |
| Alexandrescu, L; Așchie, M; Brînzan, C; Cozaru, GC; Dumitru, E; Dumitru, IM; Hanu, AC; Mitroi, AF; Tocia, C | 1 |
| Fujioka, Y; Hashiguchi, K; Imamura, I; Kakiuchi, T; Kawakubo, H; Matsuo, M; Mizoe, A; Nakayama, A; Okuda, M; Yamaguchi, D; Yamamoto, K | 1 |
| Florez Bracho, L; Lasa, JS; Paz, S; Zubiaurre, I | 1 |
| Jukic, I; Modun, D; Rusic, D; Vukovic, J | 1 |
| Avallone, L; Bazzoli, F; Compare, D; Dallio, M; Federico, A; Granata, L; Gravina, AG; Loguercio, C; Martorano, M; Miranda, A; Mucherino, C; Nardone, G; Priadko, K; Romano, L; Romano, M; Romiti, A; Romito, MR; Sgambato, D; Tuccillo, C; Zagari, RM | 1 |
| Akbaş, T; Şenocak Taşçı, E | 1 |
| Ando, T; Handa, O; Horie, R; Imamoto, E; Itoh, Y; Murakami, T; Ose, T; Sendo, R; Suzuki, N | 1 |
| Alshareef, A; Bach Dat, B; Duc, NT; Nam, NH; Ngoc, NM; Nguyen, JG; Reda, A; Thieu, H; Tien Huy, N | 1 |
| Aumpan, N; Mahachai, V; Ratanachu-Ek, T; Tshering, L; Uchida, T; Vilaichone, RK; Yamaoka, Y | 1 |
| Byun, JM; Cho, SJ; Chung, H; Hong, J; Kim, I; Kim, SG; Koh, Y; Lee, A | 1 |
| Jeon, H; Kang, SC; Kim, BY; Kim, SE; Lee, WK; Memon, A | 1 |
| Bontems, P; Cabral, J; Casswall, T; Chong, S; Cilleruelo Pascual, ML; Cseh, Á; Dolinsek, J; Homan, M; Iwanczak, B; Kalach, N; Kindermann, A; Koletzko, S; Kori, M; Le Thi, TG; Lopes, AI; Martinez Gomez, MJ; Miele, E; Misak, Z; Oleastro, M; Papadopoulou, A; Pehlivanoglu, E; Rea, F; Rogalidou, M; Roma, E; Sustmann, A; Urbonas, V; Urruzuno, P; Werkstetter, K | 1 |
| Beer, A; Gruber, S; Hader, M; Hirschl, AM; Hudler, H; Hudler, S; Kain, R; Kundi, M; Makristathis, A; Schachner, H; Täuber, V | 1 |
| Dang, NQH; Ha, TMT; Le, NDK; Nguyen, ST; Nguyen, TH; Nguyen, TMT; Pham, TTH; Tran, VH | 1 |
| Bordin, DS; Embutnieks, YV; Megraud, F; Nyssen, OP; O Morain, C; Perez-Gisbert, J; Voynovan, IN | 1 |
| Andreev, DN; Bakulin, IG; Bakulina, NV; Il'chishina, TA; Maev, IV; Murzina, AA; Savilova, IV; Zagorodnikova, KA | 1 |
| Chang, ML; Chang, PY; Cheng, HT; Chiu, CT; Hsieh, SY; Hsu, JT; Kuo, CJ; Lai, CH; Le, PH; Lin, CJ; Lin, CY; Lin, WR; Su, MY; Tseng, CN | 1 |
| Huang, Y; Lu, J; Lu, X; Miao, S; Sun, H; Wang, Y; Wu, J; Ye, Z; Zhou, Y | 1 |
| Fujimura, S; Gold, BD; Ida, S; Ishige, T; Kamiya, S; Kato, S; Konno, M; Kuwabara, K; Nakayama, Y; Shimizu, T; Toyoda, S; Ushijima, K; Yoshimura, N | 1 |
| Gotoda, T; Horii, T; Ichijima, R; Ikehara, H; Kusano, C; Suzuki, S | 1 |
| Chen, H; Chua, EG; He, Y; Huang, H; Li, X; Liu, A; Marshall, BJ; Tay, CY; Wang, X; Wise, MJ; Young, S; Zhang, S | 1 |
| Abdellahi, MVM; Amar, AM; Billoet, A; Collobert, G; Dauga, C; Gastli, N; Horma, MA; Houmeida, A; Khiddi, F; Nech, HDM; Raymond, J; Vadel, EHM | 1 |
| Calvo, PL; Cisarò, F; Pizzol, A | 1 |
| Bazzoli, F; Frazzoni, L; Fuccio, L; Marasco, G; Zagari, RM | 1 |
| Chang, JV; Goh, KL; Hwong-Ruey Leow, A | 1 |
| Fridmanis, D; Gorskis, H; Gudra, D; Leja, M; Pupola, D; Radovica-Spalvina, I; Skenders, G; Vangravs, R | 1 |
| Cheung, KS; Guo, H; Guo, J; Leung, WK; Li, Y; Lyu, T; Lyu, Z; Mu, P; Ni, L; Seto, WK; Wu, J; Yang, Q; Yu, X | 1 |
| Hu, FL | 1 |
| Yang, GB | 1 |
| Attaran, B; Eshagh Hosseini, M; Esmaeili, M; Ghadiri, B; Mohammadi, M; Salehi, N; Shakaram, M; Tashakoripour, M; Zare-Mirakabad, F | 1 |
| Abbas, Z; Asim, M; Baqai, K; Laique, N; Samejo, SA | 1 |
| Hu, JN; Ji, CR; Ji, R; Li, LX; Li, YQ; Li, YY; Lin, MJ; Liu, J; Qiao, C; Qu, JY; Zuo, XL | 1 |
| Andersen, LP; Clausen, PTLC; Hasman, H; Imkamp, F; Wagner, K; Yusibova, M | 1 |
| Argueta, EA; Moss, SF | 2 |
| Josette, R; Kalach, N | 1 |
| Chang, YL; Hsu, PI; Kim, SE; Liou, WS; Shiu, SI; Tu, YK; Tung, YC; Wu, MF; Yang, JC; Yeh, HZ | 1 |
| Han, S; Jeon, HS; Kim, S; Park, CG | 1 |
| Graham, DY; Lu, H; Shiotani, A | 1 |
| Kang, JK; Kim, JH; Lee, GH; Lee, KM; Lim, SG; Noh, CK; Shin, SJ | 1 |
| Chen, D; Gao, JG; Lu, C; Wang, JH; Xu, CF; Yan, TL | 1 |
| Jr, JM | 1 |
| Akiyama, J; Cho, H; Hisada, Y; Iwata, E; Kawazoe, M; Kimura, K; Kobayakawa, M; Komori, S; Mishima, S; Nagata, N; Okahara, K; Okubo, H; Shimada, T; Shimomura, A; Shiroma, S; Takasaki, Y; Uemura, N; Watanabe, K; Yanagisawa, N; Yokoi, C | 1 |
| Hu, F; Liu, Y; Teng, G; Wang, H; Wang, W; Wu, T | 1 |
| Arslan, M; Balamtekin, N; Günal, A | 1 |
| Elhendawy, M; Hagras, MM; Shaker, ESE; Soliman, SS | 1 |
| Jung, SH; Kim, SH; Kim, SM; Lee, DS; Lee, SW; Moon, SJ; Song, KH; Sung, JK | 1 |
| Pan, L; Tang, G; Tang, Y; Wei, Z; Zhou, S; Zhu, H | 1 |
| Boltin, D; Cohen, AD; Dotan, I; Feldhamer, I; Leibovici-Weissman, Y; Leibovitzh, H; Levi, Z; Niv, Y; Shochat, T; Snir, Y; Vilkin, A | 1 |
| Mukhopadhyay, AK; Nandi, SP; Saxena, A | 1 |
| Chen, Y; Hu, F; Liu, Q; Ma, J | 1 |
| Niu, Z; Song, Z; Suo, B; Tian, X; Xue, Y; Zhou, L | 1 |
| Jagusztyn-Krynicka, EK; Roszczenko-Jasińska, P; Wojtyś, MI | 1 |
| Behrendt, J; Bluemel, B; Eisele, B; Franz, A; Glocker, EO; Hofreuter, D; Jansen, A; Koken, M; Meyer, J | 1 |
| Berdinstein, R; Melzer, E; Shmuely, H; Topaz, S; Yahav, J | 1 |
| Aoyagi, Y; Arai, N; Hosoi, K; Ikuse, T; Jimbo, K; Kudo, T; Kyodo, R; Miyata, E; Ohtsuka, Y; Oka, I; Sato, M; Shimizu, T; Tokita, K | 1 |
| Alix, C; Bénéjat, L; Bessède, E; Charron, P; Ducournau, A; Lehours, P; Mégraud, F | 1 |
| Cho, SJ; Choi, J; Chung, H; Chung, SJ; Kim, JL; Kim, SG; Lee, A | 1 |
| Brglez Jurecic, N; Espada Sanchez, M; Gisbert, J; Mégraud, F; O'Morain, C; Perez Nyssen, O; Tepes, B; Tepes, K | 1 |
| Ahn, JY; Choi, KD; Gong, EJ; Jung, HY; Jung, KW; Kim, DH; Lee, GH; Lee, JH; Na, HK; Pih, GY; Song, HJ | 1 |
| Dhar, SK; Ghosh, A; Karmakar, BC; Kaur, I; Kumar, R; Mukhopadhyay, AK; Paul, S; Tehlan, A | 1 |
| Georgopoulos, S; Papastergiou, V | 1 |
| Bryant, RV; Costello, S; Gehlert, J; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP | 1 |
| Hashiguchi, K; Imamura, I; Kakiuchi, T; Matsuo, M; Nakayama, A; Okuda, M; Takamori, A | 1 |
| Alavifard, H; Baghaei, K; Mirzaei, N; Sadeghi, A; Smith, SM; Yadegar, A; Zali, MR | 1 |
| Andreev, DN; Dzhedzheia, LV; Fomenko, AK; Govorun, VM; Ilina, EN; Kirillova, NV; Kriukov, KA; Kucheryavyy, YA; Lobanova, EG; Maev, IV; Maevskaya, EA; Melnikova, EV; Oganesian, TS; Parfenova, TV; Zaborovskii, AV; Zayratyants, OV | 1 |
| Abdulkhakov, RA; Abdulkhakov, SR; Bordin, DS; Gimadieva, LZ; Gizdatullina, AR; Maturina, AM; Megraud, F; Nyssen, OP; O'Morain, C; Perez-Gisbert, J; Safina, DD; Safina, GM; Ziyatdinov, AI | 1 |
| Arj, A; Gilassi, H; Madani, M; Razavizadeh, M | 1 |
| Bozic, J; Bukic, J; Jukic, I; Leskur, D; Modun, D; Rusic, D; Seselja Perisin, A; Vukovic, J | 1 |
| Akashi, T; Endo, H; Esaki, M; Fujimoto, K; Fujioka, Y; Fukuda, K; Fukuyama, K; Hanada, K; Hashiguchi, K; Imamura, I; Kajiwara, T; Kakiuchi, T; Kawakubo, H; Kuwahara, A; Matsunaga, K; Matsuo, M; Muro, E; Noda, T; Ogata, S; Okuda, M; Sakata, Y; Sumino, M; Takamori, A; Taniguchi, K; Watanabe, A; Yamaguchi, D; Yamamoto, K; Yamanouchi, K; Yoshimura, M | 1 |
| Cho, YK; Choe, Y; Choi, MG; Kim, SY; Lee, HA; Lim, CH; Park, JM; Shin, GY | 1 |
| Graham, DY; Howden, CW | 1 |
| Bozic, J; Kardum, G; Mestrovic, A; Pavicic Ivelja, M; Perkovic, N; Puljiz, Z; Tonkic, A; Vukovic, J | 1 |
| Bodmer, T; Egli, K; Keller, PM; Risch, L; Risch, M; Wagner, K | 1 |
| Damanhuri, NS; Kumolosasi, E; Mansor, AH; Omar, MS; Razak, AFA | 1 |
| Abdulkhakov, R; Barrio, J; Bordin, D; Bujanda, L; Castro-Fernández, M; Fernandez-Salazar, L; Garre, A; Gasbarrini, A; Gisbert, JP; Huguet, JM; Jurecic, NB; Kupcinskas, L; Lucendo, A; Mégraud, F; Nyssen, OP; O'Morain, C; Pérez-Aisa, Á; Perez-Lasala, J; Rodrigo-Sáez, L; Romero, PM; Tepes, B; Vaira, D; Vologzhanina, L; Voynovan, I; Vujasinovic, M | 1 |
| Han, MH; Hwang, JY; Jeon, SW; Kim, C; Kwon, YH; Lee, JE; Nam, SY; Park, JH; Seo, AN | 1 |
| Beniashvili, Z; Boltin, D; Gisbert, JP; Hirsch, J; Lahat, A; Mégraud, F; Niv, Y; Nyssen, OP; O'Morain, C | 1 |
| Choi, IJ; Choi, M; Jung, HK; Kang, SJ; Kim, JG; Kim, JH; Kim, SE; Lee, YC; Lim, HC; Nam, SY; Park, JM; Park, SY; Shin, CM; Shin, WG; Yang, HJ | 2 |
| Craddock, HA; Domanovich-Asor, T; Khalfin, B; Moran-Gilad, J; Motro, Y; Peretz, A | 1 |
| Alliet, G; Baert, F; Haems, L; Hervent, AS; Lambrecht, G; Vanden Bulcke, A; Vervaeke, S; Waked, B | 1 |
| Hu, Y; Lu, NH; Ouyang, Y; Zhu, Y | 1 |
| Albasha, AM; Ali, MA; Altayb, HN; Elnosh, MM; Fadl, AAM; Osman, EH; Zeinalabdin, DM | 1 |
| Cunningham, SA; Mandrekar, JN; Marrero Rolon, R; Patel, R; Polo, ET | 1 |
| Abdel-Aziz, MM; Galal, AMF; Hanna, AG; Mohamed, HS | 1 |
| Alsamman, MA; Argueta, EA; D'Agata, EMC; Moss, SF | 1 |
| Eto, H; Gotoda, T; Ichijima, R; Ikehara, H; Ito, H; Kawabe, K; Kawamura, M; Kusano, C; Nakahara, M; Suzuki, S; Yoda, Y | 1 |
| Arenas, A; Arnold, J; Berger, Z; Camargo, MC; Castro, VG; Fuentes-López, E; González-Hormazábal, P; Jara, L; Lanzarini, E; Musleh, M; Pizarro, M; Riquelme, A; Serrano, C; Valladares, H | 1 |
| Li, Q; Liu, H; Rao, W; Tian, QJ; Xie, M; Zang, YJ; Zhang, B; Zhang, Q | 1 |
| Harada, K; Ikoshi, H; Koizumi, J; Nakaminami, H; Nakanishi-Yamasaki, M; Nakase, K; Noguchi, N; Yamada, T | 1 |
| Abay, S; Akar, M; Aydın, F; Karakaya, E; Kayman, T | 1 |
| Butt, AMK; Nadeem, MA; Sarwar, S | 1 |
| Cao, M; Chen, H; Cram, DS; Liu, X; Lv, N; Lv, T; Wang, H; Xie, Y; Zhang, C; Zhong, J; Zhou, L | 1 |
| de Korwin, JD | 1 |
| Chung, WC; Kim, DB; Kim, YJ | 1 |
| Chen, Y; Deng, X; Hou, X; Shi, Z; Ye, H; Yuan, H; Zhang, X | 1 |
| Choi, IJ; Kim, CG; Kim, YI; Lee, JY; Park, B; Park, JY | 1 |
| Fukuda, K; Fukuda, M; Hirashita, Y; Kawahara, Y; Kodama, M; Kudo, Y; Matsunari, O; Mizukami, K; Murakami, K; Ogawa, R; Okamoto, K; Okimoto, T; Wada, Y | 1 |
| Kizawa, K; Kosone, T; Marubashi, K; Takagi, H; Takakusagi, S; Tojima, H; Yokoyama, Y | 1 |
| Hu, J; Ji, C; Ji, R; Li, Y; Lin, B; Lin, M; Liu, J; Qi, Q; Qiao, C; Qu, J; Wan, M; Zuo, X | 1 |
| Andreev, DN; Kucheryavyy, YA; Maev, IV | 1 |
| Chang, EJ; Chang, YW; Jang, JY; Kim, JW; Moon, JC; Oh, CH; Shin, GY | 1 |
| Lehours, P; Mégraud, F | 1 |
| Lee, YC; Liou, JM; Wu, MS | 1 |
| Maeda, S; Sue, S | 1 |
| Buzás, GM; Fadgyas-Freyler, P; Fassan, M; Kiss, A; Kocsmár, É; Kocsmár, I; Kramer, Z; Lotz, G; Röst, G; Rugge, M; Schaff, Z; Szénás, K; Szijártó, A; Szirtes, I | 1 |
| Cheng, H; Dai, Y; Dong, XH; Gao, W; Li, J; Li, SY; Teng, GG; Wang, WH; Zhang, W; Zhang, XH | 1 |
| Bi, DY; Huo, LY; Lan, Y; Si, XB; Zhang, S | 1 |
| Ali Rahdar, H; Amini, M; Azimi, A; Davarpanah, M; Fateh, R; Ghasemi, F; Javadi, A; Kardan-Yamch, J; Mohammadzadeh, R | 1 |
| Holmes, JA; Khan, SF; Perera, C; Prendergast, L; Teng, JC; Waring, L | 1 |
| Lee, HL | 1 |
| Li, C; Shi, Y; Song, Z; Suo, B; Tian, X; Zhou, L | 1 |
| Di Leo, A; Ierardi, E; Losurdo, G | 1 |
| Bhatia, S; Chung, H; Huh, KY; Kim, YK; Lee, S; Nakaya, R; Takanami, Y; Yu, KS | 1 |
| Deguchi, H; Fukuhara, S; Kamitani, T; Yamamoto, Y; Yamazaki, H | 1 |
| Boltin, D; Gingold-Belfer, R; Levi, Z; Niv, Y; Schmilovitz-Weiss, H | 1 |
| Chen, B; Jin, S; Jin, Y; Li, Y; Lin, R; Wu, X | 1 |
| Akpınar, H; Ellidokuz, H; Gökçekuyu, BM; Şimşek, İ; Soytürk, M; Yılmaz, Ö | 1 |
| Buset, M; De Wit, S; Delforge, M; Gomez-Galdon, M; Miendje-Deyi, VY; Muls, V; Nkuize, M; Vanderpas, J | 1 |
| Bang, MTL; Duc, NM; Khoi, HH; Nghi, BTD; Ngoc, TLC; Tien, VNT; Van Bach, N; Van Thieu, H | 1 |
| Chen, H; Dai, YY; Huang, YQ; Huang, YY; Li, RJ; Li, XH; Lu, LM; Luo, XK; Qin, C; Zhao, LJ | 1 |
| Borody, TJ; Clancy, A; Dawson, MVM; Gunaratne, AW; Hamblin, H; Magat, AJMC; Tu, J | 1 |
| Saruuljavkhlan, B; Yamaoka, Y | 1 |
| Buzás, GM; Diczházi, C; Hritz, I; Kim, JJE; Kiss, A; Kocsmár, É; Kocsmár, I; Lotz, G; Rusz, O; Schaff, Z; Szijártó, A; Szirtes, I | 1 |
| Durazzo, M; Fagoonee, S; Ferro, A; Pellicano, R; Saracco, GM; Staiano, MT | 1 |
| Hu, J; Lan, CH; Mei, H; Yang, J; Zhang, Y; Zhao, JT; Zhao, Z; Zhu, YJ; Zou, PY | 1 |
| Angelov, T; Kovacheva-Slavova, M; Tropcheva, R; Valkov, H; Vladimirov, B | 1 |
| Choi, Y; Jang, JY; Kim, N; Lee, DH; Lee, JW; Nam, RH | 1 |
| Bonilla, S; Mansuri, I; Mitchell, PD | 1 |
| Barboza, KP; Castelar, BM; da Silva, FC; Lemos, LVB; Ribeiro, AEL; Souto Filho, JTD; Vieira Junior, MC | 1 |
| Fernández-Reyes, M; Ibarra, B; Lizasoain, J; Mendarte, U; Mendiola, J; Montes, M; Pérez-Trallero, E; Tamayo, E; Zapata, E | 1 |
| Fujisawa, T; Horiuchi, A; Imai, R; Kimura, T; Kiyosawa, K; Kubota, D; Maruyama, M; Matsuda, Y; Miyajima, M; Mori, H; Tanaka, N; Tokutake, K; Wada, S | 1 |
| Boyle, B; Brennan, D; Buckley, M; Crotty, P; Doyle, M; Farrell, R; Hussey, M; Kevans, D; Malfertheiner, P; McNamara, D; Megraud, F; Nugent, S; O'Connor, A; O'Morain, C; Smith, S; Weston, S | 1 |
| Gisbert, JP; Marin, AC; McNicholl, AG; Nyssen, OP | 1 |
| Bravo, LE; Bustamante-Rengifo, JA; Matta, AJ; Pazos, AJ | 1 |
| Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY | 1 |
| Boltin, D; Cohen, A; Comaneshter, D; Itskoviz, D; Leibovitzh, H; Levi, Z; Niv, Y; Tsadok Perets, T | 1 |
| Bjornsson, ES; Gudjonsson, H; Gunnarsdottir, AI; Hardardottir, H; Jonsdottir, KD | 1 |
| Fuchigami, T; Kawasaki, K; Kurahara, K; Matsumoto, T; Nakamura, S; Ohtsu, K; Oshiro, Y | 1 |
| Goldin, E; Keller, S; Mahamid, M; Melamud, B; Paz, K | 1 |
| Dolatkhah, H; Eidi, A; Noormohammadi, Z; Nouri, M; Sharifi, R; Shirmohammadi, M | 1 |
| Bacci, B; Mansfield, CS; Santos, L; Sharman, MJ | 1 |
| Jung, YS; Kim, EH; Park, CH | 2 |
| Harmandar, F; Harmandar, O; İlikhan, SU; Üstüündağn, Y | 1 |
| Beckman, E; Clark, C; Elagin, V; Fiorini, G; Gomez, C; Patel, D; Ponaka, R; Saracino, I; Slepnev, V; Vaira, D | 1 |
| Hu, Y; Lu, NH; Zhu, Y | 1 |
| Akay, S; Akpinar, Z; Unsal, B | 1 |
| Ang, D; Ang, TL; Chew, CA; Lye, TF | 1 |
| Amagai, K; Fujieda, S; Goto, M; Kamiya, S; Kato, M; Mabe, K; Okuda, M; Osaki, T; Shibata, W; Yonezawa, H; Zaman, C | 1 |
| Boal Carvalho, P; Cotter, J; Dias de Castro, F; Magalhães, J; Rosa, B | 1 |
| Amano, H; Arima, I; Fukuchi, T; Ikeda, A; Inokuchi, Y; Ishii, Y; Iwase, S; Iwata, Y; Kanno, M; Kawana, I; Kokawa, A; Komatsu, K; Kondo, M; Kunishi, Y; Kuwashima, H; Maeda, S; Miwa, H; Morimoto, M; Naito, M; Oka, H; Okazaki, H; Saito, T; Sanga, K; Sasaki, T; Shibata, W; Sue, S; Takahashi, D; Tamura, T; Terada, M | 1 |
| Alirezaei, A; Argani, H; Darvish, P; Iranshahi, M; Jamshidi Fard, A; Nooraninia, S; Talaie, R | 1 |
| Colak, Y; Doganay, L; Ozdil, K; Ozturk, O; Tuncer, I; Ulasoglu, C; Yilmaz Enc, F | 1 |
| Domracheva, EV; Rustamov, MN; Sarsenbaeva, AS | 1 |
| Leontiadis, GII; Liatsos, C | 1 |
| Ando, K; Fujinaga, A; Fujiya, M; Goto, M; Ichiishi, E; Ito, T; Kashima, S; Kawamoto, T; Kohgo, Y; Moriichi, K; Nomura, Y; Okumura, T; Otake, T; Sato, K; Sato, T; Sugano, H; Tanabe, H; Ueno, N; Utsumi, T; Yanagawa, N | 1 |
| Bilgilier, C; Biowski-Frotz, S; Blesl, A; Datz, C; Effenberger, M; Gombotz, G; Graziadei, I; Hinterberger, I; Hirschl, AM; Högenauer, C; Huber-Schönauer, U; Hubmann, R; Kastner, MT; Klimpel, S; Knoflach, P; Kundi, M; Leiner, J; Ludwiczek, O; Makristathis, A; Mitrovits, N; Moser, M; Püspök, A; Schöfl, R; Schöniger-Hekele, M; Schrutka-Kölbl, C; Siebert, F; Stadlmann, A; Steiner, P; Steininger, C; Stupnicki, T; Thannesberger, J; Tilg, H; Watzinger, N; Wewalka, F; Wurzer, H | 1 |
| Chiba, H; Chinda, D; Fukuda, S; Komai, K; Matsuzaka, M; Saito, Y; Sasaki, Y; Sawada, Y; Shimoyama, T | 1 |
| Alarcón, T; Alba, C; Blanco, A | 1 |
| Bahador, A; Banar, M; Farahmand, F; Keshavarz Valian, S; Mahmoudi, S; Mamishi, S; Najafi, M; Pourakbari, B | 1 |
| Chowers, Y; Geffen, Y; Khoury, J; Saadi, T; Shaul, R; Sholy, H | 1 |
| Arzanlou, M; Khademi, F; Peeridogaheh, H; Sahebkar, AH; Vaez, H | 1 |
| Hiroi, S; Kawakami, K; Sugano, K; Tanaka, S | 1 |
| Ang, TL; Aung, MM; Chakravuth, O; Chotivitayatarakorn, P; Fock, KM; Goh, KL; Graham, D; Harnsomburana, P; Kositchaiwat, C; Lee, YC; Leelakusolvong, S; Leow, A; Mahachai, V; Mairiang, P; Maneerattanaporn, M; Mya, SM; Pisespongsa, P; Pittayanon, R; Rani, A; Rasachak, B; Rojborwonwitaya, J; Sansak, I; Sollano, JD; Sugano, K; Syam, AF; Treeprasertsuk, S; Trong Quach, D; Vannarath, S; Vilaichone, RK; Wiwattanachang, O; Yamaoka, Y | 1 |
| Fraser, AG | 1 |
| Donday, MG; Gisbert, JP; McNicholl, AG; Ramas, M | 1 |
| Das, R; El-Omar, EM; Goh, KL; Kuo, YT; Leow, AHR; Lin, JT; Liou, JM; Lu, H; Tu, YK; Wu, JY; Wu, MS; Yamaoka, Y | 1 |
| Chen, Y; Ke, L; Li, CJ; Liang, J; Ni, Z; Shang, L; Shi, YQ; Zhang, D; Zhang, LH; Zhu, SH | 1 |
| Chen, WC; Cheng, JS; Hsu, PI; Kao, SS; Lin, KH; Sun, WC; Tsai, KW; Tsay, FW; Wang, HM; Wu, DC; Yu, HC | 1 |
| Angel Lopez-Ramirez, M; Angsantikul, P; Chen, C; de Ávila, BE; Delezuk, J; Li, J; Obonyo, M; Ramez, V; Ramírez-Herrera, DE; Samakapiruk, R; Thamphiwatana, S; Wang, J; Zhang, L | 1 |
| Choi, YJ; Kang, JB; Kim, N; Kwon, S; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Costa, S; Gonçalves, R; Soares, JB | 1 |
| Abadi, ATB | 2 |
| Choe, JW; Hyun, JJ; Jung, SW; Jung, YK; Kim, SY; Koo, JS; Lee, SW; Yim, HJ | 1 |
| Ben Zvi, I; Haj Yahia, S; Livneh, A | 1 |
| Itoh, F; Kato, M; Mabe, K; Miyamoto, S; Oikawa, R; Ono, S; Sato, Y; Watanabe, Y; Yamamoto, H | 1 |
| Azrad, M; Brodsky, D; Isakovich, N; On, A; Pastukh, N; Peretz, A | 1 |
| Ghosh, M; Graham, DJ; Izem, R; Kang, EM; Lee, JY; Major, JM; Mosholder, AD; Zhou, EH | 1 |
| Binyamin, D; On, A; Paritsky, M; Pastukh, N; Peretz, A | 1 |
| Brodsky, D; On, A; Paritsky, M; Pastukh, N; Peretz, A | 1 |
| Cerqueira, RM; Correia, M; Manso, MC; Vilar, H | 1 |
| Bellesia, A; De Francesco, V; Palma, R; Panetta, C; Pontone, S; Serviddio, G; Zullo, A | 1 |
| Chan, EW; Chen, L; Cheung, KS; Leung, WK; Wong, AYS; Wong, ICK | 1 |
| Gotoda, T; Ikehara, H; Kusano, C; Moriyama, M; Suzuki, S | 1 |
| Keller, PM; Redondo, JJ; Wagner, K; Zbinden, R | 1 |
| Hong, JB; Lu, NH; Luo, LY; Shu, X; Xie, C; Xie, Y; Ye, JF; Zhu, Y; Zhu, ZH | 1 |
| Chen, SY; Chen, Y; Chen, YX; Cheng, H; Du, YQ; Huo, LJ; Jiang, MD; Lan, CH; Li, Y; Liu, DS; Lu, H; Lu, NH; Shu, X; Wang, JB; Wang, YH; Wu, KC; Xie, Y; Xu, JM; Xu, SP; Zeng, ZR; Zhang, GX; Zhang, LX; Zhang, ZY; Zhu, X; Zhu, Y | 1 |
| Mori, H; Suzuki, H | 1 |
| Bazzoli, F; Eusebi, LH; Rabitti, S; Zagari, RM | 1 |
| Choi, IJ; Kim, BJ; Kim, JG; Kim, JI; Kim, JJ; Kim, SG; Lee, H; Lee, YC | 1 |
| Abanades-Tercero, M; Andrés Esteban, EM; Blanco-González, JJ; Jordán-Castro, JA; Muñoz-Gómez, P; Valle-Muñoz, J | 1 |
| Beer-Davidson, G; Hindiyeh, M; Muhsen, K | 1 |
| Cho, IK; Jung, JH; Lee, CH; Lim, JH; Song, GG | 1 |
| Chen, Q; Li, H; Liang, X; Lu, H; Zhang, W | 1 |
| de Boer, MGJ; Ruiter, R; Veenendaal, RA; Visser, LG; Wunderink, HF | 1 |
| Adachi, T; Asakuma, Y; Kamata, K; Kashida, H; Komeda, Y; Kono, M; Kudo, M; Matsui, S; Minaga, K; Nagai, T; Nishida, N; Okamoto, A; Okamoto, K; Sakurai, T; Takenaka, M; Watanabe, T; Yamada, M; Yamao, K | 1 |
| Arima, I; Kaneko, H; Komatsu, K; Kondo, M; Kuwashima, H; Maeda, S; Naito, M; Nakao, S; Ogushi, M; Sasaki, T; Shibata, W; Sue, S; Tamura, T | 1 |
| Furuta, T; Horio, Y; Ichikawa, H; Kagami, T; Kato, A; Ohashi, N; Sahara, S; Sakao, Y; Sugimoto, K; Sugimoto, M; Yasuda, H | 1 |
| Hsu, PI; Kao, JY; Kao, SS; Tsai, FW | 1 |
| Benedeto-Stojanov, D; Grgov, S; Radovanović-Dinić, B; Tasić, T | 1 |
| Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, AYS; Wong, ICK | 2 |
| Astegiano, M; Pellicano, R; Ribaldone, DG | 1 |
| An, Y; Li, Z; Wang, L; Wang, Y; Wang, YH; Wu, S; Xie, Y; Zhao, RL; Zhu-Ge, LY | 1 |
| Coşkun, DÖ; Deniz, K; Gürsoy, Ş; Özbakir, Ö; Yagbasan, A; Yücesoy, M | 1 |
| Mahmoudi, S; Mamishi, S; Monajemzadeh, M; Parhiz, J; Pourakbari, B; Sadeghi, RH | 1 |
| Fiorini, G; Gatta, L; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Belsey, J; Fiorini, G; Gatta, L; Ricci, C; Saracino, IM; Scarpignato, C; Vaira, D | 1 |
| Chan, EW; Chen, L; Cheung, KS; Graham, DY; Leung, WK; Wong, AYS; Wong, ICK; Wong, IOL; Yeung, KF | 1 |
| Cho, SJ; Choi, IJ; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Nam, BH; Park, B | 1 |
| Chen, J; Jin, L; Li, H; Wang, X; Xu, P; Xu, X; Ye, L | 1 |
| Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G | 1 |
| Moss, SF; Pellicano, R; Saracco, GM; Zagari, RM; Zhang, S | 1 |
| Amagai, K; Asaka, M; Kato, M; Kikuchi, S; Mabe, K; Okuda, M; Sakamoto, N; Yoshimura, R | 1 |
| Fiorini, G; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Chen, Q; Liang, X; Liu, W; Long, X; Lu, H; Yu, L | 1 |
| Álvarez, J; Arévalo-Jaimes, BV; Delgado, MP; García, D; Jaramillo, CA; Ramírez, A; Rodriguez-Urrego, PA; Rosero, YL; Vera-Chamorro, JF | 1 |
| Allem, R; Bachir, M; Benejat, L; Douidi, KT; Drici, AE; Medjekane, M; Megraud, F; Tifrit, A | 1 |
| Álvarez-Pantoja, E; Gallardo-Montoya, JM; Gallardo-Wong, I; Guerrero-Rivera, S; Gutiérrez-Espíndola, G; Maillón-García, LA; Medrano-Contreras, J; Morán-Villota, S | 1 |
| Auesomwang, C; Chey, WD; Kiratisin, P; Leelakusolwong, S; Maneerattanaporn, M; Tanwandee, T | 1 |
| Ramadan, M | 1 |
| Blümel, B; Glocker, EO; Goelz, H; Kist, M | 1 |
| Fukui, H; Horikawa, T; Li, M; Miwa, H; Oshima, T; Tomita, T; Tozawa, K; Watari, J | 1 |
| Moss, SF; Siddique, O | 1 |
| An, Z; Bie, M; Huang, H; Tang, C; Wan, L; Wang, B; Zhou, Y | 1 |
| Robotis, J; Rokkas, T; Tsiodras, S | 1 |
| Chang, YW; Cho, JH; Jang, JY; Kim, JW; Ko, WJ; Moon, JR; Oh, CH; Oh, SJ; Park, YM | 1 |
| Chen, S; Liu, D; Lu, H; Lv, N; Wang, J; Xie, Y; Zeng, Z; Zhang, L; Zhang, Z; Zhu, Z | 1 |
| Berger, Z; Castro, VG; Escandar, S; Gonzalez-Hormazabal, P; Jara, L; Lanzarini, E; Musleh, M; Valladares, H | 1 |
| Guo, Y; He, L; Liu, G; Salama, NR; Self, S; Sun, L; Talarico, S; Yao, L; You, Y; Zhang, H; Zhang, J; Zhang, Y | 1 |
| Ando, K; Fujiya, M; Ichiishi, E; Ishizuka, A; Kohgo, Y; Nomura, Y; Ohta, K; Okumura, T; Otake, T; Satoh, K; Tanabe, H; Yoshino, K | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, MJ; Chen, PY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Wu, MS; Yang, TH | 1 |
| Cho, JH; Jeon, SR; Jin, SY; Kim, HG; Park, S | 1 |
| Gweon, TG; Kim, BW; Kim, JS | 1 |
| Jeong, SJ; Jung, DH; Kang, IM; Kim, JH; Lee, KH; Park, SY; Song, YG | 1 |
| Barone, M; Di Leo, A; Giorgio, F; Girardi, B; Iannone, A; Ierardi, E; Palmer, SC; Pricci, M; Principi, M; Riezzo, G; Russo, F; Strippoli, GF | 1 |
| Hayashi, Y; Kobayashi, Y; Lefor, AK; Miura, Y; Osawa, H; Sakamoto, H; Shinozaki, S; Yamamoto, H | 1 |
| Gonçalves, JP; Lima, R; Nascimento, J; Pereira, F; Silva, GM; Silva, HM | 1 |
| Alebouyeh, M; Behzad, C; Farzi, N; Hasani, Z; Zali, MR; Zojaji, H | 1 |
| Jones, L; Kelsburg, G; Safranek, S; Ta, J | 1 |
| Han, S; Jeon, HS; Kim, S; Lee, EJ; Park, CG | 1 |
| Cai, T; Tang, D; Wang, F; Yao, Y; Yuan, L; Yue, C | 1 |
| Aldeguer, X; Badiola, C; Calafat, M; Calleja, JL; Callejo, Á; Comino, L; Gisbert, JP; Lucendo, AJ; McNicholl, AG; Modolell, I; Molina-Infante, J; Pérez-Aisa, Á; Ramas, M; Serra, J | 1 |
| Bayingana, C; Dusabejambo, V; Hale, D; Hategeka, C; Kabakambira, JD; Ndoli, J; Ngabonziza, F; Ntirenganya, C; Page, C; Walker, T | 1 |
| Chen, CC; Chen, MJ; Chen, YN; Fang, YJ; Lin, JT; Liou, JM; Wu, MS | 1 |
| Endo, H; Fujimoto, K; Hara, M; Hidaka, H; Kawachi, K; Matsunaga, T; Nakano, R; Sakata, Y; Shimoda, R; Takara, Y; Tsuruoka, N | 1 |
| Baylina, M; Calvet, X; López-Góngora, S; Muñoz, N; Sánchez-Delgado, J | 1 |
| Ennkaa, A; Mohammad, RM; Salam, A; Shaath, N | 1 |
| Ha, TMT; Le, PTQ; Phan, TN; Tran, TNH; Tran, VH | 1 |
| Chen, PY; Kuo, YT; Liou, JM; Wu, MS | 1 |
| Azmi, AN; Goh, KL; Graham, DY; Leow, AH; Loke, MF; Vadivelu, J | 1 |
| Mégraud, F | 5 |
| Akther, N; Amjad, T; Amjed, S; Ashraf, N; Jafar, J; Latif, S; Maqsood, W; Saleem, B; Usman, M; Waseem, H | 1 |
| Ashouri, S; Ehsanipour, F; Eslami, S; Haghighi, M; Noorbakhsh, S; TaheriNia, L; Yousefi, A | 1 |
| Alimov, A; Dekhnich, N; Ivanchik, N; Kirsov, P; Kozlov, R; Pandav, K; Steshits, A | 1 |
| Bastón-Rey, I; Calviño-Suárez, C; de la Iglesia-García, D; Domínguez-Muñoz, JE; Macías-García, F; Nieto-García, L | 1 |
| Cai, Y; Dai, N; Du, Q; Hu, WL; Kao, JY; Kim, JJ; Si, JM; Zhang, YW; Zheng, WF | 1 |
| Wagner, S | 1 |
| Burucoa, C; Coulibaly, A; Godonou, HSM; Guingané, A; Plouzeau, C; Sermé, AK; Sia, R; Somda, S | 1 |
| Salar, A | 1 |
| Aguilar-Luis, MA; Bazán-Mayra, J; Calderón-Rivera, A; Cornejo-Tapia, A; Del Valle, LJ; Del Valle-Mendoza, J; Espinal-Reyes, F; Levy-Blitchtein, S; Palacios-Cuervo, F; Palomares-Reyes, C; Silva-Caso, W; Zavaleta-Gavidia, V | 1 |
| De Francesco, V; Fiorini, G; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Billöet, A; Burucoa, C; Collobert, G; Delerue, T; Hays, C; Kalach, N; Lamarque, D; Raymond, J | 1 |
| Bizzarri, B; De' Angelis, GL; Di Mario, F; Gaiani, F; Iuliano, S; Kayali, S; Leandro, G; Manfredi, M; Minelli, R | 1 |
| Shahbazi, S; Vahdat Shariatpanahi, Z | 1 |
| Choi, IJ | 1 |
| Benkirane, A; Berrag, S; Berraida, R; Boutallaka, H; Elkoti, I; Loubaris, K; Nejjari, F; Seddik, H; Sentissi, S | 1 |
| Chung, WC; Kim, YJ; Ko, SW; Lee, SJ | 1 |
| Abdulkhakov, RA; Abdulkhakov, SR; Ageeva, EA; Alekseenko, SA; Bakulina, NV; Baranovskii, AY; Baryshnikova, NV; Bordin, DS; Burkov, SG; Butov, MA; Dekhnich, NN; Embutnieks, YV; Gisbert, JP; Golubev, NN; Il'chishina, TA; Kolbasnikov, SV; Kononova, AG; Kucheryavyi, YA; Livzan, MA; Lyalyukova, EA; Maev, IV; McNicholl, AG; Megraud, F; Morkovkina, LV; Nyssen, OP; O'Morain, C; Osipenko, MF; Pakhomova, AL; Plotnikova, EY; Ramas, M; Sarsenbaeva, AS; Savilova, IV; Tarasova, LV; Tsukanov, VV; Vasyutin, AV; Voinovan, IN; Vologzhanina, LG; Zaitsev, OV; Zhestkova, TV | 1 |
| Andreev, DN; Dicheva, DT; Maev, IV; Partzvania-Vinogradova, EV; Samsonov, AA | 1 |
| Andreev, DN; Dicheva, DT; Maiev, IV; Partzvania-Vinogradova, EV; Yurenev, GL | 1 |
| Fukuba, N; Ishitobi, H; Kinoshita, Y; Kobayashi, Y; Komazawa, Y; Kusunoki, M; Nagaoka, M; Shizuku, T; Takahashi, Y; Yuki, M | 1 |
| Bal, K; Cakan, H; Caliskan, R; Demirci, M; Demiryas, S; Ergin, S; Erzin, YZ; Gareayaghi, N; Kalayci, F; Kocazeybek, B; Sakli, MK; Saribas, S; Sarp, TZ; Tascı, İ; Tokman, HB; Uysal, HK; Yuksel, P | 1 |
| Chao, SH; Ding, SZ; Lan, L; Li, J; Li, YX; Wang, XM; Yang, TT; Yi, DM; Zhang, HH; Zhang, YR; Zhang, YW; Zhou, YL | 1 |
| Chu, CH; Liao, PH; Lin, YC; Liou, TC; Shih, SC | 1 |
| Chen, Y; Li, J; Liu, L; Lu, B; Wang, J | 1 |
| Chen, DF; Fan, L; Lan, CH; Wang, TY; Wang, XW; Yang, J; Zhang, Y; Zhu, YJ | 1 |
| Hsieh, MS; Hsu, WH; Hu, HM; Kuo, CH; Kuo, FC; Li, CJ; Liu, CJ; Lu, CY; Shih, HY; Tsai, PY; Wu, DC; Yu, FJ | 1 |
| Fei, GJ; Guo, T; Li, JN; Li, XQ; Li, Y; Qian, JM; Shu, HJ; Wang, Q; Wu, X | 1 |
| Kim, N; Yoon, K | 1 |
| Ji, C; Li, L; Li, Y; Liu, J; Sun, Y; Wang, T; Yang, X; Zuo, X | 1 |
| Amato, A; De Francesco, V; Fiorini, G; Mogavero, G; Monica, F; Portincasa, P; Scaccianoce, G; Urban, F; Vaira, D; Vassallo, R; Zullo, A | 1 |
| Arévalo Galvis, A; Otero Regino, W; Trespalacios Rangel, AA | 1 |
| Chen, CF; Cheng, H; Gao, HJ; Hu, F; Li, J; Lu, DR; Shen, WX; Sheng, HH; Zhang, XY | 1 |
| Cardona, F; Clemente-Postigo, M; Coin-Aragüez, L; Cornejo-Pareja, I; Martín-Núñez, GM; Moreno-Indias, I; Muñoz-Garach, A; Roca-Rodríguez, MDM; Tinahones, FJ | 1 |
| Vanegas, YAM; Vishnu, P | 1 |
| Crowe, SE | 1 |
| Cholleti, SM; Jodesty, Y; Li, D; Pham, HV; Tseng, DS; Wei, JC | 1 |
| Gülerman, F; Güven, B; Kaçmaz, B | 1 |
| Balzan, D; Callus, R; Delicata, L; Felice, T | 1 |
| Jeon, SW; Kwon, YH; Lee, HS; Nam, SY; Park, JH | 1 |
| Alcedo, J; Alekseenko, S; Alonso-Galan, H; Barrio, J; Bordin, DS; Bujanda, L; Caldas, M; Coba, C; Dominguez-Jimenez, JL; Donday, MG; Fadeenko, G; Fernandez, MC; Gisbert, JP; Gonzalez-Cordero, PL; Hinojosa, J; Ilchishina, T; Lasala, JP; Lucendo, A; McNicholl, AG; Megraud, F; Modolell, I; Molina-Infante, J; Moreno, NF; Nuñez, O; Nyssen, OP; O'Morain, C; Perez-Aisa, Á; Ruiz-Zorrilla Lopez, R; Santaella, I; Sarsenbaeva, AS; Shvetz, O; Varela, P; Vologzhanina, L; Voynovan, I; Zakharova, NV; Zaytsev, O | 1 |
| Baylina, M; Calvet, X; López-Góngora, S; Muñoz, N; Puig, I; Sánchez-Delgado, J | 1 |
| Fallone, CA; Malfertheiner, P; Moss, SF | 1 |
| Chen, Q; Chen, Y; Gao, H; Graham, DY; Ji, Y; Li, D; Liang, X; Liu, M; Liu, W; Long, X; Lu, H; Song, Y; Sun, Y; Xu, B; Xu, G; Yu, L; Zhang, W; Zhao, Y | 1 |
| Alghamdi, SA; Alsharif, KF; Eed, EM; Hawash, YA; Ismail, KA; Khalifa, AS; Saber, T; Shehab-Eldeen, SA | 1 |
| Aydın, MK; Kanık, AE; Özdemir, AA; Sezgin, O | 1 |
| Ahn, JY; Baik, GH; Cheung, DY; Cho, SJ; Choi, KD; Choi, YJ; Chung, JW; Jung, HK; Jung, HY; Kim, BW; Kim, JH; Kim, JJ; Kim, JM; Kim, SY; Lee, H; Lee, JH; Lee, SH; Lee, WS; Min, YW; Park, JC; Shin, CM; Sung, JK | 1 |
| Hanafy, AS; Seleem, WM | 1 |
| Jaka, H; Kasang, C; Mshana, SE; Mueller, A | 1 |
| Chen, YH; Hsu, PI; Kao, JY; Kao, SS; Pan, CY; Peng, NJ; Tsai, KW; Tsai, TJ; Tsay, FW; Wu, DC | 1 |
| Abu-Elhija, O; Bragazzi, NL; Ghantous, M; Khoury, T; Mahamid, M; Mari, A; Watad, A | 1 |
| Kenyon, C | 1 |
| Arabkari, V; Eslami, M; Jazayeri Moghadas, A; Kokhaei, P; Niazi, Z; Sadighi Moghadam, B; Yousefi, B | 1 |
| Andreolla, HF; Breyer, HP; Canevese, AP; da Silva, CA; da Veiga Chaves Picon, R; De Araujo, A; De Bona, LR; de Lucena Theil, A; de Magalhães Francesconi, CF; Edelweiss, MI; Krumel, CF; Longo, L; Mazzoleni, F; Mazzoleni, LE; Michalczuk, MT; Milbradt, TC; Ott, EA; Sander, GB; Schaefer, PG; Simon, D; Spinato Torresini, R; Stifft, J; Talley, NJ; Titton, NF; Uchoa, DM; Volpato, N; Von Reisswitz, PS; Wortmann, AC; Zenker, RP | 1 |
| Chayama, K; Kitadai, Y; Masaki, S; Matsuo, K; Matsuo, T; Naito, T; Sentani, K; Takigawa, H; Tanaka, S; Urabe, Y; Yuge, R | 1 |
| Bluemel, B; Eisele, B; Glocker, EO; Goelz, H; Goldmann, B; Grüger, J; Hamel, H; Hofreuter, D; Loley, K; Ludolph, T; Meyer, J; Miehlke, S; Mohr, A; Tüffers, K; Usadel, H; Vorreiter, J; Wagner, S; Wenzel, H; Wiemer, L | 1 |
| Arévalo-Jaimes, BV; de Molano, BM; Del Pilar Delgado, M; Jaramillo, CA; Rojas-Rengifo, DF; Vera-Chamorro, JF | 1 |
| Kiyotoki, S; Nishikawa, J; Sakaida, I | 1 |
| Deguchi, H; Fukuhara, S; Yamamoto, Y; Yamazaki, H | 1 |
| Fukui, K; Hayashi, S; Higaki, Y; Inada, M; Matsubara, T; Mukai, K; Nakajima, S; Nakamatsu, D; Nishida, T; Okamoto, A; Osugi, N; Sugimoto, A; Takahashi, K; Tomita, R; Tsujii, Y; Yamamoto, M | 1 |
| Lai, FP; Lo, HY; Lu, HH; Sheu, BS; Yang, YJ | 1 |
| Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, ICK | 1 |
| Kim, H; Kim, WK; Kwon, Y; Nahm, JH | 1 |
| Birkenfeld, S; Boltin, D; Dotan, I; Gabay, H; Gingold-Belfer, R; Levi, Z; Schmilovitz-Weiss, H; Shochat, T | 1 |
| Álvarez-Argüelles, ME; Armesto, E; Duque, JM; Melón, S; Morilla, AM; Villar, H | 1 |
| de Andrés, E; Gómez Hernando, C; Gómez Rodríguez, R; Muñoz Gómez, P; Sierra Bernal, C; Valle Muñoz, J | 1 |
| Attia, TZ; Derayea, SM; Tsujino, H; Tsutsumi, Y; Uno, T; Yamashita, T | 1 |
| Ashorov, O; Belfer, RG; Benejat, L; Boltin, D; Dickman, R; Hamouda, D; Niv, Y; Perets, TT | 1 |
| da Silva Patricio, FR; Godoy, AP; Kawakami, E; Ogata, SK | 1 |
| Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Sexton, R; Torres, J; Valdivieso, M | 1 |
| Johari, P; Najafipour, R; Naserpour Farivar, T | 1 |
| Abbas, Z; Abid, S; Ahmed, R; Hamid, S; Jafri, W; Mumtaz, K; Yakoob, J | 1 |
| Otsuka, SH | 1 |
| Konorev, MR | 1 |
| Malfertheiner, P | 2 |
| Imai, Y; Inokuma, T; Matsumoto, T | 1 |
| Bradbeer, L; Liu, A; Nanan, R; Thakkar, S | 1 |
| Gisbert, JP; Marin, AC; McNicholl, AG | 1 |
| Arts, J; De Cooman, L; Ducatelle, R; Flahou, B; Haesebrouck, F; Joosten, M; Meyns, T; Pasmans, F; Smet, A | 1 |
| Barrio, J; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Vinagre, G | 1 |
| Alaoui, S; Amarti, A; Benajah, DA; Bennani, B; El Abkari, M; El Rhazi, K; Ibrahimi, SA; Lahbabi, M; Mahmoud, M; Nejjari, C | 1 |
| Bai, J; Jia, Q; Qu, L; Song, C; Tao, Z; Wu, Y; Zhi, K | 1 |
| Kaul, KL; Mangold, KA; Regner, M; Schmitt, BH; Thomson, RB | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Ilieva, J; Mitov, I; Nikolov, R | 1 |
| Azevedo, NF; Brandão, C; Carneiro, F; Cerqueira, L; Dinis-Ribeiro, M; Fernandes, RM; Ferreira, RM; Figueiredo, C; Keevil, CW; Oleastro, M; Pimentel-Nunes, P; Vieira, MJ | 1 |
| Almasi, S; Mirsattari, D; Seyedmajidi, S; Seyyedmajidi, M; Zali, M; Zanganeh, E; Zojaji, H | 1 |
| Ananthakrishnan, N; Kalayarasan, R; Kate, V | 1 |
| Botero, ML; Cárdenas, A; Forero, JD; Rey, M; Sierra, F | 1 |
| Kim, H; Matsui, M; Mori, S; Mukai, M; Rimbara, E; Shibayama, K; Suzuki, S; Takahashi, S; Yamamoto, S | 1 |
| Barrio, J; Bory, F; Calvet, X; Castro, M; de la Coba, C; Ducons, J; Forné, M; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Montoro, M; Perez-Aisa, A | 1 |
| Ghafourian, S; Maleki, A; Qomi, MA; Sadeghifard, N; Seidnazari, T; Sekawi, Z; Soleimani, M | 1 |
| Abouqal, R; Ahid, S; Benkirane, A; Cherrah, Y; El Adioui, T; El Hamdi, FZ; Hassar, M; Seddik, H | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H; Suzuki, M; Takahashi, M | 1 |
| Georgopoulos, SD; Laoudi, F; Martinez-Gonzalez, B; Mentis, AF; Sgouras, DN; Spiliadi, C; Xirouchakis, E | 1 |
| Dubois, A; Francis, J; Jia, Y; Liu, H; McAvoy, TJ; Merrell, DS; Nieroda, C; Sardi, A; Semino-Mora, C; Studeman, K; Testerman, TL; Whitmire, JM | 1 |
| Bonfrate, L; Castorani, L; D'Ambrosio, P; De Francesco, V; Hassan, C; Portincasa, P; Ruggiero, V; Scaccianoce, G; Vannella, L; Zullo, A | 1 |
| Graham, DY; Lee, YC; Wu, MS | 1 |
| Boo, SJ; Cho, YK; Choi, EK; Kim, HU; Kim, JH; Kim, T; Na, SY; Shin, SY; Song, BC; Song, HJ | 1 |
| Chen, A; Chen, JJ; Hsu, PI; Hsu, WH; Kuo, CH; Kuo, FC; Liu, CJ; Liu, MK; Lu, CY; Su, YC; Wu, DC; Wu, IC; Yu, FJ | 1 |
| Raj, JM; Raj, SM | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Ghadir, MR; Iranikhah, A; Sarkeshikian, SS | 1 |
| De-Qiang, H; Lin-Lin, L; Nong-Hua, L; Yong, X; Zhen-Hua, Z | 1 |
| Benzer, E; Bilir, G; Gokcan, H; Onal, IK; Oztas, E | 1 |
| Cheung, DY; Chung, WC; Jun, EJ; Kim, BW; Kim, JI; Kim, JK; Kim, SS; Kim, TH; Lee, HJ; Oh, JH; Park, SH | 1 |
| Bontems, P; Cadranel, S; Miendje Deyi, VY; Vanderpas, J | 1 |
| Abbas, Z; Awan, S; Hamid, S; Jafri, F; Jafri, W; Naz, S; Usman, MW; Yakoob, J | 1 |
| Bassetto, MA; Cecchini, MP; De Franceschi, L; Fontana, R; Marcolini, L; Osculati, F; Pegoraro, M; Pellegrini, C; Sbarbati, A | 1 |
| Ahmad, Z; Akbar, A; Alam, SM; Hasan, R; Khan, E; Rajper, S | 1 |
| Ecker, T; Krieger, T; Leandro, G; Malfertheiner, P; Venerito, M | 1 |
| Ben-Dor, D; Delgado, JS; Landa, E | 1 |
| Almasi, V; Moradimoghadam, F; Zendedel, A; Zivarifar, H | 1 |
| Einck, L; Makobongo, MO; Merrell, DS; Peek, RM | 1 |
| Jang, JY; Jung, HK; Kim, CG; Kim, SG; Lee, H; Lee, HL; Lee, YC; Shin, ES; Shin, WG | 1 |
| Arévalo, A; Avila, J; Caminos, JE; Graham, DY; Mercado, MM; Otero, W; Poutou-Piñales, RA; Rosero, LE; Trespalacios, AA | 1 |
| Labenz, J | 4 |
| Doğan, Z; Ergül, B; Filik, L; Sarikaya, M | 2 |
| Abenavoli, L; Masarone, M; Milic, N; Persico, M | 1 |
| Hanawa, T; Kamiya, S; Kurata, S; Ochiai, K; Osaki, T; Yonezawa, H | 1 |
| Bashiardes, S; Christodoulou, C; Krashias, G; Potamitis, GS; Potamitou, A | 1 |
| Boyanova, L; Gergova, G; Mitov, I; Panov, V; Yordanov, D | 1 |
| Astegiano, M; Fagoonee, S; Pellicano, R; Smedile, A | 1 |
| Ding, ZL; Geng, L; Gong, ST; Huang, J; Li, DY; Li, ZL; Mao, M; Wang, ZL; Xu, XW; Yang, M; Zhou, L | 1 |
| Chung, JW; Jang, DK; Kang, KK; Kim, N; Lee, DH; Oh, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Furuta, T; Ichikawa, H; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
| Algaba, A; Antón, R; Barrio, J; Bermejo, F; Castro-Fernández, M; Cosme, A; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Barcenas, M; Harb, Y; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Perez-Aisa, A; Rodrigo, L; Sacristán, B | 1 |
| Choksey, A; Nasa, M; Phadke, A; Sawant, P | 1 |
| Georgopoulos, SD; Karatapanis, S; Papastergiou, V | 2 |
| Alvarez, B; Cruz, ME; Dib, J; Mendez, L | 1 |
| Furuta, T; Ichikawa, H; Kodaira, C; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
| Ateş, Y; Avşar, E; Aytuğ, N; Bektaş, A; Bölükbaş, C; Dinçer, D; Ellidokuz, E; Erzin, Y; Güliter, S; Kaymakoğlu, S; Kocakaya, O; Onuk, MD; Poturoğlu, S; Taşan, G; Tiftikçi, A; Türkay, C; Yıldırım, B; Yılmaz, U | 1 |
| Cojocariu, C; Dorobat, C; Girleanu, I; Grigore, L; Sfarti, C; Singeap, AM; Stanciu, C; Trifan, A | 1 |
| But, DY; Hsu, AS; Hung, IF; Lam, FY; Leung, WK; Liu, KS; Seto, WK; Tong, T; Wong, SY | 1 |
| Kamenwa, R; Kimang'a, AN; Laving, A; Revathi, G; Sayed, S | 1 |
| da Câmara Lopes, GA; Hung Ho, T; Lopes, RA; Sperança, MA; Suzuki, RB | 1 |
| Bazzoli, F; Calvet, X; Fallone, C; Fischbach, L; Ford, AC; Forman, D; Gisbert, JP; Khan, KJ; Leontiadis, GI; Moayyedi, P; Oderda, G; Tse, F; Yuan, Y | 1 |
| Chang, HJ; Geary, J; Goodman, KJ; Keelan, M; Morse, AL; Morse, JW; Munday, R; Sander, Vv | 1 |
| Castelli, V; De Francesco, V; Di Leo, A; Fiorini, G; Giorgio, F; Hassan, C; Ierardi, E; Lo Re, G; Saracino, I; Vaira, D; Zaccaro, C; Zullo, A | 1 |
| Asaoka, D; Hojo, M; Matsumoto, K; Nagahara, A; Osada, T; Sasaki, H; Watanabe, S | 1 |
| Altman, E; Chandan, V; Harrison, BA; Slinger, R | 1 |
| Graham, DY; Liou, JM; Wu, JY | 1 |
| Jalalzadeh, M; Nazarian, M; Vafaeimanesh, J | 1 |
| Alkhenizan, AH; Alsohaibani, FI; Peedikayil, MC | 1 |
| Almeida, N; Cardoso, O; Cipriano, MA; Donato, MM; Luxo, C; Marinho, C; Romãozinho, JM; Sofia, C | 1 |
| Cho, KB; Jang, BI; Jeon, SW; Jung, JT; Jung, MK; Jung, YS; Kim, ES; Kim, EY; Kim, KO; Kim, WJ; Kwon, JG; Lee, SH; Oh, MJ; Park, CS; Park, KS; Yang, CH | 1 |
| Adachi, E; Fujii, T; Iwamoto, A; Kikuchi, T; Koga, M; Koibuchi, T; Ohno, N; Okame, M; Ota, Y; Oyaizu, N; Sato, H; Takaya, S | 1 |
| Bosques-Padilla, FJ; Garza-González, E; Maldonado-Garza, HJ; Perez-Perez, GI | 1 |
| Barbaro, F; Cammarota, G; Campanale, M; Cesario, V; D'Angelo, G; De Pasquale, T; Di Rienzo, TA; Franceschi, F; Gasbarrini, A; Gigante, G; Nucera, E; Ojetti, V; Pecere, S; Rizzi, A; Schiavino, D | 1 |
| Choi, YJ; Jung, HC; Kim, MS; Kim, N; Lee, DH; Lee, JW; Lee, JY; Park, YS; Shin, CM; Yoon, H | 1 |
| Abdalla, AF; Al-Hussaini, AS; El-Baz, R; Galal, A; Settin, A | 1 |
| Graham, DY; Hsu, PI; Wang, WM; Wu, DC; Wu, JY | 1 |
| Mengnan, Z; Wei, Z; Wen, G; Yali, Z; Ying, L | 1 |
| Hashino, S; Ohe, M | 1 |
| Brandimarte, G; Elisei, W; Giorgetti, G; Picchio, M; Tursi, A | 2 |
| Evdokimov, VV; Evdokimova, AG; Zhukolenko, LV | 1 |
| Chen, M; He, L; Hou, X; Li, Z; Lin, S; Song, Z; Zhang, J; Zhou, L | 1 |
| Heo, J; Jeon, SW | 2 |
| Kang, BK; Kim, BW; Park, SM | 1 |
| Kim, N; Lee, JY | 1 |
| Chen, ZY; Duan, BP; Ou-Yang, HJ; Tang, J; Xu, B; You, JY; Zhao, HM | 1 |
| Du, FC; Fu, Q; Gan, le L; Guo, G; Liu, KY; Sun, HW; Yue, ZY; Zhang, WJ; Zhang, Y; Zou, QM | 1 |
| Furuta, T; Ichikawa, H; Sahara, S; Sugimoto, K; Sugimoto, M; Uotani, T; Yamade, M | 1 |
| Graham, DY; Jan, CM; Lee, YC; Wang, SS; Wang, WM; Wu, DC; Wu, JY; Yamaoka, Y | 1 |
| Ekere, F; Emanuel, AO; Igetei, R; Odiagah, JN; Onyekwere, CA; Smith, S | 1 |
| Cui, R; Ding, S; Guo, C; Huang, X; Jin, Z; Li, Y; Lin, S; Meng, L; Xue, Y; Yan, X; Zhang, J; Zhang, L; Zhou, L | 1 |
| Egawa, S; Fukui, H; Ichiba, M; Iijima, H; Inoue, A; Ishihara, R; Kishida, O; Kobayashi, I; Komori, M; Nishida, T; Ogawa, H; Oshita, M; Takeda, A; Takehara, T; Tanimura, H; Tsuji, S; Tsujii, M; Tsutsui, S; Uenoyama, N; Yasunaga, Y; Yoshio, T; Yura, M; Zushi, S | 1 |
| Andreev, DN; Barkalova, EV; Kucheriavyĭ, IuA; Maev, IV | 1 |
| Brodsky, D; Glyatman, T; Nasser, O; On, A; Paritsky, M; Peretz, A; Segal, S | 1 |
| Chen, BP; Chen, YH; Huang, GR; Huang, XF; Huang, YQ; Huang, ZS; Li, XH; Mo, XQ; Qin, YC; Tang, HY; Wang, LY; Wei, HY; Wei, LD; Zhao, LJ | 1 |
| Adebisi, AO; Conway, BR | 1 |
| Banlunara, W; Chaichanawongsaroj, N; Pan-In, P; Wanichwecharungruang, S | 1 |
| Chen, S; Lv, ZF; Wang, B; Wang, F; Wang, H; Wang, Y; Xie, Y; Yang, Y; Zhou, X | 1 |
| Alfizah, H; Campbell, BJ; Pritchard, DM; Rasheed, F; Varro, A; Yamaoka, Y; Zahra, R | 1 |
| Jeon, HK; Kim, GH | 1 |
| Ahn, JY; Choi, KD; Choi, KS; Gong, EJ; Jung, HY; Kim, DH; Kim, JH; Lee, GH; Lee, JH; Lim, H; Song, HJ; Yun, SC | 1 |
| Kato, M | 1 |
| Furuta, T; Sugimoto, M | 1 |
| Harada, N; Hosoda, Y; Inoue, S; Katayama, S; Kimura, T; Kuwai, T; Maekawa, T; Masuda, E; Miyabayashi, H; Nishizawa, T; Nishizawa, Y; Ohta, H; Saito, H; Suzuki, H; Takahashi, M; Toyokawa, T; Watanabe, N; Yamashita, H; Yoshinaga, M; Yoshio, T | 1 |
| Budak, A; Karczewska, E; Klesiewicz, K; Nowak, P; Sito, E; Skiba, I; Wojtas-Bonior, I | 1 |
| Khaĭrullaeva, SS; Khamraev, AA; Rustamova, MT | 1 |
| Hwang, JH; Jang, ES; Jeoung, SH; Jung, HC; Kang, KK; Kim, JW; Kim, N; Lee, DH; Oh, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Choi, YJ; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, JW; Nam, RH; Park, JH | 1 |
| Acosta, CP; Hurtado, FA; Trespalacios, AA | 1 |
| Akdoğan, RA; Bedir, R; Copur, A; Rakici, H; Yilmaz, A | 1 |
| Jung, HC; Kim, JM; Kim, JY; Kim, N; Lee, DH; Lee, JW; Lee, JY; Nam, RH | 1 |
| Goh, KL; Khosravi, Y; Lee, WC; Leow, AH; Loke, MF; Teh, X; Vadivelu, J | 1 |
| Bani-Sadr, F; Boulagnon, C; Diebold, MD; Hentzien, M; Jaussaud, R; Lambert, D; Nguyen, Y; Ramaholimihaso, F; Rouger, C | 1 |
| Jain, AK; Mishra, GN; Nath, G; Patel, SK; Pratap, CB | 1 |
| Chen, A; Chen, WC; Hsu, PI; Kao, SS; Lai, KH; Tsay, FW; Tseng, HH; Wang, HM; Wu, DC; Yu, HC | 1 |
| Choi, SK; Joo, YE; Jun, CH; Kim, HS; Koh, HR; Lee, SM; Lee, WS; Park, CH; Park, CS; Park, SY; Rew, JS | 1 |
| Furleta, VV; Nykula, TD | 1 |
| Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S | 1 |
| Cho, KB; Ha, CY; Heo, J; Jang, BI; Jeon, SW; Jung, JT; Kim, ES; Kim, EY; Kim, HJ; Kwon, JG; Lee, DW; Lee, SH; Park, KS; Seo, HE | 1 |
| Gisbert, JP; Molina-Infante, J | 2 |
| Aksoy, Y; Eyi, YE; Gezer, M; Oztürk, K | 1 |
| Arj, A; Dastehgoli, K; Keshavarz Azizi Raftar, S; Mirzaei Ghazi Kalayeh, H; Moniri, R; Mousavi, SG; Razavi Zadeh, M; Saffari, M | 1 |
| de Boer, EM; de Boer, WA; Schneeberger, PM | 1 |
| Baik, GH; Bang, CS; Kim, DJ; Kim, JB; Kim, YS; Park, SH; Suk, KT; Yoon, JH | 1 |
| Akyon, Y; Bayrak, A; Celikel, C; Ertem, D; Kutluk, G; Tutar, E; Volkan, B | 1 |
| Gold, BD | 1 |
| Doern, CD; Leos, NK; Mitui, M; Park, JY; Patel, A | 1 |
| Bujanda, L; Cosme, A; Fernández-Reyes, M; Ibarra, B; Martos, M; Mendarte, U; Salicio, Y; Sarasqueta, C | 1 |
| Aisa, AP; Barrio, J; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Gisbert, JL; Gisbert, JP; Marcos, S; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Rodrigo, L | 1 |
| Matongo, F; Nwodo, UU | 1 |
| Kim, BJ; Kim, JG; Lee, SW; Park, SW; Yoon, KH | 1 |
| Malfertheiner, P; Selgrad, M | 1 |
| Tu, S; Yang, H | 1 |
| Liu, XQ; Lv, ZF; Wang, B; Wang, H; Wang, YH; Xie, Y; Zhou, XJ | 1 |
| Choi, YJ; Kim, JM; Kim, N; Kwon, YH; Lee, DH; Lee, JY; Lee, S; Nam, RH; Park, YS; Shin, CM; Suh, JH; Yoon, H; Yoon, K | 1 |
| Lv, ZF; Wang, B; Wang, H; Wang, YH; Xie, Y; Xiong, HF; Yang, Y | 1 |
| Delgado, M; Eizaguirre, FJ; Fernández-Reyes, M; Montes, M; Muñoz-Seca, IM; Pérez-Trallero, E; Villalon, FN | 1 |
| Hakimi, P; Khoshnood, A; Reza Mirjalili, M; Salman-Roghani, H | 1 |
| Azmin, S; Hashim, H; Ibrahim, NM; Manaf, MR; Razlan, H; Tan, HJ; Yahya, NW | 1 |
| Chung, JW; Kim, KO; Kim, SY; Kim, YJ; Kwon, KA; Park, DK | 1 |
| Ben-Zvi, H; Boltin, D; Dickman, R; Kamenetsky, Z; Niv, Y; Perets, TT; Samra, Z | 1 |
| El-Garem, Y; El-Sawy, M; Mostafa, T | 1 |
| Ahmed, S; Atia, NN | 1 |
| Hong, SN; Kim, JJ; Lee, H; Lee, JH; Lee, YC; Min, BH; Rhee, PL | 1 |
| Mearin, ML; Mourad-Baars, PE; Veenendaal, RA; Veldkamp, KE; Wit, JM; Wunderink, HF | 1 |
| Chan, HH; Cheng, JS; Hsu, PI; Kao, SS; Lai, KH; Peng, NJ; Tsai, TJ; Tsai, WL; Tsay, FW; Tseng, HH; Wang, HM; Wu, DC | 1 |
| Adebisi, AO; Conway, BR; Laity, PR | 1 |
| Cappuccinelli, P; Le, VA; Paglietti, B; Phan, TN; Rubino, S; Santona, A; Tran, TN; Tran, VH | 1 |
| Bae, SH; Hyun, MS; Jo, JC; Joo, YD; Kim, DY; Kim, H; Kim, HJ; Kim, MK; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Ryoo, HM; Zang, DY | 1 |
| Mahachai, V; Siramolpiwat, S; Srinarong, C; Vilaichone, RK; Wongcha-um, A | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Masaoaka, T; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Agibalov, AN; Dorofeev, AÉ; Kugler, TE; Rudenko, NN; Sibilev, AV; Tomash, OV | 1 |
| Daikos, GL; Delladetsima, I; Goukos, D; Karamanolis, GP; Ladas, SD; Xouris, D | 1 |
| Akdogan, RA; Ayaz, T; Bedir, R; Rakici, H | 1 |
| Dlugosz, J; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Gosciniak, G; Iwanczak, B; Iwanczak, F; Laszewicz, W; Rozynek, M | 1 |
| Hajaghamohammadi, A; Kazemifar, AM; Oveisi, S; Safiabadi Tali, SH; Samimi, R | 1 |
| Cheung, DY; Chung, WC; Jun, EJ; Kim, BW; Kim, JI; Kim, SS; Lee, HJ; Lee, JS; Oh, JH | 1 |
| Abena, AA; Ahoui Apendi, PC; Atipo Ibara, BI; Benejat, L; Goh, KL; Ibara, JR; Lehours, P; Megraud, F; Menard, A; Moyen, R; Nguimbi, E; Niama, RF; Obengui, O; Ontsira Ngoyi, EN; Ossibi Ibara, RB; Ouamba, JM; Sifre, E; Vadivelu, J; Yala, F | 1 |
| Graham, DY; Otero, W; Reddy, R; Rimbara, E; Trespalacios, AA | 1 |
| Gao, W; Hou, P; Jin, Y; Kang, J; Liu, Q; Liu, W; Lu, J; Qi, D | 1 |
| Baltz, AC; Berry, AC; Nakshabendi, R | 1 |
| Kimko, H; Mannaert, E; Mould, DR; Thyssen, A; Treem, WR | 1 |
| Ang, D; Ang, TL; Dhamodaran, S; Fock, KM; Kwek, AB; Ong, J; Song, M; Tan, J; Teo, EK | 1 |
| Aoki, H; Itai, S; Iwao, Y; Mizoguchi, M; Noguchi, S | 1 |
| Fischbach, W; Glocker, E; Malfertheiner, P; Scherübl, H | 1 |
| Al-Adhba, HS; Ben Chaabane, N | 1 |
| Inoue, S; Itagaki, T; Kagemoto, K; Mitsui, Y; Muguruma, N; Naruse, K; Takayama, T | 1 |
| Al Bouzidi, A; Benkirane, A; Benouda, A; Bouilhat, N; Burucoa, C; El Feydi, A; El Idrissi-Lamghari, A; Elouennas, M | 1 |
| Bari, Z; Fakheri, H; Hosseini, V; Maleki, I; Metanat, HA; Taghvaei, T; Valizadeh, SM | 1 |
| Angueira, T; Ariño, I; Balboa, A; Barrio, J; Bermejo, F; Botargues-Bote, JM; Gisbert, JP; Gomez-Camarero, J; Gomez-Rodriguez, BJ; Herranz-Bachiller, MT; Huerta, A; Lucendo, AJ; Martin-Noguerol, E; McNicholl, AG; Modolell, I; Molina-Infante, J; O'Morain, C; Perez-Aisa, A; Rodriguez-Tellez, M | 1 |
| Kotsiubniak, LA; Koval', VIu; Moskal', OM | 1 |
| Andrianov, M; Azzam, R; Rivera, E | 1 |
| Long, C; Zhang, S | 1 |
| Aponte-Pieras, JR; Lee, DS; Morrissey, R; Moss, SF; Rogers, AB; Zhang, S | 1 |
| Cho, KB; Heo, J; Jang, BI; Jeon, SW; Jung, JT; Kim, HS; Kwon, JG; Lee, DW; Lee, SH; Park, JB; Park, KS; Yang, CH | 1 |
| Kim, BW; Kim, JS; Park, SM | 1 |
| Almeida, N; Calhau, C; Cardoso, O; Cipriano, MA; Donato, MM; Fernandes, A; Luxo, C; Marinho, C; Romãozinho, JM; Sofia, C | 1 |
| Acartürk, G; Aşık, G; Çiftci, İH; Dilek, FH; Şafak, B; Uğraş, M | 1 |
| Aydoğdu, S; Baran, M; Çakır, M; Tümgör, G; Yüksekkaya, HA | 1 |
| Akkan, T; Aktaş, B; Atbaşı, ST; Başyiğit, S; Nazlıgül, Y; Şimşek, G; Uzman, M; Yılmaz, B; Yüksel, O | 1 |
| Hauser, G; JajacKnez, A; Salkic, N; Stimac, D; Vukelic, K | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Lee, JY; Lin, JT; Liou, JM; Liou, TC; Luo, JC; Sheu, BS; Tseng, CH; Wang, HP; Wu, CY; Wu, JY; Wu, MS; Yang, TH | 1 |
| Hwang, JJ; Kim, N; Lee, AR; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Astegiano, M; Fagoonee, S; Pellicano, R; Ribaldone, DG; Saracco, G | 1 |
| Alonso, H; Bujanda, L; Cosme, A; Fernández-Reyes, M; Lizasoan, J; Martos, M; Mendarte, U; Montes, M; Saraqueta, C; Tamayo, E | 1 |
| Roy, BK; Shukla, HS; Srivastava, AK; Tewari, M | 1 |
| Abou Mrad, R; Chalhoub, JM; Harb, AH; Sharara, AI | 1 |
| Mahachai, V; Prapitpaiboon, H; Vilaichone, RK | 1 |
| Bojic, B; Milasin, J; Popovic, B; Zaric, S | 1 |
| Chiou, SS; Chiu, CH; Chiu, YC; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, KL; Yen, YH | 1 |
| Bai, P; He, L; Li, Y; Lin, S; Qian, J; Song, Z; Wang, Y; Xue, Y; Zhang, J; Zhou, L | 1 |
| Di Leo, A; Giorgio, F; Ierardi, E; Leandro, G; Losurdo, G; Montenegro, L; Principi, M; Sorrentino, C | 1 |
| Hashimoto, Y; Hiki, N; Honda, M; Kamiya, S; Kumagai, K; Mine, S; Nunobe, S; Ohashi, M; Sano, T; Yamaguchi, T | 1 |
| Bai, P; Ding, Y; Luo, Y; Xiao, XM; Zhou, LY | 1 |
| Dechsukhum, C; Kaewpitoon, N; Kaewpitoon, S; Leeanansaksiri, W; Loyd, RA; Matrakool, L; Panpimanmas, S; Tongtawee, T | 1 |
| Grgov, S; Katić, V; Krstić, M; Nagorni, A; Radovanović-Dinić, B; Tasić, T | 1 |
| Cohen, O; Gorshtein, A; Hershko, AY; Levy, Y; Locketz, G | 1 |
| Casado-Caballero, F; Fernández-Gutierrez, C; Fernández-Moreno, N; Fernández-Sánchez, F; Hervas-Molina, AJ; Montiel Quezel-Guerraz, N; Navarro-Jarabo, JM; Pallares-Manrique, H; Pérez-Aisa, A; Puente-Gutierrez, JJ; Rivas-Ruiz, F; Rodríguez-Ramos, C | 1 |
| Gisbert, JP; Graham, DY | 1 |
| Chalhoub, JM; Harb, AH; Sharara, AI | 1 |
| Annibale, B; Calabrese, C; Caselli, M; Di Mario, F; Farinati, F; Gasbarrini, G; Gullini, S; Ierardi, E; Luzza, F; Maconi, G; Ojetti, V; Pretolani, S; Romano, M; Rugge, M; Savio, A; Stockbrugger, R; Zagari, RM | 1 |
| Brennan, DE; Breslin, N; Haider, RB; Hall, B; Holleran, G; McNamara, D; O'Connor, HJ; O'Morain, C; Omorogbe, J; Smith, SM | 1 |
| Guo, B; Li, BZ; Li, P; Mao, C; Threapleton, DE; Wang, JY; Xu, JM; Ye, DQ; Ye, QL; Yuan, JQ; Zhang, C | 1 |
| Braden, B | 1 |
| Belzer, C; de Vos, WM; den Dunnen, JT; Devilee, P; Dingemanse, C; Günthel, M; Kuijper, EJ; Robanus-Maandag, EC; Salvatori, D; van Hijum, SA; van Ommen, GB | 1 |
| Curth, HM; Dinter, J; Hunzelmann, N; Kütting, F; Nigemeier, K; Steffen, HM | 1 |
| Bonura, C; Calà, C; Camilleri, S; Di Carlo, E; Fasciana, T; Giammanco, A; Manganaro, M; Matranga, D; Scarpulla, G | 1 |
| Chen, Q; Graham, DY; Liang, X; Liu, W; Lu, H; Xiao, S; Zhang, W | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsieh, CF; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Liou, TC; Liu, TY; Luo, JC; Shun, CT; Tsao, FY; Tseng, CH; Wu, JY; Wu, MS; Yang, TH | 1 |
| Hwang, JH; Jang, ES; Jeong, SH; Kim, J; Kim, JW; Kim, N; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Elsherif, R; Elzahry, M; Ghaith, D; Mostafa, G; Mostafa, S; Ramzy, I | 1 |
| Glocker, EO | 1 |
| Chun, J; Kim, BG; Kim, BS; Kim, JS; Kim, JW; Koh, SJ; Lee, KL; Oh, B | 1 |
| Hwang, JJ; Kim, N; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Chen, KY; Lee, HC; Lin, CL; Lin, TJ; Wang, CK; Wu, DC | 1 |
| Alexandrakis, G; Apostolopoulos, P; Dogantzis, P; Ekmektzoglou, K; Kalantzis, C; Koumoutsos, I; Tsibouris, P; Vlachou, E | 1 |
| Li, JY; Ma, JL; Pan, KF; Shen, L; You, WC; Zhang, L; Zhang, Y; Zhou, T | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Mitov, I; Yaneva, P | 1 |
| Chiang, YS; Chien, CC; Chiou, SS; Chou, YP; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, IT; Yang, SC; Yen, YH | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Kandilarov, N; Markovska, R; Mitov, I; Spassova, Z; Yaneva, P | 1 |
| Cerqueira, RM; Correia, MR; Manso, MC; Vilar, H | 1 |
| Baik, GH; Choi, SC; Chung, JW; Hong, SJ; Huh, KC; Jeon, SW; Jung, HK; Jung, WT; Kang, HM; Kim, GH; Kim, HS; Kim, HU; Kim, JG; Kim, JH; Kim, JJ; Lee, DH; Lee, J; Lee, SI; Lee, SW; Park, MI; Seol, SY; Shin, WG; Yoon, SM | 1 |
| Birk, JW; Senatore, FJ; Wilmot, J | 1 |
| Chen, DF; Han, R; Lan, CH; Li, CX; Liao, ST; Wang, CH; Yang, J; Yang, YY | 1 |
| Horio, A; Kamiya, K; Nishio, E; Tokura, Y | 1 |
| Bilici, M; Demirci, H; Köktürk, F; Kurt, Ö; Öztürk, K; Üstündağ, Y; Uygun İlikhan, S; Uygun, A | 1 |
| Ahmed, MR; Mel-Hennawi, D | 1 |
| Al Kaabi, S; Babu, R; Chandra, P; Derbala, M; Doiphode, S; John, A; Sharma, M; Yacoub, R | 1 |
| Andrzejewska, E; Eder, P; Karpiński, TM; Linke, K; Szkaradkiewicz, A | 1 |
| Alimadadi, M; Amirkhanlou, S; Hafezi, AA; Homapour, S; Seyyedmajidi, M; Vafaeimanesh, J; Vakili, MA | 1 |
| Baik, GH; Bang, CS | 1 |
| Cheon, JH; Choi, YJ; Kim, JH; Kim, SE; Ku, KH; Kwon, HJ; Lee, GW; Moon, W; Park, MI; Park, SJ; Song, SE; Yoo, CH | 1 |
| Ali Arous, N; Bachtarzi, M; Burucoa, C; Djennane-Hadibi, F; Layaida, K; Nakmouche, M; Ramdani-Bouguessa, N; Saadi, B; Tazir, M | 1 |
| Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A | 1 |
| Haider, T; Jain, A; Jain, SK; Kumar, A | 1 |
| Chung, HS; Jung, DH; Kim, JH; Lee, SK; Lee, YC; Park, JC; Shin, SH; Shin, SK | 1 |
| Asilturk, Z; Basyigit, S; Hokkaomeroglu, M; Kefeli, A; Nazligul, Y; Sapmaz, F; Uzman, M; Yeniova, AO | 1 |
| Boyanova, L; Gergova, G; Markovska, R; Mitov, I; Yordanov, D | 1 |
| Chen, A; Chen, WC; Cheng, JS; Chuah, SK; Hsu, PI; Kao, SS; Lai, KH; Peng, NJ; Tsay, FW; Wang, HM; Wu, DC; Yu, HC | 1 |
| Chan, CC; Chien, NH; Hung, CS; Lee, CL; Tu, TC; Wu, CH; Yang, YC | 1 |
| Angelidou, I; Arampatzioglou, A; Dellaporta, E; Kambas, K; Konstantinidis, T; Kouklakis, G; Mitroulis, I; Mitsios, A; Panopoulou, M; Ritis, K; Skendros, P; Tsironidou, V | 1 |
| Aramin, H; Crowe, SE; Gupta, S; Park, JY; Thung, I; Valasek, MA; Vavinskaya, V | 1 |
| Berchová, K; Hassan, ST; Majerová, M; Pokorná, M; Švajdlenka, E | 1 |
| Dechsukhum, C; Kaewpitoon, N; Kaewpitoon, SJ; Loyd, RA; Matrakool, L; Panpimanmas, S; Tongtawee, T | 1 |
| Chan, EW; Chui, CS; Douglas, IJ; Ghebremichael-Weldeselassie, Y; Root, A; Siu, CW; Smeeth, L; Wong, AY; Wong, IC | 1 |
| Alexander, GC; Iyer, G | 2 |
| Dauga, C; Raymond, J; Thiberge, JM | 1 |
| Gaüzère, BA; Malvy, D | 1 |
| Itoh, F; Kato, M; Kudo, T; Mabe, K; Miyamoto, S; Oikawa, R; Ono, S; Sakamoto, N; Watanabe, Y; Yamamoto, H | 1 |
| Mahachai, V; Mairiang, P; Rasachak, B; Vannarath, S; Vilaichone, RK; Yamaoka, Y | 1 |
| Bai, P; He, L; Song, Z; Xue, Y; Zhang, J; Zhou, L | 1 |
| Niv, Y | 3 |
| Durukan, E; Erhamamci, S; Gokturk, HS; Ozgur, GT; Unler, GK | 1 |
| Hwang, JC; Kang, JK; Kim, JH; Kim, SS; Lee, KM; Lim, SG; Park, RW; Shin, SJ; Yoon, D | 1 |
| Forte, A; Jeverica, S; Šeruga, M; Stefanovič, M; Tepeš, B; Vujasinović, M | 1 |
| Franceschi, F; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lopetuso, LR; Ojetti, V; Petruzziello, C; Scaldaferri, F; Tortora, A | 1 |
| Bakshi, SS | 1 |
| Ji, C; Kong, C; Liu, G; Meng, X; Wu, J; Yang, L; Zhao, L; Zhu, X | 1 |
| Chen, JH; Chua, CS; Hsu, YH; Huang, SY; Lee, HC; Liu, YH; Yang, KC | 1 |
| Bai, P; Ding, Y; Song, Z; Zhang, L; Zhou, L | 1 |
| Arnold, CA; Coss, E; Cryer, B; Doern, CD; Dunbar, KB; Lam-Himlin, DM; Mitui, M; Okwara, C; Park, JY; Thung, I; Valasek, MA | 1 |
| Amiri, M | 1 |
| Asaka, M; Funao, N; Murakami, K; Nishimura, A; Sakurai, Y; Shiino, M | 1 |
| Blake, Z | 1 |
| Imamura, T; Imashuku, S; Ohmae, T; Osamura, T; Todo, K | 1 |
| Wong, IC | 1 |
| Chen, A; Hsu, PI; Hsu, WH; Kuo, CH; Tsay, FW; Wu, DC | 1 |
| Fukayama, M; Hayakawa, Y; Hirata, Y; Koike, K; Niikura, R; Shichijo, S; Ushiku, T; Yamada, A | 1 |
| Akyuz, F; Baran, B; Besisik, F; Demir, K; Emrence, Z; Evirgen, S; Gokturk, S; Karaca, C; Kaymakoglu, S; Ormeci, A; Soyer, OM; Ustek, D | 1 |
| Ishihara, S; Kawashima, K; Kinoshita, Y | 1 |
| Fujimura, Y; Fujita, M; Haruma, K; Kamada, T; Kimura, T; Matsumoto, H; Murao, T; Nakato, R; Nishibayashi, H; Shiotani, A | 1 |
| Dore, MP; Graham, DY | 1 |
| Amorena, E; Campillo, A; Kutz, M; LaIglesia, M; Ostiz, M | 1 |
| Bhaskaran, K; Brauer, R; Douglas, I; Evans, SJ; Ghebremichael-Weldeselassie, Y; Navaratnam, V; Root, AA; Smeeth, L; Wong, AY; Wong, IC | 1 |
| Bilgilier, C; Dolak, W; Kiesewetter, B; Makristathis, A; Raderer, M; Simonitsch-Klupp, I; Steininger, C | 1 |
| Chiba, N; Fallone, CA; Fischbach, L; Gisbert, JP; Hunt, RH; Jones, NL; Leontiadis, GI; Marshall, JK; Moayyedi, P; Render, C; van Zanten, SV | 1 |
| Baik, GH; Hong, SJ; Kim, BW; Kim, JH; Kim, JI; Kim, JS; Kim, SW; Shim, KN; Song, HJ | 1 |
| Georgopoulos, SD; Grivas, E; Kasapidis, P; Laoudi, F; Martinez-Gonzales, B; Mentis, A; Michopoulos, S; Petraki, K; Sgouras, D; Sotiropoulou, M; Spiliadi, C; Xirouchakis, E; Zampeli, E; Zografos, K | 1 |
| Atzmüller, D; Betterklieber, C; Högenauer, C; Krause, R; Leitner, E; Mörth, E; Parsché, P; Pavek, J; Plieschnegger, W; Reicht, G; Reiter, L; Semlitsch, G; Stepan, V; Zollner-Schwetz, I | 1 |
| Chan, EW; Chang, WC; Chen, EY; Chui, CS; Lee, EH; Leung, WK; Wong, AY; Wong, IC | 1 |
| Shokri-Shirvani, J; Zamani, M; Zamani, V | 2 |
| Mayor, S | 1 |
| Oberhofer, E | 1 |
| Harris, PR; Hernandez, C; Leon, MA; Palma, C; Serrano, CA; Vera, M | 1 |
| Boudebesse, C; Etain, B; Henry, C; Legendre, T | 1 |
| Gotoda, T; Iwatsuka, K; Kusano, C; Moriyama, M; Suzuki, S | 1 |
| Bhanthumkomol, P; Chonprasertsuk, S; Mahachai, V; Phiphatpatthamaamphan, K; Pornthisarn, B; Siramolpiwat, S; Tangaroonsanti, A; Vilaichone, RK | 1 |
| Hillard, JR; Laird-Fick, HS; Saini, S | 1 |
| Fukuda, Y; Kamiya, S; Kato, M; Kikuchi, S; Mabe, K; Okuda, M; Osaki, T | 1 |
| Chang, LL; Chen, YH; Hu, HM; Kuo, CH; Kuo, FC; Liu, CJ; Ren, JL; Shih, HY; Wang, HD; Wu, DC; Wu, MC; Yang, CC | 1 |
| Katelaris, P; Mitchell, H | 1 |
| Bang, BW; Chung, JW; Han, JP; Hong, SJ; Kim, BW; Kim, CW; Kim, HG; Kim, JS; Kim, KO; Kim, SY; Kim, TH; Yun, SC | 1 |
| Ahmed, MR | 1 |
| Ida, A; Miyaki, A; Miyauchi, T; Yamaguchi, K | 1 |
| Alvaro, D; Bellesia, A; De Francesco, V; Hassan, C; Ridola, L; Vaira, D; Zullo, A | 1 |
| Abd-Elsalam, S; Ali, LA; El-Kalla, F; Elkhalawany, W; Habba, E; Kobtan, A; Mansour, L; Nawasany, SE; Rizk, F; Saif, SA; Shehata, MA; Soliman, H; Soliman, S; Yousef, M | 1 |
| Ahmed, W; Arif, A; Bibi, S; Khan, A; Siddiqui, TR | 1 |
| Hsu, TH; Huang, KW; Lin, LC; Tam, KW | 1 |
| Alarcón-Millán, J; Betancourt-Linares, R; Castañón-Sánchez, CA; Cortés-Malagón, EM; Cruz-Del Carmen, I; De Sampedro-Reyes, J; Fernández-Tilapa, G; Román-Román, A | 1 |
| Bagheri Lankarani, K; Bazargani, A; Dara, M; Dehghani, B; Khashei, R; Moeini, M; Sohrabi, M; Taghavi, A | 1 |
| Amorena, E; Campillo, A; Kutz, M; La Iglesia, M; Ostiz, M | 1 |
| Asano, M; Furuta, T; Nakamura, M; Noda, T; Ojima, T; Okada, E; Ozeki, K; Shibata, Y | 1 |
| Campitelli, E; Catalano, M; Corti, R; Goldman, C; Ibarra, D; Mendiondo, N; Salim, N; Viola, L; Wonaga, A; Zerbetto De Palma, G | 1 |
| Becquart, JP; Camuset, G; Gérardin, P; Guillemot, G; Jaubert, J; Kwiatek, S; Michault, A; Picot, S; Thomas, E; Zemali, N | 1 |
| Asaka, M; Kato, M; Kudo, T; Mabe, K; Nakamura, M; Sakamoto, N; Sato, M; Shiratori, S; Takakuwa, Y; Yoshii, S | 1 |
| Hasegawa, S; Nakamura, K; Nishimura, A; Okamoto, H; Sakurai, Y; Shiino, M | 1 |
| Hou, M; Ji, MJ; Jiao, JH; Luo, XF; Pu, HM; Qu, BJ; Yang, BY; Zhang, WY | 1 |
| Wu, LP; Xiao, MB; Xuan, SH; Zhou, YG | 1 |
| Boemi, M; Bonazzi, P; Bonfigli, AR; Brandoni, G; Ceriello, A; Festa, R; Genovese, S; Olivieri, F; Spazzafumo, L; Testa, R | 1 |
| Choi, H; Ji, JS; Kim, BW; Kim, JS; Park, SM | 1 |
| Fukui, K; Hayakawa, Y; Hirata, Y; Isomura, Y; Ito, Y; Koike, K; Matsuo, K; Mochizuki, S; Niikura, R; Okamoto, M; Omae, T; Seto, M; Shichijo, S; Sugimoto, T; Suzuki, H; Suzuki, N; Takano, N; Togo, G; Watabe, H; Yamada, A; Yamamoto, S | 1 |
| Huh, CW; Jung, da H; Kim, JH; Park, H; Park, JJ; Youn, YH | 1 |
| Hayakawa, Y; Hirata, Y; Koike, K; Sakitani, K; Serizawa, T; Shichijo, S; Suzuki, N; Yamada, A | 1 |
| Donzelli, A | 1 |
| Plate, A | 1 |
| Fujita, M; Graham, DY; Haruma, K; Ishii, M; Kamada, T; Katsumata, R; Matsumoto, H; Murao, T; Nakato, R; Shiotani, A | 1 |
| Abuhammour, A; Dajani, A; Nounou, M; Zakaria, M | 1 |
| Ho, HJ; Lin, JT; Liou, JM; Shiu, SI; Wu, CY; Wu, MS; Yeo, YH; Zou, B | 1 |
| Alves, E; Breyer, HP; Coelho, LG; Cota, B; de Souza, JD; Lima, K; Maguilnik, I; Maia, AB; Martins, GM; Mascarenhas, R; Meira, AC; Moretzsohn, LD; Passos, R; Pinto, H; Rezende-Filho, J; Ribeiro, LT; Sanches, BS; Trindade, OR | 1 |
| Barone, M; Di Leo, A; Giangaspero, A; Giorgio, F; Iannone, A; Ierardi, E; Losurdo, G; Monno, R; Principi, M; Sorrentino, C | 1 |
| Adachi, K; Ebi, M; Funaki, Y; Goji, S; Izawa, S; Kasugai, K; Noda, H; Noguchi, S; Ogasawara, N; Sasaki, M; Tamura, Y; Yamamoto, S; Yoshimine, T | 1 |
| Basso da Silva, L; Cristovam, RA; de Moraes, GS; Francesconi, CF; Klein, MG; Mazzoleni, F; Mazzoleni, LE; Nabinger, DD; Nardelli, EF; Osório, MC; Rech, TF; Sander, GB; Simon, D | 1 |
| Atherton, J; Axon, AT; Bazzoli, F; El-Omar, EM; Gasbarrini, A; Gisbert, JP; Graham, DY; Hunt, R; Kuipers, EJ; Malfertheiner, P; Megraud, F; Moayyedi, P; O'Morain, CA; Rokkas, T; Rugge, M; Selgrad, M; Suerbaum, S; Sugano, K | 1 |
| Inoue, H; Ito, M; Kasai, C; Moritani, I; Oya, Y; Shiraki, K; Sugimoto, K; Takase, K; Takei, Y; Tameda, M; Tanaka, J | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Hu, WH; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Sheu, BS; Shun, CT; Tseng, CH; Wu, JY; Wu, MS; Yang, TH | 1 |
| Barone, M; Di Leo, A; Giorgio, F; Iannone, A; Ierardi, E; Losurdo, G; Principi, M | 1 |
| Kajihara, Y; Mizuki, I; Shimoyama, T | 1 |
| Miftahussurur, M; Sharma, RP; Shrestha, PK; Subsomwong, P; Yamaoka, Y | 1 |
| Agudo, S; Aguilera-Correa, JJ; Alarcón, T; Barrio, J; Llorca, L; Martinez, MJ; Somodevilla, A; Urruzuno, P | 1 |
| Han, JP; Hong, SJ; Ko, BM; Lee, JS; Lee, MS; Lee, TH; Lee, YN; Noh, HM; Park, KW | 1 |
| Gisbert, JP | 2 |
| Cruz-Correa, M; López-Román, O; Tirado Montijo, R; Toro, DH; Urbina, R; Warrington, E | 1 |
| Adi, P; Akada, J; Akil, F; Maimunah, U; Makmun, D; Maulahela, H; Miftahussurur, M; Mustika, S; Nusi, IA; Rahardjo, D; Rezkitha, YA; Saudale, AM; Simanjuntak, D; Subsomwong, P; Suzuki, R; Syam, AF; Uwan, WB; Waleleng, JB; Waskito, LA; Wibawa, ID; Yamaoka, Y; Yusuf, F; Zein, LH | 1 |
| Elbaz, T; Elgarem, H; Elhosary, W; Elzahry, MA; Ghaith, D; Hamza, I; Mostafa, G; Ramzy, I | 1 |
| Akbay Harmandar, F; Çekin, AH; Çekin, Y; Şahintürk, Y; Uyar, S; Yolcular, BO | 1 |
| Eguchi, T; Fujita, M; Fukuchi, T; Hashimura, H; Kanamori, A; Kano, C; Koizumi, A; Matsumoto, K; Momose, K; Okada, A; Shimoyama, K; Tsujimae, M; Yamashita, H | 1 |
| Burgos García, A; Fernández Martos, R; Froilán Torres, C | 1 |
| Chey, WD; Howden, CW; Leontiadis, GI; Moss, SF | 1 |
| Chen, PY; Liou, JM; Wu, MS | 1 |
| Kato, M; Mabe, K; Nakagawa, S; Ono, S; Sakamoto, N | 1 |
| Chang, JY; Jung, HK; Jung, SA; Kim, SE; Lee, J; Lee, KE; Lee, KH; Moon, CM; Shim, KN; Tae, CH | 1 |
| Almeida, N; Branquinho, D; Cabral, JE; Casela, A; Donato, MM; Gregório, C; Tomé, L | 1 |
| Chen, H; Hao, B; Su, J; Zhang, G; Zhang, W; Zhou, X | 1 |
| Hasuda, K; Hattori, M; Ido, Y; Okuda, A; Sakurai, K; Suda, H; Takeichi, T | 1 |
| Chen, Z; Gao, S; Ge, X; Geng, X; Hong, W; Hou, G; Hu, Z; Jia, J; Li, W; Sun, Y; Zeng, B; Zhou, Y | 1 |
| Chang, WL; Chen, WY; Cheng, HC; Lin, CH; Lu, CC; Ou, HY; Sheu, BS; Wu, CT; Yang, HB; Yang, YJ | 1 |
| Attaran, B; Falsafi, T; Ghorbanmehr, N | 1 |
| Ayhan, S; Çağan-Appak, Y; Cengiz-Özyurt, B; Gazi, H; Kasırga, E; Kurutepe, S | 1 |
| Bronstein, JA | 1 |
| Deng, D; Feng, G; Gu, L; Li, Q; Liu, Z; Ma, J; Shen, J; Shen, L; You, WC; Zhang, B; Zhang, L; Zhou, J | 1 |
| Dissemond, J; Körber, A | 1 |
| Asaka, M; Itoh, T; Kato, M; Kubota, K; Nakagawa, M; Ono, S; Ono, Y; Shimizu, Y | 1 |
| Blumenthal, M; Bornstein, J; Geva, A; Geva, H; Levy, J; Ophir, E; Sabo, E | 1 |
| Bujanda, L; Calvet, X; Castro, M; Gisbert, JP; Sánchez-Delgado, J; Titó, L | 1 |
| Arkkila, PE; Kosunen, TU; Rautelin, H; Seppälä, K; Sipponen, P; Tilvis, R; Veijola, L | 1 |
| Ching, SS; Jenkinson, LR; Sabanathan, S | 1 |
| Egan, BJ; O'Connor, HJ; O'Morain, CA | 1 |
| Chang, IJ; Jung, HC; Kang, JM; Kim, JS; Kim, N; Lee, DH; Park, YS; Song, IS | 1 |
| Vakil, N | 2 |
| Hwang, JH; Jeong, SH; Jung, HC; Kim, JS; Kim, JW; Kim, MN; Kim, N; Lee, DH; Lee, SH; Park, YS; Song, IS | 1 |
| Choi, JH; Chun, HJ; Jung, SW; Kim, CD; Kim, SY; Koo, JS; Lee, HS; Lee, SW; Park, JJ; Ryu, HS; Yim, HJ | 1 |
| Amagai, K; Asaka, M; Fukase, K; Hayashi, S; Inoue, K; Kato, M; Kikuchi, S; Okamoto, S; Terao, S; Uemura, N | 1 |
| Dragomir, D; Hurduc, V; Plesca, D; Sajin, M; Vandenplas, Y | 1 |
| Aysev, D; Ensari, A; Girgin, N; Kansu, A; Kirsaçlioğlu, CT; Küçük, NO; Kuloğlu, Z; Ustündağ, G | 1 |
| Cozzolino, D; Iovene, MR; Nardone, G; Pilloni, AP; Rocco, A; Romano, M; Russo, MI; Salerno, R; Tufano, MA; Vaira, D | 1 |
| Moosavian, M; Samarbaf-Zadeh, AR; Tajbakhsh, S | 1 |
| Hassan, C; Ricci, C; Vaira, D; Vakil, N; Zullo, A | 1 |
| Hungin, AP; Jackson, W; Mason, JM; Raghunath, AS | 1 |
| Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA | 1 |
| Choi, MG; Chung, IS; Dong, MS; Lee, SB; Oh, JH; Park, YI; Yoo, HW | 1 |
| Chee, YJ; Jung, HC; Kim, IY; Kim, JM; Kim, JS; Kim, N; Kim, YJ; Lee, CH | 1 |
| Hagymási, K; Tulassay, Z | 1 |
| Astegiano, M; Berrutti, M; Fadda, M; Fagoonee, S; Morgando, A; Pellicano, R; Repici, A; Rizzetto, M; Saracco, G; Smedile, A | 1 |
| Pan, WS; Yan, XF; Zeng, S; Zhou, Q; Zhu, LL | 1 |
| Isomoto, H; Ito, M; Kohno, S; Nishiyama, H; Okamoto, K; Shikuwa, S | 1 |
| Bhattacharya, S; Ganesh, N; Jain, NK; Ramteke, S | 2 |
| Dehghani, SM; Erjaee, A; Haghighat, M; Imanieh, MH | 1 |
| Carrobles Jiménez, JM; Cuena Boy, R; de Artaza Varasa, T; García Vela, A; Martín Escobedo, R; Pérez-Grueso, MJ; Rodríguez Merlo, R; Valle Muñoz, J | 1 |
| Balasubramaniam, J; Karunagaran, LN; Mishra, B; Rajinikanth, PS | 1 |
| Aigner, T; Fritzsch, J; Krügel, V; Pluta, L; Schütz, A | 1 |
| Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Shon, CI; Song, MJ | 1 |
| De Francesco, V; Giorgio, F; Hassan, C; Ierardi, E; Panella, C; Perna, F; Vaira, D; Zullo, A | 1 |
| Arakawa, T; Fujiwara, Y; Higuchi, K; Hino, M; Koh, K; Nakao, T; Okazaki, H; Oshitani, N; Tanigawa, T; Tominaga, K; Tsumoto, C; Watanabe, K; Watanabe, T; Yamagami, H; Yamane, T | 1 |
| Cristofari, F; Hassan, C; Zullo, A | 1 |
| Altintaş, E; Aslan, G; Emekdaş, G; Serin, MS; Sezgin, O; Tezcan, S | 1 |
| Hibi, T; Iwasaki, E; Masaoka, T; Nakagawa, I; Nishizawa, T; Suzuki, H | 1 |
| Aoki, T; Itoi, T; Kataoka, M; Kawai, T; Kawakami, K; Moriyasu, F; Noguchi, N; Osaka, Y; Rimbara, E; Sakai, Y; Sasatsu, M; Sofuni, A; Takagi, Y; Yagi, K; Yamagishi, T | 1 |
| Ran, ZH; Shen, J; Tong, JL; Xiao, SD | 1 |
| Li, Y; Shen, SR; Wang, XY | 1 |
| Baranov, AA; Shcherbakov, PL | 1 |
| Oganesian, TS | 1 |
| Bengtsson, C; Granström, M; Hoang, TT; Nguyen, GK; Nguyen, TV; Phung, DC; Sörberg, M | 1 |
| Chae, HS; Chang, YW; Cho, CM; Chun, HJ; Chung, IS; Hong, SJ; Jeon, WJ; Jung, HC; Kim, HU; Kim, JG; Kim, JW; Kim, N; Kim, SW; Kim, TN; Lee, GH; Lee, KJ; Lee, OJ; Lee, SW; Park, CG; Park, CH; Park, JJ; Park, JY; Park, KS; Park, MI; Park, SH; Seo, GS; Seol, S; Shim, KN; Shin, JE; Shin, WC; Shin, YW; Song, GA; Won, SY; Yoon, BC | 1 |
| Cheon, JH; Kim, JH; Kim, TI; Kim, WH; Lee, SK; Lee, YC | 1 |
| Coelho, L; Moretzsohn, L; Sanches, B; Vieira, G | 1 |
| Sánchez-Delgado, J | 1 |
| Chin, K; Fujimura, M; Ichikawa, T; Kajimoto, S; Kamijima, S; Mikami, K; Sekita, N; Suzuki, H | 1 |
| Kim, DH; Kim, IS; Kim, MK; Kim, YJ; Park, DI; Park, H; Woo, HY | 1 |
| Filipec Kanizaj, T; Kalenic, S; Katicic, M; Plecko, V; Skurla, B; Ticak, M | 1 |
| Boziki, M; Chatzopoulos, D; Deretzi, G; Gavalas, E; Grigoriadis, N; Katsinelos, P; Kountouras, J; Tsolaki, M; Tzilves, D; Venizelos, I; Zavos, C | 1 |
| Futagami, S; Inagaki, H; Kawagoe, T; Kusunoki, M; Miyake, K; Sakamoto, C; Shindo, T; Tsukui, T; Ueki, N | 1 |
| Bravo, JC; Bravo, LE; Casabon, AL; Casabon, LA; Collazos, T; Correa, P; Fischbach, LA; Guerrero, LZ; Ojha, PR; Ojha, RP; Priest, EL; Singh, KP; Singh, PK; Zarama, GR | 1 |
| Essa, AS; Graham, DY; Kramer, JR; Treiber, G | 1 |
| Kawai, T; Noguchi, N; Rimbara, E; Sasatsu, M; Tamura, R; Tanuma, M | 1 |
| de Boer, WA; Janssen, MJ; Schrauwen, RW | 1 |
| Albrecht, P; Szajewska, H; Topczewska-Cabanek, A | 1 |
| Butt, F; Kadowaki, M; Sugiyama, T; Usmanghani, K; Yoshida, I; Yusuf, MA; Zaidi, SF | 1 |
| Arigbabu, AO; Coker, AO; Oyedeji, KS; Smith, SI | 1 |
| Barbon, V | 1 |
| Ahmed, S; Ali Shah, H; Hamid, S; Jafri, W; Salih, M | 1 |
| Gwee, KA; Ho, KY; Sutedja, DS; Teng, L; Wong, RK; Yeoh, KG | 1 |
| Deguchi, R; Fukuda, R; Matsushima, M; Mine, T; Nishina, M; Ozawa, H; Suzuki, T; Takagi, A | 1 |
| Balkarli, A; Baştürk, A; Cerçi, S; Senol, A; Songür, Y | 1 |
| Chang, WL; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB; Yang, YJ | 1 |
| Amakawa, R; Baba, S; Hoshino, S; Inaba, M; Iwai, H; Konishi, M; Nakae, K; Nakamichi, N | 1 |
| Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
| Lin, CJ; Uang, YS; Wang, TH; Yang, JC; Yang, YF | 1 |
| Abdullah, SA; Ahmad, N; Mohamed, R; Zakaria, WR | 1 |
| Bakir Ozbey, S; Keskin, M; Ozakin, C | 1 |
| Barrio, J; Castro-Fernández, M; Cosme, A; Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pérez-Aisa, A; Rodrigo, L | 1 |
| Buka, GIu; Veligotskiĭ, NN | 1 |
| Katelaris, PH | 2 |
| Kandulski, A; Malfertheiner, P; Selgrad, M | 1 |
| Esedov, EM; Magomedéminova, AS | 1 |
| Cesar, GE; Fujita, Y; Fukuda, K; Horiki, N; Iizuka, Y; Imoto, I; Ishii, N; Ito, T; Katsurahara, M; Omata, F; Suzuki, S; Takei, Y; Uemura, M | 1 |
| Cai, W; Deng, L; Ren, W; Yu, M; Zhou, L | 1 |
| Dixit, VK; Gulati, AK; Jain, AK; Maurya, P; Mishra, S; Nath, G; Rao, G; Singh, V | 1 |
| Chey, WD; Higgins, PD; Luther, J; Moayyedi, P; Schoenfeld, PS; Vakil, N | 1 |
| Bojic, B; Cakic, S; Dapcevic, B; Jankovic, Lj; Milasin, J; Popovic, B; Zaric, S | 1 |
| Mishra, B; Rajinikanth, PS | 2 |
| Chen, A; Graham, DY; Hsu, PI; Hung, WC; Kuo, CH; Opekun, AR; Wang, SS; Wu, DC; Wu, IC; Wu, JY | 1 |
| Best, L; Chan, F; Cooper-Lesins, G; Forward, K; Haldane, D; Slinger, R; Veldhuyzen van Zanten, S; Yan, L | 1 |
| Di Mario, F; Gatta, L; Leandro, G; Vaira, D; Vakil, N | 1 |
| Arslan, H; Demir, M; Gokturk, HS; Ozturk, NA; Serin, E; Yilmaz, U | 1 |
| Dabos, KJ; Giannikopoulos, G; Sfika, E; Vlatta, LJ | 1 |
| Demir, M; Gokturk, HS; Ozturk, NA; Serin, E; Yilmaz, U | 1 |
| But, D; Chan, CK; Chan, FS; Chan, P; Cheung, TK; Chu, KM; Gu, Q; Hsu, A; Hung, IF; Leung, S; Seto, WK; Tong, TS; Wong, BC; Wong, SY | 1 |
| Brnić, D; Tonkić, A; Tonkić, M | 1 |
| Choe, YH; Chung, IS; Kim, HS; Kim, JI; Kim, JJ; Kim, N | 1 |
| Hu, FL; Wang, WH; Xu, L; Zheng, XL | 1 |
| Malfertheiner, P; Moayyedi, P | 1 |
| Kucheriavyĭ, IuA | 1 |
| Sugano, H; Takahashi, S; Tanaka, A; Tokunaga, K | 1 |
| Kato, S | 2 |
| Binder, C; Bruckdorfer, A; Gadner, H; Gizci, H; Hammer, K; Hirschl, AM; Innerhofer, A; Makristathis, A; Riedl, S; Vécsei, A | 1 |
| De Francesco, V; Giorgio, F; Hassan, C; Ierardi, E; Morini, S; Panella, C; Perna, F; Vaira, D; Zullo, A | 1 |
| Bin, M; Donghai, W; Kehu, Y; Lijuan, Y; Quanlin, G; Wenzhen, Y; Yumin, L | 1 |
| ASAKA, M; HASHINO, S; IMAMURA, M; KAHATA, K; KONDO, T; MORITA, R; OKADA, K; ONOZAWA, M; TAKAHATA, M | 1 |
| Graham, DY; Rugge, M | 1 |
| Mahachai, V; Sirimontaporn, N; Thong-Ngam, D; Tumwasorn, S | 1 |
| Jian, Z; Li, Y; Tang, F; Wu, S | 1 |
| Angelini, R; Pontone, P; Pontone, S; Standoli, M | 1 |
| Chen, J; Huang, XL; Li, ZY; Yan, WH; Yu, JD; Zhang, XP | 1 |
| Hori, S; Inoue, M; Kawahara, Y; Kawano, S; Okada, H; Onishi, Y; Shiratori, Y; Takenaka, R; Toyokawa, T; Yamamoto, K | 1 |
| Al-Mekhaizeem, K; Alazmi, WM; Buhaimed, W; Siddique, I | 1 |
| Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G | 1 |
| Andrei, F; Grasso, E; Lionetti, R; Pallone, F; Paoluzi, OA; Ranaldi, R; Stroppa, I; Tosti, C; Visconti, E | 1 |
| Levy, I; Samra, Z; Shmuely, H; Yahav, J; Zevit, N | 1 |
| Baryshnikova, NV | 1 |
| Baryshnikova, NV; Denisova, EV; Kornienko, EA; Lobach, SM; Loeva, IA; Parolova, NI; Ryzhikh, VA; Smirnova, AS; Solonitsin, EG; Starostin, BD; Suvorov, AN; Suvorova, MA; Tkachenko, EI; Uspenskiĭ, IuP | 1 |
| Dutta, U; Kochhar, R; Noor, MT; Sidhu, GS; Singh, K; Udawat, H; Vaiphei, K | 1 |
| Abut, E; Bölükbaş, C; Bölükbaş, FF; Dalay, AR; Güveli, H; Kurdaş, OO; Yaşar, B | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H | 1 |
| Breslin, N; Fitzgerald, N; Murphy, P; Nami, A; O'connor, A; O'connor, H; O'moráin, C; Qasim, A; Ryan, B; Taneike, I | 1 |
| Castellaneta, S; Cavallo, L; Francavilla, R; Ierardi, E; Lionetti, E; Lorenzo, L; Margiotta, M; Piscitelli, D | 1 |
| Hwang, JH; Jeong, SH; Jung, HC; Kim, JJ; Kim, JW; Kim, N; Kwon, JH; Lee, DH; Lee, JW; Lee, SH; Park, YS; Song, BJ; Song, IS | 1 |
| Goh, KL; Ho, SL; Sam, CK; Tan, EL | 1 |
| Demir, M; Göktürk, S; Oztürk, NA; Serin, E; Yilmaz, U | 1 |
| Chang, CY; Chen, CC; Chen, MJ; Cheng, TY; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, HP; Wu, MS | 1 |
| Devani, S; Kariuki, S; Kimang'a, AN; Revathi, G; Sayed, S | 1 |
| Correa, P; Duque, X; Martinez, H; Medina, M; Mendoza, ME; Mera, R; Moran, S; Torres, J | 1 |
| Latifi-Navid, S; Massarrat, S; Saniee, P; Sheykholeslami, A; Siavoshi, F | 1 |
| Strobl, S; Zuber-Jerger, I | 1 |
| Lay, CS; Lin, CJ; Lin, JR | 1 |
| Hirata, Y; Joh, T; Kamiya, T; Kasugai, K; Kataoka, H; Mizoshita, T; Ogasawara, N; Sasaki, M; Shimura, T; Tanida, S; Utsumi, K | 1 |
| Butruk, E; Dítê, P; Eklund, S; Engstrand, L; Gottlow, M; Herszényi, L; Malfertheiner, P; Nagy, P; Stolte, M; Tchernev, K; Tulassay, Z; Wong, BC; Wrangstadh, M | 1 |
| Assumpção, MB; Barile, KA; Corvelo, TC; Silva, AL; Xavier, JN | 1 |
| Perna, F; Vaira, D | 1 |
| D'Ercole, C; De Francesco, V; Hassan, C; Vaira, D; Zullo, A | 1 |
| Belgamwar, VS; Gattani, SG; Savaliya, PJ | 1 |
| Abildstrøm, SZ; Andersen, SS; Folke, F; Fosbøl, EL; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Norgaard, ML; Raunsø, J; Torp-Pedersen, C | 1 |
| Abbas, Z; Abid, S; Jafri, W; Khalid, A; Khan, R; Naz, S; Yakoob, J | 1 |
| Akgöllü, E; Akkiz, H; Bayram, S; Bekar, A; Ozdil, B; Sandikçi, M | 1 |
| Gu, W; Liang, X; Liu, W; Lu, H; Sun, Q; Xiao, S; Zheng, Q | 1 |
| Choi, IJ; Kim, BC; Kim, CG; Nam, BH; Nam, SY; Ryu, KH | 1 |
| Hibi, T; Hirata, K; Matsuzaki, J; Muraoka, H; Nishizawa, T; Saito, Y; Suzuki, H; Tsugawa, H | 1 |
| Beck, SE; Brayton, C; Del Carmen Martino-Cardona, M; Watson, J | 1 |
| Abdelfatah, M; Assem, M; El Azab, G; Rasheed, MA; Shastery, M | 1 |
| Lassnig, RM | 1 |
| Bazzoli, F; Eusebi, LH; Fuccio, L | 1 |
| Huang, X; Li, Y; Shi, R; Yao, L; Zhang, G | 1 |
| Chang, WC; Jegal, J; Jin, CJ; Jo, YI; Lee, JH; Park, HS; Park, JH | 1 |
| Goh, KL; Manikam, J; Qua, CS | 1 |
| Hsueh, PR; Lee, PI; Yang, JC | 1 |
| Alfaresi, MS; Elkoush, AA | 1 |
| Agudo, S; Alarcón, T; López-Brea, M; Pérez-Pérez, G | 2 |
| Ayadi, A; Ben Mansour, K; Boubaker, J; Burucoa, C; Cheikh, I; Chouaib, S; Fekih, M; Fendri, C; Filali, A; Hriz, MB; Kallel, L; Karoui, S; Labbene, M; Maherzi, A; Mami, NB; Masmoudi, A; Matri, S; Najjar, T; Sfar, MT; Siala, N; Zarrouk, S; Zribi, M | 1 |
| Cabras, A; Carbone, A; Devizzi, L; Gianni, AM; Mirabile, A | 1 |
| Cho, AR; Lee, MK | 1 |
| Ashida, C; Higashida, A; Kawara, F; Mamori, S; Ohnishi, K; Senda, E; Takeda, A; Yamada, H | 1 |
| Gisbert, JP; Pajares, JM | 4 |
| Gao, XZ; Liu, F; Qiao, XL; Song, WC; Wang, XF | 1 |
| Aranda, KR; Cardoso, SR; Garcia, GT; Gonçalves, ME; Iriya, K; Scaletsky, IC; Silva, NP | 2 |
| Amendola, G; Baronci, C; Battisti, L; Bisogno, G; Branciforte, F; Ceppi, S; Corti, A; De Mattia, D; Farruggia, P; Giordano, P; Jankovic, M; Matarese, SM; Miraglia, V; Nardi, M; Nobili, B; Notarangelo, L; Palazzi, G; Parodi, E; Ramenghi, U; Russo, G; Tucci, F; Zecca, M | 1 |
| Chan, AK; Chan, FK; Chau, TS; Lee, KK; Lee, VW; Ling, TK; Waye, MM | 1 |
| Fischbach, L; Graham, DY | 1 |
| Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Martins, P; Nora, M; Vilar, H | 1 |
| Chang, JJ; Chang, LC; Chen, LW; Chien, RN; Fang, KM | 1 |
| Gon, Y; Hemmi, A; Iwamoto, M; Kato, K; Matsukawa, Y; Mizuno, S; Sawada, S; Shirinskaya, N; Takeuchi, J | 1 |
| Ahmed, MR; Youssef, TF | 1 |
| Chen, WJ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
| Bahar, K; Çinar, K; Özden, A; Seven, G; Yakut, M | 1 |
| Cuomo, A; Federico, A; Gravina, AG; Iovene, MR; Marmo, R; Miranda, A; Nardone, G; Rocco, A; Romano, M; Salerno, R; Sica, M; Tiso, A | 1 |
| Jonaitis, L; Kiudelis, G; Kupčinskas, J; Kupčinskas, L | 1 |
| Arisawa, T; Hirata, I; Ishizuka, T; Maeda, Y; Nakamura, M; Okubo, M; Shibata, T; Tahara, T; Yonemura, J; Yoshioka, D | 1 |
| Gu, WQ; Liang, X; Liu, WZ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
| Sugano, H; Takahashi, Si; Tanaka, A; Tokunaga, K | 1 |
| Agah, S; Ebrahimi-Dariani, N; Khatibian, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Pourshams, A; Riahizadeh, S; Sotoudehmanesh, R; Vahedi, H; Zendehdel, N | 1 |
| Mobarez, AM; Taghvaei, T; Talebi Bezmin Abadi, A; Wolfram, L | 1 |
| Buzás, GM | 3 |
| Hayashi, A; Jinda, S; Nakatani, K; Nishioka, J; Nobori, T; Soya, Y; Wada, H; Yasuda, K | 1 |
| Berning, M; Krasz, S; Labenz, J; Miehlke, S | 1 |
| Jamshidi, S; Khoshnegah, J; Mohammadi, M; Sasani, F | 1 |
| Bekar, O; Gulten, M; Yilmaz, Y | 1 |
| Chang, CY; Chang, SC; Chen, MJ; Chian, H; Hung, HW; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, YC; Wu, MS | 1 |
| De Francesco, V; Vaira, D; Zullo, A | 1 |
| Astegiano, M; Berrutti, M; Fagoonee, S; Morgando, A; Pellicano, R; Rizzetto, M; Strona, S | 1 |
| Aydemir, S; Cabuk, M; Demircan, N; Eren, H; Harmandar, FA; Tekin, IO | 1 |
| Aurer, A; Bago, I; Bago, J; Budimir, A; Majstorović, K; Plečko, V | 1 |
| Kilic, ZM; Nadir, I; Ozin, Y; Sezgin, O; Yonem, O | 1 |
| Boyanova, L; Cabrita, AM; de Carvalho, JN; Gonçalves, TM; Medeiros, JA; Pereira, AM; Pereira, MI | 1 |
| Lochmannová, J | 1 |
| Mahachai, V; Sirimontaporn, N; Thong-Ngam, D; Tumwasorn, S; Vilaichone, RK | 1 |
| Barbuti, RC; Eisig, JN; Felga, G; Navarro-Rodriguez, T; Silva, FM; Zaterka, S | 1 |
| Abu-Alfotuh, A; Al Shabrawi, H; Allam, MA; El-Shafie, AM; Elwan, AM; Soliman, GM | 1 |
| Fischbach, LA; Graham, DY; Rimbara, E | 1 |
| Ayala, G; Carrillo, B; Chihu, L; Fierros, G; Galván-Portillo, M; López-Carrillo, L; Román, A; Sánchez, A; Silva-Sánchez, J | 1 |
| Kim, N; Lee, BH | 1 |
| Bazzoli, F; Celiñski, K; Delchier, JC; Giguère, M; Malfertheiner, P; Mégraud, F; Rivière, M | 1 |
| Ferreri, AJM | 1 |
| Donovan, JL; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P | 1 |
| Albrecht, P; Kotowska, M; Szajewska, H | 1 |
| Asaka, M; Furukawa, K; Furuta, T; Inaba, T; Ishii, N; Kamoshida, T; Kato, M; Konda, Y; Nomura, H; Sasaki, M; Shirai, T; Sugimoto, M; Tomita, T | 1 |
| Graham, DY; Rimbara, E | 1 |
| Buonavolontà, R; Miele, E; Russo, D; Staiano, A; Vecchione, R | 1 |
| Agrawal, A; Chandra, M; Gupta, A; Koowar, S | 1 |
| Ahmad, K; Farzaneh, M; Fatemeh, F; Fatemeh, M; Hossein, FG; Kambiz, E; Mehri, N | 1 |
| Albayrak, B; Altuntas, Y; Bayraktar, B; Bugdaci, MS; Sokmen, M; Toksoy, B; Zuhur, SS | 1 |
| Graham, DY; Hsu, PI; Wu, DC; Wu, JY | 2 |
| Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
| Belousova, NL; Kashnikov, VS; Shcherbakov, PL; Shcherbakova, MIu | 1 |
| Blaser, MJ; Chhada, A; de Perez, AZ; Francois, F; Joseph, N; Pei, Z; Perez-Perez, GI; Roper, J; Shak, JR | 1 |
| Hwang, JM; Kim, GH; Kim, WJ; Lee, HS; Lee, HW; Park, DY; Ryu, DY; Song, GA | 1 |
| Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
| Cadranel, S; Casswall, T; Chong, S; Colletti, RB; Elitsur, Y; Gold, B; Goodman, KJ; Guarner, J; Jones, NL; Kalach, N; Koletzko, S; Madrazo, A; Megraud, F; Oderda, G; Rowland, M | 1 |
| Ince, AT; Kesici, B; Polat, Z; Saglam, M; Toros, AB; Uygun, A | 1 |
| Chechoulin, Y; Levi, Z; Niv, Y; Schmilovitz-Weiss, H; Schmiloviz-Weiss, H; Sehayek-Shabbat, V; Shalev, T; Shirin, H; Yishai, R | 1 |
| Goh, KL; Navaratnam, P | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Okimoto, T; Sato, R; Watanabe, K | 1 |
| Goto, Y; Hamajima, N; Inoue, S; Kamiya, Y; Kawai, S; Kondo, T; Kurata, M; Tamura, T | 1 |
| Basu, D; Jagdish, S; Kate, V; Valooran, GJ | 1 |
| Demir, M; Erbayrak, M; Gokturk, HS; Sakalli, M; Unler, GK; Yilmaz, U | 1 |
| Choi, KH; Chung, WC; Jung, SH; Kang, BK; Kim, EJ; Lee, KM; Oak, JH; Paik, CN | 1 |
| Astegiano, M; Cisarò, F; De Angelis, C; Pellicano, R; Rizzetto, M; Saracco, G | 1 |
| Chacko, Y; Holtmann, GJ | 1 |
| Furuta, T; Kodaira, C; Nishino, M; Sugimoto, M; Uotani, T; Yamade, M | 1 |
| Sheu, BS; Yang, YJ | 1 |
| Choi, JH; Chun, HJ; Jung, SW; Kim, JH; Kim, SY; Koo, JS; Lee, SW; Park, JJ; Yim, HJ | 1 |
| Binder, C; Bruckdorfer, A; Giczi, H; Graf, U; Hammer, K; Hirschl, AM; Innerhofer, A; Makristathis, A; Vécsei, A | 1 |
| Bontems, P; Cadranel, S; Kalach, N; Miendje, DY; Muyshont, L; Oderda, G; Raymond, J; Salame, A; Scaillon, M | 1 |
| Bay, A; Coskun, E; Leblebisatan, G; Yalcin, AS | 1 |
| Bauerfeind, P; Kaiser, P; Misselwitz, B; Vavricka, SR | 1 |
| Çetinkaya, ZA; Coşgun, S; Güzelbulut, F; Kurdaş, OÖ; Sezikli, M; Yeşil, A | 1 |
| Calvet, X; Gisbert, JP | 2 |
| Bo, J; Chen, MH; Fan, DM; Ge, ZZ; Ji, F; Jung, HC; Kim, JH; Lee, SW; Lee, YC; Song, KH | 1 |
| Benoliel, J; Cabral, J; Lemos, PS; Lopes, AI; Oleastro, M; Paixão, E; Ramalho, PM; Santos, A | 1 |
| Francesconi, CF; Mazzoleni, LE; Sander, GB | 1 |
| Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Torres, J; Valdivieso, M | 1 |
| Bessong, PO; Ndip, RN; Okeleye, BI | 1 |
| Choi, KD; Chung, JW; Jeong, JY; Jung, HY; Jung, JH; Kim, JH; Lee, GH; Lee, SM; Song, HJ | 1 |
| Ndip, LM; Ndip, RN; Tanih, NF | 1 |
| El-Halabi, M; Ghaith, O; Hashash, JG; Maasri, K; Malli, A; Mansour, NM; Sharara, AI; Sukkarieh, I | 1 |
| Bornschein, J; Malfertheiner, P; Selgrad, M | 2 |
| Ben Mahmoud, L; Ghozzi, H; Hakim, A; Sahnoun, Z; Zeghal, K | 1 |
| Budak, A; Karczewska, E; Sito, E; Wojtas-Bonior, I; Zwolińska-Wcisło, M | 1 |
| Chang, SN; Chen, WC; Hsu, PI; Lai, KH; Lee, CC; Peng, NJ; Tsay, FW; Tseng, HH; Wang, HM; Wang, KM; Wu, DC; Yu, HC | 1 |
| de Vrese, M; Kristen, H; Laue, C; Rautenberg, P; Schrezenmeir, J | 1 |
| Boyanova, L; Davidkov, L; Gergova, G; Ilieva, J; Kamburov, V; Katsarov, N; Mitov, I; Spassova, Z | 1 |
| Jung, SW; Kim, SY | 1 |
| Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, JY; Kim, N; Lee, DH; Lee, JH; Lee, SH; Nam, RH; Park, HK; Park, YS; Shin, CM; Song, IS | 1 |
| Guleria, K; Kaur, I; Malik, R; Radhakrishnan, G; Sikka, M | 1 |
| Campuzano-Maya, G | 1 |
| Kolesnikova, IIu; Liubskaia, LA; Volkov, VS | 1 |
| Cho, HJ; Cho, YR; Hwang, JH; Jeoung, SH; Jung, HC; Kim, JW; Kim, N; Lee, DH; Lee, SH; Oh, HS; Park, YS; Seo, JY; Shin, CM; Song, IS | 1 |
| Feng, GS; Lam, S; Li, J; Li, JY; Liu, WD; Lu, AP; Ma, JL; Pan, KF; Shen, L; Wong, BC; Xia, HH; You, WC; Zhang, L; Zhang, XD | 1 |
| Baik, GH; Kim, DJ; Kim, DY; Kim, HY; Kim, JB; Kim, KH; Kim, SJ; Kim, YS; Min, HJ; Park, SH; Shin, WG; Suk, KT; Yoon, JH | 1 |
| Dobashi, Y; Fukunishi, M; Matsumoto, S; Miyatani, H; Takamatsu, T; Ugajin, T; Yoshida, Y | 1 |
| Bresci, G; De Francesco, V; de Matthaeis, M; Gatto, G; Giorgio, F; Hassan, C; Ierardi, E; Liggi, M; Luzza, F; Manes, G; Manta, R; Marmo, R; Marone, A; Milano, A; Mirante, VG; Monica, F; Neri, M; Pallotta, S; Pedroni, A; Peri, V; Sacco, R; Suraci, E; Usai, P; Varasano, V; Zotti, M; Zullo, A | 1 |
| Basu, PP; Flynn, M; Krishnaswamy, N; Pacana, T; Rayapudi, K; Shah, NJ | 1 |
| Lehours, P; Mégraud, F; Siffré, E | 1 |
| Chuah, SK; Hsu, PI; Tsay, FW; Wu, DC | 1 |
| Baba, S; Fukuda, Y; Hattori, N; Hiraishi, T; Ishigouoka, S; Itoh, F; Maehata, T; Morita, R; Nagase, Y; Nakazawa, M; Niwa, H; Oikawa, R; Oishi, Y; Suzuki, H; Suzuki, M; Toyota, M; Watanabe, Y; Yoshida, Y | 1 |
| Aoyama, N; Fujioka, T; Kawashima, J; Kudo, M; Matsubara, Y; Miwa, J; Miwa, Y; Sakai, K; Yakabi, K | 1 |
| Cho, KB; Jeon, SW; Jung, JT; Jung, MK; Kim, ES; Kim, EY; Kim, KO; Kwon, JG; Lee, JH; Lee, SH; Park, HG; Park, KS; Seo, HE; Yang, CH | 1 |
| Bogiatzis, A; Deutschmann, A; Hauer, AC; Hoffmann, KM; Jahnel, J; Muntean, W; Prechtl, J; Savic, T | 1 |
| Deguchi, R; Fukuda, R; Igarashi, M; Koike, J; Matsushima, M; Nakaminami, H; Noguchi, N; Ozawa, H; Rimbara, E; Sasatsu, M; Suzuki, T; Takagi, A | 1 |
| Fragkou, P; Georgopoulos, SD; Karatapanis, S; Kouvidou, C; Lisgos, P; Mentis, A; Papantoniou, N; Papastergiou, V; Skorda, L | 1 |
| Annibale, B; Hassan, C; Sbrozzi-Vanni, A; Severi, C; Vannella, L; Zullo, A | 1 |
| Doosti, A; Ghorbani-Dalini, S; Kargar, M; Souod, N | 1 |
| Attumi, TA; Graham, DY; Li, Y; Reddy, R; Rimbara, E; Sabounchi, S; Thirumurthi, S; Trespalacios, A | 1 |
| Fukuhara, S; Hibi, T; Hirata, K; Matsuzaki, J; Nishizawa, T; Okada, S; Saito, Y; Suzuki, H; Tsugawa, H | 1 |
| Fragou, P; Georgopoulos, S; Karatapanis, S; Laudi, F; Lisgos, P; Papantoniou, N; Papastergiou, V; Skorda, L; Spiliadi, C; Xirouchakis, E | 1 |
| Bari, Z; Fakheri, H; Hosseini, V; Taghvaei, T | 1 |
| Kolber, MR; Korownyk, C | 1 |
| Fujioka, T; Kodama, M; Kuroda, A; Mizukami, K; Murakami, K; Nguyen, LT; Okimoto, T; Shiota, S; Yamaoka, Y | 1 |
| Ford, AC; Slater, CM | 1 |
| Gatta, L; Vaira, D; Vakil, N | 1 |
| Graham, DY; Trespalacios, AA | 1 |
| Bdioui, F; Ben Chaabane, N; Bouhlel, W; Hellara, O; Loghmari, H; Melki, W; Safer, L; Saffar, H; Zakhama, A | 1 |
| Gu, XM; Ji, R; Li, YQ; Li, Z; Yu, T; Zhou, CJ; Zuo, XL | 1 |
| Akazawa, Y; Ichikawa, T; Isomoto, H; Matsushima, K; Nakao, K; Ohnita, K; Senoo, T; Shiozawa, K; Takeshima, F; Yamaguchi, N | 1 |
| Belousova, NL; Firsova, LD; Goncharenko, LS; Govorun, VM; Ianova, OB; Kashnikov, VS; Kim, VA; Masharova, AA; Shcherbakov, PL; Shcherbakova, MIu | 1 |
| Haruma, K; Iishi, H; Inoue, K; Kamada, T; Kanzaki, T; Kimura, Y; Kusunoki, H; Murao, T; Shiotani, A; Uedo, N | 1 |
| Emer, O; Kadayifci, A; Kantarcioglu, M; Kara, M; Kilciler, G; Ozcan, A; Uygun, A | 1 |
| Gisbert, JP; McNicholl, AG | 1 |
| Dumančić, J; Hojsak, I; Jadrešin, O; Jaklin Kekez, A; Kolaček, S; Kos, T; Lukić Grlić, A; Mišak, Z | 1 |
| Chang, LL; Chen, YH; Huang, YK; Kuo, CH; Kuo, FC; Lee, YC; Wang, SS; Wang, TH; Wang, WM; Wu, DC; Wu, MC | 1 |
| Erdur, B; Gurbuz, ED; Ozturk, Y; Yilmaz, O | 1 |
| D'Arcy, S; Glocker, E; Lasseter, G; Lawson, AJ; McNulty, CA; Nichols, T; Shaw, I | 1 |
| Atherton, J; Axon, AT; Bazzoli, F; El-Omar, EM; Gensini, GF; Gisbert, JP; Graham, DY; Kuipers, EJ; Malfertheiner, P; Megraud, F; O'Morain, CA; Rokkas, T | 1 |
| Bujanda, L; Cosme, A; Gil, I; Ibarra, B; Martos, M; Mendarte, U; Montes, M; Piñeiro, L; Recasens, MT; Salicio, Y; Sarasqueta, C | 1 |
| Matsushima, M; Takagi, A | 1 |
| Akhi, MT; Ghotaslou, R; Hasani, A; Milani, M; Nahaei, MR; Rafeey, M; Sharifi, Y; Somi, MH | 1 |
| Fox, JG; Kawamura, Y; Matsui, M; Mori, S; Rimbara, E; Shen, Z; Shibayama, K; Suzuki, S; Wachino, J | 1 |
| Abid, A; Abu-Elheja, O; Diab, H; Mahamid, M; Mograbi, J; Nseir, W; Samara, M | 1 |
| Choi, JH; Chun, HJ; Hyun, JJ; Jung, SW; Kim, SY; Koo, JS; Lee, SW; Park, JJ; Yim, HJ | 1 |
| Almela, P; Barrio, J; Bermejo, F; Bory, F; Calvet, X; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; Gisbert, JP; Guerra, I; Khorrami, S; Lamas, E; Modolell, I; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A | 1 |
| Choi, HS; Chun, HJ; Jeen, YT; Keum, B; Kim, CD; Kim, YS; Lee, HS; Park, SH; Ryu, HS; Seo, YS; Um, SH | 1 |
| Bhakuni, RS; Chinniah, A; Das, PK; Goswami, S; Kar, SK; Pal, A | 1 |
| Aresti-Zárate, S; Ayestarán, B; Campos, MR; Carrascosa, MF; Cobo, M; Cuadrado-Lavín, A; Dierssen-Sotos, T; Fernández-Pousa, A; González-Colominas, E; Hernández, M; Pascual, EL; Salcines-Caviedes, JR | 1 |
| Chen, TH; Chiang, H; Chiu, HM; Lee, YC; Lin, JT; Liu, TY; Shun, CT; Wu, MS | 1 |
| Dueñas-Sadornil, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Pazos-Pacheco, C; Perez-Gallardo, B; Vinagre-Rodriguez, G | 1 |
| Amornsawadwattana, S; Kongchayanun, C; Mahachai, V; Pornthisarn, B; Vilaichone, RK | 1 |
| Bengtsson, C; Granström, M; Hoang, TT; Nguyen, GK; Nguyen, TV; Phung, DC; Sörberg, M; Yin, L | 1 |
| Brnic, D; Novak, A; Puljiz, Z; Simunic, M; Tonkic, A; Tonkic, M | 1 |
| Chung, JW; Hahm, KB; Jeong, JY; Jung, YK; Kim, JH; Kim, YJ; Kwon, KA; Lee, JJ; Lee, SM; Yun, SC | 1 |
| Georgopoulos, S; Karatapanis, S; Laoudi, F; Lisgos, P; Papantoniou, N; Papastergiou, V; Spiliadi, C; Xirouchakis, E | 1 |
| Carmine, P; Cinquepalmi, V; Giorgio, F; Ierardi, E; Monno, R; Soleo, L | 1 |
| Celik, MM; Inci, M; Kaya, OA; Köksal, F; Nagiyev, T; Yula, E | 1 |
| Azzolini, F; Bedogni, G; Camellini, L; Cavina, M; Decembrino, F; Di Mario, F; Formisano, D; Iori, V; Sassatelli, R; Sereni, G; Tioli, C | 1 |
| Ashida, C; Higashida, A; Kuwada, T; Mamori, S; Mitsuoka, T; Senda, E; Suga, Y; Taki, M; Yamada, H | 1 |
| Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H | 1 |
| Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, MS; Kim, N; Kim, SE; Lee, DH; Lee, SH; Park, YS; Shin, CM | 1 |
| Mao, M; Tong, Y; Wang, Z; Xiong, LJ | 1 |
| Andersen, LP; Berg, D; Jonaitis, L; Jørgensen, M; Kadusevicius, E; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Miciuleviciene, J; Rasmussen, L; Tamosiunas, V; Urbonaviciene, N | 1 |
| Baars, B; Huebner, J; Kist, M; Opferkuch, W; Sakinc, T; Wüppenhorst, N | 1 |
| Fakheri, H; Hosseini, V; Maleki, I; Mokhtare, M; Sardarian, H; Taghvaei, T | 1 |
| Chen, PY; Geng, LL; Gong, ST; He, WE; Huang, H; Huang, J; Liu, LY; Ou, WJ; Pan, RF; Zhou, LY | 1 |
| Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsu, SJ; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tseng, CH; Tseng, PH; Wang, HP; Wu, MS; Yang, UC | 1 |
| Alaoui, S; Amarti, A; Benajah, DA; Bennani, B; El Abkari, M; El Rhazi, K; Ibrahimi, A; Lahbabi, M; Mahmoud, M; Nejjari, C | 1 |
| Baik, GH; Baik, IH; Jang, HJ; Kim, DJ; Kim, DY; Kim, HY; Kim, JB; Kim, YS; Shin, WG; Sohn, KM; Suk, KT; Yoon, JH | 1 |
| Bessa, LJ; Cellini, L; Di Campli, E; Di Giulio, M; Di Iorio, D; Grande, R | 1 |
| Ang, D; Ang, TL; Chiam, P; Fock, KM; Teo, EK; Wang, L | 1 |
| Castelli, V; Fiorini, G; Gatta, L; Holton, J; Ricci, C; Ridola, L; Saracino, IM; Vaira, D; Zaccaro, C; Zullo, A | 1 |
| Adegbola, RA; Antonio, M; Berg, DE; Corrah, T; Galano, JJ; Sancho, J; Secka, O; Tapgun, M; Thomas, JE; Thomas, V; Walton, R | 1 |
| Castelli, V; Fiorini, G; Gatta, L; Ricci, C; Saracino, IM; Vaira, D; Vakil, N; Zaccaro, C; Zullo, A | 1 |
| Breurec, S; Burucoa, C; Dia, D; Mbengue, M; Onambele, M; Raymond, J; Seck, A | 1 |
| Choi, C; Hwang, JH; Jang, ES; Jeong, SH; Jo, HJ; Jung, HC; Kim, JW; Kim, N; Lee, DH; Lee, SH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, Is | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H; Tsugawa, H | 1 |
| Cho, WY; Choi, IJ; Jung, HC; Keum, B; Kim, JG; Kim, SG; Lee, JH; Lee, YC; Park, BJ; Park, SK; Song, HJ | 1 |
| Mahachai, V; Prasertpetmanee, S; Vilaichone, RK | 1 |
| Liang, X; Liu, W; Lu, H; Sun, Q; Xiao, S; Xu, X; Zhang, W; Zheng, Q | 1 |
| Inaba, T; Kawai, K; Miyoshi, M; Mizuno, M; Oguma, K; Okada, H; Take, S; Tsuji, T; Yokota, K | 1 |
| Adamek, HE; Riemann, JF; Schilling, D | 1 |
| Bloemena, E; Cats, A; Kuipers, EJ; Lindeman, J; Meuwissen, SG; Quint, WG; Scholte, GH; van Doorn, LJ | 1 |
| Asaka, M; Shimodan, M; Sugiyama, T; Tsuchida, M; Yokota, K | 1 |
| Hirayama, Y; Kanisawa, Y; Kogawa, K; Kohda, K; Koike, K; Kuga, T; Kuroiwa, G; Niitsu, Y; Sato, Y | 1 |
| Andreu, V; Bory, F; Calvet, X; Ducons, J; Guardiola, J; Guirao, R; Tito, L | 1 |
| Amat, C; Ancelin-Malbreil, E; Becquart, JP; Faulques, B; Michault, A; Picot, S; Sapin, G; Simac, C | 1 |
| Wallace, MR | 1 |
| Echizen, H; Nachi, S; Ohnishi, A; Ushiama, H | 1 |
| Basyuda, H; Hamada, T; Hojo, M; Kurosawa, A; Miwa, H; Ohkusa, T; Sato, N; Sugiyama, Y; Yokoyama, T | 1 |
| Fujimoto, K; Fujise, T; Ishibashi, S; Iwakiri, R; Kawasaki, S; Kikkawa, A; Oda, K; Ootani, A; Ootani, H; Sakata, H; Shimoda, R; Tadano, J; Tsunada, S; Yoshida, T | 1 |
| Bettoni, L; Cattaneo, R; Rizzini, FL; Tosoni, C | 1 |
| Blum, AL; Bolten, WW; Dragosics, B; Koelz, HR; Labenz, J; Rösch, W; Stolte, M | 1 |
| Boon, YH; Cheng, CS; Chian, LC; Chiu, TC; Kaushik, S; Vu, C | 1 |
| Alarcon, T; Andersen, LP; Broutet, N; Cantagrel, A; Glupczynski, Y; López-Brea, M; Mégraud, F | 1 |
| Chiba, T; Watanabe, T | 2 |
| Nakamura, T; Terano, A | 1 |
| Iwabuchi, H; Matsuzaki, K | 1 |
| Bégué, RE; Compton, T; Gómez, R; Vargas, A | 1 |
| Chen, JH; Lin, MD; Lin, YS; Lo, CY; Sheu, BS; Wu, HW; Wu, JJ | 1 |
| Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, AM; Wong, PN | 1 |
| Imanishi, J; Iwakura, Y; Kita, M; Kuriyama, H; Minami, M; Ohno, T; Yamamoto, T; Yan, X | 1 |
| Atherton, JC; Barrett, DA; Jenkins, D; Jordan, N; Shaw, PN; Sherwood, PV; Spiller, RC; Wibawa, JI | 1 |
| Ando, T; Ina, K; Kawamura-Sato, K; Kusugami, K; Nobata, K; Ohta, M; Tsuzuki, T | 1 |
| Fischbach, W; Goebeler-Kolve, M; Greiner, A; Müller-Hermelink, HK; Starostik, P | 1 |
| Alvares Cabral, MM; Corrêa, PR; Dani, R; Esteves, AM; Moreira, LS; Nogueira, AM; Queiroz, DM; Reis, LF; Rocha, GA; Santos, A; Silva, LD; Tanure, J | 1 |
| Kas'ianenko, VI; Vasil'ev, IuV | 1 |
| Firsanova, VIu; Kolomiets, EV; Vasil'ev, IuV; Zvenigorodskaia, LA | 1 |
| Vasil'ev, IuV; Zvenigorodskaia, LA | 1 |
| Choi, TY; Eun, CS; Han, DS; Kang, JO; Kim, KS | 1 |
| Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J | 1 |
| Coyle, W; Dunteman, T; Nemec, R; Sullivan, B | 1 |
| De Francesco, V; Faleo, D; Ierardi, E; Margiotta, M; Panella, C | 1 |
| Abe, H; Arita, T; Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S | 1 |
| Asaka, M; Kato, M; Kawarasaki, M; Kodaira, J; Komatsu, Y; Mizushima, T; Nagasako, T; Nakagawa, S; Oda, H; Perez Aldana, L; Shimizu, Y; Sugiyama, T; Takeda, H; Zheng, R | 1 |
| Goshi, S; Matsumori, N; Shimizu, T; Tamura, Y; Taneike, I; Toyoda, S; Wakisaka-Saito, N; Yamamoto, T; Yamashiro, Y; Yanase, A | 1 |
| Cheng, AF; Chung, SS; Lee, CC; Leung, WK; Ling, TK; Ng, EK; Sung, JJ; Yung, MY | 1 |
| Bellini, M; Costa, F; De Bortoli, N; Maltinti, G; Marchi, S; Petrini, M | 1 |
| Handa, Y; Kawai, T; Kawakami, K; Kudo, T; Moriyasu, F; Ogiahara, S | 1 |
| Alanís-Aguilar, O; Bosques-Padilla, FJ; Garza-González, E; Maldonado-Garza, HJ; Pérez-Pérez, GI; Tijerina-Menchaca, R | 1 |
| Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M | 1 |
| Haga, K; Hirayama, F; Iwao, E; Takagi, S; Yamamoto, K; Yokoyama, Y | 1 |
| Alarcón, T; Domingo, D; García, JA; López-Brea, M; Martínez, MJ; Vega, AE | 1 |
| Amberiadis, P; Archavlis, E; Chiotakakou, E; Christoforidis, P; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G | 1 |
| Go, MF | 1 |
| Antoni, I; Feydt-Schmidt, A; Fischer, A; Koletzko, S; Lehn, N; Rüssmann, H; Störk, D | 1 |
| Fukai, Y; Fukuchi, M; Katoh, H; Kuwano, H; Manda, R; Masuda, N; Miyazaki, T; Nakajima, M; Ojima, H; Tsukada, K; Tsukada, O | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Scalia, A; Terminella, C | 1 |
| Chung, IS; Chung, KW; Kim, JI; Kim, JK; Park, SH; Sun, HS | 1 |
| Bancel, B; Corthesy-Theulaz, I; Crabtree, JE; Diezi, J; Felley, CP; Felley-Bosco, E; Michetti, P; Ohshima, H; Patricot, LM; Pignatelli, B; Stolte, M; Van Melle, GD | 1 |
| Rai, R; Rai, S | 1 |
| Broutet, N; Lamouliatte, H; Mégraud, F; Pereira, E; Salamon, R; Tchamgoué, S | 1 |
| Arakawa, T; Fujiwara, Y; Higuchi, K; Matsumoto, T; Nakamura, S; Oshitani, N; Shiba, M; Tominaga, K; Watanabe, T | 1 |
| Bueno, ML; Castro, LP; Coelho, LG; Lopes, LG; Martins, GM; Miranda, CH; Passos, MC; Sanches, BS | 1 |
| Kullavanijaya, P; Tangkijvanich, P; Thong-Ngam, D; Treeprasertsuk, S; Wisedopas, N | 1 |
| Vasil'ev, IuV | 1 |
| Schuster, MJ | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Martínez, MJ; Vega, AE | 2 |
| Farup, PG; Høie, O; Lange, OJ; Tholfsen, J; Torp, R; Wetternus, S | 1 |
| Habu, Y; Hayakumo, T; Inokuchi, H; Kawabata, H; Kawai, K; Kimoto, K; Kiyota, K; Kobayashi, M; Kutsumi, H; Mizuno, S; Nakajima, M; Oyasu, K; Tomioka, H | 1 |
| Hopkins, RJ; Meyer, JM | 1 |
| Berg, DE; Bhattacharya, S; Chattopadhya, S; Chaudhuri, S; Chowdhury, A; Datta, S; Dhali, G; Mukhopadhyay, AK; Nair, GB; Saha, DR; Santra, A | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Kuroda, K; Maekawa, S; Miki, I; Okumura, K; Sakaeda, T; Sakai, T; Shirasaka, D; Tamura, T; Wambura, CM | 1 |
| Ala'Aldeen, DA; Jenks, PJ; Loughlin, MF | 1 |
| Adler, K; Aust, D; Feydt-Schmidt, A; Fischer, A; Koletzko, S; Rüssmann, H | 1 |
| Alarcón, T; Baquero, M; García-Samaniego, J; Toro, C | 1 |
| Celińska-Cedro, D; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Jóźwiak, P; Madaliński, K; Rozynek, E | 2 |
| Orr, CF; Rowe, DB | 1 |
| Doroud, D; Farahvash, MJ; Massarrat, S; Mohammadi, M | 1 |
| Dupont, C; Kalach, N; Raymond, J | 1 |
| Amann, G; Binder, C; Crone, J; Granditsch, G; Hirschl, AM; Huber, WD; Innerhofer, A | 1 |
| Satoh, K | 2 |
| Arima, N; Tsudo, M | 1 |
| Hu, WH; Hui, WM; Ip, WY; Lai, KC; Lam, SK; Lau, CS; Wong, BC; Wong, RW | 1 |
| Campo, SM; De Francesco, V; Faleo, D; Fornari, F; Gatta, L; Hassan, C; Ierardi, E; Marinone, G; Menegatti, M; Merla, A; Mete, LS; Miglioli, M; Morini, S; Papadìa, C; Perna, F; Perri, F; Pilati, S; Potì, R; Ricci, C; Rinaldi, V; Savioli, A; Tampieri, A; Vaira, D; Vakil, N; Zullo, A | 1 |
| Bielanski, W; Galuschka, K; Hahn, EG; Karcz, D; Konturek, PC; Konturek, SJ; Rembiasz, K; Stachura, J | 1 |
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Nishiyama, H; Omagari, K; Shikuwa, S | 1 |
| Atherton, JC; Hawkey, CJ; Ravic, M; Thjodleifsson, B; Treichel, HC | 1 |
| Dupas, JL | 1 |
| Bruley des Varannes, S | 1 |
| Orbay, E; Sargýn, H; Sargýn, M; Uygur-Bayramicli, O; Yavuzer, D; Yayla, A | 1 |
| Asaka, M | 2 |
| Angelucci, D; Cellini, L; Marzio, L | 1 |
| Itoh, T; Kai, A; Matsuda, M; Shingaki, M; Takahashi, S; Wada, S | 1 |
| Asaka, M; Fujioka, T; Fukuda, Y; Kato, M; Kimura, K; Kobayashi, S; Kuwayama, H; Satoh, K; Shimizu, K; Shimoyama, T; Sugiyama, T; Takemoto, T | 2 |
| Chayama, K; Haruma, K; Ito, M; Kamada, T; Masuda, H; Miyamoto, M; Nishisaka, T; Sumioka, M; Tanaka, S; Yoshihara, M | 1 |
| Chehter, EZ; Eisig, JN; Hashimoto, C; Laudanna, AA; Silva, FM | 1 |
| Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S | 1 |
| Azagra, R; Calvet, X; Gené, E; Gisbert, JP | 1 |
| Imamura, S; Imanishi, J; Kashima, K; Kita, M; Kodama, T; Mitsufuji, S; Ohno, T; Yamamoto, T; Yamaoka, Y | 1 |
| Huang, AH; Huang, JJ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Bermejo, F; Boixeda, D; García Plaza, A; Hernández Ranz, F; López Sanromán, A; Martín De Argila, C | 1 |
| Borda, F; Domínguez-Muñoz, JE; Ducons, J; Gallego, S; Gisbert, JP; Gomollón, F; Hervás, A; Iglesias, J; Jiménez, I; Miño, G; Pajares, JM; Pastor, G; Santolaria, S; Vázquez, MA | 1 |
| Miwa, H; Sato, N | 1 |
| Bottiglieri, ME; Budillon, G; Cuomo, R; Grasso, R; Ierardi, E; Nardone, G; Sarnelli, G; Verde, C | 1 |
| Lee, J; Machado, S; Veldhuyzen Van Zanten, S | 1 |
| Ekström, P; Hellblom, M; Kihira, K; Kimura, K; Ohlin, B; Satoh, K; Sipponen, P; Stubberöd, A; Unge, P; Yoshida, Y; Yube, T | 1 |
| Aragona, G; Cavestro, GM; Dal Bo, N; Franceschi, M; Franze, A; Iori, V; Leandro, G; Mario, FD; Moussa, AM; Pilotto, A; Rugge, M | 1 |
| Biagi, GL; Cantelli-Forti, G; Gatta, L; Miglioli, M; Paolini, M; Perna, F; Ricci, C; Sapone, A; Tampieri, A; Trespidi, S; Vaira, D | 1 |
| Kolesnikow, T; Lee, A; Leung, V; O'Rourke, JL; van Zanten, SJ | 1 |
| Chayama, K; Haruma, K; Manabe, N; Sasaki, A; Tanaka, S; Yoshihara, M | 1 |
| Fischbach, L; Nash, C; Veldhuyzen van Zanten, S | 1 |
| Ford, A; Moayyedi, P | 1 |
| Björkman, A; Granström, M; Hoang, TT; Phung, DC; Sörberg, M; Wheeldon, TU | 1 |
| Chen, TK; Huang, SH; Lai, YC; Lee, CL; Wang, TH; Wu, CH; Yang, SS | 1 |
| Aiba, Y; Koga, Y; Mine, T; Shiba, T; Takagi, A; Tanaka, K; Ushiyama, A | 1 |
| Haruma, K; Hata, J; Ito, M; Kamada, T; Kusunoki, H; Sasaki, A; Tanaka, S; Yoshihara, M | 1 |
| Hardikar, W; Midolo, PD; Rerksuppaphol, S; Ward, P | 1 |
| Prónai, L; Tulassay, Z | 1 |
| Favalli, C; Favaro, M; Fontana, C; Galante, A; Pietroiusti, A; Pistoia, ES | 1 |
| Laine, L | 1 |
| Fijen, CA; Loffeld, RJ | 1 |
| Uthaisaengsook, W | 1 |
| Bästlein, E; Bayerdörffer, E; Haferland, C; Jacobs, E; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Papke, J; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| Demleitner, K; Fischbach, W; Fuchs, W; Layer, P; Leodolter, A; Malfertheiner, P; MOssner, J; Stolte, M | 1 |
| De Francesco, V; Hassan, C; Ierardi, E; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Chayama, K; Haruma, K; Hiyama, T; Ito, M; Kitadai, Y; Kose, K; Masuda, H; Shima, H; Shimamoto, F; Sumii, M; Tanaka, S; Tuncel, H; Uemura, N; Yoshihara, M | 1 |
| Berg, DE; Chan, AO; Chan, CK; Fung, FM; Gu, Q; Hu, WH; Hui, CK; Lai, KC; Lam, SK; Wang, WH; Wong, BC; Wong, WM; Xia, HH; Yuen, MF | 1 |
| Bensler, JM; Bruce, MG; Bruden, DL; Butler, JC; Hennessy, TW; Hurlburt, DA; McMahon, BJ; Morris, JM; Parkinson, AJ; Reasonover, AL; Sacco, F | 1 |
| Andersson, DI; Blaser, MJ; Engstrand, L; Sjölund, M; Wreiber, K | 1 |
| Cohen, L; Fedorak, RN; Lambert, J; Vanjaka, A; Veldhuyzen van Zanten, S | 1 |
| Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, PN | 1 |
| Chan, CC; Chen, TK; Lee, CL; Liao, CC; Liu, CC; Tu, TC; Wu, CH | 1 |
| Hoshino, Y; Ishii, H; Kurabayashi, K; Masaoka, T; Minegishi, Y; Nomura, S; Suzuki, H; Suzuki, M | 1 |
| Hansen, LB; Malaty, W; Stigleman, S | 1 |
| Chayama, K; Haruma, K; Hiyama, T; Masuda, H; Shimamoto, F; Tanaka, S; Yoshihara, M | 1 |
| Copie-Bergman, C; Costa, JM; Deforges, L; Delchier, JC; Lamarque, D; Lascols, C; Le Glaunec, JM; Petit, JC; Soussy, CJ; Tankovic, J | 1 |
| Choi, BK; Chung, JM; Jang, YS; Lee, SH; Lee, YJ; Park, ET; Seol, SY; Yang, SY | 1 |
| Barkun, A; Chiba, N; Cockeram, A; Dallaire, C; Fallone, C; Farley, A; Nicholls, B; Simms, L; Veldhuyzen van Zanten, S | 1 |
| Barthelemy, P; Bretagne, JF; Courillon-Mallet, A; De Korwin, JD; Delchier, JC; Fauchère, JL; Fléjou, JF; Labigne, A; Lamouliatte, H; Mégraud, F | 1 |
| Bästlein, E; Bayerdörffer, E; Buchner, M; Ebert, S; Haferland, C; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| Balatsinou, C; Caldarella, MP; Cuccurullo, F; Di Bonaventura, G; Lapenna, D; Laterza, F; Milano, A; Neri, M; Piccolomini, R | 1 |
| Chan, CK; Chan, OO; Chu, KM; Hu, HC; Hui, WM; Kwok, KF; Lai, KC; Lam, SK; Wong, BC; Wong, WM | 1 |
| Chang, FY; Chen, CY; Jium, KL; Lee, SD; Lu, CL; Luo, JC | 1 |
| Bianchi Porro, G; Cucino, C; Parente, F | 1 |
| Marzio, L; Toracchio, S | 1 |
| Bautista, CT; Berg, DE; Dailide, G; Gilman, RH; Katz, U; Meza, R; Monath, TP; Ogura, M; Razuri, M; Roth, DE; Soto, G; Taylor, DN; Velapatiño, B | 1 |
| Atisook, K; Kachintorn, U; Kositchaiwat, C; Ovartlarnporn, B | 1 |
| Garrido-Serrano, A; Hergueta, P; Martínez-Delgado, C; Montojo, C; Navarro, JM; Romero-Gómez, M; Santos, O | 1 |
| Carpenter, CF; Neuhann, HF; Shao, O; Swai, B | 1 |
| Ashman, O; Borody, TJ | 1 |
| Aragona, G; Cavallaro, L; Cavestro, GM; Comparato, G; Dal Bò, N; Di Mario, F; Franzè, A; Iori, V; Leandro, G; Pilotto, A | 1 |
| Aoyama, N; Fukuda, M; Kachi, M; Kasuga, M; Kuroda, K; Maekawa, S; Miki, I; Shirasaka, D; Tamura, T; Wambura, C; Watanabe, Y | 1 |
| Cruz Vicente, JM; Fernández Fernández, F; González Macías, J; Olmos Martínez, JM | 1 |
| Herszényi, L | 1 |
| Candelli, M; Franceschi, F; Gasbarrini, G; Mettimano, M; Migneco, A; Montebelli, R; Ojetti, V; Savi, L; Specchia, L | 1 |
| Bochenek, WJ; Davis, KD; El-Zimaity, HM; Fraga, PD; Graham, DY; Mack, ME; Osato, MS; Peters, S; Wang, W | 1 |
| Inaba, T; Ishiki, K; Mizuno, M; Nagahara, Y; Oguma, K; Okada, H; Shiratori, Y; Take, S; Yamamoto, K; Yokota, K; Yoshida, T | 1 |
| Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansia, C; Savarino, V; Usai, P; Vigneri, S; Zentilin, P | 1 |
| Ayyagari, A; Bhasin, D; Das, BK; Dharmalingam, S; Habibullah, CM; Khan, AA; Naik, SR; Rajasambandam, P; Ramathilagam, B; Rao, UA; Ray, P; Sharma, MP; Thyagarajan, SP | 1 |
| Hino, M; Kokubo, Y; Kudo, S; Narato, R; Ono, Y; Soma, T; Tanaka, Y; Uehara, T; Yoshioka, Y | 1 |
| Ando, T; Hasegawa, T; Ina, K; Kusukami, K; Nohata, K; Ota, M; Tsuzuki, T | 1 |
| Dragosics, B; Fischbach, W; Goebeler-Kolve, ME; Greiner, A; Stolte, M | 1 |
| Gasbarrini, A; Gasbarrini, G; Migneco, A; Nista, EC; Ojetti, V; Zocco, MA | 1 |
| Bae, JS; Jung, HS; Kim, HJ; Lee, JK; Lee, SB; Park, SJ; Park, SM; Ryu, JK | 1 |
| Abdulkhakov, RA; Isakov, VA; Kononov, AV; Livzan, MA; Maev, IV; Predvechnaia, IK; Simanenkov, VI; Zakharova, NV | 1 |
| Farup, PG | 1 |
| Chan, FK; Ching, JY; Chung, SC; Hui, Y; Leong, R; Leung, WK; Sung, JJ; Wu, JC | 1 |
| Branca, G; Cammarota, G; Cannizzaro, O; Cesaro, P; Cianci, R; di Caro, S; Fedeli, P; Gasbarrini, G; Lecca, PG; Martino, A | 1 |
| Díaz de Rojas, F; Esteban López Jamar, JM; González Carro, P; Legaz Huidobro, ML; Pedraza Martín, C; Pérez Roldán, F; Ponte Tellechea, A; Ruiz Carrillo, F; Sáez Bravo, JM; Valenzuela Gámez, JC | 1 |
| Aiba, M; Hamaguchi, K; Katsube, T; Konno, S; Ogawa, K | 1 |
| Barone, M; Berloco, P; Burattini, O; De Francesco, V; Di Leo, A; Francavilla, A; Ierardi, E; Marangi, S; Margiotta, M; Minenna, MF; Morini, S; Panella, C; Russo, F; Stoppino, V; Zullo, A | 1 |
| Saltanova, SD; Tkach, OS | 1 |
| Chen, JH; Chen, TJ; Lee, SC; Wang, GM; Yang, KC | 1 |
| Armstrong, D; Barkun, A; Chiba, N; Escobedo, S; Grace, E; Lee, J; Sinclair, P; Thomson, AB; Veldhuyzen Van Zanten, SJ | 1 |
| Zakharova, NV | 1 |
| Hao, YT; He, XX; Zhao, YH | 1 |
| Boyacioglu, S; Cosar, AM; Gumurdulu, Y; Gur, G; Gursoy, M; Kayaselcuk, F; Ozer, B; Ozsahin, K; Serin, E; Yilmaz, U | 1 |
| Guo, CY; Liu, HL; Wu, JY; Wu, YB; Zhong, MZ | 1 |
| El-Omar, EM; Furuta, T; Ishizaki, T; Ohashi, K; Rabkin, CS; Shirai, N; Sugimura, H; Xiao, F | 1 |
| Buckley, M; O'Connor, H; O'Morain, C; Qasim, A; Sebastian, S | 1 |
| Cuomo, A; De Simone, T; Del Vecchio Blanco, C; Iovene, MR; Marmo, R; Montella, F; Mucherino, C; Nardone, G; Romano, M; Tufano, MA | 1 |
| Hotz Dagger, J; Leodolter, A; Malfertheiner, P; Peitz, U; Plein, K; Raps, S | 1 |
| Asaka, M; Sugiyama, T | 1 |
| Jüttner, S; Kirsch, C; Lehn, N; Miehlke, S; Pfeuffer, T; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| Chayama, K; Haruma, K; Hiyama, T; Masuda, H; Tanaka, S; Yoshihara, M | 1 |
| Klochko, OG; Kornienko, EA | 1 |
| Alderborn, A; Engstrand, L; Fock, C; Hjalmarsson, S; Kling, H; Muldin, I; Uhlén, M | 1 |
| Cammarota, G; Candelli, M; Crea, F; Gasbarrini, A; Gasbarrini, G; Marietti, G; Nista, EC; Petrucci, S; Pignataro, G; Rigante, D; Schiavino, A | 1 |
| Avni, Y; Birkenfeld, S; Boaz, M; Epstein, J; Levine, A; Niv, Y; Shevah, O; Shirin, H | 1 |
| Howden, CW; Sharma, VK | 1 |
| Inami, N; Kanazawa, S; Nomura, S | 1 |
| Fujioka, T; Kobayashi, I; Muraoka, H; Nasu, M; Nishida, M; Saika, T | 1 |
| Furuta, Y; Miyasaka, K; Sugiyama, T; Yoshioka, M | 1 |
| Bodrug, NI; Butorov, IV; Butorov, SI; Kirika, NV | 1 |
| Amoruso, A; De Francesco, V; Della Valle, N; Ierardi, E; Muscatiello, N; Panella, C; Stoppino, V | 1 |
| Färkkilä, MA; Heikkinen, M; Koivisto, TT; Niemelä, SE; Rautelin, HI; Sipponen, PI; Voutilainen, ME | 1 |
| Amarapurkar, A; Amarapurkar, D; Das, HS; Makesar, M | 1 |
| Baldwin, L; Bell, GD; Cameron, EAB; Jones, P; Powell, KU; Williams, SGJ | 1 |
| Ahuja, V; Bal, C; Bhatia, V; Das, B; Sharma, MP | 1 |
| Iijima, K; Imatani, A; Koike, T; Ohara, S; Sekine, H; Shimosegawa, T | 1 |
| Haga, K; Hirayama, F; Iwao, E; Yamamoto, K; Yokoyama, Y | 1 |
| Fujimura, S; Iinuma, K; Kato, S; Watanabe, A | 1 |
| Altintas, E; Aydin, O; Camdeviren, H; Sezgin, O; Ulu, O | 1 |
| Ishiki, K; Mizuno, M; Nagahara, Y; Oguma, K; Okada, H; Shiratori, Y; Take, S; Yamamoto, K; Yokota, K; Yoshida, T | 1 |
| Altun, S; Aslan, M; Kocazeybek, B; Memisoglu, N; Öner, YA; Saribas, S; Seyhun, Y | 1 |
| Kemona, A; Namiot, DB; Namiot, Z; Stasiewicz, J | 1 |
| de Boer, WA; Kuipers, EJ; Kusters, JG | 1 |
| De Francesco, V; Della Valle, N; Hassan, C; Ierardi, E; Minenna, MF; Monno, R; Morini, S; Panella, C; Pietrini, L; Stoppino, V; Winn, S; Zullo, A | 1 |
| Granström, M; Hoang, TT; Nilsson, LE; Phuncarg, DC; Sörberg, M; Wheeldon, TU | 1 |
| Fujiyama, Y; Inoue, T; Kakinoki, R; Sakabe, H; Yagi, Y; Yoshikawa, K | 1 |
| Asaumi, N; Niiya, K; Niiya, M; Shibakura, M; Tanimoto, M; Yoshida, C | 1 |
| Barth, J; Lanza, F; Schwartz, H; Vakil, N | 1 |
| Gościniak, G; Grabińska, J; Iwańczak, B; Iwańczak, F; Przondo-Mordarska, A | 1 |
| Shigeto, N; Shimizu, S | 1 |
| Chen, A; Chen, JL; Hsu, PI; Jou, HS; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Peng, NJ; Shie, CB; Tsai, PM; Tseng, HH; Wu, CJ | 1 |
| Karaoglu, AO; Yasa, MH; Yukselen, V | 1 |
| Wollner, T | 1 |
| Chen, XX; Ou, BY; Qü, YP; Shang, SQ; Tang, HF; Wu, XY; Zhou, XL | 1 |
| Doherty, GM; Farrell, S; McCallion, WA; Milliken, I; Murphy, JL; Wootton, SA | 1 |
| Nakagawa, S; Suzuki, K; Taneike, I; Yamamoto, T | 1 |
| Ando, T; El-Omar, E; Goto, H; Ichiyama, S; Iinuma, Y; Ina, K; Kusugami, K; Minami, M; Nada, T; Nobata, K; Ohta, M; Tsuzuki, T | 1 |
| Hasegawa, N; Ishii, H; Ishii, K; Kaneko, F; Kawata, K; Kurabayshi, K; Miyairi, M; Nakamizo, H; Otani, S; Saito, H; Suzuki, H | 1 |
| Ishii, H; Kamiya, AG; Masaoka, T; SuzukiKurabayashi, HK | 1 |
| Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Tanida, S | 1 |
| Chan, FK; Ching, JY; Lau, JY; Leung, WK; Lin, SR; Ng, EK; Sung, JJ; To, KF | 1 |
| Ashorn, M; Karikoski, R; Kokkonen, J; Rägö, T; Rautelin, H; Ruuska, T | 1 |
| Ghazzawi, IM; Obeidat, WA; Zuriekat, FA | 1 |
| Akarsu, M; Bozbas, A; Hulagu, S; Kadayifci, A; Koruk, M; Savas, MC; Simsek, I; Sivri, B; Tozun, N; Uraz, S | 1 |
| Ahmad, MM; Khan, R; Nahar, S; Rahman, M; Sultana, J | 1 |
| Chan, AO; Cheung, HK; Gu, Q; Lam, SK; Liu, XG; Wang, JD; Wang, WH; Wong, BC; Wong, WM; Xia, HH; Yuen, MF | 1 |
| Schluter, PJ; Wallace, RA; Webb, PM | 1 |
| Aceto, GM; Battista, P; Mariani-Costantini, R; Marzio, L; Toracchio, S | 1 |
| Güliter, S; Kandilci, U | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| Bago, J; Bago, P; Belosić Halle, Z; Bevanda, M; Bilić, A; Galović, A | 1 |
| Fujioka, T; Kodama, M; Miyajima, H; Murakami, K; Nasu, M; Ogata, M; Ohtsuka, E; Okimoto, T; Saburi, Y; Sato, R; Watanabe, K | 1 |
| Grossman, E; Leiba, A; Leibowitz, A | 1 |
| Dragosics, B; Hirschl, AM; Hufnagl, P; Kovách, Z; Makristathis, A; Puz, S; Rotter, M; Schabereiter-Gurtner, C | 1 |
| Barros, H; David, L; Lunet, N; Mendes, N; Serpa, J | 1 |
| Sherman, PM | 1 |
| Cinar, K; Ozden, A; Soykan, I | 1 |
| Bax, DA; de Jong, A; Gerrits, MM; Kuipers, EJ; Kusters, JG; Thijs, JC; van der Wouden, EJ; van Vliet, AH; van Zwet, AA | 1 |
| Fukuda, Y; Sakagami, T | 1 |
| Cieśla, J; Kaczmarski, M; Kondej-Muszyńska, K; Kowalczuk, J; Maciorkowska, E; Musaibili, S; Roszko, I; Zielińska, A | 1 |
| Celaya, MC; Ducóns, J; Ferrero, M; Gomollón, F; Montoro, M; Revillo, MJ; Santolaria, S; Sicilia, B; Villar, M | 1 |
| Branca, G; Cammarota, G; Fadda, G; Gasbarrini, A; Gasbarrini, GB; Schito, AM; Spanu, T | 1 |
| Bagchi, D; Chatterjee, A; Stohs, SJ; Yasmin, T | 2 |
| Cao, X; Kaminishi, M; Kumagai, T; Mizoshita, T; Nozaki, K; Shimizu, N; Tatematsu, M; Tsukamoto, T | 1 |
| Fukuda, S; Fukushi, M; Mikami, T; Munakata, A; Shimoyama, T | 1 |
| Buzás, GM; Józan, J | 1 |
| Isakov, VA | 1 |
| Fujioka, T; Kashimura, K; Kodama, M; Miura, M; Miyajima, H; Murakami, K; Nasu, M; Okimoto, T; Ootsu, S; Sato, R; Watanabe, K | 1 |
| Jung, HC; Kim, JM; Kim, JS; Kim, N; Kim, YJ; Song, IS | 1 |
| Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N | 1 |
| Cammarota, G; Candelli, M; Cazzato, IA; Cremonini, F; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Nista, EC; Zocco, MA | 1 |
| Hirashima, N; Ito, K; Kato, A; Kato, H; Kondo, H; Matsunaga, S; Nukaya, H; Sakakibara, K; Sakamoto, T; Tanaka, Y | 1 |
| Arakawa, Y; Kanai, K; Shibayama, K; Suzuki, S; Wachino, J | 1 |
| Gunaid, AA; Hassan, NA; Murray-Lyon, IM | 1 |
| Engstrand, L; Jönsson, M; Qvarnström, Y; Swedberg, G | 1 |
| Chen, FB; Chen, J; Huang, XL; Li, ZY; Yu, JD; Zhang, XP | 1 |
| Chan, CK; Chen, MH; Cui, Y; Gu, Q; Hu, PJ; Hu, WH; Huang, JQ; Lai, KC; Lam, SK; Li, CJ; Wang, WH; Wong, BC; Wong, WM; Wu, SM; Xia, HH; Xiao, SD | 1 |
| Kunicki, PK; Sobieszczańska-Małek, M | 1 |
| Bellotti, M; Botta, F; Chiarbonello, B; Cotelessa, T; Emanuela, T; Fumagalli, A; Giannini, E; Malfatti, F; Milazzo, S; Podestà, E; Polegato, S; Testa, R | 1 |
| Schuster, M | 1 |
| Aydemir, S; Boyacioglu, S; Can, FK; Demirbilek, M; Gur, G; Korkmaz, M; Yilmaz, U | 1 |
| Chen, TW; Cheng, HC; Hunag, SF; Kao, AW; Lu, CC; Sheu, BS; Wu, JJ | 1 |
| Imase, K; Ishida, H; Itoh, T; Kai, A; Sugano, H; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K | 1 |
| Bory, F; Calvet, X; Ducons, J; Guardiola, J; Marko, D; Tito, L | 1 |
| Iinuma, K; Kato, S; Minoura, T; Ohyauchi, M; Ozawa, K; Sekine, H; Shimosegawa, T | 1 |
| Dassanayake, AS; de Silva, HA; de Silva, HJ; Hewavisenthi, J; Navaratne, NM; Pathmeswaran, A; Peiris, R | 1 |
| Arslan, H; Boyacioğlu, S; Can, F; Demirbilek, M; Selçuk, H | 1 |
| Capodicasa, S; Cellini, L; Marzio, L; Soraja, DB; Toracchio, S | 1 |
| Fukuda, Y; Hori, K; Matsumoto, T; Miwa, H; Ohkusa, T; Shintani, S; Tanaka, J; Tomita, T | 1 |
| Candelli, M; Carloni, E; Cazzato, A; Di Campli, C; Fini, L; Gasbarrini, A; Gasbarrini, G; Nista, EC; Pignataro, G; Zocco, MA | 1 |
| Castellaneta, S; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Rigillo, N; Ros, P | 1 |
| de Mascarel, A; Dubus, P; Lavergne-Slove, A; Megraud, F; Merlio, JP; Ruskone-Fourmestraux, A | 1 |
| Chang, CC; Chen, SH; Fang, CL; Hsieh, CR; Lee, YJ; Lien, GS; Lou, HY; Pan, S | 1 |
| Feng, LY; Jiang, SL; Yao, XX | 1 |
| Chey, WD; Saad, R | 1 |
| Kawai, T; Matsumoto, Y; Noguchi, N; Rimbara, E; Sasatsu, M; Tanabe, M | 1 |
| Färkkilä, MA; Heikkinen, MT; Koivisto, TT; Koskenpato, JP; Rautelin, HI; Voutilainen, ME | 1 |
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Ohnita, K; Wen, CY | 1 |
| Chen, CB; Chou, JW; Hsu, CH; Lai, HC; Liao, KF; Lin, ZY; Wang, HH | 1 |
| Jeong, BC; Kang, GH; Lee, HK; Lee, JH; Lee, SH; Roe, IH; Shin, JH; Sohn, SG | 1 |
| Terano, A | 1 |
| Arranz Martínez, E; Gordillo López, FJ; Hermosa Hernán, JC; Ruiz García, A; Villares Rodríguez, JE | 1 |
| Amadori, S; Newland, AC; Provan, D; Rossi, Z; Stasi, R; Stipa, E | 1 |
| Bauerfeind, P; Bernardi, M; Fried, M; Yuen, B; Zbinden, R | 1 |
| Cao, DZ; Fu, XL; Hu, JM; Ou, XL; Su, H; Sun, WH; Sun, YL; Yu, Q; Yu, T; Zhu, F | 1 |
| Cheng, HC; Kao, AW; Lin, CY; Sheu, BS; Sheu, MJ; Wu, JJ; Yang, HB | 1 |
| Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF | 1 |
| Cho, YK; Jeon, WK; Keum, DK; Kim, BI; Kim, HJ; Kim, SH; Park, DI; Park, SH; Sohn, CI; Sung, IK | 1 |
| Barisić, IG; Jukić, I; Mise, S; Tonkić, A; Tonkić, M | 1 |
| Caner, B; Gedik, GK; Karaduman, A; Sivri, B | 1 |
| Bar-Meir, M; Benenson, S; Faber, J; Halle, D; Rachman, E; Rudensky, B; Schlesinger, Y; Sirota, G; Stankiewic, H; Wilschanski, M | 1 |
| Hahm, JS; Han, DS; Jang, MK; Kim, HY; Kim, KH; Lee, JH; Lee, JY; Park, JY; Yoo, JY | 1 |
| Ignat'ev, VK; Karel'skaia, IA | 1 |
| Cartell, A; Edelweiss, MI; Francesconi, CF; Mazzoleni, LE; Ott, EA; Prolla, JC; Rivero, LF; Sander, GB; Somm, G; Theil, AL; Uchôa, DM; Wortmann, AC | 1 |
| Breathnach, A; Elviss, NC; Owen, RJ; Palmer, C; Shetty, N | 1 |
| Calvet, X; Gisbert, JP; Gonzalez, L | 1 |
| Booka, M; Hayashi, H; Miyashiro, E; Okuda, M; Shin, K; Tamura, Y; Yamauchi, K; Yoshikawa, N | 1 |
| Choi, HK; Chun, MK; Sah, H | 1 |
| Hara, H; Miyokawa, N; Ohtubo, C; Sano, H; Tanabe, H | 1 |
| Watanabe, K | 1 |
| Hershko, C; Hoffbrand, AV; Keret, D; Lahad, A; Maschler, I; Monselise, Y; Souroujon, M | 1 |
| Lengyel, G; Zsolt, T | 1 |
| Dobrenko, VA; Grinevich, VB; Gubonina, IV; Sablin, OA | 1 |
| Cao, Q; Si, JM; Wu, JG | 1 |
| Bernabucci, V; Cavina, M; De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
| Egashira, T; Furuta, T; Hishida, A; Ishizaki, T; Kenmotsu, K; Kodaira, M; Nagano, M; Nakamura, A; Ohashi, K; Sagehashi, Y; Shirai, N; Sugimoto, M; Ueda, K; Yoneyama, M | 1 |
| Almeida, JR; Campos, LT; Guerrazzi, F; Lorena, SL; Mesquita, MA; Montes, CG; Zeitune, JM | 1 |
| Berg, DE; Bhattacharya, SK; Chattopadhyay, S; Chowdhury, A; Datta, S; De, R; Hembram, J; Mukhopadhyay, AK; Nair, GB; Patra, R; Ramamurthy, T | 1 |
| Kawai, T; Narui, K; Noguchi, N; Rimbara, E; Sasatsu, M; Yamaguchi, T | 1 |
| De Francesco, V; Hassan, C; Ierardi, E; Morini, S; Panarese, A; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Akamatsu, T; Hidaka, E; Matsuzawa, K; Okiyama, Y; Ota, H; Sano, K | 1 |
| Furuta, T; Hishida, A; Ishizaki, T; Nakamura, A; Shirai, N; Sugimoto, M | 1 |
| Berg, DE; Bruce, MG; Bruden, DL; McMahon, BJ; Morris, JM; Parkinson, AJ; Reasonover, AL; Sacco, FD | 1 |
| Chiba, N; Fischbach, L; Khurana, R; Veldhuyzen van Zanten, S | 1 |
| Eichenberger, P; Eigenmann, F; Güller, R; Komminoth, P; Meier, J; Perren, A; Schmid, S; Soltermann, A; Weber, KB | 1 |
| Botta, F; Fumagalli, A; Giannini, EG; Malfatti, F; Mamone, M; Polegato, S; Savarino, V; Testa, E; Testa, R | 1 |
| Boyacioğlu, S; Gür, G; Kanbay, M; Yilmaz, U; Yücel, M | 1 |
| Cheng, N; Dai, G; Dong, L; Muramatsu, M; Wang, MW; Xiao, S; Zhu, DX | 1 |
| Bonner, RA; Delaney, KH; Gee, LC; Jury, J; Perdue, MH | 1 |
| Asaka, M; Ehira, N; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Mori, A; Obara, S; Ogura, N; Tanaka, J; Tsutsumi, Y; Umehara, S; Yamato, H | 1 |
| Bory, F; Bujanda, L; Calvet, X; Ducons, J; Gisbert, JP; Montserrat, A | 1 |
| Bayeli, PF; Cerretani, D; Giorgi, G; Marzocca, G; Pellegrini, M; Urso, R | 1 |
| Bjarnason, IT; Charlett, A; Dobbs, RJ; Dobbs, SM; Ibrahim, MA; Kerwin, RW; Mahler, RF; Oxlade, NL; Peterson, DW; Plant, JM; Price, AB; Weller, C | 1 |
| Balaban, YH; Gunes, DD; Hascelik, G; Ozarlan, E; Simsek, H; Tatar, G | 1 |
| Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nakao, H; Ogasawara, N; Ohara, H; Okada, N; Oshima, T; Sano, H; Sasaki, M; Sobue, S; Tanida, S | 1 |
| Klotz, U; Schwab, M; Treiber, G | 1 |
| Chen, YH; Li, HY; Wang, H; Wang, WM | 1 |
| Ahlawat, S; Benjamin, S; Cohen, P; Haddad, N; Kanber, Y; Ozdemirli, M | 1 |
| Cho, YS; Kim, SS; Konkin, TA; Meitner, P; Moss, SF; Resnick, MB | 1 |
| Budzyńska, A; Celińska-Cedro, D; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Jarosz, M; Jóźwiak, P; Nowak, J; Pawłowska, J; Prosiecki, R; Romańczuk, W; Rozynek, E; Szadkowski, A | 1 |
| Domínguez-Martín, A; Domínguez-Muñoz, A; Gisbert, JL; Gisbert, JP; Marcos, S | 1 |
| Aizawa, H; Kinoshita, T; Rikimaru, T; Yokoyama, T | 1 |
| Chen, X; Jia, Y; Liu, SJ; Shen, SR; Tang, WL; Wang, F; Wang, XY; Xu, CX | 1 |
| Bergeret, M; Dupont, C; Kalach, N; Nguyen, B; Raymond, J | 1 |
| Arslan, H; Atac, FB; Bilezikci, B; Boyacioglu, S; Can, F; Demirbilek, M; Kunefeci, G; Sahin, FI; Selcuk, H; Yilmaz, Z | 1 |
| Ando, T; El-Omar, E; Goto, H; Ina, K; Ishiguro, K; Kusugami, K; Minami, M; Mizuno, T; Nishiwaki, T; Nobata, K; Shimada, M; Tsuzuki, T; Watanabe, O | 1 |
| Carvalhaes, A; Magalhães, AF; Natan-Eisig, J; Paraíso-Ferraz, JG; Trevisan, M; Zaterkaad, S | 1 |
| Arai, D; Chen, G; Fukuchi, K; Gomi, K; Kikuchi, R; Takeuchi, Y | 1 |
| Baggett, HC; Bruce, MG; Dunaway, E; Gessner, BD; Gold, BD; Muth, PT; Parkinson, AJ | 1 |
| Hibi, T; Ishii, H; Masaoka, T; Sakai, G; Suzuki, H | 1 |
| Pan, Y; Xiao, SD; Zhang, L; Zheng, Q | 1 |
| Ateş, Y; Bağci, S; Ciğerim, M; Dağalp, K; Kadayifçi, A; Karslioğlu, Y; Savaş, MC; Uygun, A; Yeşilova, Z | 1 |
| Cengiz, DU; Güliter, S; Keleş, H; Kolukisa, E; Ozkurt, ZN | 1 |
| Chen, JL; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Tsay, FW; Tseng, HH; Wu, CJ; Yamaoka, Y; Yu, HC | 1 |
| Branca, G; Cammarota, G; De Carlo, M; Fadda, G; Posteraro, B; Posteraro, P; Rahimi, S; Ranno, S; Sanguinetti, M | 1 |
| Amoruso, A; Boscarelli, G; Castellaneta, SP; Cavallo, L; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Piscitelli, D | 1 |
| Cheng, H; Hu, FL | 1 |
| Krishna, M; Lalmuanpuii, J | 1 |
| Demirturk, L; Gurbuz, AK; Ozel, AM; Ozturk, R; Yazgan, Y; Yildirim, S | 1 |
| Demiray, E; Yilmaz, O | 2 |
| Imase, K; Sugano, H; Takahashi, S | 1 |
| Aoyagi, K; Maeda, K; Nishiyama, M; Sakisaka, S | 1 |
| Kawai, T; Kawakami, K; Moriyasu, F; Takagi, Y | 1 |
| Matsushima, M; Mine, T | 1 |
| Furuta, T; Miura, S; Okudaira, K; Shirai, N; Sugimoto, M | 1 |
| Takeda, H | 2 |
| Yanaka, A; Zhang, S | 1 |
| Nagahara, A; Sato, N | 1 |
| Furuta, T; Nakamura, A; Shirai, N; Sugimoto, M | 2 |
| Fujishiro, M; Kobayashi, K; Oka, M; Omata, M | 1 |
| Fujishiro, M; Ichinose, M; Oka, M; Omata, M | 1 |
| Asaka, M; Kato, M; Nakagawa, M; Nakagawa, S; Shimizu, Y | 1 |
| Konno, M | 1 |
| Kaminishi, M; Kubota, K; Shimizu, N | 1 |
| Katoh, H; Kuwano, H; Miyazaki, T; Tsukada, K | 1 |
| Sakaki, N | 2 |
| Nakajima, S; Setoguchi, Y; Yamamoto, S | 1 |
| Abe, C; Hikichi, T; Irisawa, A; Obara, K; Sato, Y | 1 |
| Ishiki, K; Mizuno, M; Take, S | 1 |
| Barsaoui, S; Boukthir, S; Fdhila, F; Fendri, C; Mrad, SM | 1 |
| Bertin, P; Broutet, N; Combe, B; Joubert-Collin, M; Lamouliatte, H; Mégraud, F; Perié, F; Schaeverbeke, T; Zerbib, F | 1 |
| Campos, A; Cardenas, VM; Chavez, A; El-Zimaity, HM; Graham, DY; Guerrero, L; Opekun, AR | 1 |
| Barros, SG; Cartell, A; Edelweiss, MI; Francesconi, CF; Fritscher, LG; Mazzoleni, LE; Ott, EA; Polanczyk, CA; Prolla, JC; Rivero, LF; Sander, GB; Theil, AL; Uchôa, DM; Wortmann, AC | 1 |
| Sugiyama, T | 1 |
| Burattini, O; De Francesco, V; Di Leo, A; Hassan, C; Ierardi, E; Marangi, S; Margiotta, M; Monno, R; Morini, S; Panella, C; Russo, F; Stella, F; Stoppino, V; Troiani, L; Zullo, A | 1 |
| Amoruso, A; Burattini, O; Cea, U; de Francesco, V; Hassan, C; Ierardi, E; Margiotta, M; Morini, S; Panella, C; Stella, F; Stoppino, G; Valle, ND; Zullo, A | 1 |
| Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F | 1 |
| Donovan, JL; Egger, M; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P; Noble, S | 1 |
| Chan, AO; Chan, CK; Cheung, HK; Kwong, YL; Lai, KC; Lam, SK; Peng, JZ; Rashid, A; Wong, BC; Yuen, MF | 1 |
| Bayerdörffer, E; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neuber, F; Rappel, S; Seitz, G; Stolte, M | 1 |
| Borody, TJ; Clancy, R; Herdman, K; Llorente, R; Ng, C; Pang, G; Surace, R; Wettstein, AR | 1 |
| Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A | 1 |
| Deguchi, R; Kobayashi, I; Kobayashi, K; Kurumada, T; Masui, A; Matsushima, M; Mine, T; Muraoka, H; Shirai, T; Suzuki, T; Takagi, A; Watanabe, K; Watanabe, S | 1 |
| Abe, T; Arita, T; Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S; Watanabe, K | 1 |
| Hassan, C; Morini, S; Panarese, A; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Butorov, IV; Butorov, SI; Maksimov, VV; Osoianu, IuP | 2 |
| Barry, M; Bennett, K; Keeling, PW; O'Morain, C; Walshe, V | 1 |
| Franceschi, M; Leandro, G; Perri, F; Pilotto, A | 1 |
| Ariyama, I; Furusyo, N; Hayashi, J; Kochi, S; Kubo, N; Murata, M | 1 |
| Alonzo, V; Cannatelli, MA; Cellini, L; Di Bartolomeo, S; Di Campli, E; Grande, R; Marzio, L; Nostro, A; Procopio, F | 1 |
| Elitsur, Y; Koletzko, S; Lawrence, Z; Rüssmann, H | 1 |
| Akarca, US; Aydin, A; Musoğlu, A; Onder, GF; Tekin, F; Tunçyürek, M | 1 |
| Aladağ, M; Alan, H; Ateş, F; Cikim, K; Demirel, U; Harputluoğlu, MM; Hilmioğlu, F; Kantarçeken, B; Karincaoğlu, M; Sertkaya, A; Yildirim, B | 1 |
| Egashira, T | 1 |
| Andersson, T; Hassan-Alin, M; Liljeblad, M; Niazi, M; Persson, BA; Röhss, K | 1 |
| Castro-Fernández, M; Cosme, A; Gisbert, JP; Gómez, B; Herrerías, JM; Luna, M; Monés, J; Olivares, D; Pajares, JM; Sánchez-Pobre, P | 1 |
| Chen, JY; Ji, F; Li, YM; Ning, JW; Wang, QY; Wang, ZW | 1 |
| Ashorn, M; Bodanszky, H; Bontems, P; Casswall, T; Celinska-Cedro, D; Crone, J; Gottrand, F; Kalach, N; Kolacek, S; Koletzko, S; Martínez-Gómez, MJ; Mégraud, F; Monteiro, ML; Orderda, G; Richy, F; Roma-Giannikou, E; Urruzuno, P | 1 |
| Aghakhani, S; Bahremand, S; Fourutan, H; Mir, E; Nematollahi, LR; Nouripour, S; Tirgari, F | 1 |
| Aragona, G; Benedetti, E; Cavallaro, L; Cavestro, GM; Chilovi, F; Comparato, G; Dal Bó, N; De Bastiani, R; Di Mario, F; Fedrizzi, F; Franceschi, M; Franzè, A; Iori, V; Leandro, G; Maino, M; Marcon, V; Marin, R; Monica, F; Olivieri, P; Orzès, N; Piazzi, L; Pilotto, A; Rugge, M; Salvat, MH; Tafner, G; Valiante, F; Vecchiati, U | 1 |
| Lule, GN | 1 |
| Amayo, EO; Kariuki, S; Lwai-Lume, L; Ogutu, EO | 1 |
| Chan, FK; Ching, JY; Lau, W; Lee, IY; Lee, KK; You, JH; Yung, M | 1 |
| Asaka, M; Kato, M; Katsuyama, T; Kikuchi, S; Tominaga, S | 1 |
| Gjøde, P; Jensen, S; Krogfelt, KA; Petersen, AM; Vinge, OD | 1 |
| Athanasiou, E; Delli, FS; Kountouras, I; Kountouras, J; Mandekou-Lefaki, I; Mattheou-Vakali, G | 1 |
| Fujioka, T; Kobayashi, I; Murakami, K; Muraoka, H; Saika, T | 1 |
| Alarcón, T; Díaz-Reganon, J; Domingo, D; López-Brea, M | 1 |
| Graham, DY; Lu, H | 1 |
| Cammarota, G; Candelli, M; Cazzato, A; Finizio, R; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lauritano, EC; Nista, EC; Ojetti, V; Santoro, M; Zocco, MA | 1 |
| Desar, IM; Jansen, JB; Keuter, M; Raemaekers, JM; van der Meer, JW; van Krieken, JH | 1 |
| Arakawa, T; Asaka, M; Fujioka, T; Haruma, K; Ishii, H; Kinoshita, Y; Kobayashi, K; Sakaki, N; Sakamoto, C; Shimosegawa, T; Sugiyama, T; Takahashi, S; Terano, A; Yoshikawa, T | 1 |
| Goh, KL; Rizal, AM; Rosmadi, MY; Tan, HJ | 1 |
| Quandalle, P; Tran, TT | 2 |
| O'Morain, C | 1 |
| Díte, P; Dostalík, Z; Hegyi, P; Hůlek, P; Králová, Z; Kunovská, M; Kyzeková, J; Matejovic, F; Novotný, I; Pásková, J; Petrtýl, J; Procházka, V; Pulgretová, D; Samek, M; Vyhnálek, P; Weinberg, J; Woznica, V; Zelenková, J | 1 |
| Hamajima, N; Hirose, K; Ito, H; Matsuo, K; Nakamura, T; Saito, T; Sawaki, A; Suzuki, T; Tajima, K; Wakai, K; Yamao, K | 1 |
| Havelund, T; Jarbol, DE; Kragstrup, J; Schaffalitzky de Muckadell, OB; Stovring, H | 1 |
| Bytzer, P | 1 |
| Ferrara, EC; Manes, G; Porro, GB | 1 |
| Takahashi, S; Tanaka, A; Tokunaga, K | 1 |
| Hatao, K; Takahashi, T; Yamada, K | 1 |
| Chan, AO; Chan, CK; Fung, FM; Gu, Q; Lai, KC; Lam, SK; Wang, JD; Wong, BC; Wong, KW; Wong, WM; Xia, HH; Yuen, MF | 1 |
| Lee, KH; Tam, YH; Yeung, CK | 1 |
| Classen, M; Li, J; Lin, SR; Liu, WD; Ma, JL; Pan, KF; Shen, L; Xiao, SD; You, WC; Zhang, L | 1 |
| Altintaş, E; Sezgin, O; Tataroğlu, C; Uçbilek, E | 1 |
| Bästlein, E; Bayerdörffer, E; Hansky, K; Jacobs, E; Kirsch, C; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M | 1 |
| Thompson, K; van Zanten, SV | 1 |
| Hayashi, K; Hisanaga, Y; Ichikawa, H; Kawachi, T; Kawase, N; Kiriyama, S; Kumada, T; Kuzuya, T; Nonogaki, K; Shimizu, J; Sone, Y; Tanikawa, M; Toyoda, H; Yamauchi, T | 1 |
| Alberer, M; Antos, D; Arenz, T; Buderus, S; Kappler, M; Koletzko, S; Rüssmann, H | 1 |
| Htut, Y; Kunanayagam, S; Poi, PJ | 1 |
| Akyol Erikci, A; Ozturk, A; Sayan, O | 1 |
| Gisbert, JP; Olivares, D; Pajares, JM; Torrado, G; Torrado, S | 1 |
| Hirakawa, K; Inoue, T; Komoto, M; Nakata, B; Takashima, T; Tominaga, K | 1 |
| Cavallaro, LG; Di Mario, F; Egan, B; O'Morain, C | 1 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Ang, TL; Chan, YH; Chua, TS; Fock, KM; Ng, TM; Tan, JY; Teo, EK | 1 |
| Abouzari, M; Hasibi, M; Mirbagheri, SA; Rashidi, A | 1 |
| Ahmed, K; Baglan, PH; Bozdayi, AM; Bozdayi, G; Ozden, A; Ozkan, M | 1 |
| Fujioka, T; Inoue, K; Kodama, M; Miyajima, H; Murakami, K; Okimoto, T; Ono, M; Otsu, S; Sato, R; Watanabe, K | 1 |
| Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA | 1 |
| Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR | 1 |
| Goić-Barisić, I; Jukić, I; Punda-Polić, V; Simunić, M; Tonkić, A; Tonkić, M | 1 |
| Bazzoli, F; Bianchi-Porro, G; Fiocca, R; Gasbarrini, G; Roda, E; Zagari, RM | 1 |
| Chen, A; Hsu, PI; Lai, KH; Lo, GH; Tsay, FW; Tseng, HH; Wang, WM; Wu, CJ; Wu, DC; Wu, IC; Wu, JY | 1 |
| Ziemniak, W | 1 |
| Dzieniszewski, J; Jarosz, M | 1 |
| Stege, PW; Vega, AE | 1 |
| Cheon, JH; Choi, YS; Jung, HC; Kim, JM; Kim, JS; Kim, N; Kim, SG; Lee, DH; Lee, JY; Song, IS | 1 |
| Doratotaj, D; Fallahi, GH; Khatami, GR; Mirnaseri, MM; Safari, F; Siavoshi, F | 1 |
| Apikoglu-Rabus, S; Besisik, F; Dulger, G; Izzettin, FV; Sancar, M; Tozun, N | 1 |
| Dinari, G; Evans, CT; Niv, Y; Passaro, DJ; Samra, Z; Shmuely, H; Yahav, J | 1 |
| Bella, A; Caracciolo, F; Crispino, P; Gurnari, M; Iacopini, F; Nardi, F; Paoluzi, P; Pica, R; Rivera, M; Rossi, P; Zippi, M | 1 |
| Byeon, JS; Choi, KD; Hong, SS; Hong, WS; Jo, JY; Jung, HY; Kim, JH; Kim, KJ; Lee, GH; Min, YI; Myung, SJ; Oh, TH; Song, HJ; Yang, SK | 1 |
| Berg, DE; Bruce, MG; Bruden, DL; Hennessy, TW; Hurlburt, DA; Martinez, P; McMahon, BJ; Morris, J; Parkinson, AJ; Parks, D; Peters, H; Reasonover, A; Sacco, F; Swenson, M | 1 |
| Bowlus, CL; Date, Y; Hoshino, H; Ishino, Y; Kita, H; Nakazato, M; Ohnishi, H; Osawa, H; Satoh, K; Shiiya, T; Sugano, K; Ueno, H; Watanabe, E | 1 |
| Kast, RE | 1 |
| Ahlroos, T; Korpela, R; Myllyluoma, E; Rautelin, H; Tynkkynen, S; Veijola, L | 1 |
| Arakawa, T; Asahina, K; Chouno, S; Endo, M; Hayakumo, T; Higuchi, K; Hirano, M; Inomoto, T; Maekawa, T; Matsuura, N; Nakagawa, K; Orino, A; Sakamoto, C; Tanimura, H; Tomono, N | 1 |
| Choe, YH; Choi, J; Jang, JY; Kim, JS; Kim, KM; Park, HY | 1 |
| Alliet, P; Bontemps, P; Cadranel, S; Lauvau, D; Van Biervliet, S; Vandenhoven, G; Vandenplas, Y | 1 |
| Cheng, H; Hu, FL; Li, J | 1 |
| Burattini, O; Cea, U; D'Angelo, R; De Francesco, V; Giorgio, F; Hassan, C; Ierardi, E; Margiotta, M; Monno, R; Morini, S; Panella, C; Stoppino, G; Valle, ND; Zullo, A | 1 |
| Buyukhatipoglu, H; Cemil Savas, M; Kadayifci, A; Simsek, I | 1 |
| Furuta, T; Hishida, A; Ishizaki, T; Iwaizumi, M; Kodaira, M; Kuriyama, S; Nogaki, A; Ohashi, K; Shirai, N; Sugimoto, M; Terakawa, I; Yamade, M | 1 |
| Bertoli Neto, JL; Bertoli, CF; Bueno, AG; Lourenço, LG; Sabbi, AR; Ulbrich, FS | 1 |
| Baik, GH; Chun, HJ; Hahm, KB; Hong, SJ; Jung, HC; Kim, BG; Kim, BW; Kim, HY; Kim, JJ; Kim, SG; Kim, SK; Kim, SW; Lee, DH; Lee, JH; Lee, KH; Lee, SW; Lee, YC; Park, CY; Park, JJ; Ye, BD | 1 |
| Bucki, R; Gotebiewska, M; Kemona, A; Namiot, DB; Namiot, Z | 1 |
| Chatzimavroudis, G; Katsinelos, P; Katsinelos, T; Papaziogas, B; Paroutoglou, G; Pilpilidis, I; Triantafillidis, I; Tziomalos, K; Vasiliadis, T | 1 |
| Higuchi, K | 1 |
| Arvanitakis, SN; Ashorn, M; Bontems, P; Cadranel, S; Canani, RB; Casswall, T; Celinska-Cedro, D; De Giacomo, C; Drumm, B; Gandullia, P; Gómez, MJ; Gottrand, F; Kalach, N; Oderda, G; Pehlivanoglu, E; Ravelli, A; Roggero, P; Roma, E; Romano, C; Rutigliano, V; Shcherbakov, P; Urruzuno, P | 1 |
| Bergeret, M; Burucoa, C; Decoster, A; Dupont, C; Kalach, N; Pietrini, O; Raymond, J; Wann, A | 1 |
| Bellini, M; Ciancia, E; Costa, F; Cristiani, F; de Bortoli, N; Leonardi, G; Marchi, S; Merlo, A; Mumolo, MG; Ricchiuti, A; Rossi, M; Santi, S | 1 |
| Chang, WC; Chu, SJ; Tsai, SH; Wu, CP | 1 |
| Burattini, O; Cea, U; De Francesco, V; Giorgio, F; Hassan, C; Ierardi, E; Margiotta, M; Morini, S; Pace, A; Panella, C; Stoppino, G; Zotti, M; Zullo, A | 1 |
| Bernasconi, G; Calafatti, SA; Deguer, M; Ecclissato, CC; Marchioretto, MA; Moraes, LA; Ortiz, RA; Pedrazzoli, J; Ribeiro, ML | 1 |
| Bashiri, H; Keshavarz, AA; Rahbar, M | 1 |
| Tepes, B | 1 |
| Dorchy, H; Khalil, T; Melot, C; Scaillon, M | 1 |
| Arakawa, Y; Hatta, Y; Hayashi, I; Iwamoto, M; Kato, K; Kurihara, R; Kurosaka, H; Matsukawa, Y; Mizuno, S; Sawada, S | 1 |
| Hayashida, Y; Itatsu, T; Kubota, M; Miwa, H; Miyazaki, A; Nagahara, A; Sato, N | 1 |
| Aydinli, B; Basoglu, M; Gursan, N; Ozturk, G; Yildigan, MI; Yilmaz, O | 1 |
| Koletzko, S; Lottspeich, C; Panthel, K; Rüssmann, H; Schwarzer, A | 1 |
| Bosques Padilla, FJ; Garza González, E; Giasi González, E; González, GM; Maldonado Garza, HJ; Martínez Vázquez, MA; Pérez Pérez, GI | 1 |
| Aoyama, N; Asaka, M; Fujioka, T; Fukuda, Y; Hirai, Y; Kuwayama, H; Sugiyama, T | 1 |
| Cheng, CC; Hu, CT; Lin, CY; Lin, NT; Su, SC; Tseng, YH; Wu, CC | 1 |
| Burdina, EG; Ivanova, OI; Minushkin, ON; Shuleshova, AG; Volodin, DV; Zverkov, IV | 1 |
| Cindoruk, M; Deger, SM; Kan, E; Karakan, T; Unal, S; Yetkin, I | 1 |
| Ishiki, K; Ishioka, H; Mizuno, M; Nagahara, Y; Oguma, K; Okada, H; Take, S; Yokota, K; Yoshida, T | 1 |
| Chodick, G; Koren, R; Niv, Y; Ofek, I; Samra, Z; Shmuely, H; Yahav, J | 1 |
| Heijboer, H; Neefjes, VM; Tamminga, RY | 1 |
| Cáceres, D; Defilippi, C; Garrido, L; Madrid, AM; Toledo, H; Vallejos, C | 1 |
| Haruma, K; Iishi, H; Ishiguro, S; Kamada, T; Merchant, JL; Nakae, Y; Shiotani, A; Tatsuta, M; Uedo, N | 1 |
| Aoki, T; Itoi, T; Kawai, T; Kawakami, K; Matsumoto, Y; Mikinori, K; Moriyasu, F; Noguchi, N; Rimbara, E; Sasatsu, M; Takagi, Y; Takei, K; Watanebe, K | 1 |
| Hassan, C; Morini, S; Perna, F; Ricci, C; Saracino, I; Vaira, D; Zullo, A | 1 |
| Hirasaki, S; Ikeda, F; Matsubara, M; Suzuki, S; Taniguchi, H | 1 |
| Kamiya, S | 1 |
| Tang, Y; Wen, FQ; Xiang, L; Zuo, WH | 1 |
| Abbott, E; Arellano, M; Arrese, M; Bustamante, A; Greig, D; Medina, B; Otarola, F; Pattillo, A; Pedreros, C; Riquelme, A; Rollan, A; Soza, A; Valenzuela, F | 1 |
| Demirci, H; Ersoy, O; Ersoy, R; Tatlican, S; Yayar, O | 1 |
| Kawai, T; Kijima, H; Noguchi, N; Rimbara, E; Sasatsu, M; Yamaguchi, T | 1 |
| De Francesco, V; Hassan, C; Morini, S; Perna, F; Ricci, C; Tampieri, A; Vaira, D; Zullo, A | 1 |
| Shen, SR; Wang, F; Xu, CX; Zhou, JD | 1 |
| Cannaviello, C; De Francesco, V; Efrati, C; Hassan, C; Ierardi, E; Maconi, G; Manes, G; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Chen, XY; Ge, ZZ; Li, XB; Liu, WZ | 1 |
| Buzás, GM; Kiss, A; Lotz, G | 1 |
| Anbo, T; Asaka, M; Fujinaga, A; Hagiwara, T; Imamura, A; Kato, M; Nakagawa, M; Nakagawa, S; Shimizu, Y; Suga, T; Takeda, H; Uchida, T; Yamamoto, J | 1 |
| Asmar, E; Bergeret, M; Campeotto, F; Charkaluk, ML; Decoster, A; Dehecq, E; Dupont, C; Kalach, N; Raymond, J; Serhal, L; Spyckerelle, C | 1 |
| Almela, P; Aznárez, R; Benages, A; Borda, F; Bory, F; Calvet, X; Cañete, N; Castro, M; Cosme, A; Fernández, N; Feu, F; García-Grávalos, R; Gisbert, JP; Montoro, M; Pérez-Aisa, A; Piqué, JM; Santolaria, S | 1 |
| Fan, D; Guo, W; Han, Y; Hong, L; Li, X; Wang, J; Zhao, Y | 1 |
| Cindoruk, M; Dursun, A; Erkan, G; Karakan, T; Unal, S | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Kodaira, C; Nishino, M; Shirai, N; Sugimoto, M | 1 |
| Chang, WL; Chen, WY; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Bozzi, R; Cozzolino, A; Di Girolamo, E; Morante, A; Pasquale, L; Rispo, A | 1 |
| Hirschl, AM; Koletzko, S; Makristathis, A; Rüssmann, H | 1 |
| Boĭmatova, MB; Ishankulova, DM; Mirodzhev, GK; Negmatova, FA | 1 |
| Chen, TA; Chuah, SK; Hsu, PI; Lai, KH; Lin, WS; Lo, GH; Peng, NJ; Tsay, FW; Tseng, HH; Wu, CJ | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Kodaira, C; Kumagai, J; Matsushita, F; Nakajima, H; Nishino, M; Senoo, K; Shirai, N; Sugimoto, M; Umemura, K; Watanabe, H; Yamade, M | 1 |
| Akarca, U; Aydin, A; Ilter, T; Onder, G; Ozutemiz, O; Tekin, F | 1 |
| Arakawa, T; Haruma, K; Higuchi, K; Joh, T; Kobayashi, K; Murakami, K; Sugiyama, T; Suzuki, H; Terano, A; Yoshikawa, T | 1 |
| Engstrand, L; Fall, K; Fjelstad, B; Jakobsson, H; Nyrén, O; Wreiber, K | 1 |
| Richter, JA; Seabrook, ME; Shmunes, E | 1 |
| Bae, JM; Choi, IJ; Hong, EK; Kim, CG; Kim, YW; Kook, MC; Lee, JH; Lee, JY; Park, S; Ryu, KW; Song, HJ | 1 |
| Kullavanijaya, P; Mahachai, V; Noophun, P; Thong-Ngam, D; Tumwasorn, S | 1 |
| Barbatzas, C; Demonakou, M; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koussoulas, V; Spyridaki, E; Vaki, I; Vassiliou, S | 1 |
| Bijlsma, JW; Boers, M; de Leest, HT; Dijkmans, BA; Houben, HH; Huisman, AM; Kadir, SW; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; van de Laar, MA; van Tulder, MW; Vonkeman, HE | 1 |
| Hanemaaijer, R; Kubben, FJ; Lamers, CB; Schram, MT; Sier, CF; van Duijn, W; Veenendaal, RA; Verheijen, JH; Verspaget, HW; Witte, AM | 1 |
| Garrido, L; Toledo, H | 1 |
| Magen, E; Mishal, J; Scharf, S; Schlesinger, M | 1 |
| Almela, P; Barrio, J; Benito, LM; Bermejo, F; Bory, F; Calvet, X; Carneros, JA; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; García-Durán, F; Gisbert, JP; Khorrami, S; Lamas, E; Modolell, I; Niño, P; O'Callaghan, E; Ortiz, V; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A; Valer, MP | 1 |
| Ando, K; Hirata, H; Inoue, H; Joh, T; Kamiya, T; Kataoka, H; Kubota, E; Mizoshita, T; Mizushima, T; Mori, Y; Nakao, H; Ogaswara, N; Ohara, H; Okamoto, Y; Sasaki, M; Shimura, T; Wada, T | 1 |
| Basso, D; D'Odorico, A; Fadi, E; Fasolo, M; Fogar, P; Greco, E; Navaglia, F; Padoan, A; Pedrazzoli, S; Plebani, M; Schiavon, S; Stranges, A; Sturniolo, GC; Zambon, CF | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Vega, AE | 1 |
| Moayyedi, P | 2 |
| König, B; König, W; Layer, F; Moder, KA | 1 |
| Fujioka, T; Furuta, T; Hishida, A; Kodaira, C; Murakami, K; Nakamura, A; Nishino, M; Okimoto, T; Okuda, M; Shirai, N; Soya, Y; Sugimoto, M | 1 |
| Achiel, K; Hazazi, R; Lederfein, T; Niv, Y; Waked, A | 1 |
| Azuma, T; Fujioka, T; Fukuda, Y; Haruma, K; Kato, M; Kato, S; Katsuyama, T; Kobayashi, I; Murakami, K; Nasu, M; Takahashi, S; Uemura, N | 1 |
| Axon, AT; Crocombe, WD; Ford, AC; Forman, D; Moayyedi, P; Nathan, J | 1 |
| Hassan, C; Lorenzetti, R; Zullo, A | 1 |
| Bagci, S; Ilgan, S; Kadayifci, A; Safali, M; Uygun, A | 1 |
| Fariña, N; Kasamatsu, E; Laspina, F; Morán, M; Samudio, M; Sanabria, R | 1 |
| Bair, MJ; Chang, WH; Chen, JJ; Hsu, PI; Kuo, FC; Lu, CY; Wang, TE; Wang, WM; Wu, DC; Wu, IC; Wu, JY; Yu, FJ | 1 |
| Cho, YK; Choi, HS; Hwang, SJ; Jeon, WK; Kim, BI; Kim, HJ; Park, DI; Park, JS; Sohn, CI | 1 |
| Hojo, M; Kawabe, M; Kurosawa, A; Miwa, H; Nagahara, A; Ohkusa, T; Osada, T; Watanabe, S; Yoshizawa, T | 1 |
| Shaoul, R; Shehada, S; Srugo, I | 1 |
| Ali, M; Whitehead, M | 1 |
| Chen, J; Hu, HJ; Huang, XL; Li, ZY; Yan, WH; Yu, JD | 1 |
| Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
| Chan, FK; Lee, CC; Lee, VW; Ling, TK | 1 |
| Ahn, SB; Bang, SY; Eun, CS; Han, DS; Jeon, YC; Kang, JO; Kim, JE; Sohn, JH | 1 |
| Chaumette-Planckaert, MT; Deforges, L; Delchier, JC; Launay, N; Le Glaunec, JM; Soussy, CJ; Tankovic, J | 1 |
| Chen, S; Li, Y; Yu, C | 1 |
| Jain, NK; Ramteke, S | 1 |
| Bisogno, G; Carli, M; Colleselli, P; Da Dalt, L; Errigo, G; Grotto, P; Pusiol, A; Rossetti, F; Sainati, L | 1 |
| Arzanian, MT; Gachkar, L; Hamidieh, AA; Pasha, F | 1 |
| Roblin, X | 1 |
| Harris, EJ; Krishna, U; Peek, RM; Perez-Perez, GI; Romero-Gallo, J; Washington, MK | 1 |
| Esfahani, FS; Keshtkar-Jahromi, M; Rahnavardi, M; Rostami, N | 1 |
| Bästlein, E; Haferland, C; Jebens, C; Kirsch, C; Knoth, H; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M; Zekorn, C | 1 |
| Chisholm, SA; Owen, RJ | 1 |
| Bergeret, M; Dupont, C; Kalach, N; Raymond, J; Serhal, L; Spyckerelle, C | 1 |
| Buzás, GM; Széles, I | 1 |
| Amenta, PS; Das, KK; Das, KM; Geng, X; Kohgo, Y; Lin, JJ; Tanabe, H; Tanaka, A; Watari, J | 1 |
| Cai, JT; Chen, SJ; Chen, T; Si, JM; Wang, LJ; Zhu, Q | 1 |
| Cavanna, L; Pagani, R; Paties, C; Seghini, P; Zangrandi, A | 1 |
| Akoachere, JF; Luma, HN; MacMillan, M; Malange Takang, AE; Malongue, A; Ndip, LM; Ndip, RN; Ojongokpoko, JE; Weaver, LT | 1 |
| Castellanos Monedero, JJ; González Carro, P; Legaz Huidobro, ML; Pérez Roldán, F; Roncero García-Escribano, O; Ruiz Carrillo, F; Villafáñez García, MC | 1 |
| Ilgan, S; Kadayifci, A; Karaeren, N; Safali, M; Uygun, A; Yesilova, Z | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Okimoto, T | 1 |
| Choi, JH; Chun, HJ; Hyun, JJ; Jung, SW; Kim, CD; Kim, DI; Koo, JS; Lee, HS; Lee, SW; Park, JJ; Ryu, HS; Um, SH; Yim, HJ | 1 |
| Fox, JG; Ge, Z; Lee, CW; Rickman, B; Rogers, AB; Wang, TC | 1 |
| Abdullahi, M; Annibale, B; Capoccia, D; Lahner, E; Leonetti, F; Osborn, J; Severi, C; Tari, R | 1 |
| Hallas, J; Hansen, JM; Schaffalitzky de Muckadell, OB; Wildner-Christensen, M | 1 |
| Khamaisi, M; Leitersdorf, E | 1 |
| Burucoa, C; Fauchère, JL; Garnier, M; Silvain, C | 1 |
| Cakal, B; Kiliç, ZM; Köksal, AS; Kuran, S; Nadir, I; Ozin, YO; Sahin, B | 1 |
| Butruk, E; Dite, P; Eklund, S; Engstrand, L; Gottlow, M; Malfertheiner, P; Nagy, P; Sjölund, M; Stolte, M; Tchernev, K; Tulassay, Z; Wong, BC; Wrangstadh, M | 1 |
| Landivar, B; Moncayo, M; Parrales, J; Robles-Jara, C; Robles-Medranda, C | 1 |
| Cole, CR; Frem, JC; Gold, BD; Shehata, BM | 1 |
| Schepp, W | 1 |
| Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yoshida, Y | 2 |
| Aisawa, T; Akagi, T; Fukuda, S; Fukushi, M; Mizuki, I; Munakata, A; Ohkawa, K; Sakata, Y; Shimoyama, T; Yoshida, Y | 1 |
| Fukuda, Y; Okui, M; Shimoyama, T; Tonokatsu, Y; Yamamoto, I | 1 |
| Ashworth, HM; Baron, JH; Gummett, PA; Harris, AW; Logan, RP; Misiewicz, JJ | 1 |
| al-Assi, MT; Cole, RA; el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
| Domizio, P; Farthing, MJ; Katelaris, PH; Patchett, SE; Zhang, ZW | 1 |
| Armstrong, D; Blum, AL; Kreiss, C | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 2 |
| de Boer, WA; Tytgat, GN | 1 |
| Beattie, S; Cahill, RJ; Hamilton, H; Kilgallen, C; O'Morain, C; Xia, H | 1 |
| Johnson, CD; Ozmen, MM | 1 |
| Ahrends, H; Frotz, H; Hebbeln, H; Klass, D; Miederer, SE; Mittelstaedt, A; Rolfs, HC; von Geldern, R | 1 |
| Celle, G; Mela, GS; Savarino, V; Vigneri, S; Zentilin, P | 1 |
| Getz, HD; Metz, DC | 1 |
| Börsch, G; Labenz, J | 1 |
| Coll, I; Espinós, JC; Forné, M; Garau, J; Tresserra, F; Viver, JM | 1 |
| Reed, PI | 1 |
| Kuwayama, H; Nakajima, M; Sunairi, M; Suzuki, T; Tanaka, N; Watanabe, K | 1 |
| Fujioka, T; Fujiyama, K; Kawasaki, H; Kodama, R; Kubota, T; Nasu, M | 1 |
| Booth, JC; Brown, JL; Martin, J; Teare, JP; Thomas, HC | 1 |
| Jaup, BH; Norrby, A | 2 |
| Burette, A; Glupczynski, Y | 1 |
| Celle, G; Mela, GS; Savarino, V; Vigneri, S | 1 |
| Adamek, RJ; Opferkuch, W; Wegener, M | 1 |
| Goddard, A; Logan, R | 1 |
| Becker, T; Börsch, G; Labenz, J; Rühl, GH; Sollböhmer, M; Stolte, M; Tillenburg, B | 1 |
| Goh, KL; Parasakthi, N | 1 |
| Arslan, M; Kadayifçi, A; Simsek, H; Tatar, G | 1 |
| Adamek, RJ; Opferkuch, W; Pfaffenbach, B; Ricken, D; Szymanski, C; Wegener, M | 1 |
| Bertrams, J; Börsch, G; Domian, C; Labenz, J; Stolte, M | 1 |
| Domschke, W | 1 |
| Gad, A; Unge, P | 1 |
| al-Assi, MT; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
| Cuccurullo, F; Di Iorio, P; Laterza, F; Mezzetti, A; Neri, M; Seccia, G; Susi, D | 1 |
| al-Assi, MT; Genta, RM; Graham, DY; Lew, GM; Ramirez, FC | 1 |
| Beglinger, C; Binek, J; Frei, R; Fried, R; Mossi, S; Schaufelberger, H; Sieber, CC; Stalder, GA | 1 |
| Labenz, J; Stolte, M | 2 |
| Baron, JH; Greaves, RR; Gummett, PA; Logan, RP; Mendelson, GM; Misiewicz, JJ; Schaufelberger, HD; Thomas, PH; Walker, MM | 1 |
| De Korte, H; Moolenaar, W; Oom, JA; Runhaar, EA; Thijs, JC; Van Zwet, AA | 1 |
| Adamek, RJ; Börsch, G; Labenz, J; Opferkuch, W; Rühl, GH; Wegener, M | 1 |
| Blaser, MJ; Drnec, J; Genta, RM; Graham, DY; Klein, PD; Marshall, B; Peterson, WL; Prokocimer, P; Siepman, N; Stratton, CW | 1 |
| Nasu, M | 1 |
| Graham, DY; Klein, PD; Opekun, AR | 1 |
| Ramírez Ramos, A | 1 |
| Celle, G; Sandro Mela, G; Savarino, V; Vigneri, S | 1 |
| Boixeda, D; Gisbert, JP; Martín de Argila, C; Monés, J; Mur Villacampa, M; Sáinz Samitier, R | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Axon, AT; Moayyedi, P; Sahay, P; Tompkins, DS | 1 |
| Fujioka, T; Kawasaki, H; Kubota, T; Murakami, K; Nasu, M; Uribe, RU | 1 |
| Buset, M; De Koster, E; Deltenre, M; Jonas, C; Otero, J; van Gossum, M | 1 |
| Fukuda, Y; Okui, M; Shimoyama, T; Tamura, K; Tonokatsu, Y; Yamamoto, I | 1 |
| Hrruma, K; Kaji, M; Kajiyama, G; Mukai, T; Okamoto, S; Sumii, K; Uemura, N; Yamaguchi, S | 1 |
| Diehl, HG | 1 |
| Bernards, S; Götz, JM; Lamers, CB; Veenendaal, RA; Veselic, M | 1 |
| Hentschel, E; Schütze, K | 1 |
| Fennerty, MB; Vakil, N | 1 |
| Treiber, G | 1 |
| Dammann, HG | 2 |
| Hunt, RH | 1 |
| Alván, G; Blomgren, K | 1 |
| Fukuda, S; Fukuda, Y; Munakata, A; Shimoyama, T; Yoshida, Y | 2 |
| Lambert, JR | 1 |
| Unge, P | 3 |
| Bazzoli, F | 2 |
| Goddard, AF; Logan, RP | 1 |
| Berg, D; Gilman, RH; Gutierrez, V; Mayta, H; McDonald, JJ; Valdez, Y; Vasquez, A; Westblom, TU | 1 |
| Carli, G; Dalla Libera, M; Gamberini, S; Gullini, S; Merighi, A; Pazzi, P; Scagliarini, R | 1 |
| Caucheteur, B; De Koster, E; Deltenre, M; Jonas, C; Otero, J | 1 |
| Cayla, R | 1 |
| Domon, H; Ishii, C; Kawada, H; Koga, T; Utsui, Y; Yasuda, H | 1 |
| Markham, A; McTavish, D | 1 |
| Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C | 1 |
| Cammarota, G; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A | 2 |
| Debets-Ossenkopp, YJ; Kolkman, JJ; Kusters, JG; Sparrius, M; Vandenbroucke-Grauls, CM | 1 |
| Baniukiewicz, A; Bielański, W; Gabryelewicz, A; Hahn, EG; Jedynak, M; Konturek, PC; Konturek, SJ; Kwiecień, N; Sito, E | 1 |
| Gabryelewicz, A | 1 |
| Burette, A; Cozzoli, A; de Koster, E; Deltenre, M; Denis, P; Jonas, C; Otero, J | 1 |
| Roesch, W | 1 |
| Ciociola, AA; McSorley, DJ; Peterson, WL; Sykes, DL; Webb, DD | 1 |
| Barthelemy, P; Chaussade, S; Delchier, JC; Elamine, I; Goldfain, D; Idström, JP | 1 |
| Broadbent, A; Chambers, S; Gould, SR; Mistry, R; Ranganath, L; Weldon, MJ | 1 |
| Branca, G; Cammarota, G; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Trua, F; Tursi, A; Veneto, G | 1 |
| Chuah, SY; Goh, KL; Lo, YL; Navaratnam, P; Peh, SC; Rahman, NA; Wong, NW | 1 |
| Webb, DD | 1 |
| Cole, RA; el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 2 |
| el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
| Chiba, N | 2 |
| Hackelsberger, A; Malfertheiner, P | 1 |
| Dhaenens, L; Husson, MO; Szczebara, F | 1 |
| Herman, R; Konturek, JW; Konturek, SJ; Lorens, K; Tabor, S; Thor, P | 1 |
| De Fanis, C; Di Virgilio, M; Magnarini, C; Masciulli, V; Pantaleone, U; Pizzicannella, G; Sciampa, G; Spadaccini, A | 1 |
| Hentschel, E; Hirschl, AM; Schütze, K | 1 |
| Buiatti, E; Kato, I; Muñoz, N; Oliver, W; Vivas, J | 1 |
| Dankert, J; ten Kate, FJ; Tytgat, GN; van der Ende, A; van der Hulst, RW; Weel, JF | 1 |
| Alder, JD; Ewing, PJ; Mitten, MJ; Oleksijew, A; Tanaka, SK | 1 |
| Carpintero, P; García Grávalos, R; Hermida, C; Lara, S; Moreno, JA; Pajares, JM; Santander, C | 1 |
| Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y | 1 |
| Fukuda, Y; Shimoyama, T; Tamura, K; Tonokatsu, Y; Tsujiai, T | 1 |
| Fujioka, T; Kodama, R; Kubota, T; Murakami, K; Nagai, J; Nasu, M; Nishizono, A; Tokieda, M | 1 |
| Cammarota, G; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A; Veneto, G | 1 |
| Baron, JH; Gabe, SM; Harris, AW; Karim, QN; Langworthy, H; Misiewicz, JJ; Pryce, DI; Walker, MM | 1 |
| Brill, S; Bujanover, Y; Gilat, T; Hallak, A; Konikoff, FM; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Estrada, R; Fukanaga, K; Laine, L; Neil, G; Trujillo, M | 1 |
| Fischbach, W; Greiner, A; Konrad, H; Tacke, W | 1 |
| Freston, JW; Murphy, K; Taylor, JL; Zagari, M | 1 |
| de Boer, WA; Jansz, AR; Schneeberger, PM; Thijs, JC; van Zwet, AA; Weel, J | 1 |
| Beyer, J; Flamm, RK; Graham, DW; Shortridge, VD; Stone, GG; Tanaka, SK; Versalovic, J | 1 |
| Bock, H; Mares, A | 1 |
| Cammarota, G; Cannizzaro, O; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A; Veneto, GM | 1 |
| Paar, D; Sauerbruch, T; Terjung, B | 1 |
| Kajiwara, M; Kawada, H; Kidaira, K; Kimura, K; Nishifuku, K; Sato, K; Sohara, H; Taniguchi, Y; Wang, XM | 1 |
| Alarcón, T; Díaz de Rojas, F; Domingo, D; López-Brea, M; Sánchez, I | 1 |
| Dohil, R; Hassall, E; Israel, DM | 1 |
| Aubert, E; Berge, T; Breder, O; Farup, P; Flaaten, B; Haug, JB; Høie, O; Lerang, F; Moum, B; Søberg, T; Tolås, P | 1 |
| Axon, AT; Ireland, A; Rooprams, PD; Smith, MJ | 1 |
| Adamek, RJ; Börsch, G; Idström, JP; Labenz, J; Peitz, U; Tillenburg, B | 1 |
| Labenz, J; Lütke, A; Stolte, M; Tillenburg, B; Weismüller, J | 1 |
| Barrett, DA; Erah, PO; Goddard, AF; Shaw, PN; Spiller, RC | 1 |
| Axon, AT; Chalmers, DM; Moayyedi, P | 1 |
| Johnston, BJ; Reed, PI | 1 |
| Akahane, T; Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Shimizu, T | 1 |
| Block, SL; Harris, J; Kolokathis, A; Tarlow, MJ | 1 |
| Fernández Cadenas, F; García Calero, C; García Saavedra, L; Lomo Montero, J; Rodrigo Sáez, L | 1 |
| Bargiggia, S; Bianchi Porro, G; Lazzaroni, M | 1 |
| Beyer, J; Flamm, RK; Shortridge, D; Stamler, D; Stone, GG; Tanaka, SK | 1 |
| Bortoli, A; Colombo, E; Imperiali, G; Lesinigo, E; Minoli, G; Spinzi, G; Terruzzi, V; Venturelli, R | 1 |
| Peterson, WL | 1 |
| Misiewicz, JJ | 1 |
| Drumm, B; Durnin, M; Goggin, N; Moriarty, S; Rowland, M; Walsh, D | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Siehoff, S; Tillenburg, B | 1 |
| Hunt, RH; Sherman, PM; Veldhuyzen van Zanten, SJ | 1 |
| Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N | 1 |
| Buckley, M; Keane, CT; O'Morain, CA; Xia, HX | 1 |
| Aka, H; Gullu, IH; Kadayifçi, A | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M | 1 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Brenner, C; Ebell, MH; Warbasse, L | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Angeletti, S; Annibale, B; Bordi, C; Delle Fave, G; Malagnino, F; Mancino, C; Marignani, M | 1 |
| Ebina, K; Kato, S; Naganuma, H; Takeyama, J | 1 |
| Biemond, I; Götz, JM; Lamers, CB; Offerhaus, GJ; Thio, JL; Veenendaal, RA; Verspaget, HW | 1 |
| Kim, MJ; Michener, R; Triadafilopoulos, G | 1 |
| Chambers, S; Gould, SR; Lim, AG; Walker, C | 1 |
| Boixeda, D; Gisbert, JP; Martín de Argila, C | 2 |
| Iida, M; Matsumoto, T; Shimizu, M | 1 |
| Hoffman, JS | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; García Plaza, A; Gisbert, JP; Martín De Argila, C | 1 |
| Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S | 1 |
| Chan, CK; Ching, CK; Lai, CL; Lai, KC; Lam, SK; Ong, L; Wong, BC | 1 |
| Hirakawa, T | 1 |
| Matsukura, N | 1 |
| Hogan, J; Krasner, N; Lombard, M; Purkayastha, SK; Tan, WC | 1 |
| Kobler, E; Reinhart, WH; Werth, B; Wüst, W | 1 |
| Bardhan, KD; Dallaire, C; Duggan, AE; Eisold, H | 1 |
| Beyer, J; Flamm, RK; Ghoneim, AT; Shortridge, D; Stone, GG; Tanaka, SK | 1 |
| Bisso, G; Caroli, M; Celle, G; Mansi, C; Mela, GS; Mele, MR; Olivieri, A; Saggioro, A; Savarino, V; Termini, R; Tosatto, R; Vigneri, S | 1 |
| Hamilton, MR; Pounder, RE; Sercombe, JC; Williams, MP | 1 |
| Wright, DH | 1 |
| Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM | 1 |
| Baker, A; Frantz, JE; Laine, L; Neil, GA | 1 |
| Attili, AF; Diana, F; Pugliano, F; Rinaldi, V; Valente, C; Zullo, A | 1 |
| Breuer, T; el-Zimaity, HM; Graham, DY; Kim, JG; Nakajima, S; Nikajima, S; Osato, M; Ota, H | 1 |
| Archambault, A; Archimandritis, A; Bazzoli, F; Fedorak, R; Hentschel, E; Megraud, F; Mora, P; Rodrigo, L; Rokkas, T; Skandalis, N; Stamler, D; Wurzer, H | 1 |
| Harris, A | 3 |
| Lal, S; Sheikh, RM; Zuberi, BF | 1 |
| Attili, AF; Diana, F; Pugliano, F; Rinaldi, V; Zullo, A | 1 |
| Cervantes Bustamante, R; Cuevas, S; Mata Rivera, N; Oyervides Garcia, I; Ramirez Mayans, JA; Zamora Davila, E; Zarate Mondragón, FE | 1 |
| Buckley, MJ; Hyde, DM; Keane, CT; O'Morain, CA; Xia, HX | 1 |
| Engstrand, L; Gibreel, A; Hultén, K; Sköld, O | 1 |
| Aoyagi, K; Fujishima, M; Hizawa, K; Kawasaki, M; Nakamura, S | 1 |
| Adamek, RJ; Pfaffenbach, B; Szymanski, C | 1 |
| Ando, H; Kagaya, T; Noda, Y; Takemori, Y | 1 |
| Haber, M; Kidd, S; Riff, DS; Rose, P; Siepman, N; Weissfeld, A | 1 |
| Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A | 1 |
| Haber, M; Kidd, S; Krause, R; Rose, P; Sahba, B; Schwartz, H; Siepman, N; Weissfeld, A | 1 |
| Jaup, BK | 1 |
| Axon, AT; Chalmers, DM; Dixon, MF; Langworthy, H; Moayyedi, P; Shanahan, K; Tompkins, DS | 1 |
| Malfertheiner, P; Mégraud, F | 1 |
| Dettmer, A; Fraser, AG; O'Morain, C; Rambow, A; von Fritsch, E | 1 |
| Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M | 1 |
| Keller, JJ; Rauws, EA; Tytgat, GN; van der Hulst, RW | 1 |
| Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
| Minocha, A; Srinivasan, R | 1 |
| Dixon, JS; Pipkin, GA; Williamson, R; Wood, JR | 1 |
| Perkin, J; Smith, C; Tompkins, DS | 1 |
| Engstrand, L; Hultén, K; Jaup, B; Stenquist, B | 1 |
| Bhutta, AS; Bindel, H; Cunnane, K; Loane, J; O'Connor, HJ | 1 |
| Isomoto, H; Kohno, S; Matsunaga, K; Mizuta, Y; Oofukuji, M; Osabe, M; Syukuwa, S; Takeno, Y | 1 |
| Beyer, J; Flamm, RK; Idler, K; Shortridge, D; Stone, GG; Tanaka, SK; Versalovic, J; Zulawinski, L | 1 |
| Bardhan, KD; Graham, DY; Hunt, RH; O'Morain, CA | 1 |
| Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Seki, M; Takimoto, T; Taniguchi, Y; Yoshida, Y | 1 |
| Innerhofer, M; Malfertheiner, P; Pieramico, O; Zanetti, MV | 1 |
| Bailey, RJ; Duggan, AE; Louw, JA; Ohlin, B; Pounder, RE; Wyeth, JW | 1 |
| Berge, T; Haug, JB; Lerang, F; Moum, B; Sandvei, PK; Tolås, P; Torp, R; Tønnesen, T | 1 |
| Bazzoli, F; Pozzato, P | 1 |
| Dixon, JS; Mills, JG; Pipkin, GA; Wood, JR | 1 |
| Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y | 1 |
| Fennerty, MB | 1 |
| Espinós, JC; Esteve, M; Fernández-Bañares, F; Forné, M; Garau, J; Lite, J; Quintana, S; Salas, A; Viver, JM | 1 |
| Bardhan, KD; Cooper, BT; Dixon, MF; Harris, AW; Kerr, GD; Langworthy, H; Levi, S; Misiewicz, JJ; O'Morain, C; Piper, D | 2 |
| Archimandritis, A; Balatsos, V; Davaris, P; Delis, V; Kanellopoulou, E; Manika, Z; Skandalis, N; Souyioultzis, S; Tzivras, M | 1 |
| Hamilton, W; Price, J | 1 |
| Cammarota, G; Cannizzaro, O; Cianci, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, G; Papa, A; Tursi, A | 1 |
| Boixeda de Miquel, D | 1 |
| Alberdi, JM; Beckford, C; Blanco, MA; Carnicero, JA; Casanova, A; Crespo, L; Fernández Velázquez, J; Galán, JL; García Benito, MD; Güemes, C; Pérez Mota, A; Pérez Muñoz, C; Pita, L; Villalgordo, C | 1 |
| Hirayama, F; Hisadome, M; Ikeda, Y; Kusuhara, H; Matsuyuki, H | 1 |
| Berg, DE; Blaser, MJ; Dubois, A; Fiala, N; Heman-Ackah, LM; Perez-Perez, GI | 1 |
| Pipkin, GA; Williamson, R; Wood, JR | 2 |
| Adamek, RJ; Opferkuch, W; Pfaffenbach, B; Suerbaum, S | 1 |
| Bardhan, KD; Jahnsen, J; Lotay, N; Marcelino, M; Roberts, PM; Wurzer, H | 1 |
| Abbasciano, V; Caselli, M; Ruina, M; Sartori, S; Trevisani, L; Verdianelli, G | 1 |
| Fendrick, AM; Laine, L | 1 |
| Berquist, WE | 1 |
| Abraira, V; Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C; Moreno, L; Redondo, C | 1 |
| Leri, O; Losi, T; Mastropasqua, M; Perinelli, P; Tubili, S | 1 |
| El-Zimaity, HM; Graham, DY; Kim, JG; Osato, MS; Perng, CL | 1 |
| Ammon, S; Klotz, U; Schneider, E; Treiber, G | 1 |
| Johnsen, R; Lindsetmo, RO; Revhaug, A | 1 |
| Calvet, X; Comet, R; García, N; Navarro, M; Sanfeliu, I | 1 |
| Carnicer, J | 1 |
| Bloom, BS; Cutler, AF; Schwartz, JS; Sonnenberg, A; Vakil, N | 1 |
| Battaglia, G; Buda, A; Cassaro, M; Dal Bo', N; Di Mario, F; Kusstatscher, S; Leandro, G; Pilotto, A; Rugge, M; Salandin, S; Vianello, F; Vigneri, S | 1 |
| Cunnane, K; Kelly, S; Laundon, J; McLoughlin, R; O'Connor, HJ | 1 |
| Scott, BB | 1 |
| Blum, AL; Malfertheiner, P | 1 |
| Freston, J; Haber, M; Krause, R; Rose, P; Sahba, B; Schwartz, H; Siepman, N; Weissfeld, A | 1 |
| Huang, AH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Liu, W; Lü, B; Xiao, S | 1 |
| Bei, L; Chen, S; Chen, Z | 1 |
| Axon, AT; Mapstone, N; Moayyedi, P; Ragunathan, PL; Tompkins, DS | 2 |
| Honda, T; Matsumoto, T; Mori, K; Nagatomi, Y; Takaba, M; Tsuneoka, H | 1 |
| Archimandritis, A; Katsorida, M; Souyioultzis, S; Tzivras, M | 1 |
| Krogfelt, KA; Petersen, AM; Schradieck, W | 1 |
| Battaglia, G; Benvenuti, ME; Del Bò, N; Di Mario, F; Donisi, PM; Leandro, G; Pasini, M; Pasquino, M; Vianello, F; Vigneri, S | 1 |
| Miwa, H; Murai, T; Nagahara, A; Ogihara, T; Ohkura, R; Sato, N; Watanabe, S; Yamada, T | 1 |
| Calvet Calvo, X | 1 |
| Fukuda, Y; Shimoyama, T; Tanida, N | 1 |
| Kimura, K; Sato, K | 1 |
| Aoyama, N | 1 |
| Fujioka, T; Kubota, T; Murakami, K; Sato, R | 1 |
| Asaka, M; Hirayama, Y; Nakamura, T; Takahashi, S; Uemura, N | 1 |
| Bianchi Porro, G; Cucino, C; Imbesi, V; Maconi, G; Manzionna, G; Parente, F; Vago, L | 1 |
| Arber, N; Brill, S; Bujanover, Y; Halpern, Z; Moshkowitz, M; Reif, S; Ringel, Y | 1 |
| Bierti, L; Bortoli, A; Colombo, E; Fertitta, AM; Lanzi, GL; Minoli, G; Spinzi, GC; Venturelli, R | 1 |
| Alampi, G; Bazzoli, F; Fossi, S; Nicolini, G; Pozzato, P; Ricciardiello, L; Roda, A; Roda, E; Simoni, P; Sottili, S; Varoli, O; Zagari, M | 1 |
| Bazzoli, F; Cardelli, A; Catalano, FA; Giglio, A; Lami, F; Olivieri, A; Pilotto, A; Pozzato, P; Roda, E; Scarpulla, G; Spadaccini, A; Susi, D; Tosatto, R; Zagari, M | 1 |
| Cheah, PL; Chin, SC; Chuah, SY; Goh, KL; Lo, YL; Parasakthi, N | 1 |
| Crobach, LF; Geraedts, AA; Kolkman, JJ; Nicolai, JJ; Oudkerk Pool, M; Tan, TG; Timmerman, RJ; Van Der Laan, J; Van Kleef, WA; Wolff, AA | 1 |
| Ballester Belenguer, J; Bonet Pla, A; García Tell, G; Jimeno Bernard, R; Navarro Pérez, J; Pereiró Berenguer, I; Sanfélix Genovés, J | 1 |
| de Boer, WA; Haeck, PW; Mulder, CJ; Otten, MH | 1 |
| Dore, MP; el-Zaatari, FA; Graham, DY; Kwon, DH; Osato, MS | 1 |
| Andriulli, A; Clemente, R; Conoscitore, P; Festa, V; Ghoos, Y; Niro, G; Perri, F; Quitadamo, M; Rutgeerts, P | 1 |
| Adams, S; Borody, T; Chang, FY; Chen, TS; Cheung, K; Daskolopolos, G; Full-Young, C; Lau, A; Talley, NA; Talley, NJ; Tseng-Shing, C; Wyatt, JM | 1 |
| Bazzoli, F; Cannizzaro, O; D'Angelo, A; Ederle, A; Fossi, S; Gerace, G; Iaquinto, G; Olivieri, A; Pozzato, P; Reina, G; Ricciardiello, L; Roda, E; Scarpulla, G; Spadaccini, A; Tosatto, R; Zagari, M | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianei, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, A; Gasbarrini, G; Papa, A; Tursi, A | 1 |
| Girdwood, AH; Grundlings, HD; Hanslo, D; Louw, JA; Marks, IN; van Rensburg, CJ | 1 |
| Ahuja, V; Bal, C; Dhar, A; Sharma, MP | 1 |
| Barthelemy, P; Bigard, MA; Delchier, JC; Riachi, G; Thibault, P | 1 |
| Bardhan, KD; Brookes, A; Cherian, P; Jones, RB; McCaldin, B; Morris, P; Morton, D; Perry, MJ; Slater, DN; Thompson, M | 1 |
| Hashimoto, Y | 1 |
| Adler, G; Ellenrieder, V; Fensterer, H; Glasbrenner, B; Waurick, M | 1 |
| Jiang, Q; Taylor, DE; Wang, G | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; van der Wouden, EJ; van Zwet, AA | 1 |
| Améndola, R; Corti, R; Ferro, FE; Kogan, Z; Lineado, A; Morgade, L; Musi, AO; Roldán, CD; Schenone, L; Solagna, A; Valero, J; Zerbo, O | 1 |
| Cecchi, R; Torelli, E | 1 |
| Higashi, Y; Kashima, K; Kodama, T; Sasaki, Y; Sawai, N; Tanahashi, T; Tatsumi, Y; Yamaoka, Y | 1 |
| Gamberini, S; Gullini, S; Matarese, V; Pazzi, P; Rizzo, C; Scagliarini, R | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Sung, JJ; Yung, MY | 1 |
| Figura, N; Graham, DY; Olson, CA; Osato, MS; Zhang, J | 1 |
| Bazzoli, F; Berretti, D; De Luca, L; Fossi, S; Nicolini, G; Pozzato, P; Ricciardiello, L; Zagari, M | 1 |
| Ciociola, AA; Heath, A; Lanza, FL; McSorley, DJ; Sontag, SJ; Sykes, DL | 1 |
| Hahn, B; McSorley, D; Vakil, N | 1 |
| Branicki, FJ; Choi, HK; Chu, KM; Law, SY; Tuen, HH; Wong, J | 1 |
| Cayla, R; de Mascarel, A; Forestier, S; Joubert-Collin, M; Lamouliatte, H; Mégraud, F; Zerbib, F | 1 |
| Cheng, AF; Chung, SC; Lau, JY; Leung, WK; Ling, JM; Ling, TK; Ng, EK; Siu, LK; Sung, JY | 1 |
| Delchier, JC; Lamarque, D; Sevin, E; Soussy, CJ; Tankovic, J | 1 |
| Ho, AS; Hsu, CT; Huang, WH; Lee, MM; Lee, SC; Shyu, RY | 1 |
| Filipowicz-Sosnowska, A; Gillon, KR; Hawkey, CJ; Lanas, A; Peacock, RA; Szczepanski, L; Tulassay, Z; van Rensburg, CJ; Wason, CM | 1 |
| Doermann, HP; Mégraud, F | 1 |
| Kotze, D; Louw, JA; Marks, IN; Moola, S; Van Rensburg, CJ | 1 |
| Connors, A; Frantz, J; Laine, L; Neil, G; Suchower, L | 2 |
| Adamek, RJ; Bethke, TD | 1 |
| Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D | 1 |
| Meier, E; Meining, A; Stolte, M | 1 |
| Alfvén, G; Bergström, M; Casswall, TH; Dahlström, KA; Drapinski, M | 1 |
| González Carro, P; Legaz Huidobro, ML; Pedraza Martín, C; Pérez Roldán, F; Ruíz Carrillo, F; Sáez Bravo, JM | 1 |
| Ho, B; Ho, KY; Hua, J; Ng, HC; Yeoh, KG | 1 |
| Borody, TJ | 1 |
| Cestari, R | 1 |
| De Fanis, C; Di Virgilio, M; Pantaleone, U; Pizzicanella, G; Russo, L; Sciampa, G; Silla, M; Spadaccini, A | 1 |
| Bortolotti, M; Brunelli, F; Mari, C; Miglioli, M; Sarti, P | 2 |
| Hynes, B | 1 |
| Hori, M; Iijima, H; Kawai, N; Kawano, S; Murata, H; Sawaoka, H; Tsuji, S; Tsujii, M | 1 |
| Howden, CW; Hunt, RH | 1 |
| Pigatto, P; Valsecchi, R | 1 |
| Kalantar, J; Talley, NJ; Xia, HH | 1 |
| Borody, TJ; Reyes, E; Shortis, NP | 1 |
| Ariake, K; Fujiki, K; Horiuchi, T; Ishii, K; Kumagai, J; Ohkusa, T; Sakurazawa, T; Shimoi, K; Suzuki, S; Takashimizu, I; Tanizawa, T | 1 |
| Asaka, M; Iinuma, K; Kato, S; Ohnuma, K; Ritsuno, H; Sugiyama, T | 1 |
| Bermejo, F; Boixeda, D; García Arata, I; García Plaza, A; Gisbert, JP; Martín de Argila, C; Moreno, L; Ramos, F | 1 |
| Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C | 2 |
| Bardhan, KD; Duggan, AE; Gudjonsson, H; Hoie, O; Kliebe-Frisch, C; Kristensen, ES; Pipkin, GA; Schuetz, E | 1 |
| Coudron, PE; Stratton, CW | 1 |
| Fukuda, S; Haga, Y; Mikami, T; Munakata, A; Murata, Y; Shimoyama, T; Tanaka, M; Yamagata, R; Yoshimura, T | 1 |
| Blum, AL; Bolling-Sternevald, E; Junghard, O; Labenz, J; Louw, JA; O'Moráin, C; Stolte, M; Stubberöd, A; Sundin, M; Talley, NJ; Theodórs, A; van Zanten, SV | 1 |
| Kanai, F; Maeda, S; Ogura, K; Omata, M; Shiratori, Y; Yoshida, H | 1 |
| Chan, CC; Chen, TK; Huang, SH; Lee, CL; Lee, SC; Tu, TC; Wu, CH | 1 |
| Fujita, T; Kobayasi, I; Mine, T; Suzuki, J | 1 |
| Arakawa, T; Kamisawa, T; Kato, H; Kozawa, H; Momma, K; Sakaki, N; Yamada, Y | 1 |
| Fuentes, J; García, S; Gomollón, F; Martín Mir, ML; Simón, MA; Val, J; Yus, C | 1 |
| Baena Díez, JM; Comet Jaumet, D; Jiménez Navarrete, S; López Mompó, C; Rams Rams, F; Sancho Perpiñán, A | 1 |
| Andersen, LP; Aursnes, I; Farup, P; Kleveland, PM; Lerang, F; Lygren, I; Vatn, M | 1 |
| Biagini, R; Bilardi, C; Bisso, G; Celle, G; Mansi, C; Mele, MR; Pivari, M; Savarino, V; Termini, R; Vigneri, S; Zentilin, P | 1 |
| Garrido, A; Guerrero, FJ; Lepe, JA; Palomo, S | 1 |
| Bardhan, KD; Bayerdörffer, E; Cederberg, C; Hellblom, M; Lind, T; Mégraud, F; O'morain, C; Spiller, R; Unge, P; Veldhuyzen Van Zanten, S; Wrangstadh, M; Zeijlon, L | 1 |
| Klinkenberg-Knol, EC; Kuipers, EJ | 1 |
| Baquero, F; Bermejo, F; Boixeda, D; Cantón, R; de Rafael, L; García-Arata, MI; Gisbert, JP; Martín de Argila, C | 1 |
| Fujita, R; Kirihara, K; Kojima, T; Sakurai, K; Takahashi, H; Yamada, M; Yamaguchi, Y | 1 |
| Kimoto, M; Murakami, K | 1 |
| Maeda, S; Yoshida, H | 1 |
| Iijima, K; Kato, K; Ohara, S; Sekine, H | 1 |
| Iwasaki, A | 2 |
| Habu, Y; Inokuchi, H; Kiyota, K; Ko, K; Sugano, Y; Waki, S | 1 |
| Harasawa, S; Kouda, K; Kurumada, T; Miwa, T; Shirai, T; Tada, U; Takagi, A; Wada, T; Watanabe, S | 1 |
| Kawamura, N; Nakagawa, M; Nakagawa, S; Ooishi, M; Ooizumi, H; Saitou, M; Yoda, Y | 1 |
| Kihira, K; Kimura, K; Kumakura, Y; Sato, K; Sugano, K; Yoshida, Y | 1 |
| Goto, T; Hisiki, S; Kawaguchi, Y; Komatu, K; Siwa, T; Suzuki, R; Tanaka, M; Tochikubo, O; Yokoyama, N | 1 |
| Keto, Y; Okabe, S; Takahashi, S | 1 |
| Nilsson, F; Walder, M | 1 |
| Braegger, CP; Schultz-Süchting, F; Stallmach, T | 1 |
| Bordas, JM; de la Rosa, C; Elizalde, JI; Fernández, RM; Ginès, A; Llach, J; Mas, A; Piqué, JM; Santamaría, J; Terés, J; Vásconez, C | 1 |
| Owen, RJ | 1 |
| Barrachina, M; Bixquert, M; Cuquerella, J; del Val, A; García-Romero, E; Garrigues, V; Higón, MD; Ponce, J; Pons, V | 1 |
| Bolling-Sternevald, E; Janssens, J; Lauritsen, K; Rácz, I; Talley, NJ | 1 |
| Arosio, C; Bertinieri, G; Blasi, F; Ceriani, G; Cosentini, R; Mandelli, C; Perondi, R; Ranzi, ML; Tarsia, P; Tien, TV; Torgano, G | 1 |
| Navuluri, R; Yue, S | 1 |
| Finkel, Y; Sandstedt, B; Tirén, U | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Osato, MS; Qureshi, W | 1 |
| Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L | 1 |
| Chan, CK; Ching, CK; Ho, J; Hu, WH; Lai, CL; Lai, KC; Lam, SK; Lau, GK; Wong, BC; Yuen, ST | 1 |
| Hu, PJ; Liu, WZ; Tytgat, GN; Xia, DH; Xiao, SD | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; Van der Wouden, EJ; Zwet, AA | 1 |
| Liu, WZ; Shi, Y; Tytgat, GN; Wu, SM; Xiao, SD; Xu, WW; Zhang, DZ | 1 |
| Huang, J; Hunt, RH | 2 |
| Craig, AM; Davey, P; Malek, M; Murray, F | 1 |
| de Pablo, J; García, F; Gómez-Gil, E; Martínez, JA; Mensa, J; Pintor, L | 1 |
| Caetano, JA; Caetano, JM; da Silva, JA; Marote, G; Pessanha, MA; Rosário, M | 1 |
| Blanchard, J; Boden, J; Ermak, T; Georgakopoulos, K; Giannasca, P; Gray, H; Hill, J; Ingrassia, J; Kleanthous, H; Lee, CK; Monath, TP; Soike, K; Tibbitts, T; Weltzin, R | 1 |
| Olson, CA; Sonnenberg, A; Zhang, J | 1 |
| Ashktorab, H; Hinds, T; Jagtap, J; Kim, KS; Scott, VF; Smoot, DT | 1 |
| Cheybani, K; Estrada, R; Laine, L; Neil, G; Smith, S; Trujillo, M; Yeramian, P | 1 |
| Miwa, H; Murai, T; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Shimizu, H; Watanabe, S | 1 |
| Hassan, M; Ikezawa, K; Kashimura, H; Mutoh, H; Nakahara, A; Sawahata, T; Suzuki, K; Tanaka, N; Watanabe, T | 1 |
| Cave, DR; Hoffman, JS; Katz, LM | 1 |
| Axon, AT; Everett, S; Langworthy, H; Mapstone, NP; Moayyedi, P; Neville, PM; Tompkins, D | 1 |
| Breslin, NP; Buckley, MJ; Hyde, DK; Lee, JM; O'Morain, CA | 1 |
| Tytgat, GN; van 't Hoff, BW; van der Ende, A; van der Hulst, RW | 1 |
| Cutler, A; Vakil, N | 1 |
| Abdul Aal, GM; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, M; Ukabam, S | 1 |
| Abdul Aal, G; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, MA; Ukabam, S | 1 |
| Levenson, SD; Pauly, MP; Schwartz, JS; Sonnenberg, A | 1 |
| Debets-Ossenkopp, YJ; Herscheid, AJ; Kuipers, EJ; Kusters, JG; Pot, RG; Vandenbroucke-Grauls, CM | 1 |
| Kim, IH; Kim, JG; Oh, CH; Son, SW | 1 |
| Bozzola, L; Di Mario, F; Fortunato, A; Franceschi, M; Leandro, G; Meli, S; Pilotto, A; Rassu, M; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Jacoby, EB; Porter, KB | 1 |
| Arber, N; Brill, S; Halpern, Z; Konikoff, FM; Moshkowitz, M; Reif, S | 1 |
| Bhasin, DK; Ray, P; Sharma, BC; Singh, K; Sinha, SK; Vaiphei, K | 1 |
| Becker, M; Behrens, R; Bindl, L; Keller, KM; Küster, P; Lang, T; Rodeck, B; Stolte, M; Wündisch, GF | 1 |
| Bamford, JT; Blankush, JL; Gangeness, DE; Tilden, RL | 1 |
| Beneduce, F; Ciamarra, P; Del Vecchio Blanco, C; Delle Cave, M; Marmo, R; Romano, M; Vitale, LM | 1 |
| Schubert, ML | 1 |
| Are, BM; Atzei, A; Carta, M; Cugia, L; Dore, MP; Graham, DY; Maida, A; Manca, A; Massarelli, G; Mura, I; Piana, A; Realdi, G | 1 |
| McSorley, DJ; Perschy, TB; Schwartz, HI; Sorrells, SC | 1 |
| Hirai, S; Miwa, H; Murai, T; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Watanabe, S | 1 |
| Ducóns, JA; Ferrero, M; Gomollón, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
| Barè, M; Calvet, X; Cubells, M; Gálvez, E; López-Lorente, M; Molina, E | 1 |
| Fuchs, W; Hörner, M; Schlauch, D; Sellinger, M; Sieg, A | 1 |
| Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
| Ende, AV; Hensen, EF; Hoff, BW; Houben, MH; Hulst, RW; Kate, FJ; Rauws, EA; Tytgat, GN | 1 |
| Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL | 1 |
| Neiger, R; Schmassmann, A; Seiler, G | 1 |
| Grimm, KJ | 1 |
| Gibson, J; Lorenz, E; Owen, RJ; Slater, ER; Tompkins, DS | 1 |
| Baena Díez, JM; Barrera Aguilera, N; Hernández Chafes, FJ; López Gosp, D | 1 |
| Acciardi, C; Ali', A; Gatta, L; Holton, J; Landi, F; Menegatti, M; Miglioli, M; Ricci, C; Vaira, D | 1 |
| Björkholm, B; Engstrand, L; Enroth, H | 1 |
| Bardhan, KD; Farley, A; French, PC; Paré, P; Roberts, PM; Romãozinho, JM | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Brandstätter, G; Dragosics, B; Gschwantler, M; Hentschel, E; Hirschl, AM; Klimpfinger, M; Oberhuber, G; Pasching, E; Schütze, K; Weiss, W; Wimmer, M; Wurzer, H | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Nuciforo, G | 2 |
| Chen, X; Haruma, K; Kajiyama, G; Kamada, T; Kawamura, Y; Komoto, K; Mihara, M; Sumii, K; Tahara, K; Yoshihara, M | 1 |
| Caballero Plasencia, A; Carmona Soria, I; Herrerías Gutiérrez, J; López-Andrade, A; Martín Ruiz, J; Rodríguez Téllez, M; Valenzuela Barranco, M | 1 |
| Graham, DY; Osato, MS; Reddy, R | 1 |
| Adler, G; Boeck, W; Ellenrieder, V; Glasbrenner, B; Marre, R; Richter, C | 1 |
| Spiller, RC | 1 |
| Bazzoli, F; Berretti, D; De Luca, L; Fossi, S; Nicolini, G; Pozzato, P; Zagari, M | 1 |
| Angeles Arpa, M; Bermejo, F; Boixeda, D; García Arata, I; García Plaza, A; Gisbert, JP; Jesús Higes, M; Martín de Argila, C; Nieves Rincón, M | 1 |
| Ates, Y; Cetin, C; Dagalp, K; Erdil, A; Gulsen, M; Kadayifci, A; Karaeren, N; Uygun, A | 1 |
| Ballard, ED; Fennerty, MB; Talley, NJ; Vakil, N | 1 |
| Dagalp, K; Kadayifci, A; Kilinc, R; Uygun, A | 1 |
| Burke, B; Gibson, JR; Owen, RJ; Saunders, NA | 1 |
| Ariyama, I; Furusyo, N; Hayashi, J; Kanamoto, K; Kashiwagi, S; Nakamura, S; Suekane, H; Yano, Y; Yao, T | 1 |
| Bruno, S; Bustos Fernandez, LM; Gonzalez Cueto, D; Narbaitz, M | 1 |
| Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM | 1 |
| Evans, MF; Hammett, DC | 1 |
| Adamsson, I; Edlund, C; Lundquist, P; Nord, CE; Sjöstedt, S | 1 |
| Boixeda, D; Martín de Argila, C | 1 |
| Abdulle, AM; Adeyemi, EO; Benedict, S; Danial, MF; Helal, T | 1 |
| Howden, CW; Sharma, VK; Vasudeva, R | 1 |
| De Mascarel, A; Lamouliatte, H; Megraud, F; Samoyeau, R | 1 |
| Bytzer, P; Madsen, JL; Madsen, LG; Taskiran, M | 1 |
| Mach, T; Zahradnik-Bilska, J | 1 |
| Aller, R; Boixeda de Miquel, D; de la Calle, H; de Luis, DA; Garcia Avello, A; Lasuncion, MA; Martin de Argila, C | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y | 1 |
| Cabral, MM; Dani, R; De Castro, LP; Dias, MG; Franco, JM; Magalhães, LC; Mendes, GS; Moreira, LS; Queiroz, DM; Rocha, GA; Salles, PG; Toppa, NH | 1 |
| Ducóns, JA; Ferrero, M; García Cabezudo, J; Gomollón, F; Guirao, R; Montoro, M; Simón, MA | 1 |
| Cryer, B; Feldman, M; Lee, E; Sammer, D; Spechler, SJ | 1 |
| Chott, A; Mannhalter, C; Pfeffel, F; Pohl, G; Raderer, M; Valencak, J | 1 |
| Borda, F; Domínguez, E; Gisbert, JP; Sainz, R | 1 |
| Habu, Y; Inokuchi, H; Kawai, K; Kimoto, K; Kiyota, K; Mizuno, S; Sugano, Y | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Kodama, F; Okumura, K; Sakai, T; Shirakawa, K; Shirasaka, D; Tanigawara, Y | 1 |
| Fujishiro, M; Gotoda, T; Kondo, H; Oda, I; Ono, H; Saito, D; Yamaguchi, H | 1 |
| Kawamata, O; Maeda, S; Matsunaga, H; Ogura, K; Omata, M; Shiratori, Y; Yoshida, H | 1 |
| Lugannani, C; Strickland, C | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Papa, A; Pastorelli, A | 1 |
| Hoshiya, S; Ishida, H; Itoh, T; Ninomiya, H; Saito, S; Shingaki, M; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K | 1 |
| Fujioka, T | 1 |
| Axon, AT; Bardhan, KD; Braun, W; Cooper, BT; Dillon, J; Gatz, G; Tildesley, G; Wyatt, JI | 1 |
| Ivandić, A; Pezerović, D; Stimac, D; Takac, B; Vcev, A; Vceva, A | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Gentiloni, N; Ojetti, V; Pastorelli, A; Pirozzi, G | 1 |
| Anti, M; Armuzzi, A; Branca, G; Candelli, M; Canducci, F; Fadda, G; Fedeli, G; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pastorelli, A; Pola, P; Torre, ES | 1 |
| Chan, FK; Chung, SC; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Opekun, AR; Osato, MS | 1 |
| Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD | 1 |
| Chelvam, P; Fock, KM; Lim, SG | 1 |
| Chiba, N; Marshall, CP | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Prieto, N | 1 |
| Hoshi, T; Kato, K; Nagura, H; Ohara, S; Sasano, H; Shimosegawa, T; Toyota, T | 1 |
| Akamatsu, T; Furihata, K; Miyabayashi, H; Shimizu, T; Ueno, I | 1 |
| Dammann, HG; Fölsch, UR; Hahn, EG; Kirchner, T; Kist, M; Klör, HU; Strobel, S; von Kleist, DH | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Titó, L | 1 |
| Ertugrul, C; Fevzi Ersoy, F; Isitan, F; Sarikaya, M; Suleymanlar, G; Suleymanlar, I; Tugrul Sezer, M; Tuncer, M; Yakupoglu, G | 1 |
| Hanai, H; Kajimura, M; Kaneko, E; Sugimoto, M | 1 |
| Bayerdörffer, E | 1 |
| Bielański, W; Karczewska, E; Konturek, SJ; Pytko-Polonczyk, J; Sliwowski, Z; Szlachcic, A | 1 |
| Artikis, V; Georgopoulos, SD; Karatapanis, S; Ladas, SD; Mentis, A; Raptis, SA; Spiliadi, C | 1 |
| Miwa, H; Murai, T; Nagahara, A; Ogihara, T; Ohkura, R; Ohta, K; Sato, K; Sato, N; Takei, Y; Yamada, T | 1 |
| Berkowitz, D; Naveh, Y; Rosenthal, E; Shamaly, H | 1 |
| Fitscha, P; Schweeger, I; Sinzinger, H | 1 |
| Ling, KL; Luman, W; Ng, HS | 1 |
| Bueno, ML; Castro, LP; Coelho, LG; Gomes, BS; Lopes, LG; Martins, GM; Passos, MC | 1 |
| Brousal, A; Kearney, DJ | 1 |
| Ducóns, JA; Gomollón, F; Guirao, R; Montoro, M; Santolaria, S; Vera, J | 1 |
| Beglinger, C; Drewe, J; Lehmann, FS; Terracciano, L | 1 |
| Hirai, S; Kikuchi, S; Miwa, H; Murai, T; Nagahara, A; Nishira, T; Sato, N; Takei, Y; Watanabe, S | 1 |
| Ballardini, G; Boni, F; Bortoli, A; Colombo, E; Minoli, G; Spinzi, GC; Venturelli, R | 1 |
| Blackington, E | 1 |
| Lin, CH; Peters, J; Rabah, R; Shashidhar, H; Thomas, R; Tolia, V | 1 |
| de Boer, WA; Joosen, EA; Manders, JM; Reininga, JH; ten Ham, JC | 1 |
| Faller, G; Haas, R; Heesemann, J; Kirchner, T; Kist, M; Panthel, K; Strobel, S; Trebesius, K; Vogt, K | 1 |
| Bloemena, E; Festen, HP; Klinkenberg-Knol, EC; Kuipers, EJ; Lindeman, J; Luckers, AE; Meuwissen, SG; Nelis, GF; Schenk, BE; Snel, P; Thijs, JC; Viergever, PP | 1 |
| Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Adamsson, I; Edlund, C; Nord, CE | 1 |
| Fox, JG; Marini, RP; McColm, AA; Taylor, NS; Williamson, R; Yan, L | 1 |
| Calvet, X; García, N; Gené, E; Gisbert, JP; López, T; Roque, M | 1 |
| Iglesias Rodríguez, M; Jovell Fernández, E; Roca Figueras, G; Roca Fusalba, A; Ureña Tapia, MM; Vernet Vernet, M | 1 |
| Boyanova, L; Katzarov, N; Koumanova, R; Mitov, I; Spassova, Z; Stancheva, I | 1 |
| Azuma, T; Ito, S; Ito, Y; Kato, T; Kuriyama, M; Miyaji, H; Suto, H; Yamazaki, Y | 1 |
| Carpio, D; García Grávalos, R; Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 1 |
| Kaushik, SP; Vu, C | 1 |
| Laine, L; Neil, G; Suchower, L; Sugg, J | 1 |
| Bernal, S; Castro Fernández, M; Grande, L; Otero, MA; Romero Gómez, M; Vargas, J | 1 |
| Baños, F; Burrull, M; Cabezas, C; Lafuente, C; Madridejos, R; Morera, R | 1 |
| Attili, AF; Hassan, C; Lionetti, R; Meddi, P; Rinaldi, V; Ripani, C; Tomaselli, G; Winn, S; Zullo, A | 1 |
| Atha, P; Axon, AT; Brown, J; Crocombe, W; Dowell, AC; Feltbower, R; Mason, S; Moayyedi, P; Richards, ID | 1 |
| Adamthwaite, D; Davidson, G; Katelaris, PH; Lambert, J; Midolo, P; Yeomans, ND | 1 |
| Ammon, S; Kees, F; Klotz, U; Treiber, G | 1 |
| Bhasin, DK; Pathak, CM; Ray, P; Sharma, BC; Singh, K | 1 |
| Iida, N; Kurosawa, A; Miwa, H; Nagahara, A; Ogawa, K; Ohkura, R; Sato, N | 1 |
| Fraser, AG; Hackett, M; Hollis, B; Moore, L | 1 |
| Delchier, JC | 1 |
| Arai, K; Kobayashi, R; Mori, M; Ohki, I; Saito, K | 1 |
| Bilardi, C; Bisso, G; Borgonovo, G; Borro, P; De Salvo, L; Dulbecco, P; Mansi, C; Pivari, M; Raffaella Mele, M; Savarino, V; Tessieri, L; Vigneri, S; Zentilin, P | 1 |
| Berg, DE; Cho, CH; Fung, FM; Hu, WH; Hui, WM; Lai, KC; Lam, SK; Mukhopadhyay, AK; Wang, WH; Wong, BC | 1 |
| Chao, W; Ching, JY; Chung, SC; Lau, JY; Lee, YT; Leung, WK; Lin, SR; Ng, EK; Sung, JJ; To, KF; Wang, RT; Yeung, CK; Zhou, LY | 1 |
| Joubert-Collin, M; Lamouliatte, H; Perie, F | 1 |
| Imai, T; Konno, M; Muraoka, S; Takahashi, M | 1 |
| Asaka, M; El-Zaatari, FA; Graham, DY; Kashima, K; Kato, M; Kim, JJ; Kwon, DH; Osato, MS; Reddy, R; Yamaoka, Y | 1 |
| Annese, V; Bortolotti, M; Lopilato, C; Mari, C; Miglioli, M; Porrazzo, G | 1 |
| Axon, AT; Brown, J; Dowell, AC; Feltbower, R; Mason, J; Mason, S; Moayyedi, P; Nathan, J; Richards, ID | 1 |
| Kurosawa, A; Minowa, T; Miwi, H; Murai, T; Nagahara, A; Ohkura, R; Ohtaka, K; Sato, K; Sato, N; Yamada, T | 1 |
| De Boer, WA; Jansen, JB; Van Oijen, AH; Verbeek, AL | 1 |
| Grundmeijer, HG; Hurenkamp, GJ; Tytgat, GN; Van Der Ende, A; Van Der Hulst, RW | 1 |
| Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC | 1 |
| Battaglia, G; Di Mario, F; Franceschi, M; Germanà, B; Leandro, G; Marin, R; Pilotto, A; Valerio, G | 1 |
| Fukazawa, K; Ishino, Y; Kawakami, S; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Sugano, K | 1 |
| Haruma, K; Hattori, N; Kajiyama, G; Kamada, T; Kawamura, Y; Kitadai, Y; Mihara, M; Miyoshi, E; Mukai, T; Sumii, K; Tahara, K; Yoshihara, M | 1 |
| Mansi, C; Savarino, V; Vigneri, S | 1 |
| Ajioka, Y; Fujino, MA; Maruta, K; Nishikura, K; Watanabe, H; Yamashita, H | 1 |
| Daudén, E; García-Díez, A; Jiménez-Alonso, I | 1 |
| Barrera, F; Fuentes, J; Garuz, R; Gomollón, F; Malo, J; Simón, MA; Tirado, M; Valdepérez, J | 1 |
| Piqué, JM | 1 |
| Castellote, J; Porta, F | 1 |
| Calvet, X; Gabriel, R; Gisbert, JP; González, L; Pajares, JM; Roqué, M | 1 |
| Daake, H; Frevel, M; Janisch, HD; Kellner, HU; Krezdorn, HG; Tanneberger, D; Wack, R | 1 |
| Bart, A; Beumer, HJ; Cattoli, G; Klaver, PS; Kuipers, EJ; Kusters, JG; Pot, RG; Robijn, RJ; van der Gaag, I; van Vugt, R; Vandenbroucke-Grauls, CM | 1 |
| Buzás György, M; Illyés, G; Székely, E; Széles, I | 1 |
| Hentschel, E | 1 |
| Howden, CW | 1 |
| Bagnolo, F; Testoni, PA | 1 |
| Huang, AH; Huang, CC; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Kaneko, K; Ohkura, R; Segawa, O; Shimizu, T; Taneike, I; Yamamoto, T; Yamashiro, Y; Yarita, Y | 1 |
| Bermejo, F; Boixeda, D; Defarges, V; García Plaza, A; Gisbert, JP; Martín de Argila, C; Sanz, JM | 1 |
| Calvet, X; Gabriel, R; García, N; Gisbert, JP; González, L; López, T; Pajares, JM; Roqué, M | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R | 1 |
| Ducóns, JA; Ferrero, M; Gomollón, F; Revillo, MJ; Sicilia, B; Sierra, E | 1 |
| Apfalter, P; Barousch, W; Binder, C; Hirschl, AM; Kuderna, C; Makristathis, A; Pasching, E; Rotter, ML | 1 |
| Cayla, R; Lamouliatte, H; Mégraud, F | 1 |
| Cheah, P; Chin, S; Goh, K; Parasakthi, N; Ranjeev, C; Rosmawati, M; Tan, Y | 1 |
| Braegger, CP; Frank, F; Stallmach, T; Stricker, T | 1 |
| Botta, F; Chiarbonello, B; Fasoli, A; Giannini, E; Lantieri, PB; Malfatti, F; Risso, D; Romagnoli, P; Savarino, V; Testa, R | 1 |
| Bhasin, DK; Ray, P; Sharma, BC | 1 |
| Färkkilä, M; Hyvärinen, H; Kosunen, TU; Miettinen, TA; Nuutinen, H; Rautelin, H; Sarna, S; Seppälä, K; Sipponen, P | 1 |
| Herr, H; You, CH | 1 |
| Abbas, Z; Abid, S; Chang, FY; Chen, PC; Destefano, M; Hamid, SS; Lam, SK; Lin, BR; Schneider, H; Seebaran, A; Simjee, AE; Van Rensburg, C; Wong, BC; Zhang, J | 1 |
| Ansaldi, N; Gaido, F; Lerro, P; Lombardo, L; Morra, I; Perrucci, V | 1 |
| Fock, KM | 1 |
| Fallone, CA; Hunt, RH; Sherman, PM; Smaill, FM; Thomson, AB; Veldhuyzen van Zanten, SJ | 1 |
| Aydin, A; Isler, M | 1 |
| Akura, Y; Fujiwara, T; Hamazaki, K; Ikeda, Y; Matsumoto, T; Murashima, N; Nishisita, C; Umekawa, Y | 1 |
| Cockeram, A; De Argila, CM; Delchier, JC; Göthe, L; Hasselgren, G; Labenz, J; Lauritsen, K; Lind, T; Sinclair, P; Stubberöd, A; Treichel, HC; Veldhuyzen Van Zanten, S; Wrangstadh, M | 1 |
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Morikawa, T; Murase, K; Murata, I; Nishiyama, T; Omagari, K | 1 |
| Cappello, G; Cellini, L; Ciccaglione, AF; Di Campli, E; Ferri, A; Grossi, L; Malatesta, MG; Marzio, L; Toracchio, S | 1 |
| Akagi, K; Hizawa, K; Inuzuka, S; Matsumoto, T; Nakahara, T; Yano, Y | 1 |
| Autenrieth, IB; Heesemann, J; Kempf, VA; Koletzko, S; Rüssmann, H | 1 |
| Benhamou, PH; Bergeret, M; Dupont, C; Kalach, N; Raymond, J | 1 |
| García, S; Gomollón, F; Lago, A; Sicilia, B; Sierra, E; Villar, M | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M | 1 |
| Anti, M; Armuzzi, A; Bartolozzi, F; Cammarota, G; Candelli, M; Canducci, F; Cremonini, F; De Lorenzo , A; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pola, P | 1 |
| Fennerty, MB; Laine, L; Levine, JG; Osato, M; Probst, P; Suchower, L; Sugg, J | 1 |
| Fanti, L; Guslandi, M; Ieri, R; Mezzi, G; Passaretti, S; Testoni, PA | 1 |
| Cabezudo, JG; Ducóns, J; Gomollon, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
| Hikiba, Y; Matsumura, M; Ogura, K; Omata, M; Shiratori, Y; Togo, G; Tsukuda, I; Ushikawa, K | 1 |
| Maggi-Solcà, N; Piffaretti, JC; Valsangiacomo, C | 1 |
| Adamsson, I; Edlund, C; Engstrand, L; Seensalu, R | 1 |
| Aegerter, PH; de Mascarel, A; Lavergne, A; Megraud, F; Molina, T; Palazzo, L; Rambaud, JL; Ruskoné-Fourmestraux, A | 1 |
| Armuzzi, A; Bartolozzi, F; Cammarota, G; Candelli, M; Canducci, F; Cremonini, F; De Lorenzo, A; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pola, P; Santarelli, L | 1 |
| Axon, AT; Bardhan, K; Dixon, MF; Moayyedi, P; Peacock, R; Walan, A; Wason, C | 1 |
| Mégraud, F; Roberts, P; Williamson, R | 1 |
| Gisbert, JP; María Pajares, J | 1 |
| Aller, R; Boixeda, D; Caballero, C; Cantón, R; Cordero, JM; de la Calle, H; de Luis, DA | 1 |
| Taylor, DE | 1 |
| Gaudreau, C; Lahaie, RG | 1 |
| Cullen, DJ; McGechie, DB; Mollison, LC; Stingemore, N; Wake, RA | 1 |
| Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T | 1 |
| Bauerfeind, P; Blum, AL; Brassart, D; Corthésy-Theulaz, I; Felley, CP; Kaufmann, M; Michetti, P; Pfeifer, A; Rivero, JL; Sipponen, P; Wiesel, PH | 1 |
| Chan, CK; Chu, KM; Fung, FM; Hu, WH; Lai, KC; Lam, SK; Lau, GK; Leung, SY; Wang, WH; Wong, BC; Wong, WM; Yuen, MF; Yuen, ST | 1 |
| Kurosawa, A; Miwa, H; Nagahara, A; Ohkura, R; Sato, N; Yamada, T | 1 |
| Alizadeh, BZ; Fakheri, H; Fazel, A; Khatibian, M; Malekzadeh, R; Massarrat, S; Merat, S | 1 |
| Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Rassu, M | 1 |
| Asaka, M; Hokari, K; Kagaya, H; Kato, M; Sugiyama, T; Takeda, H | 1 |
| Inoue, K; Muto, H; Satoh, K; Sugano, K | 1 |
| Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Okimoto, T; Satoh, R | 1 |
| Kohgo, Y; Satoh, T; Shibata, N; Tanabe, H; Watari, J; Yokota, K | 1 |
| Ohkusa, T; Watanabe, M | 1 |
| Hoekstra, JB; Kuck, EM; Pijlman, AH; van Puijenbroek, EP | 1 |
| Harada, H; Kobayashi, S; Miki, H; Ohmori, M; Sotozono, M; Uraoka, T; Yamanoi, Y | 1 |
| Baik, SK; Cho, MY; Jeong, YS; Kim, HS; Kim, JW; Kim, KH; Kwon, SO; Lee, DK; Seo, JI | 1 |
| Arakawa, Y; Ishii, Y; Kato, K; Kawamura, F; Kawamura, Y; Komuro, S; Nagata, T; Nemoto, N; Nishinarita, S; Sugitani, M; Takahashi, Y; Yanai, M | 1 |
| Bianchi Porro, G; Imbesi, V; Maconi, G; Parente, F; Russo, A; Vago, L | 1 |
| Furuta, T; Hanai, H; Ishizaki, T; Kaneko, E; Ohashi, K; Shirai, N; Sugimura, H; Takashima, M; Xiao, F | 1 |
| Graham, DY; Leung, WK | 1 |
| Bastens, B; Delforge, M; Demoulin, JC; Fontaine, F; Gerard, A; Gillard, V; Lutgen, N | 1 |
| Fock, KM; Khor, CJ; Ng, A; Ng, TM; Sim, CS; Tan, AL; Teo, EK | 1 |
| Ferraro, MJ; Fox, JG; Peña, JA; Versalovic, J | 1 |
| Endo, H; Higuchi, S; Ohmi, N; Yoshida, H | 1 |
| El-Zaatari, FA; Graham, DY; Kim, JG; Kim, JJ; Kwon, DH; Lee, M; Osato, MS; Reddy, R | 1 |
| Gopanpallikar, A; Rathi, P; Sawant, P | 1 |
| Fock, KM; Law, NM; Lim, CC; Ng, HS; Ng, TM | 1 |
| Chisholm, SA; Owen, RJ; Saverymuttu, S; Teare, EL | 1 |
| Broutet, N; de Mascarel, A; Lamouliatte, H; Marais, A; Mégraud, F; Salamon, R; Samoyeau, R | 1 |
| Palka, M; Zwolińska-Wcisło, M | 1 |
| Avidan, B; Bar-Meir, S; Keller, N; Melzer, E | 1 |
| Caffarelli, C; Caruana, P; de'Angelis, GL; Fornaroli, F; Magliani, W; Manfredi, M; Street, ME | 1 |
| Glennon, M; Maher, M; Moran, AP; Ryan, KA; Smith, T; van Doorn, LJ | 1 |
| De Boer, WA; Jansen, JB; Janssen, MJ; Van Oijen, AH; Verbeek, AL | 1 |
| Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 2 |
| Itoh, H; Matsunaka, M; Nishioka, S; Okada, K; Sakurane, M; Shiotani, A; Yanaoka, K | 1 |
| Baffone, W; Bruscolini, F; Citterio, B; Lombardelli, G; Pianetti, A; Vittoria, E | 1 |
| Chen, JD; Lin, Z; McCallum, RW; Parolisi, S; Peura, DA; Shifflett, J | 1 |
| Graham, DY; Malaty, HM; Osato, MS; Penland, RL; Reddy, R; Reddy, SG | 1 |
| Axon, AT; Barrowclough, S; Crocombe, W; Moayyedi, P; Neville, PM; Wrangstadh, M | 1 |
| Chayama, K; Haruma, K; Hiyama, T; Ito, M; Kitadai, Y; Masuda, H; Miyamoto, M; Shimamoto, F; Sumii, K; Tanaka, S; Yoshihara, M | 1 |
| Kölbel, CB; Lüth, S; Singer, MV; Teyssen, S | 1 |
| Chejfec, G; O'Connell, S; Schnell, T; Seidel, J; Sonnenberg, A; Sontag, SJ | 1 |
| Boknik, P; Domschke, W; Fischer, H; Huber, V; Konturek, JW; Luess, H; Neumann, J; Schmitz, W | 1 |
| Drewe, J; Geiser, HR; Meier, R; Wettstein, A | 1 |
| Bucki, R; Gołebiewska, M; Kemona, A; Namiot, DB; Namiot, Z | 1 |
| Belmonte, A; Cavaliere, C; Ciliberto, E; Fiocca, R; Frandina, C; Giglio, A; Luzza, F; Pallone, F; Saccà, N; Trimboli, V | 1 |
| Belcari, C; Bellini, M; Costa, F; Maltinti, G; Marchi, S; Mumolo, MG; Spisni, R; Torelli, E; Tornar, A | 1 |
| Nguyen, HN | 1 |
| Cathomas, G; Dent, J; Fried, M; Guldenschuh, I; Menne, D; Schwizer, W; Thumshirn, M | 1 |
| Benhamou, PH; Bergeret, M; Campeotto, F; Dupont, C; Kalach, N; Raymond, J | 1 |
| Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Rassu, M; Soffiati, G; Valerio, G | 1 |
| Andriulli, A; Festa, V; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Gorensek, M; Gubina, M; Krizman, I; Orel, I; Tepes, B | 1 |
| Calvet, X; Gené, E; Gisbert, JP; López, T | 1 |
| Fan, XG; Hu, GL; Li, TG; Liu, L; Liu, SH; Tan, DM; Yakoob, J; Yang, HX; Zhang, Z | 1 |
| Hopkins, RJ | 1 |
| Goshi, S; Ohara, T; Tamura, Y; Taneike, I; Yamamoto, T; Zhang, HM | 1 |
| Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 2 |
| Moayyedi, P; Murphy, B | 1 |
| Kuipers, EJ; Kusters, JG | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Yamada, T | 1 |
| Bateson, MC | 1 |
| Kawabe, T; Maeda, S; Ogura, K; Okamoto, M; Omata, M; Shiratori, Y; Yamaji, Y; Yoshida, H | 1 |
| Dankert, J; Feller, M; Rooijakkers, S; Tytgat, GN; van der Ende, A; van Doorn, LJ | 1 |
| Kawamura, K; Kimura, M; Mukai, K; Nakamura, S; Nakamura, T; Sawa, H; Shiku, H; Suzuki, H; Toyoda, H; Yamaguchi, M | 1 |
| Huang, JJ; Sheu, BS; Wang, YL; Yang, HB | 1 |
| Chan, KL; Ng, DK; Tam, PK; Zhou, H | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Sato, N | 1 |
| Ashorn, M; Mäkipernaa, A; Ruuska, T | 1 |
| Chang, MH; Jeng, YM; Ni, YH; Yang, JC; Yang, YJ | 1 |
| Kurt, N; Oncel, M; Walsh, M | 1 |
| Bidaut-Mazel, C; Bruley Des Varannes, S; Colin, R; Fléjou, JF; Meunier, A; Zaïm, M | 1 |
| Adachi, K; Fujishiro, H; Hashimoto, T; Hattori, S; Hirakawa, K; Ishihara, S; Ishimura, N; Kaji, T; Kawamura, A; Kinoshita, Y; Niigaki, M; Sato, H; Watanabe, M | 1 |
| Bardhan, KD; Mitchell, TR; Morris, P; Morton, D; Perry, MJ; Roberts, PM; Rowland, A; Sanders, DS; Thompson, M | 1 |
| Asato, Y; Mukai, M; Ochiai, A; Shimoyama, Y | 1 |
| Bayerdörffer, E; Graham, DY; Miehlke, S | 1 |
| Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, SY; Wong, AM | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Martínez, MJ | 1 |
| Bentivoglio, AR; Carloni, E; Cicconi, V; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Manna, R; Nocente, R; Servidei, S; Silveri, NG | 1 |
| Kaisho, T; Kanamaru, T; Miyagawa, KI; Nakano, Y; Nakao, M; Tada, M; Toyoda, Y | 1 |
| Avcu, F; Avcu, N; Beyan, C; Kaptan , K; Nevruz, O; Ozyurt, M; Ural, AU; Yalçin, A | 1 |
| Azuma, T; Dojo, M; Ito, Y; Kato, T; Kuriyama, M; Ohtani, M; Suto, H | 1 |
| Beglinger, C; Burnand, B; Froehlich, F; Gonvers, JJ; Hildebrand, P; Saraga, E; Schneider, C; Vader, JP; Wietlisbach, V | 1 |
| Bianchi Porro, G; Cucino, C; Imbesi, V; Maconi, G; Russo, A | 1 |
| Fedorov, AV; Sazhin, VP | 1 |
| Kullavanijaya, P; Mahachai, V; Phaosawadi, K; Vilaichone, RK; Wongkusoltham, P | 1 |
| Bujanda, L; Cosme, A; Iriondo, C; Muñoz, C; Sánchez, A; Santos, A | 1 |
| Beales, IL | 1 |
| Aragona, F; Di Vita, G; Leo, P; Montalto, G; Patti, R | 1 |
| Burm, M; Faigel, D; Fennerty, MB; Kelly, C; Magaret, N; Peterson, W | 1 |
| Bayerdörffer, E; Müller, H; Rappel, S; Stolte, M; Wündisch, T | 1 |
| Bühling, A; Malfertheiner, P; Müller, WA; Radun, D | 1 |
| Asaka, M; Hige, S; Hokari, K; Ishizuka, J; Kagaya, H; Kato, M; Komatsu, Y; Kudo, M; Miyagishima, T; Mizushima, T; Nishikawa, K; Saito, M; Sugiyama, T; Takeda, H | 1 |
| Doulgeroglou, V; Kamberoglou, D; Patra, E; Polymeros, D; Sanidas, I; Savva, S; Tzias, V | 1 |
| Hsu, CT; Kuo, CF; Wang, CS; Wang, TH; Yang, JC; Yang, KC | 1 |
| Hirakoba, M; Kume, K; Murata, I; Otsuki, M; Yoshikawa, I | 1 |
| Chey, WD; Fendrick, AM | 1 |
| Mikelsaar, M; Peetsalu, A; Peetsalu, M; Sillakivi, T | 1 |
| Fan, X; Hu, G; Liu, L; Yakoob, J; Zhang, Z | 1 |
| Ho, B; Ling, KL; Luman, W; Ng, HS | 1 |
| Bigard, MA | 1 |
| Fuchs, KH; Greiner, A; Sailer, M; Timm, S | 1 |
| Axon, AT; Bardhan, C; Brown, L; Dixon, MF; Moayyedi, P; Young, L | 1 |
| Ebata, M; Keto, Y; Okabe, S | 1 |
| Adler, K; Gebert, B; Haas, R; Heesemann, J; Koletzko, S; Rüssmann, H | 1 |
| Asaka, M; Hamashima, C; Ikeda, S; Tamamuro, T | 1 |
| Barthélemy, P; Caekaert, A; Fléjou, JF; Laurent, J; Mégraud, F | 1 |
| Asaka, M; Fukuda, Y; Kimura, K; Murakami, K; Ota, H; Satoh, K; Shimoyama, T; Sugano, K; Sugiyama, T; Takahashi, S | 1 |
| Kaddu, S; Kränke, B; Mayr-Kanhäuser, S; Müllegger, RR | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Barthélemy, P; Dupont, C; Gottrand, F; Guimber, D; Husson, MO; Kalach, N; Lachaux, A; Lenaerts, C; Maurage, C; Morali, A; Mougenot, JF; Roquelaure, B; Spyckerelle, C; Tounian, P | 1 |
| Misawa, H; Miwa, H; Nagahara, A; Ohtaka, K; Sato, N; Yamada, T | 1 |
| Esaki, M; Fukuda, T; Kurahara, K; Kusano, Y; Matsumoto, T; Nakamura, S | 1 |
| Bartuzi, Z; Dite, P; Hasselgren, G; Kleczkowski, D; Kryszewski, A; Larkö, A; Rudzinski, J; Tulassay, Z; Wrangstadh, M | 1 |
| Alpen, B; Neubauer, A; Röbbecke, J; Stolte, M; Wündisch, T | 1 |
| Bento, AP; Calafatti, SA; de Nucci, G; Deguer, M; Dias, FE; Ferraz, JG; Lerner, F; Mendes, FD; Ortiz, RA; Pedrazzoli, J; Pereira, AA; Piovesana, H | 1 |
| Starostin, BD | 1 |
| Dankert, J; Pan, ZJ; Su, WW; Tytgat, GN; van der Ende, A | 1 |
| Bhattacharyya, H; Hopkins, RJ; King, EC; Meyer, JM; Morris, D; Siepman, NY; Silliman, NP; Sugg, JE; Wang, W; Zhang, J | 1 |
| Andersen, LP; Glupczynski, Y; Lopez-Brea, M; Mégraud, F | 1 |
| Azuma, T; Dojo, M; Kuriyama, M; Muramatsu, A; Ohtani, M; Saito, T | 1 |
| De Francesco, V; Faleo, D; Hassan, C; Ierardi, E; Morini, S; Panella, C; Zullo, A | 1 |
| Barbir, A; Hovat, D; Ivandić, A; Kurbel, S; Mihaljević, S; Ostojić, R; Stimac, D; Takac, B; Vcev, A; Vceva, A | 1 |
| Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J | 1 |
| Aoyama, N; Okumura, K; Shirasaka, D | 1 |
| Bavbek, N; Koçkar, C; Oztürk, M | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Antos, D; Bayerdörffer, E; Dite, P; Dragosics, B; Ehninger, G; Gschwantler, M; Kirsch, C; Labenz, J; Läuter, J; Leodolter, A; Malfertheiner, P; Miehlke, S; Neubauer, A; Oberhuber, G; Stolte, M | 1 |
| Sung, JJ; Wu, JC | 1 |
| Jung, HC; Kim, CW; Kim, CY; Kim, JS; Kim, YS; Lee, CH; Song, IS | 1 |
| Fujimura, S; Iinuma, K; Kato, S; Maisawa, S; Ozawa, K; Shimizu, T; Udagawa, H | 1 |
| Fujino, M; Miyagaw, K; Nakano, Y; Nakao, M; Nishimura, O; Sakane, T; Tada, M | 1 |
| Goto, H; Hino, R; Kikuta, T; Ota, A; Tsuji, H | 1 |
| Messerer, P; Ott, MG; Riemann, JF; Schauwecker, P; Schilling, D; Zober, A | 1 |
| Furukawa, F; Sakurane, M; Shiotani, A | 1 |
| Khan, Z; Nair, P; O'Shea, C; Playford, RJ; Spiers, N; Wicks, AC | 1 |
| Andreu, R; De la Rubia, J; Gomis, F; Jarque, I; Jiménez, C; Llopis, I; Martín, G; Martínez, JA; Ponce, J; Sanz, GF; Sanz, MA; Senent, L | 1 |
| Chi, CH; Huang, CC; Kao, AW; Sheu, BS; Wang, YL; Yang, HB | 1 |
| Alampi, G; Bazzoli, F; Berretti, D; De Luca, L; Di Pietro, C; Fossi, S; Morelli, P; Nicolini, G; Pozzato, P; Ricciardiello, L; Roda, E; Zagari, RM | 1 |
| Ahn, DS; Choi, IJ; Choi, KW; Chung, IS; Chung, JM; Hong, WS; Jung, HC; Kim, JH; Lee, SI; Rew, JS; Rhee, JC; Yang, US | 1 |
| Choi, IJ; Jung, HC; Kim, BG; Kim, JS; Kim, SG; Park, MJ; Song, IS | 1 |
| Chang, CS; Chen, GH; Lai, CH; Poon, SK; Su, J; Wang, WC; Yang, CC | 1 |
| Börsch, G; Kahl, S; Labenz, J; Leodolter, A; Malfertheiner, P; Peitz, U; Stolte, M; Sulliga, M; Von Arnim, U; Wolle, K | 1 |
| Fujimura, S; Kato, S; Kawamura, T; Watanabe, A | 1 |
| Brousse, N; Copie-Bergman, C; de Mascarel, A; Delchier, JC; Flejou, JF; Gaulard, P; Hemery, F; Lavergne-Slove, A; Levy, M; Traulle, C | 1 |
| Burton, MP; Narayani, RI; Young, GS | 1 |
| Shcherbakov, PL | 1 |
| Bartolozzi, F; Cammarota, G; Candelli, M; Cremonini, F; Di Caro, S; Gasbarrini, A; Lupascu, A; Nista, EC; Ojetti, V; Zocco, MA | 1 |
| Chan, FK; Lee, YT; Leung, WK; Sung, JJ; Wong, SK; Wu, JC | 1 |
| Artikis, V; Georgopoulos, SD; Karatapanis, S; Ladas, SD; Mentis, A; Raptis, SA; Spiliadi, C; Triantafyllou, K | 1 |
| Axon, AT; Brown, J; Crocombe, W; Drummond, M; Duffett, S; Feltbower, R; Forman, D; Mason, J; Mason, S; Moayyedi, P | 1 |
| Bujanda, L; Castiella, A; Cosme, A; De Argila, CM; Elizalde, I; Elizalde, JI; Moreno, V; Morillas, JD; Piqué, JM; Ros, E | 1 |
| Barbier, C; Benhamou, PH; Bergeret, M; Dupont, C; Gottrand, F; Husson, MO; Kalach, N; Raymond, J | 1 |
| Koyama, H; Nomura, F; Odaka, T; Saisho, H; Yamaguchi, T | 1 |
| Bazzoli, F; Bianchi Porro, G; Bianchi, MG; Molteni, M; Pazzato, P; Zagari, RM | 1 |
| Malfertheiner, P; Pilotto, A | 1 |
| Hu, F; Wang, W; Zheng, X | 1 |
| Baena, JM; García, M; Hernández, MR; Hidalgo, A; Jiménez, S; López, C; Rams, F | 1 |
| Chong, SK; Uc, A | 1 |
| Brouwers, JR; De Jong-Van den Berg, LT; Klok, RM; Postma, MJ; Tolley, K; Van den Berg, PB | 1 |
| Ando, T; Hasegawa, T; Imada, A; Ina, K; Kaneko, H; Konagaya, T; Kusugami, K; Nagasaka, T; Nishiwaki, T; Nobata, K; Ohta, M; Saburi, N; Tsuzuki, T; Ueda, M | 1 |
| Chiba, N; Escobedo, S; Ferguson, RA; Grace, E; Sinclair, P; Van Zanten, SJ | 1 |
| Fukuda, Y; Sakagami, T; Shimoyama, T; Yamamoto, N | 1 |
| Imase, K; Takahashi, S | 1 |
| Murakami, K; Nasu, M | 2 |
| Nakamura, T | 1 |
| Asaka, M; Kato, M; Komatsu, Y; Shimizu, Y; Sugiyama, T; Takeda, H | 1 |
| Fu, HY; Kawano, S; Tanimura, H | 1 |
| Ohkusa, T; Sato, N | 1 |
| Furuta, T; Shirai, N | 1 |
| Miwa, H; Miyazaki, A; Nagahara, A; Sato, N | 1 |
| Takahashi, S; Tokunaga, K | 1 |
| Ishitobi, H; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Mitsuno, Y; Yoshida, H | 1 |
| Asaka, M; Kagaya, H; Kato, M | 1 |
| Inoue, K; Sugano, K | 1 |
| Kurosawa, A; Miwa, H; Sato, N | 1 |
| Haruma, K; Kamada, T; Kusunoki, H | 1 |
| Sawada, A | 1 |
| Sugano, K | 2 |
| Yoshino, J | 1 |
| Kawata, H; Satoh, K | 1 |
| Nakamura, T; Yakabi, K | 1 |
| Hiraishi, H; Kanke, K; Terano, A | 1 |
| Azuma, T; Ito, S; Yamazaki, Y | 1 |
| Fukuda, Y; Shimoyama, T | 1 |
| Kiriyama, Y; Koizumi, K; Kuwayama, H; Ohara, T; Suga, M; Suzuki, K; Takahashi, M; Takata, H | 1 |
| Chayama, K; Haruma, K; Ito, M; Kamada, T; Kawamura, Y; Kitadai, Y; Yoshihara, M | 1 |
| Nakagawa, S; Tamura, Y; Taneike, I; Yamamoto, T | 1 |
| Isomoto, H; Kohno, S | 1 |
| Baumann, R; Buri, P; Cunningham, M; Dederding, JP; Gallaz, L; Girard, L; Godin, N; Merki, H; Metry, JM; Sitavanc, R; Wermeille, J; Zelger, G | 1 |
| Cuchí Burgos, E; Forné Bardera, M; Garau Alemany, J; Lite Lite, J; Quintana Riera, S | 1 |
| Kapp, A; Wedi, B | 1 |
| Affonso de Oliveira, C; Aguiar Rocha, G; Camargos Rocha, AM; Campos Barbosa, DV; De Magalhães Queiroz, DM; Martins Teixeira, L; Nogueira Mendes, E; Prazeres Magalhães, P; Santos, A; Valle Corrêa, PR | 1 |
| Kolosovych, IV; Korotkyĭ, VM | 1 |
| Dhir, V; Laine, L | 1 |
| Calvet, X; Gisbert, JP; Vallve, M; Vergara, M | 1 |
| Colin, R | 1 |
| Kato, K; Nagura, H; Noguchi, K; Ohara, S; Sekine, H; Shimosegawa, T; Suzuki, T | 1 |
| Azagra, R; Calvet, X; Cubells, MJ; Gené, E; López, T | 1 |
| Berrutti, M; Fagoonee, S; Massimetti, E; Palmas, F; Pellicano, R; Rizzetto, M | 1 |
| Carrera, P; Cavallero, A; Cernuschi, M; Lazzarin, A; Mezzi, G; Scarpellini, P; Testoni, PA; Zingale, A | 1 |
| Bachor, J; Dinari, G; Fishman, M; Gal, E; Geler, A; Niv, Y; Passaro, DJ; Samra, Z; Shmuely, H; Yahav, J | 1 |
| Gościmski, A; Matras, J; Wallner, G | 1 |
| Arand, F; Bayerdörffer, E; Klein, U; Knippig, C; Leodolter, A; Malfertheiner, P; Nilius, M | 1 |
| Donovan, JL; Egger, M; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P | 1 |
| Ateşkan, U; Mas, MR; Ozdemir, A; Sağlamkaya, U; Sahin, S | 1 |
| Blaser, MJ | 1 |
| Ando, R; Hasegawa, M; Kawamura, M; Kobayashi, I; Muraoka, H; Nishida, M; Saika, T | 1 |
| Domon, H; Inoue, H; Ishii, C; Koga, T; Okazaki, Y; Utsui, Y | 1 |
| Baron, JH; Gummett, PA; Hegarty, BT; Logan, RP; Misiewicz, JJ; Walker, MM | 1 |
372 review(s) available for clarithromycin and Infections, Helicobacter
| Article | Year |
|---|---|
V Spanish Consensus Conference on Helicobacter pylori infection treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2021 |
V Spanish Consensus Conference on Helicobacter pylori infection treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2022 |
The Ideal Helicobacter pylori Treatment for the Present and the Future.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2022 |
The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cysteine; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2022 |
Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Levofloxacin | 2022 |
Worldwide and Regional Efficacy Estimates of First-line Helicobacter pylori Treatments: A Systematic Review and Network Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bayes Theorem; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Network Meta-Analysis; Proton Pump Inhibitors | 2022 |
Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials, Phase III as Topic; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Physicians; Proton Pump Inhibitors | 2022 |
The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Comparison of sequential therapy with concomitant therapy in first-line treatment of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2022 |
Diagnosis and Treatment of
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2022 |
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Reference Standards | 2022 |
[Helicobacter pylori-New aspects of forthcoming guidelines].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2022 |
Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome | 2022 |
Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome | 2022 |
Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Rifabutin; Tetracycline; United States | 2022 |
Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Potassium; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2022 |
Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Resistance, Microbial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2022 |
Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Prevalence | 2022 |
Host Cell Antimicrobial Responses against
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline; Virulence Factors | 2022 |
Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Carnosine; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Zinc Compounds | 2022 |
Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)-based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
Rifabutin as salvage therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rifabutin; Salvage Therapy | 2022 |
How widespread and convenient
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2023 |
Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Treatment Outcome | 2023 |
Antibiotic Resistance of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Turkey | 2023 |
Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction | 2023 |
Optimizing
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Critical appraisal of international guidelines for the management of Helicobacter pylori infection in case of dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans | 2023 |
Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Pyrroles; Treatment Outcome | 2023 |
The prevalence of clarithromycin-resistant
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Prevalence | 2023 |
Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2023 |
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans | 2023 |
Primary antibiotic resistance in Helicobacter pylori in China: a systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2023 |
Global Estimate of Clarithromycin Resistance in Clinical Isolates of Helicobacter pylori: a Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2023 |
Updates to the Diagnosis and Clinical Management of Helicobacter pylori Infections.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 2023 |
Antibiotic Resistance, Susceptibility Testing and Stewardship in
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2023 |
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
[First line eradication treatment of Helicobacter pylori in 2019].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2019 |
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Proton Pump Inhibitors; Singapore | 2021 |
High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Chile; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prevalence; Prospective Studies | 2019 |
Effectiveness and Safety of Vonoprazan versus Proton Pump Inhibitors for Second-Line Helicobacter pylori Eradication Therapy: Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2021 |
Trends in
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genome, Bacterial; Genomics; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Phenotype; RNA, Ribosomal, 23S | 2020 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Delphi Technique; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Japan; Microbial Sensitivity Tests; Proton Pump Inhibitors; Stomach Neoplasms | 2020 |
Treatment of Helicobacter pylori infection: a clinical practice update.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Meta-Analysis as Topic; Practice Guidelines as Topic; Probiotics; Proton Pump Inhibitors; Salvage Therapy; Systematic Reviews as Topic | 2021 |
Management of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2020 |
Efficacy of second-line regimens for
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Outcome Assessment, Health Care; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Randomized Controlled Trials as Topic; Tetracycline | 2020 |
Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
Topics: Amoxicillin; Antimicrobial Stewardship; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Failure; Treatment Outcome | 2021 |
Topics: Amoxicillin; Anti-Bacterial Agents; Biological Products; Bismuth; Clarithromycin; Drug Therapy, Combination; Dysbiosis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Phytochemicals; Plant Extracts; Plants, Medicinal; Probiotics | 2020 |
Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Pharmaceutical Preparations | 2020 |
An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2021 |
Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; New Zealand; Tetracycline | 2021 |
Evidence-Based Guidelines for the Treatment of
Topics: Clarithromycin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Randomized Controlled Trials as Topic; Republic of Korea | 2021 |
Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2021 |
[Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Russia | 2020 |
Treatment of Refractory
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2022 |
Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Potassium; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Gastric Juice-Based Genotypic Methods for Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance Testing: A Systematic Review and Meta-analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Microbiological Techniques | 2021 |
Helicobacter pylori antimicrobial resistance in Melbourne, Australia. Time to review therapeutic guidelines?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Observational Studies as Topic; Retrospective Studies; Young Adult | 2021 |
PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Asia; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Susceptibility-guided versus empirical treatment for Helicobacter pylori infection: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Long-term complete remission of primary gastric plasmacytoma following endoscopic resection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Plasmacytoma; Remission Induction; Stomach Neoplasms | 2017 |
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Proton Pump Inhibitors; Quinolones | 2017 |
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2017 |
Novel and Effective Therapeutic Regimens for
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Mutation; Prevalence; Probiotics; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides; Tetracycline; Tetracycline Resistance | 2017 |
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Remission Induction; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome | 2017 |
Antibiotic resistance in Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2017 |
Characterization of clarithromycin-resistant Helicobacter pylori strains in Iran: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Databases, Factual; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Iran; Microbial Sensitivity Tests; Molecular Epidemiology; Point Mutation; Prevalence; RNA, Ribosomal, 23S | 2017 |
Helicobacter pylori management in ASEAN: The Bangkok consensus report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Consensus; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Proton Pump Inhibitors; Taiwan; Tetracycline; Thailand; Treatment Outcome; United States | 2018 |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Asia; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Pacific Islands; Prevalence; Tetracycline | 2017 |
[RESISTANCE OF HELICOBACTER PYLORI TO ANTIBIOTICS IN ISRAEL: PAST VS PRESENT].
Topics: Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Microbial Sensitivity Tests | 2017 |
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
Topics: Anti-Bacterial Agents; Clarithromycin; Consensus; Disease Eradication; Drug Resistance, Bacterial; Gastritis; Health Planning Guidelines; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Japan; Metronidazole; National Health Programs; Quinolones; Rifabutin; Stomach Neoplasms | 2018 |
Treatment of Helicobacter pylori infection: A clinical practice update.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Failure | 2018 |
A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans | 2018 |
Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018.
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Protocols; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Pyrroles; Sulfonamides | 2018 |
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2018 |
Clinical Inquiries: What's the best secondary treatment for patients who fail initial triple therapy for H pylori?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2018 |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole; Treatment Outcome | 2018 |
Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Substitution; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Observational Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Failure | 2018 |
Toward population specific and personalized treatment of Helicobacter pylori infection.
Topics: Algorithms; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Models, Theoretical | 2018 |
[Update H. pylori therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2018 |
Gastric MALT lymphoma and Helicobacter pylori.
Topics: Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Organometallic Compounds; Practice Guidelines as Topic; Proton Pump Inhibitors; Salvage Therapy; Stomach Neoplasms | 2019 |
[
Topics: Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Guidelines as Topic; Helicobacter Infections; Meta-Analysis as Topic; Proportional Hazards Models; Stomach Neoplasms | 2018 |
Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome | 2019 |
Management of Helicobacter pylori in Patients with Immune Thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Blood Platelets; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Male; Platelet Count; Prospective Studies; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Retrospective Studies; Treatment Outcome | 2019 |
Topics: Adult; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Practice Guidelines as Topic; Treatment Failure | 2019 |
Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Treatment Outcome | 2019 |
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Canada; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Tetracycline; United States | 2019 |
Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Treatment Outcome; Turkey | 2019 |
Are probiotics useful for therapy of Helicobacter pylori diseases?
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Probiotics; Treatment Outcome | 2019 |
Efficacy of Vonoprazan for Helicobacter pylori Eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2020 |
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Treatment Failure | 2013 |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a systematic review of recent evidence.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2013 |
Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Pharmacogenetics | 2014 |
Optimum duration of regimens for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Quinolones | 2013 |
Evidence-based recommendations for successful Helicobacter pylori treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2014 |
Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.
Topics: Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Probiotics; Reproducibility of Results; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome; Urea; Urease | 2014 |
[Changes in the eradication rate of conventional triple therapy for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Republic of Korea | 2014 |
[New therapeutic strategies against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors | 2014 |
[Future trends of Helicobacter pylori eradication therapy in Korea].
Topics: Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones; Republic of Korea; Treatment Failure | 2014 |
[Eradication therapy for Helicobacter pylori infection: review of world trends].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2014 |
Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis.
Topics: Abietanes; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2014 |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Communicable Disease Control; Cytochrome P-450 CYP3A Inhibitors; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Republic of Korea; Tinidazole | 2014 |
[Expanded indication of National Health Insurance for H. pylori associated gastritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; National Health Programs; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2014 |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.
Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proton Pump Inhibitors; Treatment Outcome | 2014 |
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Cytochrome P-450 CYP2C19; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymorphism, Genetic; Prevalence; Proton Pump Inhibitors; Treatment Outcome | 2014 |
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance.
Topics: Algorithms; Anti-Bacterial Agents; Clarithromycin; Critical Pathways; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2014 |
Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms | 2014 |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Combined Modality Therapy; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Odds Ratio; Proton Pump Inhibitors; Treatment Outcome | 2014 |
Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
[What is new in treating Helicobacter pylori infection?].
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Quinolones; Stomach Neoplasms | 2015 |
Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Databases, Bibliographic; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Rho Guanine Nucleotide Exchange Factors; Treatment Outcome | 2015 |
Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Randomized Controlled Trials as Topic | 2015 |
Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Treatment Outcome | 2015 |
Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Clarithromycin; Colchicine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Familial Mediterranean Fever; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunologic Factors; Male; Middle Aged; Polypharmacy; Rhabdomyolysis | 2015 |
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Nitroimidazoles; Probiotics; Proton Pump Inhibitors | 2015 |
Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.
Topics: Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Stomach Neoplasms | 2015 |
Helicobacter pylori treatment: Still a work in progress.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Review article: the global emergence of Helicobacter pylori antibiotic resistance.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; China; Clarithromycin; Drug Resistance, Microbial; Female; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Prevalence; Treatment Failure; Treatment Outcome | 2016 |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline | 2016 |
Helicobacter pylori therapy: a paradigm shift.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Standard of Care; Treatment Outcome | 2016 |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Canada; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2016 |
[Antibiomania: Think of the manic syndrome secondary to antibiotic therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Bipolar Disorder; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Peptic Ulcer | 2017 |
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts.
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Early Detection of Cancer; Helicobacter Infections; Helicobacter pylori; Humans; Mass Screening; Prevalence; Primary Prevention; Proton Pump Inhibitors; Risk Assessment; Socioeconomic Factors; Stomach Neoplasms | 2016 |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; New Zealand; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Treatment Outcome | 2016 |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Metronidazole; Patient Compliance; Peptic Ulcer; Prevalence; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Singapore; Taiwan | 2016 |
Detection of clarithromycin-resistant Helicobacter pylori in clinical specimens by molecular methods: A review.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Fluorescence Resonance Energy Transfer; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2016 |
First-line
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Randomized Controlled Trials as Topic | 2018 |
Helicobacter pylori-related diseases.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Spain | 2016 |
What is new in the management of Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Practice Guidelines as Topic; Probiotics; Proton Pump Inhibitors; Rifabutin; Tetracycline | 2008 |
Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracycline; Treatment Outcome | 2008 |
[The new aspects of the eradication of Helicobacter pylori and the importance of bacterial resistance].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Patient Compliance; Proton Pump Inhibitors; Risk Factors; Salvage Therapy; Treatment Failure | 2008 |
Efficient identification and evaluation of effective Helicobacter pylori therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Proton Pump Inhibitors; Stomach; Treatment Outcome | 2009 |
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tinidazole; Treatment Outcome | 2009 |
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Helicobacter pylori: diagnosis and treatment.
Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Treatment Failure | 2009 |
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Outcome Assessment, Health Care; Patient Compliance; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2010 |
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole | 2009 |
[The present status and problems of Helicobacter pylori first-line eradication therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2009 |
[Helicobacter pylori eradication therapy in children].
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole | 2009 |
Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials.
Topics: Aza Compounds; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Moxifloxacin; Odds Ratio; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Clinical practice: diagnosis and evaluation of dyspepsia.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 2010 |
Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2010 |
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.
Topics: Anti-Infective Agents; Aza Compounds; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Retreatment | 2010 |
Treatment of Helicobacter pylori infection: the past and the future.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ofloxacin | 2010 |
[Helicobacter pylori -- 2010].
Topics: Age Factors; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carbonic Anhydrases; Clarithromycin; Disease Progression; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; History, 19th Century; History, 20th Century; Humans; Peptic Ulcer; Prevalence; Recurrence; Remission, Spontaneous; Urease | 2010 |
[Modern Helicobacter pylori therapies in times of increasing anti biotic resistance].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gastroscopy; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Medication Adherence; Metronidazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Proton Pump Inhibitors; Treatment Failure | 2010 |
[Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors | 2010 |
Optimal therapy for Helicobacter pylori infections.
Topics: Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2011 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
[New options for helicobacter pylori antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Precision Medicine; Proton Pump Inhibitors; Retreatment; Stomach Diseases; Treatment Failure | 2011 |
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2011 |
A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole | 2011 |
Guidelines for treatment of Helicobacter pylori in the East and West.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Quinolones; Treatment Outcome; Vaccination | 2011 |
[Helicobacter pylori eradication therapy in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
[Helicobacter pylori: an infection with local complications and systemic effects].
Topics: Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Asthma; Clarithromycin; Cross-Sectional Studies; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Metronidazole; Obesity; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Risk Factors; Stomach Neoplasms; Virulence | 2011 |
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Spain; Statistics as Topic; Time Factors; Treatment Outcome | 2011 |
A new look at anti-Helicobacter pylori therapy.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Tetracycline | 2011 |
[Helicobacter pylori - 2012].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Emigrants and Immigrants; Endoscopy, Gastrointestinal; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Levofloxacin; Ofloxacin; Peptic Ulcer; Polymerase Chain Reaction; Stomach Neoplasms | 2012 |
Detection of clarithromycin-resistant Helicobacter pylori by stool PCR in children: a comprehensive review of literature.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Reproducibility of Results | 2013 |
Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Gene Expression Regulation, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Virulence | 2012 |
[Clinical features of peptic ulcer disease in the elderly].
Topics: Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer | 2002 |
[Eradication therapy of Helicobacter pylori for elderly patients in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Practice Guidelines as Topic | 2002 |
[The treatment of peptic ulcer in elderly CRF patients].
Topics: Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Clarithromycin; Helicobacter Infections; Histamine H2 Antagonists; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Treatment and management of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Cardiovascular Diseases; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Rabeprazole; Stomach Neoplasms; Treatment Outcome | 2002 |
Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2003 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Follow-Up Studies; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Risk; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Time Factors | 2002 |
[New triple therapy for Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2003 |
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Stomach Neoplasms; Thyroid Neoplasms; Thyroiditis, Autoimmune | 2003 |
[First line therapy for Helicobacter pylori eradication in France].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; France; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Practice Guidelines as Topic; Recurrence | 2003 |
[How to treat after Helicobacter pylori eradication failure?].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Recurrence; Rifabutin | 2003 |
[Guidelines in the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Microbiology; Omeprazole; Peptic Ulcer; Polyps; Practice Guidelines as Topic; Proton Pump Inhibitors; Societies, Medical; Stomach Neoplasms | 2003 |
Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Ditiocarb; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2003 |
What are the global response rates to Helicobacter pylori eradication therapy?
Topics: Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2003 |
How can the current strategies for Helicobacter pylori eradication therapy be improved?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Time Factors | 2003 |
Is it time for quadruple therapy to be first line?
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Apoptosis; Chemistry, Clinical; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Japan; Lansoprazole; Omeprazole; Peptic Ulcer; Urease | 2003 |
Clinical inquiries. What regimens eradicate Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2003 |
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine | 2003 |
[Eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole | 2003 |
[Clarithromycin--standard component of anti-Helicobacter therapy].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Humans; Macrolides; Omeprazole; Treatment Outcome | 2003 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Ulcer | 2004 |
[What is Helicobacter pylori?: associated diseases in human].
Topics: Amoxicillin; Animals; Clarithromycin; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 2004 |
Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline | 2004 |
[Eradication of Helicobacter pylori for idiopathic thrombocytopenic purpura].
Topics: Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Minocycline; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Eradicate H. pylori with effective treatment regimens.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Proton Pump Inhibitors; Salicylates; Tetracycline; Treatment Outcome | 2004 |
H pylori antibiotic resistance: prevalence, importance, and advances in testing.
Topics: Adult; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2004 |
Appropriate strategies for testing and treating Helicobacter pylori in children: when and how?
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Breath Tests; Carrier State; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Mass Screening; Metronidazole; Middle Aged; Recurrence; Risk Assessment; Sex Distribution; Treatment Outcome | 2004 |
[The several problems and cautions in treatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention; Stomach Neoplasms | 2004 |
[Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Imidazoles; Organometallic Compounds; Practice Guidelines as Topic; Prevalence; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Reproducibility of Results | 2004 |
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2004 |
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic | 2004 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Neoplasms | 2004 |
Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter heilmannii; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole | 2005 |
Treatment of H. pylori infection: a review.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Clarithromycin; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Ofloxacin; Polypharmacy; Ranitidine; Rifabutin | 2005 |
A clinician's guide to managing Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Endoscopy; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 2005 |
[Diagnosis of and therapy for peptic ulcer].
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemostasis, Endoscopic; Histamine H2 Antagonists; Humans; Japan; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Proton Pump Inhibitors; Stress, Psychological; Sucralfate | 2005 |
Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 2005 |
[Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; Metronidazole; Tetracycline | 2005 |
Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Gastroesophageal Reflux; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole | 2005 |
An update on anti-Helicobacter pylori treatment in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
[Eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Stomach Neoplasms; Sulfoxides | 2005 |
[Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Stomach Neoplasms; Stomach Ulcer | 2005 |
[Guidelines in the management of H. pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2005 |
[Drug sensitivity test for Helicobacter pylori].
Topics: Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Proton Pump Inhibitors; Specimen Handling | 2005 |
[Cap polyposis and Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Intestinal Polyposis; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Recent topics on important drugs for H. pylori eradication: Clarithromycin (CAM)].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; RNA, Ribosomal, 23S | 2005 |
[Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic | 2005 |
[Triple therapy for eradication of Helicobacter pylori in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Insurance, Health; Japan; Lansoprazole; Omeprazole; Patient Compliance; Practice Guidelines as Topic; Proton Pump Inhibitors | 2005 |
[Adverse effects of Helicobacter pylori eradication and its prevention].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 2005 |
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Susceptibility to antibiotics and drug metabolism in patients with H. pylori infection refractory to the initial treatment--therapeutic strategy based on susceptibility to CAM and CYP2C19 polymorphism].
Topics: Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2005 |
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2005 |
[Investigation about 3rd line eradication of H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ampicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2005 |
[Helicobacter pylori eradication therapy for children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2005 |
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Stump; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Stomach Neoplasms; Tranexamic Acid | 2005 |
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dialysis; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2005 |
[Gastroduodenal erosions observed after Helicobacter pylori eradication].
Topics: Adult; Amoxicillin; Clarithromycin; Duodenitis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Omeprazole; Ranitidine | 2005 |
[Effect of probiotics on the prevention of diarrhea in Helicobacter pylori therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Probiotics; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2005 |
[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Influence of interleukin-1beta genetic polymorphism on H. pylori eradication therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Genetic diagnosis of H. pylori infection].
Topics: Antigens, Bacterial; Bacterial Adhesion; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Lewis Blood Group Antigens; Lewis X Antigen | 2005 |
[Development and clinical application of invader assay--detection of resistant mutation to clarithromycin in Helicobacter pylori].
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Gastric Mucosa; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Mixed Function Oxygenases; Mutation; Pharmacogenetics; Polymorphism, Single Nucleotide; RNA, Bacterial; RNA, Ribosomal, 23S | 2006 |
Role of Helicobacter pylori in functional dyspepsia.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Dyspepsia; Endoscopy; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Time Factors | 2006 |
[Generalization of Helicobacter pylori eradication therapy and its future in Japan].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Purpura, Thrombocytopenic, Idiopathic | 2006 |
Treatment of Helicobacter pylori infection.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2006 |
Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Disease-Free Survival; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome; Turkey | 2006 |
Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence | 2007 |
[Helicobacter pylori infection and probiotics].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Bifidobacterium; Clarithromycin; Clostridium butyricum; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Lansoprazole; Probiotics; Saccharomyces | 2007 |
[Treatment for Helicobacter pylori: current criteria].
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome | 2007 |
High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Omeprazole; Proton Pump Inhibitors; Remission Induction; Stomach Neoplasms | 2008 |
[Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines].
Topics: Amoxicillin; Clarithromycin; Consensus Development Conferences as Topic; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Practice Guidelines as Topic; Proton Pump Inhibitors; Stomach Neoplasms | 2008 |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].
Topics: Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic | 1995 |
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Treatment Outcome; Uncoupling Agents | 1995 |
Omeprazole, Helicobacter pylori, and gastritis.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1994 |
Antibacterial therapy of Helicobacter pylori-associated peptic ulcer disease: a new strategy. The Swedes go for it.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1994 |
[Helicobacter pylori therapy with omeprazole and clarithromycin: current status].
Topics: Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic | 1994 |
[Current therapy of Helicobacter pylori infection].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Recurrence | 1994 |
[Helicobacter pylori infections].
Topics: Amphotericin B; Bismuth; Clarithromycin; Drug Resistance, Microbial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Tetracyclines | 1993 |
[Treatment of Helicobacter pylori infection: current status].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Time Factors | 1995 |
Clarithromycin for treatment of Helicobacter pylori infections.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 1995 |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Omeprazole; Penicillins; Regression Analysis; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 1996 |
Review of Helicobacter pylori eradication regimens.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole | 1996 |
[How to eradicate Helicobacter pylori in 1995? Critical review of available treatments].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Omeprazole; Penicillins; Ranitidine | 1996 |
[How to eradicate Helicobacter pylori?].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Penicillins; Proton Pump Inhibitors; Proton Pumps | 1996 |
Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1996 |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracyclines; Tinidazole | 1996 |
Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Belgium; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 1996 |
Cost-effectiveness of H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Markov Chains; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms; Treatment Outcome | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Risk Assessment; Tetracyclines | 1996 |
Efficacy of clarithromycin in eradicating Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer | 1996 |
[Current developments in Helicobacter pylori therapy].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Stomach Ulcer | 1996 |
Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Monte Carlo Method; Organometallic Compounds; Patient Compliance; Proton Pump Inhibitors; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1997 |
Treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors | 1997 |
Future indications for macrolides.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Helicobacter Infections; Humans; Malaria; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial | 1997 |
The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Management of Helicobacter pylori-related disorders.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pumps | 1997 |
Helicobacter pylori: new developments and treatments.
Topics: Algorithms; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
[What is the current role of clarithromycin in the eradication of Helicobacter pylori?].
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans | 1997 |
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Tinidazole | 1997 |
[Diagnosis and treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Polymerase Chain Reaction; Ranitidine | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome | 1996 |
Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Ranitidine | 1997 |
Therapy of H. pylori infection.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine; Tinidazole | 1997 |
Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1997 |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1997 |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1998 |
Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1998 |
[Helicobacter pylori infection and ulcer].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Treatment Outcome; Virulence | 1998 |
Current regimens for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Diseases; Treatment Outcome | 1998 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Tetracycline; Time Factors | 1998 |
[Antibiotic therapy in eradicating Helicobacter pylori infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Penicillins; Peptic Ulcer; Primary Health Care; Proton Pump Inhibitors | 1998 |
[Recent topics on Helicobacter pylori--Historic background and problems caused by bacteria].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1998 |
[Efficacy of antibiotic therapy in eradicating Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 1998 |
[Problems following antibiotic therapy for eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Esophagitis, Peptic; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 1998 |
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Selection; Penicillins; Peptic Ulcer; Randomized Controlled Trials as Topic | 1998 |
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Proton Pump Inhibitors | 1998 |
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine | 1998 |
Eradication therapies for Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometallic Compounds; Stomach Diseases | 1998 |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1998 |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 1998 |
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 1999 |
[Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1999 |
[Antibiotic-resistant H. pylori strains in the last ten years in Japan].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Penicillin Resistance; Penicillins; Peptic Ulcer; Time Factors | 1999 |
[Detection of Helicobacter pylori 23S rRNA gene mutation associated with clarithromycin resistance and its clinical applicability].
Topics: Anti-Bacterial Agents; Base Sequence; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 23S; Sensitivity and Specificity; Sequence Homology, Nucleic Acid | 1999 |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Patient Education as Topic; Stomach Ulcer; Sweden | 1999 |
Antibiotic treatment of Helicobacter pylori infection.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic | 1999 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Stomach Ulcer | 1999 |
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Nitroimidazoles; Omeprazole; Penicillins | 1999 |
The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 1999 |
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection].
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Plasmacytoma; Stomach Neoplasms | 1999 |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Duodenitis; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lymphoma, B-Cell, Marginal Zone; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Ranitidine; Stomach Neoplasms; Stomach Ulcer | 1999 |
The gastric demon. An update on Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nurse Practitioners; Peptic Ulcer; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2000 |
[How to eradicate Helicobacter pylori?].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins | 1999 |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
Helicobacter pylori and idiopathic chronic urticaria.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Case-Control Studies; Chronic Disease; Clarithromycin; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Turkey; Urea; Urticaria | 2000 |
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 2000 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine; Stomach Neoplasms | 2000 |
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors | 2000 |
Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Point Mutation | 2000 |
Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada.
Topics: Anti-Bacterial Agents; Canada; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole | 2000 |
[Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Spain | 2001 |
Pathophysiology of antibiotic resistance: clarithromycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; RNA, Bacterial | 2000 |
Helicobacter pylori antibiotic resistance: trends over time.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2000 |
[Recent guidelines for the management of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2001 |
[Antimicrobial resistant test of H. pylori].
Topics: Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 23S | 2001 |
[Selection of antibiotics and planning of eradication for H. pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2001 |
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Patient Compliance; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure | 2001 |
Clarithromycin for Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Helicobacter Infections; Helicobacter pylori; Humans | 2000 |
Helicobacter pylori: a clinical update.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2001 |
Antibiotic resistance of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Penicillins; Peptic Ulcer; Tetracycline | 2001 |
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Topics: Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Research Design; Tetracycline; Treatment Outcome | 2001 |
Treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2001 |
Helicobacter pylori therapy: first-line options and rescue regimen.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Salvage Therapy; Treatment Outcome | 2001 |
[Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Stomach Neoplasms | 2001 |
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indomethacin; Omeprazole; Recurrence; Stomach Neoplasms; Stomach Ulcer | 2001 |
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Ethnicity; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Penicillins; Population Surveillance; Prevalence; Risk Factors; Sex Factors; Stomach Ulcer; United States | 2002 |
[Progress of tailor-made treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Ulcer and gastritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Precancerous Conditions; Proton Pump Inhibitors; Rifabutin; Stomach Neoplasms | 2002 |
Treatment of Helicobacter pylori infection. Indications and regimens: an update.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Ranitidine | 2002 |
Review article: an approach to Helicobacter pylori infection in the elderly.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Peptic Ulcer; Treatment Failure | 2002 |
[Development of Helicobacter pylori eradication therapy].
Topics: Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Diagnosis of Helicobacter pylori infection by culture method].
Topics: Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Specimen Handling | 2002 |
[Drug sensitivity test for Helicobacter pylori].
Topics: Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Insurance, Health, Reimbursement; Metronidazole; Microbial Sensitivity Tests | 2002 |
[The outline of medical treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Current role of acid suppressants in the treatment of peptic ulcer disease].
Topics: Amoxicillin; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Guidelines for the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Practice Guidelines as Topic | 2002 |
[Guidelines of Helicobacter pylori eradication in children].
Topics: Amoxicillin; Breath Tests; Child; Clarithromycin; Drug Therapy, Combination; Europe; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; North America; Omeprazole; Pediatrics; Practice Guidelines as Topic | 2002 |
[New triple therapy for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2002 |
[Dual therapy for Helicobacter pylori resistance to anti microbial agents].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2002 |
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tetracycline | 2002 |
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2002 |
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure; Treatment Outcome | 2002 |
[Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2002 |
[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Omeprazole; Rabeprazole; Treatment Failure | 2002 |
[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Diterpenes; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure | 2002 |
[Adverse effects of H. pylori eradication therapy and its measure].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Diarrhea; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Lansoprazole; Mouth Diseases; Omeprazole; Skin Diseases | 2002 |
[Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication].
Topics: Acute Disease; Amoxicillin; Clarithromycin; Esophagitis, Peptic; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Omeprazole; Peptic Ulcer | 2002 |
[H. pylori eradication therapy and natural history of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention | 2002 |
[Peptic ulcer in the elderly].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2002 |
[Proton pump inhibitors: Omeprazole].
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
[Proton pump inhibitors: Rabeprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Depression, Chemical; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2002 |
[Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Depression, Chemical; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 2002 |
[Clarithromycin (CAM)].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2002 |
[The role of H2RA in the eradication therapy of Helicobacter pylori].
Topics: Amoxicillin; Clarithromycin; Depression, Chemical; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 2002 |
[Sucralfate].
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Sucralfate; Treatment Outcome; Urease | 2002 |
[Plaunotol].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Resistance, Bacterial; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Neutrophil Activation; Omeprazole; Peptic Ulcer; Prognosis | 2002 |
[Sofalcone].
Topics: Amoxicillin; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Treatment Outcome | 2002 |
[Polaprezinc].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Carnosine; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Urease; Zinc Compounds | 2002 |
[Non-ulcer dyspepsia and H. pylori].
Topics: Amoxicillin; Clarithromycin; Dyspepsia; Gastric Acid; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Randomized Controlled Trials as Topic | 2002 |
[CRHP (clarithromycin-resistant H. pylori) infection in children].
Topics: Adult; Alcohol Oxidoreductases; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Genome, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Infectious Disease Transmission, Vertical; Male; Peptidyl Transferases; RNA, Ribosomal, 23S | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2002 |
[Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2002 |
Helicobacter pylori infection in skin diseases: a critical appraisal.
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Omeprazole; Prognosis; Risk Factors; Severity of Illness Index; Skin Diseases, Bacterial; Urticaria | 2002 |
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Histamine H2 Antagonists; Humans; Metronidazole; Patient Care Planning; Penicillins; Proton Pumps; Ranitidine; Recurrence | 2002 |
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome | 2002 |
951 trial(s) available for clarithromycin and Infections, Helicobacter
| Article | Year |
|---|---|
Influence of adding vitamin D3 to standard clarithromycin-based triple therapy on the eradication rates of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Cholecalciferol; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies | 2021 |
Pretreatment with Ranitidine Bismuth Citrate May Improve Success Rates of Helicobacter pylori Eradication: A Prospective, Randomized, Controlled and Open-Label Study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Treatment Failure; Treatment Outcome | 2021 |
Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school-aged children: A randomized non-blinded trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Laboratories; Pepsinogen C; Schools | 2021 |
Randomized clinical trial: 7-day vonoprazan-based versus 14-day omeprazole-based triple therapy for Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |
Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; Prospective Studies; Proton Pump Inhibitors | 2022 |
Comparison of tailored
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Republic of Korea; Treatment Outcome | 2022 |
Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Outcome | 2022 |
Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Neoplasm Recurrence, Local; Pyrroles; Sulfonamides | 2022 |
Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Helicobacter pylori; Humans; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2022 |
Randomised clinical trial: comparison of efficacy and adverse effects of a standard triple clarithromycin-containing regimen with high-dose amoxicillin and bismuth therapy in Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome | 2022 |
Nitazoxanide-based therapeutic regimen as a novel treatment for Helicobacter pylori infection in children and adolescents: a randomized trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitro Compounds; Proton Pump Inhibitors; Thiazoles; Treatment Outcome | 2022 |
Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2022 |
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome; United States | 2022 |
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Fatty Acids, Volatile; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Pyrroles; RNA, Ribosomal, 16S; Sulfonamides | 2022 |
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of
Topics: Amoxicillin; Anti-Bacterial Agents; Benzene Derivatives; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Potassium; Proton Pump Inhibitors; Treatment Outcome | 2022 |
High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; China; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2023 |
A randomized controlled trial to compare Helicobacter pylori eradication rates between the empirical concomitant therapy and tailored therapy based on 23S rRNA point mutations.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Point Mutation; Proton Pump Inhibitors; Rabeprazole; RNA, Ribosomal, 23S | 2022 |
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbiota; Proton Pump Inhibitors; Pyrroles; RNA, Ribosomal, 16S; Sulfonamides | 2022 |
[A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of
Topics: Amoxicillin; Anti-Bacterial Agents; Bifidobacterium longum; Bismuth; Clarithromycin; Drug Therapy, Combination; Enterococcus faecium; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A, Secretory; Omeprazole; Probiotics; Prospective Studies; Urease | 2021 |
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Bacterial Agents; Aspirin; Clarithromycin; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Helicobacter pylori; Hot Temperature; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Primary Health Care; Primary Prevention | 2022 |
Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Nausea; Pectins; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Prevalence; Republic of Korea; Tertiary Care Centers | 2023 |
Pharmacokinetic Interaction of Anaprazole, Amoxicillin and Clarithromycin after Single-Dose Simultaneous Administration and the Effect of Adding Bismuth on Their Pharmacokinetics in Healthy Male Chinese Subjects.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Combinations; East Asian People; Helicobacter Infections; Humans; Male; Proton Pump Inhibitors | 2023 |
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Topics: Adult; Anti-Bacterial Agents; Australia; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; RNA, Ribosomal, 16S; Young Adult | 2023 |
Ten-day concomitant and sequential therapy for Helicobacter pylori effective in region with high antibiotic resistance rates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome; Urea | 2022 |
Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Metronidazole; Proton Pump Inhibitors; Quinolones; Treatment Outcome | 2023 |
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; COVID-19; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Pandemics; Proton Pump Inhibitors; Treatment Outcome | 2023 |
A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors | 2022 |
Ten-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Vonoprazan is noninferior to proton pump inhibitors in bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: A propensity score matching analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Propensity Score; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
Quantitative PCR of string-test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptibility-guided therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Polymerase Chain Reaction; Retrospective Studies; Treatment Outcome | 2023 |
Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome | 2023 |
Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; RNA, Ribosomal, 23S | 2023 |
Susceptibility-guided sequential strategy versus empirical therapy for Helicobacter pylori infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms; Treatment Outcome | 2023 |
Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Berberine; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2023 |
Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; China; Clarithromycin; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Rabeprazole; Randomized Controlled Trials as Topic; Single-Blind Method | 2023 |
Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Thailand | 2023 |
Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2023 |
A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Sulfonamides; Treatment Outcome | 2023 |
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome | 2019 |
Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Treatment Outcome | 2019 |
[Tailored therapy in treatment of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2019 |
Effects of addition of probiotic and/or bismuth to triple therapy of H. pylori and analysis of genetic variation of 23S rRNA gene between patients with clarithromycin sensitivity and resistance.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Asian People; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Esomeprazole; Female; Gene Frequency; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymorphism, Single Nucleotide; Probiotics; RNA, Ribosomal, 23S; Treatment Outcome | 2019 |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Female; Follow-Up Studies; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metabolic Syndrome; Metronidazole; Middle Aged; Organometallic Compounds; Prevalence; Tetracycline | 2019 |
Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability.
Topics: Amoxicillin; Clarithromycin; Drug Costs; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Myanmar; Rabeprazole; Tinidazole; Treatment Outcome | 2020 |
Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Brassica; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Probiotics; Proton Pump Inhibitors; Republic of Korea | 2020 |
Efficacy and Cost-effectiveness Comparison of 10-Day, 14-Day Sequential Versus 14-Day Triple Therapies for Treating Helicobacter pylori Infection in Egyptian Patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Egypt; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Outcome | 2020 |
Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.
Topics: Adenomatous Polyps; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitoring; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Outcome Assessment, Health Care; Proton Pump Inhibitors; Stomach Neoplasms | 2020 |
Family History of Gastric Cancer and
Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Kaplan-Meier Estimate; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2020 |
10-Day Versus 14-Day Quadruple Concomitant Nonbismuth Therapy for the Treatment of Helicobacter pylori Infection: Results From a Randomized Prospective Study in a High Clarithromycin Resistance Country.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Treatment Outcome | 2020 |
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 2020 |
Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Male; Probiotics; Pyrroles; Sulfonamides | 2020 |
Searching for an optimal therapy for H pylori eradication: High-dose proton-pump inhibitor dual therapy with amoxicillin vs. standard triple therapy for 14 days.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2020 |
Addition of bismuth to standard triple therapy for Helicobacter pylori eradication: a randomised controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole | 2020 |
Susceptibility-guided quadruple therapy is not superior to medication history-guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Treatment Outcome | 2020 |
Positive Effect of Helicobacter pylori Treatment on Outcome of Patients With Chronic Spontaneous Urticaria.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Urticaria; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2021 |
The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies | 2020 |
Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 cases.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Rabeprazole; Treatment Outcome | 2020 |
A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome | 2020 |
Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Republic of Korea; RNA, Ribosomal, 23S; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2020 |
Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Organometallic Compounds; Tinidazole | 2020 |
Randomised clinical trial comparing concomitant and hybrid therapy for eradication of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Croatia; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Concomitant Therapy versus Triple Therapy: Efficacy in H. Pylori Eradication and Predictors of Treatment Failure.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Treatment Failure; Treatment Outcome | 2021 |
Application of a semi-automatic, intensive follow-up for improving efficacy and adherence of Helicobacter pylori eradication therapy: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Medication Adherence; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Republic of Korea | 2021 |
Clarithromycin versus furazolidone for naïve Helicobacter pylori infected patients in a high clarithromycin resistance area.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome | 2021 |
Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Pyrroles; Sulfonamides; Treatment Outcome | 2022 |
Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Single-Blind Method; Sulfonamides; Treatment Outcome | 2017 |
Effect of treatment failure on the CagA EPIYA motif in
Topics: Adult; Amino Acid Motifs; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Breath Tests; Clarithromycin; Colombia; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Phylogeny; Prevalence; Proton Pump Inhibitors; Random Amplified Polymorphic DNA Technique; Treatment Failure; Treatment Outcome; Virulence Factors | 2017 |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.
Topics: Adult; Amoxicillin; Carnosine; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Treatment Outcome; Zinc Compounds | 2017 |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Apoptosis; Caspase 3; Clarithromycin; Dietary Fats, Unsaturated; Double-Blind Method; Dyspepsia; Fatty Acids, Unsaturated; Female; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proto-Oncogene Proteins c-bcl-2; Stomach | 2017 |
The efficacy of sequential therapy in eradication of
Topics: Anti-Bacterial Agents; Clarithromycin; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Turkey | 2017 |
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors | 2017 |
Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Young Adult | 2017 |
Randomized Controlled Trial for Helicobacter pylori Eradication in a Naive Portuguese Population: Is Sequential Treatment Superior to Triple Therapy in Real World Clinical Setting?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Portugal; Prospective Studies; Proton Pump Inhibitors | 2017 |
Helicobacter pylori Eradication With Levofloxacin or Clarithromycin in Dialysis Versus Nonuremic Patients.
Topics: Adult; Antigens, Bacterial; Clarithromycin; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Levofloxacin; Male; Middle Aged; Renal Dialysis; Time Factors; Treatment Outcome; Uremia | 2017 |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome; Young Adult | 2017 |
[[Clinical Relevance Helicobacter Pylori Genotypes in Patients with Chronic Pancreatitis and Concomitant Infections Helicobacter Pylori].]
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Pancreatitis, Chronic; Rabeprazole; Treatment Outcome; Virulence; Virulence Factors | 2016 |
Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole | 2017 |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Young Adult | 2017 |
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial.
Topics: Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Berberine; Bismuth; Body Mass Index; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Severity of Illness Index; Sex Factors | 2017 |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Prospective Studies; Tetracycline | 2017 |
Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors | 2018 |
Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2018 |
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial.
Topics: Amoxicillin; Clarithromycin; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Sample Size | 2017 |
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies | 2017 |
Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.
Topics: Aged; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2018 |
Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Levofloxacin; Male; Middle Aged; Prevalence; Renal Dialysis; Treatment Outcome | 2018 |
Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Probiotics; Prospective Studies; Proton Pump Inhibitors; Serbia; Time Factors; Treatment Outcome; Young Adult | 2016 |
A Prospective, randomized study comparing 7-day and 14-day quadruple therapies as first-line treatments for helicobacter pylori infection in patients with functional dyspepsia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates | 2018 |
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis, Atrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Stomach; Stomach Neoplasms | 2018 |
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; China; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Young Adult | 2018 |
Randomized controlled trial: PPI-based triple therapy containing metronidazole versus clarithromycin as first-line treatment for Helicobacter pylori in adolescents and young adults in Japan.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Hospitals; Humans; Japan; Male; Metronidazole; Proton Pump Inhibitors | 2018 |
Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2018 |
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dizziness; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Patient Compliance; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2018 |
Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter,
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; China; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Rabeprazole; Tetracycline; Young Adult | 2018 |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Clarithromycin; Clinical Decision-Making; Doxycycline; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Taiwan; Tetracycline; Time Factors; Treatment Outcome | 2018 |
New fecal test for non-invasive
Topics: Adult; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Point Mutation; Predictive Value of Tests; Prospective Studies; Reference Standards; Sensitivity and Specificity | 2018 |
Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus plantarum; Male; Metronidazole; Middle Aged; Pediococcus acidilactici; Probiotics | 2018 |
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Disease Eradication; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Rwanda; Treatment Failure | 2018 |
Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Time Factors; Treatment Outcome | 2018 |
Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; Young Adult | 2018 |
Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Cross-Sectional Studies; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2019 |
Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial.
Topics: Adult; Amoxicillin; Clarithromycin; Dysgeusia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Patient Compliance; Tinidazole; Treatment Failure; Treatment Outcome; Young Adult | 2018 |
Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probiotics; Prospective Studies; Proton Pump Inhibitors; Random Allocation; Saccharomyces boulardii | 2019 |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Topics: Adult; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Prospective Studies; Quinolones; Treatment Outcome | 2018 |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome | 2018 |
Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome | 2019 |
Intraluminal therapy for Helicobacter pylori infection.
Topics: Acetylcysteine; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Powders; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Therapeutic Irrigation; Time Factors; Treatment Outcome; Young Adult | 2019 |
Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trial.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Treatment Outcome | 2019 |
Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Costs; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Organometallic Compounds; Treatment Outcome; Urea | 2019 |
Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Patient Education as Topic; Pectins; Prospective Studies; Text Messaging; Young Adult | 2019 |
Sequential therapy for first-line Helicobacter pylori eradication: 10- or 14-day regimen?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Time Factors; Tinidazole; Treatment Outcome | 2019 |
Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Polymorphism, Genetic; Precision Medicine | 2019 |
H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Gastrointestinal Microbiome; Glucose; Helicobacter Infections; Helicobacter pylori; Homeostasis; Humans; Male; Middle Aged; Omeprazole; RNA, Bacterial; RNA, Ribosomal, 16S; Sequence Analysis, RNA | 2019 |
Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Prospective Studies | 2019 |
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2019 |
Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Body Mass Index; Clarithromycin; Esophagitis; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Waist Circumference; Young Adult | 2020 |
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Latin America; Male; Medication Adherence; Metronidazole; Middle Aged; Primary Prevention; Recurrence; Risk; Stomach Neoplasms; Young Adult | 2013 |
[Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Clinical Protocols; Drug Costs; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2012 |
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Peptic Ulcer; Stomach Neoplasms; Taiwan | 2013 |
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Failure | 2013 |
Penbactam for Helicobacter pylori eradication: a randomised comparison of quadruple and triple treatment schedules in an Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Sulbactam; Urea; Young Adult | 2013 |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome; Urea; Young Adult | 2014 |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 2013 |
Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Young Adult | 2013 |
Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution.
Topics: Adenocarcinoma, Mucinous; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; beta Catenin; Cell Membrane; Cell Nucleus; Clarithromycin; Combined Modality Therapy; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization; Lansoprazole; Middle Aged; Peritoneal Neoplasms; Protein Transport; Pseudomyxoma Peritonei; Treatment Outcome | 2013 |
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Tinidazole; Urea | 2013 |
Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenoscopy; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2013 |
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Omeprazole; Treatment Outcome | 2013 |
Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Point Mutation; Polymerase Chain Reaction; Proton Pump Inhibitors; Rabeprazole; RNA, Ribosomal, 23S; Treatment Outcome; Young Adult | 2013 |
The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Young Adult | 2013 |
Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; China; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2013 |
Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2014 |
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salvage Therapy; Spain; Surveys and Questionnaires; Tetracycline; Time Factors; Treatment Failure | 2014 |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Pantoprazole; Prospective Studies; Tinidazole; Treatment Outcome | 2013 |
Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Proton Pump Inhibitors; Venezuela; Young Adult | 2013 |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Time Factors; Treatment Outcome | 2014 |
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome; Young Adult | 2013 |
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Breath Tests; China; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome | 2014 |
Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Dyspepsia; Feces; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Kenya; Male; Metronidazole; Treatment Outcome | 2013 |
A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inuit; Male; Medication Adherence; Metronidazole; Middle Aged; Northwest Territories; Proton Pump Inhibitors; Rabeprazole | 2013 |
Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Breath Tests; Chi-Square Distribution; Clarithromycin; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Renal Dialysis; Time Factors; Treatment Outcome | 2014 |
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Contraindications; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Nickel; Pilot Projects | 2014 |
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2014 |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; China; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Tinidazole; Treatment Outcome; Young Adult | 2014 |
[Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children].
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Probiotics; Prospective Studies; Saccharomyces | 2014 |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Time Factors; Treatment Outcome; Urea; Young Adult | 2014 |
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stomach Neoplasms | 2014 |
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Humans; Japan; Lansoprazole; Male; Middle Aged; Prospective Studies; Time Factors; Young Adult | 2014 |
Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Rabeprazole; Urea | 2015 |
Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Treatment Outcome | 2014 |
Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2014 |
A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome | 2014 |
The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Blood Glucose; Clarithromycin; Drug Therapy, Combination; Female; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Homeostasis; Humans; Insulin Resistance; Lansoprazole; Male; Prospective Studies; Single-Blind Method | 2015 |
Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Pantoprazole | 2014 |
Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms, Glandular and Epithelial; Proton Pump Inhibitors; Stomach Neoplasms | 2014 |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinolones; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2015 |
A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Metronidazole; Middle Aged; Multivariate Analysis; Prospective Studies; Republic of Korea; Time Factors; Treatment Outcome | 2014 |
Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pronase; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Treatment Outcome | 2015 |
Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Treatment Outcome | 2014 |
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Spain; Time Factors; Treatment Outcome | 2014 |
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial.
Topics: Amoxicillin; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Omeprazole; Stomach Ulcer | 2014 |
Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antiparkinson Agents; Breath Tests; Clarithromycin; Comorbidity; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Quality of Life; Treatment Outcome | 2014 |
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Treatment Outcome; Urea | 2015 |
Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Treatment Outcome; Young Adult | 2015 |
Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Probiotics; Prognosis; Prospective Studies; Salicylates; Thailand | 2014 |
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2014 |
Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome | 2014 |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Stomach Ulcer; Time Factors; Treatment Outcome | 2015 |
Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Real-Time Polymerase Chain Reaction; Treatment Outcome; Young Adult | 2015 |
Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2015 |
Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Treatment Outcome; Young Adult | 2015 |
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Pantoprazole; Peptic Ulcer; Tinidazole | 2015 |
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Young Adult | 2015 |
[Estimation of efficiency of anti-helicobacter therapy in patients with a chronic pancreatitis combined with an erosive gastropathy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pancreatitis, Chronic; Pantoprazole; Synbiotics | 2014 |
Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Antioxidants; Breath Tests; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Prospective Studies; Proton Pump Inhibitors; Vitamin E | 2014 |
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dental Amalgam; Dental Restoration, Permanent; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Male; Metronidazole; Middle Aged; Outpatients; Prospective Studies; Rabeprazole; Tetracycline; Treatment Outcome; Turkey; Urea | 2015 |
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bifidobacterium; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Placebos; Probiotics; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2015 |
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Multivariate Analysis; Odds Ratio; Pilot Projects; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Stomach Diseases; Time Factors; Treatment Outcome | 2015 |
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Breath Tests; Clarithromycin; Cytochrome P-450 CYP2C19; Dexlansoprazole; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Thailand | 2015 |
Eradication of gastric Helicobacter pylori ameliorates halitosis and tongue coating.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Case-Control Studies; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Follow-Up Studies; Halitosis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Saliva; Stomach; Tongue; Young Adult | 2015 |
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged | 2015 |
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bismuth; China; Clarithromycin; Cytochrome P-450 CYP2C19; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Tertiary Care Centers; Treatment Outcome; Young Adult | 2016 |
Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Postoperative Care; Preoperative Care; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2015 |
Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus delbrueckii; Male; Metronidazole; Middle Aged; Probiotics; Prognosis; Prospective Studies; Streptococcus; Young Adult | 2015 |
A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Ireland; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2015 |
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Young Adult | 2015 |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of
Topics: Adult; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Lansoprazole; Male; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial.
Topics: Acetylcysteine; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Pilot Projects; Rabeprazole; Treatment Outcome | 2016 |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Ribosomal; Drug Therapy, Combination; Female; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Sequence Analysis, DNA; Stomach Neoplasms | 2016 |
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Time Factors; Treatment Outcome | 2015 |
Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Taiwan; Time Factors; Treatment Outcome | 2015 |
Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; China; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach; Stomach Neoplasms | 2015 |
Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Health Knowledge, Attitudes, Practice; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Patient Satisfaction; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Telephone; Time Factors; Treatment Outcome | 2015 |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Case-Control Studies; Child; Child, Preschool; Chronic Disease; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Impact of creatinine clearance on Helicobacter pylori eradication rate in patients with peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Creatinine; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 2015 |
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method | 2015 |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome; Young Adult | 2016 |
[Minocycline quadruple versus tailored therapy in retreatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Colony Count, Microbial; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Dyspepsia; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Minocycline; Retreatment; Time Factors; Treatment Outcome | 2015 |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Rabeprazole; Risk Factors; Stomach Diseases; Treatment Outcome | 2016 |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome | 2016 |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Urea | 2016 |
Helicobacter pylori-Clarithromycin Resistance in Symptomatic Pediatric Patients in a High Prevalence Country.
Topics: Adolescent; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Child; Child, Preschool; Chile; Clarithromycin; Developing Countries; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Nitroreductases; Point Mutation; Polymorphism, Restriction Fragment Length; Prevalence; RNA, Ribosomal, 23S; Sequence Deletion; Treatment Outcome | 2017 |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospecti
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Male; Metronidazole; Middle Aged; Polymorphism, Genetic; Prognosis; Prospective Studies; Rabeprazole; Young Adult | 2016 |
A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice.
Topics: Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Cytochrome P-450 CYP2C19; Gastric Juice; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity; Urease | 2016 |
Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study.
Topics: Adult; Aged; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome; Urea | 2016 |
Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Italy; Levofloxacin; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Time Factors; Treatment Outcome | 2016 |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Nitro Compounds; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Thiazoles; Treatment Outcome | 2016 |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Healthy Volunteers; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Blood Glucose; Clarithromycin; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Homeostasis; Host-Pathogen Interactions; Humans; Inflammation Mediators; Insulin; Insulin Resistance; Italy; Male; Middle Aged; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2016 |
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Time Factors; Treatment Outcome | 2017 |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retreatment; Young Adult | 2016 |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Taiwan; Tetracycline; Urea | 2016 |
Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Time Factors | 2016 |
Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Amoxicillin; Anorexia; Anti-Bacterial Agents; Bifidobacterium animalis; Clarithromycin; Diarrhea; Dizziness; Drug Eruptions; Drug Resistance; Drug Therapy, Combination; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Nausea; Numbers Needed To Treat; Pantoprazole; Probiotics; Proton Pump Inhibitors; Symptom Assessment; Treatment Outcome | 2017 |
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2017 |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diabetes Mellitus, Type 2; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome | 2017 |
Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.
Topics: Adult; Amoxicillin; China; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Point Mutation; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2008 |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, General; Hospitals, Rural; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline; Treatment Outcome | 2008 |
The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Probiotics; Prospective Studies; Proton Pump Inhibitors; Yogurt | 2008 |
Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2008 |
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Clarithromycin; Endoscopy, Gastrointestinal; Endpoint Determination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms | 2008 |
A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Probiotics; Prospective Studies; Proton Pump Inhibitors; Saccharomyces | 2009 |
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Dyspepsia; Follow-Up Studies; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Proton Pump Inhibitors; Quality of Life; Treatment Outcome; United Kingdom | 2008 |
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Gene Frequency; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Logistic Models; Male; Middle Aged; Odds Ratio; Pantoprazole; Phenotype; Polymorphism, Genetic; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure | 2009 |
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Single-Blind Method; Treatment Outcome; Urea | 2009 |
[Effect of Helicobacter pylori eradication on patients with functional dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Rabeprazole; Young Adult | 2008 |
Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adrenal Cortex Hormones; Adult; Aged; Amoxicillin; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Platelet Count; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Time Factors; Treatment Outcome | 2009 |
Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2008 |
Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Feces; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Patient Selection; Point Mutation; Proton Pump Inhibitors; Ribotyping; Treatment Outcome | 2008 |
[Efficacy of 4 kinds of triple strategy for Helicobacter pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Stomach Ulcer; Young Adult | 2008 |
[Interleukin-1beta gene polymorphism as a predictor of eradication treatment efficacy in gastric and duodenal ulcer associated with Helicobacter pylori].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Endoscopy, Digestive System; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1beta; Middle Aged; Omeprazole; Peptic Ulcer; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Young Adult | 2008 |
Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antigens, Bacterial; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Stomach; Vietnam | 2008 |
Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Lansoprazole; Male; Middle Aged; Piperidines; Pyridines; Time Factors; Treatment Outcome | 2008 |
Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2008 |
Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Doxycycline; Female; Furazolidone; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Rabeprazole; Treatment Failure; Treatment Outcome; Urea | 2008 |
Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 2009 |
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cognition Disorders; Comorbidity; Endpoint Determination; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Neuropsychological Tests; Omeprazole; Prevalence; Treatment Outcome; Urease | 2009 |
Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2009 |
A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Colombia; Developing Countries; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Single-Blind Method; Treatment Outcome | 2009 |
Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Combined Modality Therapy; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Male; Omeprazole; Placebos; Probiotics | 2009 |
The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Drug Utilization; Dyspepsia; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Severity of Illness Index; Tinidazole; Treatment Outcome; Young Adult | 2009 |
Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Sensitivity and Specificity | 2009 |
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome; Young Adult | 2009 |
Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metabolic Clearance Rate; Middle Aged; Rabeprazole; Treatment Outcome; Young Adult | 2009 |
Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2009 |
Periodontal therapy improves gastric Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Biofilms; Chlorhexidine; Clarithromycin; Dental Plaque; Dental Scaling; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Pocket; Prospective Studies; Proton Pump Inhibitors; Recurrence; Root Planing; Stomach Diseases; Young Adult | 2009 |
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Male; Middle Aged; Proton Pump Inhibitors; Taiwan; Treatment Outcome; Urease | 2010 |
Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diabetes Mellitus, Type 2; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Polymerase Chain Reaction | 2009 |
The effect of mastic gum on Helicobacter pylori: a randomized pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Mastic Resin; Pantoprazole; Pilot Projects; Pistacia; Resins, Plant; Single-Blind Method | 2010 |
Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Ranitidine | 2009 |
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin | 2009 |
[Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Breath Tests; Clarithromycin; Cohort Studies; Cytochrome P-450 CYP2C19; DNA; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metabolic Clearance Rate; Moscow; Omeprazole; Peptic Ulcer; Polymorphism, Single Nucleotide; Prospective Studies | 2009 |
[Anti-Helicobacter pylori treatment in patients with idiopathic thrombocytopenic purpura].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Young Adult | 2009 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2010 |
Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Proton Pump Inhibitors; Quality of Life; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Stomach Ulcer; Treatment Outcome | 2010 |
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult | 2010 |
Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Tinidazole; Treatment Outcome; Young Adult | 2010 |
Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Amoxicillin; Biopsy; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Expectorants; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Thioglycolates; Thiophenes; Treatment Outcome | 2010 |
Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Statistics, Nonparametric; Surveys and Questionnaires; Tetracycline; Treatment Outcome | 2010 |
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult | 2010 |
Effect of eradication of Helicobacter pylori and iron supplementation on the iron status of children with iron deficiency.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iron; Male; Mexico; Omeprazole; Placebos | 2010 |
Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers.
Topics: Amoxicillin; Clarithromycin; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 2010 |
High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2010 |
Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, CD1; Clarithromycin; Complement Factor D; Drug Combinations; Female; Helicobacter; Helicobacter Infections; Immunocompromised Host; Male; Metronidazole; Mice; Mice, Inbred Strains; Mice, Knockout; Omeprazole; Rodent Diseases | 2010 |
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Single-Blind Method; Young Adult | 2010 |
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Bismuth; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Omeprazole; Pectins; Prospective Studies | 2010 |
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Blood Platelets; Child; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2011 |
Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Breath Tests; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Middle Aged; Mutation; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Rabeprazole; Urea | 2010 |
Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2010 |
Treatment of clinically diagnosed laryngopharyngeal reflux disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Egypt; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Laryngopharyngeal Reflux; Laryngoscopy; Male | 2010 |
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 2010 |
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Costs; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
Sequential metronidazole-furazolidone or clarithromycin-furazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: a double-blind randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Young Adult | 2010 |
Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cultured Milk Products; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged | 2011 |
Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Arginine; Atherosclerosis; Cardiovascular Abnormalities; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitric Oxide Synthase Type III; Young Adult | 2010 |
Comparison of two different treatment protocols in Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Tetracycline; Turkey | 2011 |
Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Probiotics; Single-Blind Method; Treatment Outcome; Urea; Young Adult | 2011 |
Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Brazil; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 2010 |
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tablets; Tetracycline; Young Adult | 2011 |
Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study.
Topics: Adult; Body Mass Index; Body Weight; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Placebos; Ranitidine; Treatment Outcome | 2011 |
Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Omeprazole; Proton Pump Inhibitors; Tinidazole; Urea | 2011 |
Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Failure | 2011 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Humans; Magnesium Hydroxide; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Urea | 2011 |
Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Ammonia; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hepatic Encephalopathy; Humans; Lansoprazole; Liver Cirrhosis; Male; Psychometrics; Tinidazole | 2011 |
The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hypothyroidism; Male; Metronidazole; Middle Aged; Tetracycline; Thyrotropin; Thyroxine; Triiodothyronine | 2011 |
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2011 |
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2011 |
The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Drug Therapy, Combination; Female; Food; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Leptin; Male; Middle Aged; Proton Pump Inhibitors | 2011 |
A new modified concomitant therapy for Helicobacter pylori eradication in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Treatment Outcome; Young Adult | 2011 |
High eradication rates of Helicobacter pylori infection following sequential therapy: the Israeli experience treating naïve patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole; Treatment Outcome | 2011 |
Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Young Adult | 2011 |
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Prospective Studies; Rifamycins; Rifaximin | 2011 |
Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome | 2012 |
Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Treatment Outcome | 2011 |
Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Clarithromycin; Combined Modality Therapy; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Male; Middle Aged; Outpatient Clinics, Hospital; Proton Pump Inhibitors; Turkey; Vitamin E | 2012 |
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Quinolones; Stomach Ulcer; Treatment Outcome; Wound Healing; Young Adult | 2011 |
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Urea | 2011 |
A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole | 2011 |
Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity.
Topics: Adult; Amoxicillin; Bifidobacterium; Breath Tests; Clarithromycin; Cultured Milk Products; Diarrhea; Double-Blind Method; Female; Fruit; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Middle Aged; Probiotics; Urea | 2011 |
Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study.
Topics: Adolescent; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Helicobacter Infections; Helicobacter pylori; Humans; Iron, Dietary; Omeprazole; Pilot Projects; Pregnancy; Pregnancy Complications | 2011 |
Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Republic of Korea | 2012 |
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; Clarithromycin; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Pyrazoles; Stomach; Stomach Neoplasms; Sulfonamides | 2012 |
Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Data Interpretation, Statistical; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Time Factors; Treatment Outcome | 2011 |
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Levofloxacin; Male; Middle Aged; Nitro Compounds; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Recurrence; Thiazoles; Young Adult | 2011 |
A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Rabeprazole; Sex Factors; Young Adult | 2012 |
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Rabeprazole; Republic of Korea; Time Factors; Treatment Outcome | 2012 |
Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibiosis; Breath Tests; Clarithromycin; Combined Modality Therapy; Drug Resistance, Bacterial; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lactobacillus; Male; Middle Aged; Rabeprazole; Yogurt | 2012 |
"7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: are they still effective? A randomized trial".
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Young Adult | 2011 |
Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies | 2012 |
A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Organometallic Compounds; Pantoprazole | 2012 |
Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Omeprazole; Prospective Studies | 2012 |
[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hydroxybenzoates; Male; Metronidazole; Nitrofurans; Pantoprazole; Peptic Ulcer; Treatment Outcome | 2011 |
Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Tetracycline; Young Adult | 2012 |
Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2012 |
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Simvastatin; Treatment Outcome | 2012 |
Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Algorithms; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2013 |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Stomach Ulcer; Tinidazole | 2012 |
Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Single-Blind Method; Spain; Time Factors; Treatment Outcome; Urea; Young Adult | 2012 |
Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Young Adult | 2012 |
Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Prospective Studies; Rabeprazole; Thailand; Time Factors; Young Adult | 2012 |
Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Vietnam | 2012 |
Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Male; Metronidazole; Middle Aged; Patient Compliance; Republic of Korea; Urea | 2012 |
Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome; Urea | 2013 |
Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Pantoprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome | 2013 |
[A 10-day sequential therapy for eradication of Helicobacter pylori infection in children].
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Time Factors; Treatment Outcome | 2012 |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Ofloxacin | 2013 |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: result of the HPFEZ randomised study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Young Adult | 2013 |
Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; Urea | 2013 |
Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2013 |
Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Thailand; Treatment Outcome | 2013 |
Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Treatment Outcome; Urea; Young Adult | 2013 |
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2002 |
Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Gastroesophageal Reflux; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Paraffin Embedding; Stomach | 2002 |
One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline; Treatment Outcome | 2002 |
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrocortisone; Lansoprazole; Liver Function Tests; Male; Middle Aged; Omeprazole; Oxidoreductases, N-Demethylating; Penicillins; Protein Synthesis Inhibitors | 2002 |
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Topics: Adult; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pain; Peptic Ulcer; Treatment Outcome | 2002 |
Effect of Helicobacter pylori eradication in the glycemia of children with type 1 diabetes: a preliminary study.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clarithromycin; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Time Factors | 2002 |
Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Bifidobacterium; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Probiotics; Yogurt | 2002 |
[Fromilid (clarithromycin) in eradication patients in patients with duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variations)].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction | 2002 |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 2002 |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastrins; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins; Precancerous Conditions; Recurrence; Risk Factors; ROC Curve; Stomach Neoplasms | 2002 |
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Prospective Studies; Stomach Diseases | 2002 |
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2002 |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2002 |
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline; Wound Healing | 2002 |
Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients.
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Diseases; Male; Middle Aged; Omeprazole; Renal Dialysis; Retreatment; Sex Factors; Time Factors; Treatment Outcome; Urea | 2002 |
Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Patient Compliance; Prospective Studies; Proton-Translocating ATPases; Rabeprazole | 2002 |
The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Circadian Rhythm; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acid; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2002 |
Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Catalase; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Oxidative Stress; Superoxide Dismutase | 2002 |
Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Wound Healing | 2003 |
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Family Health; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Neoplasms; Tablets; Treatment Outcome | 2003 |
Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Stomach; Thailand; Treatment Outcome | 2002 |
[Pharmacoeconomic aspects of the 1-week eradication treatment of duodenal ulcer associated with Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Administration Schedule; Duodenal Ulcer; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins | 2002 |
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Tetracycline | 2002 |
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2003 |
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure; Treatment Outcome | 2003 |
[New triple therapy for Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2003 |
Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Stomach Ulcer | 2003 |
High eradication rates of Helicobacter pylori with a new sequential treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Rabeprazole; Tinidazole; Treatment Outcome | 2003 |
Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Piperidines; Prospective Studies; Pyridines | 2003 |
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Safety | 2003 |
Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial.
Topics: Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Tinidazole | 2003 |
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2003 |
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Stomach Ulcer; Sulfoxides | 2003 |
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Male; Middle Aged; Omeprazole; Treatment Outcome | 2003 |
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Confidence Intervals; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Likelihood Functions; Male; Middle Aged; Omeprazole; Penicillins; ROC Curve; Sensitivity and Specificity; Time Factors; Urea | 2003 |
One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2003 |
Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Sweden; White People | 2003 |
Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Tinidazole; Treatment Outcome | 2003 |
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2003 |
Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Wound Healing | 2003 |
The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2003 |
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tetracycline; Urea | 2003 |
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2003 |
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Tinidazole; Treatment Outcome | 2003 |
Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Probability; Reference Values; Severity of Illness Index; Treatment Outcome | 2003 |
Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Breath Tests; Carbolines; Clarithromycin; Drug Therapy, Combination; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Secondary Prevention; Treatment Outcome | 2003 |
[A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Rabeprazole | 2003 |
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Ranitidine; Time Factors; Urea | 2003 |
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Failure | 2003 |
Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2003 |
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Tinidazole; Treatment Outcome | 2003 |
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Peptic Ulcer; Secondary Prevention; Treatment Outcome | 2003 |
Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Rabeprazole; Treatment Outcome | 2003 |
Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clavulanic Acids; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Recurrence; Stomach Ulcer; Treatment Failure | 2003 |
Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 2003 |
Use of bovine lactoferrin for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Breath Tests; Cattle; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Omeprazole; Proton-Translocating ATPases; Rabeprazole; Time Factors; Tinidazole | 2003 |
Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Bismuth; Blood Pressure; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Male; Middle Aged; Prevalence; Ranitidine | 2003 |
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Treatment Outcome | 2003 |
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Multivariate Analysis; Omeprazole; Polymorphism, Genetic; Probability; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Statistics, Nonparametric; Treatment Outcome | 2003 |
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2003 |
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2004 |
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; beta-Lactamases; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance | 2004 |
[Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Russia; Treatment Outcome | 2003 |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Internet; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Tetracycline | 2003 |
Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proportional Hazards Models; Statistics, Nonparametric; Treatment Failure | 2004 |
High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Rabeprazole; Treatment Outcome | 2004 |
[Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2004 |
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; DNA; Drug Evaluation; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Rabeprazole; Risk Factors; Smoking; Tinidazole; Treatment Outcome | 2004 |
[Efficacy of anti-Helicobacter therapy in children with ulcer-like functional dyspepsia].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2003 |
Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2003 |
Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2004 |
[Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; China; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Rabeprazole; Treatment Outcome | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach Ulcer; Tetracycline; Treatment Outcome; Turkey | 2004 |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome | 2004 |
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Genetic Predisposition to Disease; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Patient Compliance; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome | 2004 |
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost Savings; Cost-Benefit Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prevalence; Proton Pump Inhibitors; Proton Pumps; Statistics as Topic; Tetracycline; Treatment Outcome | 2003 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Ulcer | 2004 |
[Comparative efficacy of proton pump inhibitors in children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acidity Determination; Gastric Juice; Gastroenteritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2003 |
[Efficacy of different schemes of anti-helicobacter therapy in duodenal ulcer].
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Josamycin; Male; Metronidazole; Treatment Outcome | 2004 |
Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Tinidazole; Treatment Outcome | 2004 |
Helicobacter pylori eradication: efficacy of conventional therapy in India.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Tinidazole; Treatment Outcome | 2004 |
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome; Wound Healing | 2004 |
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2004 |
The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Rabeprazole; Smoking; Tinidazole; Treatment Outcome | 2004 |
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2004 |
Seven-day therapy for Helicobacter pylori in the United States.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Treatment Outcome | 2004 |
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dizziness; Drug Therapy, Combination; Endoscopes, Gastrointestinal; Exanthema; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Sulfoxides; Tranexamic Acid; Treatment Outcome | 2004 |
In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2003 |
[Long-term therapeutic effect of triple therapy consisted of omeperazole, clarithromycin and amoxycillin in children with Helicobacter pylori infection and approach to re-treatment after failure of the treatment].
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence; Time Factors; Treatment Outcome | 2004 |
Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Family Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Urea | 2004 |
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Omeprazole; Peptic Ulcer; Retrospective Studies | 2004 |
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metaplasia; Middle Aged; Omeprazole; Precancerous Conditions; Prospective Studies; Risk Factors; Stomach Neoplasms | 2004 |
Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial.
Topics: Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies; Recurrence; Time Factors | 2004 |
The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Wound Healing | 2004 |
The effect of Helicobacter pylori eradication on gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopes, Gastrointestinal; Female; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Treatment Outcome; Urease | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Care Management; Treatment Outcome | 2004 |
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence | 2004 |
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Lewis and Secretor status and Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Phenotype; Tinidazole; Treatment Outcome; Urea | 2004 |
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bacillus; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Probiotics; Prospective Studies; Rabeprazole | 2004 |
Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Aminopyrine; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Sex Characteristics | 2005 |
Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin.
Topics: Adult; Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Uremia | 2005 |
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Chi-Square Distribution; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mixed Function Oxygenases; Omeprazole; Risk | 2005 |
Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Protocols; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2005 |
Comparison of one week and two weeks of triple therapy for the eradication of Helicobacter pylori in a Sri Lankan population: a randomised, controlled study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Clarithromycin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Probability; Risk Assessment; Sri Lanka; Tinidazole; Treatment Outcome | 2004 |
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Recurrence; Wound Healing | 2005 |
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Ranitidine; Risk Factors | 2005 |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chalcone; Chalcones; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole | 2005 |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Treatment Outcome; Urea | 2005 |
Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Peptic Ulcer; RNA, Ribosomal, 23S; Treatment Outcome | 2005 |
[Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Odds Ratio; Omeprazole; Treatment Outcome | 2005 |
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2005 |
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey | 2005 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects | 2005 |
Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Treatment Outcome | 2005 |
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Follow-Up Studies; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Risk Assessment; Single-Blind Method | 2005 |
[Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 2005 |
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endosonography; Female; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Ulcer; Wound Healing | 2005 |
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Rabeprazole; Treatment Outcome | 2005 |
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome | 2005 |
Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Prospective Studies | 2005 |
Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aminopyrine; Anti-Bacterial Agents; Anti-Infective Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Liver; Liver Function Tests; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole | 2005 |
Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Omeprazole | 2005 |
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Treatment Outcome | 2005 |
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2005 |
Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2005 |
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-b
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Omeprazole; Parkinson Disease; Treatment Outcome | 2005 |
[Comparison of esomeprazole- and omeprazole-based triple therapy regimens for duodenal ulcer with Helicobacter pylori infection].
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2005 |
Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2005 |
[Five-day rabeprazole-based triple therapy for helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Rabeprazole | 2004 |
Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Recurrence; Tinidazole; Treatment Outcome | 2005 |
A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prevalence; Prospective Studies; Risk Factors; Treatment Failure | 2005 |
Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors | 2005 |
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides; Treatment Outcome | 2004 |
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Patient Compliance; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Remission Induction; Tinidazole; Treatment Outcome | 2005 |
Effect of N-acetyl cysteine on Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
[H. pylori eradication package set (Lansap)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Packaging; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2005 |
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Tranexamic Acid; Treatment Outcome | 2005 |
[Children Helicobacter pylori infection: antibiogram results].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prospective Studies; Stomach | 2005 |
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Needs Assessment; Omeprazole; Peptic Ulcer; Probability; Reference Values; Rheumatic Diseases; Risk Assessment; Statistics, Nonparametric; Treatment Outcome | 2005 |
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Brazil; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2006 |
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Point Mutation; Rabeprazole; Treatment Outcome | 2006 |
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Patient Acceptance of Health Care; Peptic Ulcer; Quality of Life; Ranitidine | 2006 |
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cadherins; Chronic Disease; Clarithromycin; DNA Methylation; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Intestines; Male; Metaplasia; Middle Aged; Omeprazole; Promoter Regions, Genetic; Prospective Studies | 2006 |
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 2006 |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2006 |
Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Tinidazole; Treatment Outcome | 2006 |
[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Russia; Tetracycline; Treatment Outcome | 2005 |
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 2006 |
Studies on drug interactions between esomeprazole, amoxicillin and clarithromycin in healthy subjects.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Drug Antagonism; Esomeprazole; Female; Half-Life; Helicobacter Infections; Humans; Male; Mixed Function Oxygenases | 2006 |
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Polyps; Proton Pump Inhibitors; Stomach Neoplasms; Tinidazole | 2006 |
Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Treatment Outcome | 2006 |
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Cattle; Chi-Square Distribution; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Prospective Studies; Tinidazole; Treatment Outcome | 2006 |
Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Protocols; Combined Modality Therapy; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Middle Aged; Omeprazole; Proportional Hazards Models; Research Design; Sample Size; Stomach Neoplasms | 2006 |
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Rifamycins; Rifaximin; Treatment Outcome | 2006 |
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Pilot Projects; Quinolones; Stomach Ulcer; Treatment Outcome | 2006 |
Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Dyspepsia; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome; Virulence; Virulence Factors | 2006 |
[Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Ornidazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Linear Models; Male; Middle Aged; Omeprazole; Prevalence; Prospective Studies; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2006 |
Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Prospective Studies; Ranitidine | 2006 |
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Prospective Studies; Rural Population | 2006 |
Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Ranitidine; Tetracycline; Treatment Outcome; Urease; Young Adult | 2006 |
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Rifabutin; Treatment Outcome | 2006 |
Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Cisapride; Clarithromycin; Domperidone; Dopamine Antagonists; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Treatment Outcome | 2006 |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds | 2006 |
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Middle Aged; Proton Pump Inhibitors; Proton Pumps; Treatment Failure | 2006 |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Furazolidone-based triple therapy for H pylori gastritis in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies | 2006 |
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2007 |
Randomized comparison of two rescue therapies for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline | 2006 |
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lactobacillus acidophilus; Male; Metronidazole; Middle Aged; Pantoprazole; Probiotics; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole; Treatment Outcome | 2006 |
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Melena; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Taste Disorders; Time Factors; Treatment Outcome | 2006 |
Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure.
Topics: Anti-Bacterial Agents; Biopsy; Cells, Cultured; Clarithromycin; Cohort Studies; Disease Susceptibility; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Stomach; Treatment Failure | 2006 |
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton Pumps | 2006 |
A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Proton Pumps; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2006 |
Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bifidobacterium; Cell Count; Clarithromycin; Combined Modality Therapy; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Middle Aged; Probiotics; Propionibacterium; Treatment Outcome | 2007 |
Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients: a randomised, double-blind, multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mixed Function Oxygenases; Omeprazole | 2006 |
Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome; Urease | 2007 |
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Costs and Cost Analysis; Cytochrome P-450 CYP2C19; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Genetic; RNA, Ribosomal | 2007 |
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome | 2007 |
Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth Mucosa; Omeprazole; Oral Hygiene; Peptic Ulcer; Tinidazole; Treatment Outcome | 2007 |
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Probiotics; Prospective Studies; Treatment Outcome | 2007 |
Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Case-Control Studies; Chromatography, High Pressure Liquid; Clarithromycin; Cross-Over Studies; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Proton Pump Inhibitors; Time Factors | 2007 |
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Iran; Male; Middle Aged; Omeprazole | 2007 |
Eradication of Helicobacter pylori in hemodialysis patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Male; Middle Aged; Renal Dialysis | 2007 |
[Helicobacter pylori erradication and its relation to antibiotic resistance and CYP2C19 status].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Data Interpretation, Statistical; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Mixed Function Oxygenases; Rabeprazole; Time Factors | 2007 |
Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2007 |
[Age and eradication treatment of duodenal ulcer].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Severity of Illness Index; Treatment Outcome | 2007 |
Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Beverages; Clarithromycin; Double-Blind Method; Female; Fruit; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Phytotherapy; Placebos; Proton Pump Inhibitors; Vaccinium macrocarpon | 2007 |
H. pylori infection in childhood chronic immune thrombocytopenic purpura.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Netherlands; Omeprazole; Platelet Count; Prevalence; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Remission Induction | 2007 |
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Phenotype; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Retreatment; Stomach Diseases; Treatment Outcome | 2007 |
[Different courses of esomeprazole-based triple therapy for Helicobactor pylori infection in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2007 |
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chile; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Treatment Outcome | 2007 |
H pylori infection in patients with Behcet's disease.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Behcet Syndrome; Biopsy; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Pyloric Antrum; Tetracycline | 2007 |
13C-urea breath test values and Helicobacter pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Treatment Outcome; Urea | 2008 |
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Middle Aged; Ofloxacin; Rabeprazole; Tinidazole; Treatment Outcome | 2007 |
Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Piperidines; Pyridines | 2007 |
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Time Factors; Treatment Outcome | 2007 |
Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hepatitis B; Humans; Liver Cirrhosis; Male; Middle Aged; Migraine Disorders; Omeprazole; Time Factors; Treatment Outcome | 2007 |
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Probiotics; Prospective Studies; Saccharomyces; Stomach Diseases; Treatment Outcome | 2007 |
Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Gastric Acid; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2007 |
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Constipation; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Nausea; Ofloxacin; Treatment Outcome; Vomiting | 2007 |
High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Pilot Projects; Prospective Studies; Treatment Outcome | 2007 |
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Prevalence; Proton Pump Inhibitors; Quinolones; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2007 |
Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Follow-Up Studies; Gastrectomy; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Postoperative Care; Preoperative Care; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Stomach Neoplasms; Treatment Outcome | 2008 |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Male; Membrane Glycoproteins; Middle Aged; Omeprazole; Receptors, Immunologic; Severity of Illness Index; Stomach Ulcer; Tissue Culture Techniques; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha | 2007 |
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors; Treatment Outcome | 2007 |
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2007 |
Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Autoantibodies; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Skin Tests; Treatment Outcome; Urticaria | 2007 |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Urea | 2008 |
Sequential regimens for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome | 2007 |
Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
Topics: Adult; Alkylating Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Tinidazole | 2007 |
The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Middle Aged; Single-Blind Method; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 2007 |
Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Proton Pump Inhibitors; Rabeprazole | 2007 |
Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole | 2007 |
Efficacy of Lansap combination therapy for eradication of H. pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance | 2007 |
The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Chronic Disease; Clarithromycin; Colony Count, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Platelet Count; Prospective Studies; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Recovery of Function; Recurrence | 2008 |
Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Iran; Male; Middle Aged; Omeprazole; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Splenectomy | 2008 |
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Aza Compounds; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Mixed Function Oxygenases; Moxifloxacin; Polymorphism, Restriction Fragment Length; Prospective Studies; Quinolines; Rifabutin | 2008 |
Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Urea | 2008 |
Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2008 |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Community Health Services; Cost-Benefit Analysis; Cross-Sectional Studies; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2008 |
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Humans; Male; Middle Aged; Moxifloxacin; Pilot Projects; Prospective Studies; Quinolines; Ranitidine; Treatment Outcome; Young Adult | 2008 |
Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Secondary Prevention; Severity of Illness Index; Stomach Ulcer; Treatment Outcome; Young Adult | 2008 |
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ecuador; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 2008 |
Efficacy of lansoprazole in eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 1995 |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Recurrence; Stomach Ulcer | 1995 |
Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Fatty Alcohols; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Recurrence; Stomach Ulcer | 1995 |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole | 1995 |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Dizziness; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Pruritus | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 1995 |
Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Clarithromycin; Drug Therapy, Combination; Epithelium; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole | 1995 |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors | 1995 |
[Ranitidine and clarithromycin for eradication of Helicobacter pylori in patients with duodenal ulcer].
Topics: Adult; Aged; Clarithromycin; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine | 1995 |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study.
Topics: Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1995 |
The ECP-IM intervention study.
Topics: Ascorbic Acid; Clarithromycin; Double-Blind Method; Drug Combinations; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Placebos; Stomach Neoplasms | 1994 |
Combination therapy with clarithromycin and sofalcone for eradication of Helicobacter pylori.
Topics: Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Outcome | 1994 |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome | 1995 |
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1995 |
Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia.
Topics: Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Microbial Sensitivity Tests; Omeprazole | 1995 |
Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease.
Topics: Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Time Factors | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy, Digestive System; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Stomach; Stomach Ulcer; Stomatitis; Sulfoxides | 1995 |
High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1995 |
Clarithromycin-amoxycillin therapy for Helicobacter pylori infection.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Pyloric Antrum; Ranitidine | 1994 |
Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1994 |
Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Tetracycline | 1994 |
[Omeprazole modified antibiotic therapy of Helicobacter pylori infection: can clarithromycin be replaced by roxithromycin?].
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Roxithromycin | 1994 |
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial.
Topics: Adult; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Predictive Value of Tests | 1993 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Remission Induction; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Single-Blind Method; Tinidazole | 1995 |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 1995 |
Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Colony Count, Microbial; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Stomach Ulcer | 1995 |
Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1995 |
Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence | 1995 |
Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 1995 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Stomach Ulcer; Time Factors | 1996 |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole | 1996 |
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine; Recurrence | 1996 |
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance | 1996 |
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1996 |
A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Urea | 1996 |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole | 1996 |
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome; Wound Healing | 1996 |
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 1996 |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance | 1996 |
Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Chi-Square Distribution; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole | 1996 |
Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Statistics, Nonparametric | 1996 |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anticarcinogenic Agents; Antioxidants; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Placebos; Precancerous Conditions; Stomach Neoplasms; Vitamins | 1996 |
Therapeutic options after failed Helicobacter pylori eradication therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retreatment; Treatment Failure | 1996 |
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Stomach Ulcer | 1996 |
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Protease Inhibitors; Stomach Ulcer | 1996 |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors | 1996 |
Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer; Tinidazole; Treatment Failure | 1996 |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antibodies, Bacterial; Azithromycin; Biomarkers; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pepsinogens | 1996 |
Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins | 1996 |
Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Bacterial Typing Techniques; Clarithromycin; Double-Blind Method; Duodenal Ulcer; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Open Reading Frames; Polymorphism, Restriction Fragment Length; United States | 1997 |
Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Tinidazole | 1996 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Norway; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Stomach Ulcer | 1997 |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine | 1997 |
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Time Factors | 1997 |
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Diarrhea; Drug Hypersensitivity; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides | 1997 |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Single-Blind Method; Time Factors | 1997 |
Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1997 |
One week treatment for Helicobacter pylori infection.
Topics: Adolescent; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Metronidazole; Organometallic Compounds | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Child; Chronic Disease; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Acid; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Peptic Ulcer; Pyloric Antrum; Treatment Outcome | 1997 |
Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 1997 |
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Ranitidine; Treatment Outcome; Wound Healing | 1997 |
PCR-RFLP typing of ureC from Helicobacter pylori isolated from gastric biopsies during a European multi-country clinical trial.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Double-Blind Method; Duodenal Ulcer; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 1997 |
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Pyloric Antrum; Ranitidine | 1997 |
Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tetracycline | 1997 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Dyspepsia; Evaluation Studies as Topic; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Taste Disorders | 1997 |
A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; United States | 1997 |
The management of failed dual or triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Tetracycline; Treatment Failure | 1997 |
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Korea; Male; Middle Aged; Nizatidine; Penicillins; Peptic Ulcer | 1997 |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Canada; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tetracycline; Tinidazole | 1997 |
[Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
Topics: Abdominal Pain; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Longitudinal Studies; Male; Prospective Studies; Ranitidine; Recurrence | 1996 |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides | 1997 |
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 1996 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Eruptions; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome | 1996 |
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Safety; Taste Disorders; Treatment Outcome | 1996 |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenitis; Esophagitis; Female; Helicobacter Infections; Helicobacter pylori; Hernia, Hiatal; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Smoking; Treatment Outcome | 1996 |
Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Recurrence; Treatment Outcome | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1996 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Pyloric Antrum; Treatment Outcome | 1997 |
Combination treatment with ranitidine is highly efficient against Helicobacter pylori despite negative impact of macrolide resistance.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymecycline; Male; Middle Aged; Mouth Diseases; Nausea; Ranitidine; Sensitivity and Specificity; Taste Disorders; Tongue | 1997 |
One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Taste Disorders; Time Factors; Treatment Outcome; Treatment Refusal | 1997 |
Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Recurrence; Smoking | 1997 |
The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole | 1997 |
Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1997 |
Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Organometallic Compounds; Ranitidine; Treatment Outcome | 1997 |
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Oxytetracycline; Prospective Studies | 1997 |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline | 1998 |
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Time Factors | 1998 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method | 1997 |
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ornidazole; Prospective Studies; Smoking; Treatment Outcome | 1997 |
Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Time Factors; Tinidazole | 1997 |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 1998 |
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole; Treatment Outcome | 1998 |
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1998 |
[Effects of the triple therapy in the eradication of Helicobacter pylori: comparison of 3 different antibiotics].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Time Factors | 1997 |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies | 1998 |
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Vagotomy | 1998 |
Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Linear Models; Male; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 1998 |
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks?
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pilot Projects; Treatment Outcome | 1998 |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Diarrhea; Drug Therapy, Combination; Endoscopes; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Taste Disorders; Time Factors; Treatment Outcome | 1998 |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anus Diseases; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Diarrhea; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hallucinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Omeprazole; Peptic Ulcer; Pregnancy; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Taste Disorders; Time Factors; Tongue Diseases; Treatment Outcome; Urea; Vomiting | 1998 |
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Recurrence | 1998 |
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Treatment Failure | 1998 |
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds | 1996 |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins | 1996 |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastric Acid; Gastric Emptying; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pepsinogens; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 1998 |
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tinidazole | 1998 |
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Stomach Ulcer | 1998 |
Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Research Design; Tinidazole | 1998 |
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine | 1998 |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method; Treatment Outcome | 1997 |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing | 1997 |
[Helicobacter pylori: 6-day triple therapy in duodenal ulcer].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1998 |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Stomach Ulcer; Tetracycline; Treatment Outcome | 1998 |
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tinidazole; Treatment Outcome; Urea | 1998 |
Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nizatidine; Penicillins | 1998 |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole | 1998 |
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole | 1998 |
Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Single-Blind Method; Sulfoxides; Treatment Outcome | 1998 |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pefloxacin; Proton Pump Inhibitors | 1998 |
One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Treatment Outcome | 1998 |
[Eradication therapies for Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Tinidazole | 1998 |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides | 1998 |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Time Factors; Treatment Failure | 1998 |
Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Tinidazole; Treatment Outcome | 1998 |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pumps; Ranitidine; Single-Blind Method; Treatment Outcome | 1998 |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Treatment Outcome | 1998 |
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Recurrence; Treatment Outcome | 1998 |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1998 |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1998 |
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; China; Clarithromycin; Culture Media; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Pilot Projects; Prospective Studies; Rural Health; Stomach | 1998 |
New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1998 |
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Risk Factors | 1998 |
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1998 |
Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins | 1998 |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Time Factors | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton-Translocating ATPases; Rabeprazole; Time Factors; Treatment Outcome | 1998 |
Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Time Factors; Tinidazole | 1998 |
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Time Factors; Tinidazole | 1998 |
Effects of oral clarithromycin and amoxycillin on interdigestive gastrointestinal motility of patients with functional dyspepsia and Helicobacter pylori gastritis.
Topics: Administration, Oral; Adult; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 1998 |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Proton Pump Inhibitors; Sensitivity and Specificity; Time Factors; Urease | 1998 |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; United States | 1998 |
Chronic urticaria and Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Blood Donors; Breath Tests; Carbon Isotopes; Chronic Disease; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Remission Induction; Stomach; Urea; Urticaria | 1998 |
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polyps; Proton Pump Inhibitors; Single-Blind Method; Statistics, Nonparametric; Stomach Neoplasms | 1998 |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Treatment Outcome | 1998 |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1998 |
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 1998 |
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Treatment Outcome | 1998 |
Preliminary study on a novel quadruple eradication therapy with a mucoprotective drug, sofalcone, for Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 1998 |
[Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Retrospective Studies | 1998 |
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Odds Ratio; Omeprazole; Penicillins; Prognosis; Prospective Studies; Time Factors | 1998 |
[Treatment with omeprazole, clarithromycin and amoxicillin for one week. Their efficacy and tolerance in eradicating Helicobacter pylori in primary care].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Primary Health Care; Prospective Studies; Remission Induction; Time Factors | 1998 |
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome; Urea | 1999 |
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1999 |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Recurrence; Time Factors; Treatment Failure | 1999 |
[Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 1999 |
[A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Treatment Outcome | 1999 |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1999 |
[Erosive duodenitis after eradication therapy for Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenitis; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Peptic Ulcer | 1999 |
[Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence; Time Factors | 1999 |
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome | 1999 |
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Omeprazole; Risk Factors; Tinidazole | 1999 |
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Prospective Studies; Time Factors | 1999 |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1999 |
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Secondary Prevention; Sucralfate; Urea | 1999 |
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Ranitidine; Stomach Ulcer | 1999 |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds | 1999 |
The effect of antibiotic therapy on bleeding from duodenal ulcer.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine; Risk Factors; Time Factors | 1999 |
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
Topics: Adult; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Ranitidine; Time Factors | 1999 |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens.
Topics: Adult; Amoxicillin; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pilot Projects | 1999 |
Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Time Factors | 1999 |
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Carnosine; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Protective Agents; Zinc Compounds | 1999 |
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 1999 |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Single-Blind Method; Treatment Outcome | 1999 |
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach Ulcer; Time Factors | 1999 |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Penicillins; Ranitidine; Urea | 1999 |
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Severity of Illness Index; Sulfoxides; Treatment Outcome | 1999 |
One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 1999 |
Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Drug Utilization; Duodenal Ulcer; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Managed Care Programs; Omeprazole; Prospective Studies; Ranitidine; United States | 1999 |
The response of rosacea to eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nizatidine; Penicillins; Rosacea | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Time Factors; Tinidazole | 1999 |
Helicobacter pylori eradication: comparison of three treatment regimens in India.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Treatment Outcome | 1999 |
Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies | 1999 |
Effect of treatment of Helicobacter pylori infection on rosacea.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Rosacea | 1999 |
Seven days of ranitidine bismuth citrate plus two antimicrobials for Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Middle Aged; Ranitidine; Tinidazole; Treatment Outcome | 1999 |
H. pylori and nonulcer dyspepsia: not guilty as charged.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Treatment Failure | 1999 |
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline; Treatment Failure | 1999 |
Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ranitidine | 1999 |
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole | 1999 |
Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Primary Health Care | 1999 |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Single-Blind Method | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome | 1999 |
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Ethics, Medical; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Risk Factors; Stomach Neoplasms | 1999 |
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Ranitidine | 1999 |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 1999 |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Stomach Ulcer | 1999 |
Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome | 1999 |
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Smoking | 1999 |
Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Penicillins; Sulfoxides | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Peptic Ulcer; Prospective Studies; Statistics, Nonparametric; Sulfoxides; Treatment Failure | 1999 |
The OAC and OMC options.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Treatment Outcome | 1999 |
Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Multicenter Studies as Topic; Omeprazole; Proton Pump Inhibitors | 1999 |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ornidazole; Patient Dropouts; Random Allocation; Roxithromycin; Tinidazole; Turkey | 1999 |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Treatment Outcome | 1999 |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine; Turkey | 1999 |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 1999 |
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Humans; Omeprazole; Penicillins; Prognosis; Treatment Outcome | 1999 |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metronidazole; Middle Aged; Mouth; Omeprazole; Penicillins; Stomach | 1999 |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Contraindications; Drug Resistance, Microbial; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 1999 |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Sulfoxides | 1999 |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication].
Topics: Adult; Amoxicillin; Bismuth; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Wound Healing | 1999 |
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients.
Topics: Adult; Amoxicillin; Analysis of Variance; Body Mass Index; Breath Tests; Cholesterol; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Hemostasis; Humans; Lipids; Male; Middle Aged; Omeprazole; Tissue Plasminogen Activator | 1999 |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Brazil; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Time Factors | 1999 |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Esophagitis; Female; Food; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrins; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Penicillins; Polyethylene Glycols; Postprandial Period; Solvents | 1999 |
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Single-Blind Method; Time Factors; Treatment Outcome | 1999 |
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tinidazole; Treatment Outcome; Urea | 1999 |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Duodenum; Dyspepsia; Female; Gastritis; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Infusions, Intravenous; Male; Manometry; Middle Aged; Myoelectric Complex, Migrating; Stomach | 1999 |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Double-Blind Method; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Patient Compliance; Proton Pump Inhibitors; Quality Control; Sulfoxides; Treatment Outcome; Urea | 2000 |
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides | 2000 |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Prospective Studies; Ranitidine; Tinidazole; Urea | 2000 |
Efficacy of a multistep strategy for Helicobacter pylori eradication.
Topics: Algorithms; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole; Treatment Failure | 2000 |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Salvage Therapy | 2000 |
Furazolidone combination therapies for Helicobacter pylori infection in the United States.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Time Factors; United States | 2000 |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Asia; Breath Tests; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Risk Factors; Urea | 2000 |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asia, Southeastern; Biopsy; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method | 2000 |
Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 2000 |
Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Dental Plaque; DNA, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Mouth Mucosa; Omeprazole; Polymerase Chain Reaction; Saliva; Sensitivity and Specificity; Treatment Outcome; Urease | 2000 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bronchitis; Clarithromycin; Diarrhea; Digestive System; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides; Time Factors; Treatment Outcome | 2000 |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2000 |
Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peritoneal Dialysis, Continuous Ambulatory | 1999 |
[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 2000 |
Helicobacter pylori and its eradication in rosacea.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rosacea | 1999 |
Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole | 2000 |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Treatment Failure; Vomiting | 2000 |
One week triple therapy for Helicobacter pylori associated duodenal ulcer disease.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Retrospective Studies; Tinidazole; Treatment Outcome | 1999 |
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Family; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Stomach Neoplasms | 2000 |
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ornidazole; Penicillins; Peptic Ulcer; Treatment Outcome | 2000 |
Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Time Factors; Treatment Outcome | 2000 |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 2000 |
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Omeprazole; Prospective Studies | 2000 |
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Esophagitis, Peptic; Female; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 2000 |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Tinidazole | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Helicobacter; Helicobacter Infections; Ovariectomy; Ranitidine; Time Factors | 1999 |
Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2000 |
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Ranitidine; Sulfoxides; Treatment Outcome | 2000 |
Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; China; Clarithromycin; Drug Therapy, Combination; Ethnicity; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Likelihood Functions; Logistic Models; Malaysia; Male; Middle Aged; Omeprazole; Prospective Studies; Singapore | 2000 |
Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Double-Blind Method; Endoscopy, Gastrointestinal; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Sensitivity and Specificity | 2000 |
[Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 2000 |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Stomach Ulcer; Tinidazole; Treatment Outcome | 2000 |
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Omeprazole; Patient Compliance; Sex Factors; Stomach Neoplasms; Tinidazole; Treatment Outcome | 2000 |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2000 |
Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins | 2000 |
Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome | 2000 |
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma.
Topics: Adenoma; Aged; Aged, 80 and over; Amoxicillin; Carcinoma; Cell Transformation, Neoplastic; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Omeprazole; Probability; Reference Values; Statistics, Nonparametric; Stomach Neoplasms; Treatment Outcome | 2000 |
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 2000 |
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Endoscopy; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metaplasia; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 2000 |
[Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins | 2000 |
Dose-related stimulatory effect of clarithromycin on interdigestive gastroduodenal motility.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Duodenum; Female; Gastrointestinal Motility; Helicobacter Infections; Humans; Male; Manometry; Middle Aged | 2000 |
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
Topics: Adult; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Omeprazole; Peptic Ulcer; Quality of Life; Sickness Impact Profile; Tinidazole | 2000 |
Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Penicillins; Prospective Studies; Sensitivity and Specificity | 2000 |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer | 2000 |
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Aging; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Diseases; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Stomach Diseases; Sulfoxides | 2000 |
Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Rabeprazole; Treatment Outcome | 2000 |
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Regional Blood Flow; Smoking; Tranexamic Acid; Treatment Outcome | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Primary Health Care; Prospective Studies; Stomach Ulcer; Tetracycline; Time Factors | 2000 |
[Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Time Factors | 2000 |
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 2000 |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2000 |
Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Stomach; Sulfoxides; Time Factors | 2000 |
In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern.
Topics: Administration, Oral; Adult; Analysis of Variance; Biopsy, Needle; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Male; Manometry; Middle Aged; Omeprazole; Probability; Statistics, Nonparametric; Tinidazole; Urea | 2000 |
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Treatment Outcome | 2000 |
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors | 2000 |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Compliance; Peptic Ulcer; Prospective Studies; Urea | 2000 |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Radioisotopes; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides | 2000 |
Relationship between Helicobacter pylori and rosacea: it may be a myth.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cohort Studies; Erythema; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prevalence; Rosacea | 2000 |
Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Hong Kong; Humans; Omeprazole; Pakistan; Penicillins; South Africa; Taiwan; Treatment Outcome | 2000 |
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stereoisomerism | 2000 |
5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole | 2000 |
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Tinidazole | 2000 |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Agents; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2000 |
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Male; Omeprazole; Probiotics; Prospective Studies; Rabeprazole; Tinidazole; Treatment Outcome | 2001 |
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials.
Topics: Adult; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Prospective Studies; Protein Synthesis Inhibitors; Proton Pump Inhibitors | 2000 |
Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Sensitivity and Specificity; Tinidazole | 2001 |
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Diarrhea; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Sulfoxides; Taste Disorders; Tinidazole; Treatment Outcome | 2001 |
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole | 2000 |
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Synergism; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine | 2000 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Quinolones; Stomach; Time Factors | 2000 |
Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.
Topics: Animals; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Milk; Pyloric Antrum | 2001 |
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Ranitidine; Treatment Outcome; Urea | 2001 |
Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Rabeprazole; Treatment Outcome | 2001 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 2001 |
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Clarithromycin; Confidence Intervals; Culture Techniques; Drug Resistance, Microbial; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Prevalence; Probability; Risk Factors; Sex Distribution; Statistics, Nonparametric | 2000 |
[Usefulness of new triple therapy containing PPI].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors | 2001 |
Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Capsules; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tablets | 2001 |
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Omeprazole; Prognosis; Prospective Studies; Proton Pump Inhibitors; Time Factors | 2001 |
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Duodenal Ulcer; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Treatment Outcome | 2001 |
Comparison of two regimens on eradication of Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Tinidazole | 2000 |
A randomised trial of amoxycillin versus clarithromycin in combination with omeprazole for eradication of Helicobacter pylori infection in Singapore.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Penicillins; Singapore; Treatment Outcome | 2000 |
cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; Double-Blind Method; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Polymerase Chain Reaction; Sulfoxides; Treatment Outcome | 2001 |
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Penicillins; Peptic Ulcer; Time Factors; Treatment Failure | 2001 |
Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Omeprazole; Ranitidine; Treatment Outcome | 2001 |
Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.
Topics: Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Probability; Reference Values; Treatment Outcome | 2001 |
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Penicillins; Ranitidine; Veterans | 2001 |
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electrophoresis, Polyacrylamide Gel; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Isoenzymes; Lansoprazole; Membrane Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Prostaglandin-Endoperoxide Synthases | 2001 |
Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Fish Oils; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 2001 |
[The effect of cigarette smoking and alcohol consumption on efficacy of Helicobacter pylori eradication].
Topics: Adult; Alcohol Drinking; Amoxicillin; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Smoking; Tinidazole; Treatment Outcome | 2000 |
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pruritus; Ranitidine; Recurrence; Taste Disorders; Tinidazole; Treatment Outcome | 2001 |
Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Sucralfate; Treatment Outcome | 2001 |
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Recurrence; Treatment Outcome | 2001 |
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea | 2001 |
Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Aged, 80 and over; Aging; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2001 |
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Humans; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Smoking; Sulfoxides; Urea | 2001 |
Is a one-week course of triple anti-Helicobacter pylori therapy sufficient to control active duodenal ulcer?
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Placebos; Treatment Outcome | 2001 |
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 2001 |
Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Tetracycline | 2001 |
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polymerase Chain Reaction; Time Factors | 2001 |
Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Clarithromycin; Constipation; Diarrhea; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Kidney Failure, Chronic; Male; Middle Aged; Nausea; Omeprazole; Penicillins; Renal Dialysis; Treatment Outcome; Vomiting | 2001 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Urea | 2001 |
There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Pain Measurement; Penicillins; Quality of Life; Ranitidine; Treatment Outcome | 2001 |
Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Prospective Studies; Treatment Outcome; Urea; Urease | 2001 |
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome; Urea; Urease | 2001 |
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absenteeism; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Health Status; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Satisfaction; Penicillins; Referral and Consultation | 2001 |
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2000 |
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 2001 |
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 2001 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2001 |
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 2001 |
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1999 |
Efficacy of a nitroimidazole containing tripletherapy regime in Singapore.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitroimidazoles; Omeprazole; Singapore; Tinidazole | 2001 |
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.
Topics: Adult; Aged; Clarithromycin; Double-Blind Method; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Recurrence; Tinidazole | 2001 |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Administration, Oral; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Treatment Outcome; Urea | 2001 |
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Omeprazole; Peptic Ulcer | 2001 |
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Retrospective Studies | 2001 |
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies; Treatment Outcome | 2001 |
One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Time Factors; Treatment Outcome | 2001 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Metronidazole; Omeprazole; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2001 |
Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biological Transport, Active; Chromatography, High Pressure Liquid; Clarithromycin; Cross-Over Studies; Drug Synergism; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Time Factors | 2001 |
[Modern means of anti-Helicobacter therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Proton-Translocating ATPases; Rabeprazole | 2001 |
Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Treatment Outcome | 2001 |
Two new treatment regimens for Helicobacter pylori eradication: a randomised study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 2001 |
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sucralfate; Sulfoxides | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome | 2002 |
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Clarithromycin; Disulfides; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Sulfinic Acids | 2001 |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms | 2001 |
[Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Perforation; Prevalence; Stomach Ulcer; Suture Techniques; Treatment Outcome; Vietnam | 2002 |
Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Skin Diseases; Treatment Outcome | 2002 |
Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding.
Topics: Administration, Oral; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Recurrence; Treatment Outcome; Urea | 2002 |
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Tinidazole; Treatment Outcome; Urea | 2002 |
Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Recurrence | 2002 |
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Taiwan | 2002 |
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Omeprazole; Treatment Outcome | 2002 |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Topics: Adult; Aged; Amoxicillin; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chlorambucil; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Predictive Value of Tests; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2002 |
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Combinations; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Moxifloxacin; Omeprazole; Patient Compliance; Quinolines; Treatment Outcome | 2002 |
Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Treatment Outcome | 2002 |
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Omeprazole; Tetracycline; Treatment Failure | 2002 |
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Dyspepsia; Female; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Male; Markov Chains; Mass Screening; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk Factors; Tinidazole | 2002 |
Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen.
Topics: Adult; Aged; Amoxicillin; Biomarkers; Clarithromycin; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Lipids; Male; Middle Aged; Omeprazole; Risk Factors | 2002 |
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.
Topics: Adult; Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Smoking; Time Factors | 2002 |
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Canada; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Primary Health Care; Prospective Studies; Quality of Life; Treatment Outcome | 2002 |
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroesophageal Reflux; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Quality of Life; Urea | 2002 |
Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Treatment Outcome; Urea | 2002 |
Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors | 2002 |
[Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Candida albicans; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Escherichia coli; Esophagitis, Peptic; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Staphylococcus aureus; Sulfoxides | 2002 |
A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: study design and response rates of the Bristol Helicobacter Project.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dyspepsia; England; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Risk Factors; Socioeconomic Factors | 2002 |
1404 other study(ies) available for clarithromycin and Infections, Helicobacter
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Stability; Fluoroquinolones; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Ofloxacin; Quinolones; Solutions; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Drug Design; Erythromycin; Ethers; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Models, Chemical; Oximes | 2006 |
Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Curcumin; Helicobacter Infections; Helicobacter pylori; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Sequence Data; Stomach | 2009 |
Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colombia; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Tetracycline | 2009 |
Identification of 3',4',5'-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Line; Chalcones; Epithelial Cells; Gastritis; Helicobacter Infections; Helicobacter pylori; Host-Pathogen Interactions; Humans; Interleukin-8; NF-kappa B | 2010 |
Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Cell Adhesion; Cell Line; Epithelial Cells; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoblotting; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2012 |
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulcer; Enzyme Inhibitors; Gastritis; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Conformation; Stomach Neoplasms; Stomach Ulcer | 2014 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2021 |
Tailored eradication strategy
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea | 2021 |
Long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population-based cohort study.
Topics: Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged | 2021 |
Clinical audit of current
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Audit; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Singapore; Treatment Outcome | 2022 |
Keep an eye on the proton pump inhibitor.
Topics: Clarithromycin; Helicobacter Infections; Humans; Proton Pump Inhibitors | 2021 |
Vonoprazan-containing therapy has an
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |
Adaptation of an in-house PCR for the detection of Helicobacter pylori and the mutations associated with macrolide resistance into ready-to-use PCR microwell strips.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2021 |
Point Mutations at gyrA and gyrB Genes of Levofloxacin Resistant Helicobacter pylori Strains and Dual Resistance with Clarithromycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Point Mutation | 2021 |
Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Colitis, Ulcerative; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Recurrence | 2021 |
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastroenterologists; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Surveys and Questionnaires | 2022 |
Antibiotic resistances and eradication rates in Helicobacter pylori infection.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Retrospective Studies | 2021 |
Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2022 |
Comparison of Drug Resistance of Helicobacter pylori Between Children and Adults in Jilin, China.
Topics: Adult; Amoxicillin; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Child; China; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; RNA, Ribosomal, 16S; Tetracyclines | 2021 |
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Stomach; Stomach Neoplasms; Tinidazole | 2021 |
Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detection.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S | 2022 |
'Helicobacter pylori antimicrobial resistance in Melbourne, Australia. Time to review therapeutic guidelines?'
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans | 2021 |
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Penicillins; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Tetracycline | 2022 |
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high-migrant Singaporean cohort.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Transients and Migrants; Treatment Outcome | 2022 |
Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans | 2022 |
In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Biofilms; Biological Products; Catalytic Domain; Clarithromycin; Diosgenin; Drug Evaluation, Preclinical; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Binding; Protein Conformation; Pyrophosphatases; Virulence | 2021 |
Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2022 |
Genotypic detection of metronidazole and clarithromycin resistance in dyspeptic patients with helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole-genome sequencing-based study in Southern China.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S | 2022 |
Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans | 2022 |
Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori.
Topics: Anti-Bacterial Agents; Capsules; Clarithromycin; Drug Delivery Systems; Helicobacter Infections; Helicobacter pylori; Humans; Lipids; Nanocapsules; Research Design | 2022 |
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing.
Topics: Agar; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Identification of multiple single-nucleotide variants for clinical evaluation of Helicobacter pylori drug resistance.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Nucleotides | 2022 |
Geospatial analysis of Helicobacter pylori infection in South Australia: Should location influence eradication therapy?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; South Australia | 2022 |
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Stomach Neoplasms; Systematic Reviews as Topic; Treatment Failure | 2022 |
Second-line Therapy for Helicobacter Pylori Eradication: State of the Art.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2022 |
Risk factors of furazolidone-associated fever.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Retrospective Studies; Risk Factors; Treatment Outcome | 2022 |
Biofilm Formation of
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Microfluidics | 2022 |
Age of eradication and failure rates of clarithromycin-containing triple therapy for Helicobacter pylori: A 15-year population-based study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Retrospective Studies | 2022 |
Chemoenzymatic synthesis of an α-1,6-glucan-based conjugate vaccine against Helicobacter pylori.
Topics: Animals; Clarithromycin; Glucans; Glycoconjugates; Helicobacter Infections; Helicobacter pylori; Lipopolysaccharides; Mice; Rabbits; Vaccines, Conjugate | 2022 |
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Protein Synthesis Inhibitors; Tetracycline | 2022 |
Automation of RIDA®GENE Helicobacter pylori PCR on the BD MAX™ System.
Topics: Animals; Anti-Bacterial Agents; Automation; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Microbial Sensitivity Tests; Polymerase Chain Reaction; Scrapie; Sheep | 2022 |
Direct Detection of Antibiotic Resistance in Chinese
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2022 |
Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China.
Topics: Anti-Bacterial Agents; Child; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 23S | 2022 |
Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Family Practice; Helicobacter Infections; Helicobacter pylori; Humans; Prevalence; Refugees; United States | 2022 |
Kaempferol inhibits the growth of Helicobacter pylori in a manner distinct from antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Biological Products; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Kaempferols; Terpenes | 2022 |
Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Fosfomycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Rifampin | 2022 |
Octreotide-based therapies effectively protect mice from acute and chronic gastritis.
Topics: Animals; Clarithromycin; Ethanol; Gastric Mucosa; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Inflammation; Male; Mice; Mice, Inbred C57BL; Octreotide; Omeprazole | 2022 |
[Important rise in antibiotic resistance rates inHelicobacter pyloriin the Netherlands].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Netherlands; Retrospective Studies | 2022 |
Smart Gene™ as an effective non-invasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Point-of-Care Testing | 2022 |
Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin.
Topics: Clarithromycin; Delayed-Action Preparations; Esomeprazole; Excipients; Helicobacter Infections; Helicobacter pylori; Humans; Solubility; Tablets | 2022 |
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rifabutin; Treatment Outcome | 2022 |
A Survey of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests | 2022 |
The Activity of Liposomal Linolenic Acid Against
Topics: alpha-Linolenic Acid; Amoxicillin; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Liposomes; Metronidazole; Microbial Sensitivity Tests | 2022 |
[Personalized therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2022 |
Antimicrobial evaluation of the Cynara cardunculus extract in Helicobacter pylori cells using mid-infrared spectroscopy and chemometric methods.
Topics: Anti-Bacterial Agents; Chemometrics; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared | 2022 |
Accelerated cycling PCR: A novel tool for rapid, sensitive and specific detection of single-nucleotide mutation within 30 min.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Nucleotides; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2022 |
Recent trends in the antibiotic resistance of Helicobacter pylori in patient with dyspepsia.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Turkey | 2022 |
The Current Role of Vonoprazan in Helicobacter pylori Treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2022 |
Helicobacter pylori eradication in elderly patients: can we assume that a bismuth-based therapy is effective as in young people?
Topics: Adolescent; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2022 |
7-day versus 14-day tegoprazan-based triple therapy to treat Helicobacter pylori infection: Real-world evidence.
Topics: Amoxicillin; Anti-Bacterial Agents; Benzene Derivatives; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Potassium; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2022 |
Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
Role of Tegoprazan in
Topics: Amoxicillin; Anti-Bacterial Agents; Benzene Derivatives; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Proton Pump Inhibitors | 2022 |
Real-Time Polymerase Chain Reaction for the Detection of
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Prospective Studies; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2023 |
Clarithromycin-resistant H. pylori primary strains and virulence genotypes in the Northeastern region of Brazil.
Topics: Adult; Anti-Bacterial Agents; Brazil; Child; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Virulence | 2022 |
Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study in Ch
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Potassium; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Urease | 2022 |
Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2022 |
Letter: a promising Helicobacter pylori regimen-vonoprazan-based therapy. Author's reply.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2022 |
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole | 2022 |
Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Tibet | 2022 |
Comparative Study of Helicobacter Pylori Resistance to Clarithromycin and Metronidazole and Its Association with Epidemiological Factors in A Moroccan Population.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
Region-specific genomic signatures of multidrug-resistant Helicobacter pylori isolated from East and South India.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Genomics; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Phylogeny; Polymorphism, Single Nucleotide; Virulence Factors | 2022 |
Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2022 |
REAP-HP survey 2020: Comparing the real-world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastroenterologists; Helicobacter Infections; Helicobacter pylori; Humans; Motivation; Surveys and Questionnaires; Treatment Outcome | 2022 |
Effective Eradication Regimen and Duration According to the Clarithromycin Susceptibility of
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Multiplex Polymerase Chain Reaction; Oligonucleotides; Retrospective Studies | 2023 |
Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Proton Pump Inhibitors | 2023 |
Clinical effect of Anwei Qingyou recipe on peptic ulcer and its effect on the levels of EGF and PGE2: A retrospective study.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dinoprostone; Drug Therapy, Combination; Epidermal Growth Factor; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Retrospective Studies | 2022 |
Clinical evaluation of a novel molecular diagnosis kit for detecting Helicobacter pylori and clarithromycin-resistant using intragastric fluid.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2022 |
Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracyclines | 2022 |
Assessment of Helicobacter pylori positive infected patients according to Clarithromycin resistant 23S rRNA, rpl22 associated mutations and cyp2c19*1, *2, *3 genes pattern in the Early stage of Gastritis.
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Proton Pump Inhibitors; Ribosomal Proteins; RNA, Ribosomal, 23S | 2022 |
Effect of metronidazole resistance on Helicobacter pylori eradication regimens.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2022 |
Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Concentrating on the Long Topic of Empirical or Not Conventional Helicobacter pylori Eradication Regimens.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2023 |
Transcriptomic and Functional Approaches Unveil the Role of tmRNA in Zinc Acetate Mediated Levofloxacin Sensitivity in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Transcriptome; Zinc Acetate | 2022 |
Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2022 |
Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests | 2023 |
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Stomach Diseases; Treatment Outcome | 2023 |
Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; East Asian People; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Tailored Treatment Based on Helicobacter pylori Genetic Markers of Resistance Is Associated With Higher Eradication Success.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Genetic Markers; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Effectiveness and safety of high-dose dual therapy PPI-amoxicillin dual therapy for first-line Helicobacter pylori in Chile: Experience from the retrospective study.
Topics: Amoxicillin; Anti-Bacterial Agents; Chile; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Metronidazole; Penicillins; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Proton Pump Inhibitors | 2023 |
Geographic distribution of antibiotic resistance of Helicobacter pylori: A study in Bulgaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; COVID-19; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Pandemics | 2023 |
A real-world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin-containing therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Feasibility Studies; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Penicillins; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2023 |
Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Retrospective Studies; Switzerland; Tertiary Care Centers; Treatment Failure; Treatment Outcome | 2023 |
Antibiotic Resistance of
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline; Ulcer | 2022 |
Cost-Effectiveness of Vonoprazan-Based and Rifabutin-Based vs Other Regimens as First-Line Treatment of Helicobacter pylori Infection in the United States.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rifabutin; Treatment Outcome; United States | 2023 |
Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016-2019.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors | 2023 |
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Body Size; Body Weight; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Response to: a true point-of-care molecular testing method for tailored therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Diagnostic Techniques; Point-of-Care Systems; Proton Pump Inhibitors | 2023 |
A true point-of-care molecular testing method for tailored therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Molecular Diagnostic Techniques; Point-of-Care Systems; Proton Pump Inhibitors | 2023 |
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Tetracycline | 2023 |
Mistakes in the diagnosis and treatment of Helicobacter pylori infection in daily clinical practice.
Topics: Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Male; Urea | 2023 |
Helicobacter pylori Antimicrobial Resistance in a Pediatric Population From the New England Region of the United States.
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; New England; United States | 2023 |
Time trend prevalence of helicobacter pylori infection and endoscopic findings in symptomatic children in Portugal: A retrospective study based on three time points in 2009, 2014, and 2019.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Clarithromycin; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Portugal; Prevalence; Retrospective Studies | 2023 |
Considering the Long-Conflicting Topic of Empirical or Nonconventional
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2023 |
RIDA®GENE Helicobacter pylori PCR on the ELITe InGenius System.
Topics: Animals; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Microbial Sensitivity Tests; Polymerase Chain Reaction; Scrapie; Sheep | 2023 |
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S; Whole Genome Sequencing | 2023 |
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Middle Aged | 2023 |
Risk factors for adverse events in first-line Helicobacter pylori eradication therapy with vonoprazan, amoxicillin, and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Risk Factors; Treatment Outcome | 2023 |
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline | 2023 |
Long-Read- and Short-Read-Based Whole-Genome Sequencing Reveals the Antibiotic Resistance Pattern of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nucleotides; RNA, Ribosomal, 23S; Tetracycline | 2023 |
Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
RE: Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
In
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Antibiotic resistance characteristics and risk factors analysis of
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Risk Factors; Tetracycline | 2023 |
RELATIONSHIP OF HELICOBACTER PYLORI CAGA AND VACA STATUS TO MORPHOLOGICAL CHANGES OF GASTRIC MUCOSA AND PRIMARY CLARITHROMYCIN RESISTANCE RATE IN PATIENTS WITH CHRONIC GASTRITIS: A CROSS-SECTIONAL STUDY.
Topics: Atrophy; Bacterial Proteins; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation | 2023 |
Quantitative multiplex real-time polymerase chain reaction assay for the detection of Helicobacter pylori and clarithromycin resistance.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Multiplex Polymerase Chain Reaction; Oligonucleotides; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2023 |
Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Serbia; Tetracycline; Treatment Outcome | 2023 |
Susceptibility patterns and virulence genotypes of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Egypt; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Virulence | 2023 |
Can the optimal treatment duration be determined in bismuth-containing therapies for Helicobacter pylori eradication?
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duration of Therapy; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome | 2023 |
Molecular detection of Helicobacter pylori and its genotypic antimicrobial resistance patterns in dyspeptic Mozambican patients.
Topics: Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Mozambique; RNA, Ribosomal, 23S | 2023 |
Diagnostic and Treatment Practices for Helicobacter Pylori Infection in an Academic Pediatric Hospital.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hospitals, Pediatric; Humans; Metronidazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Treatment Outcome | 2023 |
Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline | 2023 |
Pyrosequencing analysis for rapid and accurate detection of clarithromycin resistance-associated mutations in Iranian Helicobacter pylori isolates.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Iran; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2023 |
Surveillance of Helicobacter pylori resistance over 22 Years (2000-2021) in Northern Spain.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Spain | 2023 |
Artesunate Dry Emulsion Formulation Combined with Antibiotics for Treatment of
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Artesunate; Clarithromycin; Drug Therapy, Combination; Emulsions; Helicobacter Infections; Helicobacter pylori; Rats | 2023 |
Antibiotic resistance profile of
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2023 |
Physiologically based pharmacokinetic modeling to assess the drug-drug interactions of anaprazole with clarithromycin and amoxicillin in patients undergoing eradication therapy of H. pylori infection.
Topics: Amoxicillin; Clarithromycin; Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Models, Biological | 2023 |
Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Southeast Asian People; Tetracycline | 2023 |
Roles of Lipopolysaccharide Glycosyltransferases in Maintenance of
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Wall; Clarithromycin; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Metronidazole; Microbial Sensitivity Tests; Permeability; Rifampin | 2023 |
Research trends on vonoprazan-based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Helicobacter pylori Antimicrobial Resistance Using Next-Generation Sequencing in Stool Samples in a Pediatric Population.
Topics: Agar; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Metronidazole; Microbial Sensitivity Tests | 2023 |
Efficacy and safety of vonoprazan-based dual therapy and esomeprazole-based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Propensity Score; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome; Young Adult | 2023 |
Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction | 2023 |
A comprehensive study of Helicobacter pylori infection: molecular analysis, antibacterial susceptibility, and histopathological examination.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2023 |
Urolithin B alleviates Helicobacter pylori-induced inflammation and oxidative stress in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Metronidazole; Mice; Oxidative Stress | 2023 |
Real-world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia.
Topics: Amoxicillin; Anti-Bacterial Agents; Asia, Southeastern; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Physicians; Proton Pump Inhibitors; Surveys and Questionnaires | 2023 |
Antibiotic-Resistant Strains of Helicobacter pylori in 50 Antibiotic Treatment-Naive Children in Northeast Poland Diagnosed by Gastric or Duodenal Biopsy Between February 2019 and May 2022.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Poland | 2023 |
Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Curcumin; Helicobacter Infections; Helicobacter pylori; Mice; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared | 2023 |
Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Croatia; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Docking Simulation; RNA, Ribosomal, 23S | 2023 |
Helicobacter pylori Empirical and Tailored Eradication Therapy and Factors Influencing Eradication Rate: a 4-Year Single-Center Study.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Retrospective Studies; Treatment Outcome | 2023 |
The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance.
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies | 2023 |
Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Retrospective Studies | 2023 |
High incidence of antibiotic resistance amongst isolates of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; United Kingdom | 2023 |
The epidemiology of Helicobacter pylori resistance in a university affiliated hospital: a comparison between two time periods-a cross-sectional design.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Hospitals; Humans; Metronidazole; Microbial Sensitivity Tests; Universities | 2023 |
Molecular characterization of Helicobacter pylori isolated from Nile Tilapia (Oreochromis niloticus) and fish handlers.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cichlids; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Phylogeny | 2023 |
Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Failure | 2023 |
Empiric Versus Resistance-Guided Therapy in Obese Patients with Helicobacter Pylori Infection.
Topics: Clarithromycin; Consensus; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Obesity, Morbid | 2019 |
Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atherosclerosis; Cholesterol, HDL; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Metabolism; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2019 |
Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2020 |
Treating Helicobacter pylori infection in the face of growing antibiotic resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2019 |
Effects of anti-H. pylori triple therapy and a probiotic complex on intestinal microbiota in duodenal ulcer.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bacillus subtilis; Biodiversity; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enterococcus faecium; Female; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Probiotics; Proton Pump Inhibitors | 2019 |
Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Republic of Korea; Young Adult | 2019 |
Mutations in the Helicobacter pylori 23S rRNA gene associated with clarithromycin resistance in patients at an endoscopy unit in Medellín, Colombia
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Colombia; Cross-Sectional Studies; Drug Resistance, Bacterial; Dyspepsia; Female; Gastritis; Genes, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mutation, Missense; Point Mutation; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Young Adult | 2019 |
Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Colombia; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Gastroscopy; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2019 |
Eradicating H. pylori.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Drug Therapy, Combination; Esophageal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Mortality; Myocardial Infarction; Patient Selection; Practice Guidelines as Topic; Quinolones; Risk; Risk Assessment; Stomach Neoplasms; United States | 2019 |
Histological changes in refractory Helicobacter pylori infection and its relationship with increased levels of resistance to antibiotics and therapeutic regimens: one-year follow-up.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Biopsy; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histological Techniques; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Stomach | 2020 |
Molecular detection of
Topics: Animals; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Scrapie; Sheep | 2021 |
Planning mass eradication of Helicobacter pylori infection for indigenous Taiwanese peoples to reduce gastric cancer.
Topics: Areca; Clarithromycin; Cost of Illness; Drug Therapy, Combination; Gastritis; Healthcare Disparities; Helicobacter Infections; Helicobacter pylori; Incidence; Indigenous Peoples; Prevalence; Risk Factors; Smoking; Stomach Neoplasms; Taiwan | 2020 |
Polysorbate 80 add-on therapy in the treatment of Helicobacter pylori infection: Polysorbate 80 and HP antibiotic resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Polysorbates | 2019 |
Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Young Adult | 2020 |
Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept.
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged | 2020 |
First Detection in
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter heilmannii; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mutation | 2020 |
Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Self Report; Young Adult | 2019 |
Vonoprazan-Based Triple-Therapy Could Improve Efficacy of the Tailored Therapy of Helicobacter pylori Infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2019 |
Development of a high throughput human stool specimen processing method for a molecular Helicobacter pylori clarithromycin resistance assay.
Topics: Anti-Bacterial Agents; Body Fluids; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Genotype; Helicobacter Infections; Helicobacter pylori; High-Throughput Screening Assays; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2019 |
Which should be the first-line treatment for Helicobacter pylori in Colombia? A lesson from a recent study.
Topics: Anti-Bacterial Agents; Clarithromycin; Colombia; Drug Combinations; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Point Mutation; Tetracycline | 2019 |
[Dual therapy with rabeprazole and amoxicillin four times daily for 14 days for the first-line eradication of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2019 |
Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease.
Topics: Cholangitis; Clarithromycin; Cohort Studies; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2020 |
Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Erythema Multiforme; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sex Factors; Stevens-Johnson Syndrome; Sulfonamides | 2020 |
Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mutation | 2020 |
Letter in response to
Topics: Clarithromycin; Female; Habits; Helicobacter Infections; Helicobacter pylori; Humans | 2020 |
Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Mutation; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Sensitivity and Specificity | 2020 |
[Helicobacter pylori infection in the HIV + population: a comorbidity to think about].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Ulcer Agents; Clarithromycin; Comorbidity; Drug Therapy, Combination; Dyspepsia; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Spain | 2020 |
Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies | 2020 |
A Never Ending Case of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Hypersensitivity; Drug Resistance, Bacterial; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Penicillins; Skin Tests; Treatment Outcome | 2020 |
Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Child; China; Clarithromycin; Cross-Sectional Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors | 2020 |
Evaluation of Mutations in 23S rRNA, rdxA and frxA Genes of Helicobacter pylori in Paraffin-Embedded Gastric Biopsy Specimens from Iranian Gastric Cancer and Gastritis Patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Molecular Epidemiology; Mutation; Nitroreductases; Retrospective Studies; RNA, Ribosomal, 23S; Stomach Neoplasms | 2021 |
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Hypersensitivity; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Registries; Tetracycline | 2020 |
Genetic Antibiotic Resistance of Helicobacter pylori in South-Eastern Romania.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Romania; Stomach | 2020 |
[Helicobacter pylori infection. Frequency of first-line treatment failure].
Topics: Amoxicillin; Anti-Bacterial Agents; Argentina; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2020 |
Response to the Letter to the Editor entitled "Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment Consensuses: A poor or a proper match?"
Topics: Clarithromycin; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2020 |
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study.
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Case-Control Studies; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Treatment Outcome | 2020 |
The Relationship between the Sydney Classification and the First-Line Treatment Efficacy in Helicobacter-Associated Gastritis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Middle Aged; Pantoprazole; Severity of Illness Index | 2020 |
Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2020 |
Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors.
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Peptic Ulcer; Tetracycline; Vietnam | 2020 |
Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bhutan; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Prevalence; Tetracycline | 2020 |
Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Blood Platelets; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2020 |
Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Chromatography, High Pressure Liquid; Clarithromycin; Cytokines; DNA, Bacterial; Drug Evaluation, Preclinical; Flowers; Gastric Mucosa; Gastritis; Glycyrrhiza; Helicobacter Infections; Helicobacter pylori; Immunoglobulin G; Male; Mice; Mice, Inbred C57BL; Monoterpenes; Omeprazole; Pinus; Plant Extracts; Specific Pathogen-Free Organisms | 2020 |
Helicobacter pylori Infection in Pediatric Patients Living in Europe: Results of the EuroPedHP Registry 2013 to 2016.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Registries; Turkey | 2020 |
Apparent Intracellular Helicobacter pylori Detected by Immunohistochemistry: The Missing Link in Eradication Failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Metronidazole; Proton Pump Inhibitors | 2021 |
High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Vietnam | 2020 |
[European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow].
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Moscow; Prospective Studies; Proton Pump Inhibitors; Registries; Russia | 2020 |
[Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β].
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors | 2019 |
Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Pharmaceutical Preparations; Rifabutin; Treatment Outcome | 2020 |
Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
Topics: Adolescent; Anti-Bacterial Agents; Bismuth; Child; Clarithromycin; Cross-Sectional Studies; Drug Hypersensitivity; Dysbiosis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors | 2020 |
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Students; Sulfonamides; Treatment Outcome | 2020 |
Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.
Topics: Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Mutation; Phylogeny; RNA, Ribosomal, 23S | 2020 |
Characteristics of Helicobacter pylori strains isolated from Mauritanian patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Bacterial; Bacterial Proteins; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mauritania; Middle Aged; Virulence Factors; Young Adult | 2020 |
Helicobacter pylori and antibiotic resistance in the pediatric population: an update from Vietnam.
Topics: Amoxicillin; Bismuth; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Probiotics; Proton Pump Inhibitors; Vietnam | 2020 |
Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori-infected subjects before and 2 years after a single eradication event.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Helicobacter Infections; Humans; Latvia; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors | 2020 |
High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prevalence; Prospective Studies; Risk Factors | 2020 |
[More importance should be attached to appropriate application of antibiotics in the treatment of
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans | 2020 |
[Several issues on amoxicillin in
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2020 |
The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Escherichia coli; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Ribosomes; RNA, Ribosomal, 23S | 2020 |
CRHP Finder, a webtool for the detection of clarithromycin resistance in Helicobacter pylori from whole-genome sequencing data.
Topics: Anti-Bacterial Agents; Clarithromycin; Denmark; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Software | 2020 |
[Helicobacter pylori infection in children].
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2020 |
Validation of loop-mediated isothermal amplification to detect Helicobacter pylori and 23S rRNA mutations: A prospective, observational clinical cohort study.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Point Mutation; Prospective Studies; Reproducibility of Results; RNA, Ribosomal, 23S; Sensitivity and Specificity | 2021 |
Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Current status of
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Risk Factors | 2020 |
Rifabutin triple therapy increased
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Patients; Rifabutin | 2020 |
Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome; Young Adult | 2020 |
Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by
Topics: Amoxicillin; Animals; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Mice; Proton Pump Inhibitors; Rabeprazole; Sucralfate | 2020 |
Efficacy of a novel sequential treatment regimen containing bismuth for Helicobacter pylori eradication in Turkish children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Outcome; Turkey | 2020 |
Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2020 |
Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies; Body Mass Index; Clarithromycin; Confidence Intervals; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Middle Aged; Odds Ratio; Parietal Cells, Gastric; Precancerous Conditions; Proton Pump Inhibitors; Retrospective Studies; Smoking; Stomach | 2021 |
Antimicrobial resistance of Helicobacter pylori in an eastern German region.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests | 2021 |
High Metronidazole and Clarithromycin Resistance of Helicobacter Pylori Isolated from Previously Treated and Naïve Patients.
Topics: Academic Medical Centers; Adult; Chi-Square Distribution; Clarithromycin; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Statistics, Nonparametric | 2020 |
Eradication therapy for Helicobacter pylori infection based on the antimicrobial susceptibility test in children: A single-center study over 12 years.
Topics: Anti-Bacterial Agents; Breath Tests; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2021 |
Survey of the antimicrobial resistance of Helicobacter pylori in France in 2018 and evolution during the previous 5 years.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; France; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin | 2021 |
Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Health Plan Implementation; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Registries; Slovenia | 2021 |
Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Pilot Projects; Prospective Studies | 2021 |
Antibacterial action of acriflavine hydrochloride for eradication of the gastric pathogen Helicobacter pylori.
Topics: Acriflavine; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Mice; Microbial Sensitivity Tests; Treatment Outcome | 2020 |
Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Indicators and Reagents; Japan; Microbial Sensitivity Tests | 2020 |
Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional Study.
Topics: Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Virulence | 2021 |
[Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Russia | 2020 |
[European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors; Registries | 2020 |
Adherence to Maastricht V/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Croatia; Cross-Sectional Studies; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Physicians, Primary Care; Proton Pump Inhibitors; Students, Medical | 2021 |
Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; Retrospective Studies; RNA, Ribosomal, 23S; Treatment Outcome | 2021 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests | 2020 |
The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Proton Pump Inhibitors; Rats, Sprague-Dawley; Rifampin; Stomach Ulcer | 2021 |
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Proton Pump Inhibitors; Registries | 2022 |
Dual Clarithromycin and Metronidazole Resistance Is the Main Cause of Failure in Ultimate Helicobacter pylori Eradication.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2021 |
European Registry on Helicobacter pylori management (Hp-EuReg): First-line Therapy in Israel.
Topics: Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Medication Adherence; Middle Aged; Proton Pump Inhibitors; Registries; Retreatment; Treatment Outcome | 2021 |
Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Phylogeny | 2021 |
Antimicrobial resistance of
Topics: Anti-Bacterial Agents; Belgium; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin | 2022 |
Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 23S; Sudan | 2021 |
Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Retrospective Studies | 2021 |
Complete symptom resolution as predictor of Helicobacter pylori eradication and factors affecting symptom resolution: Prospective follow up study.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Ethiopia; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Medicine, Traditional; Middle Aged; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Young Adult | 2021 |
Development, synthesis, and biological evaluation of sulfonyl-α-l-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors.
Topics: Amino Acids; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Discovery; Drug Synergism; Enzyme Inhibitors; Guanine Nucleotides; Helicobacter Infections; Helicobacter pylori; Humans; IMP Dehydrogenase; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Biosynthesis; Structure-Activity Relationship; Sulfonamides | 2021 |
Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rhode Island; Rifabutin; Tetracycline; Young Adult | 2021 |
Impact of body size on first-line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Body Size; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2021 |
Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients.
Topics: Aged; Anti-Bacterial Agents; Chile; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence | 2021 |
Preliminary single-center experience of Helicobacter pylori eradication among the liver transplant recipients.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Liver Transplantation; Transplant Recipients | 2021 |
Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Chinese Herbal; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2021 |
Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin; Turkey; Young Adult | 2021 |
Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study.
Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; RNA, Bacterial; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S | 2021 |
Molecular-based Helicobacter pylori Susceptibility Testing Is Almost Ready for Prime Time.
Topics: Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans | 2021 |
[Helicobacter pylori: When to look for an infection and treat it in adults?]
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2021 |
Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Treatment Outcome | 2021 |
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Sex Factors; Young Adult | 2021 |
Changes of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Positron-Emission Tomography; Stomach; Stomach Neoplasms; Tomography | 2021 |
Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Retrospective Studies | 2022 |
Culture-Based Antimicrobial Susceptibility Testing for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin | 2021 |
Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Prevalence; Retrospective Studies; Risk Factors; Sex Factors; Young Adult | 2021 |
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.
Topics: Amoxicillin; Anti-Bacterial Agents; Beijing; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies | 2021 |
Construction of metronidazole capped in gold nanoparticles against
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gold; Helicobacter Infections; Helicobacter pylori; Humans; Metal Nanoparticles; Metronidazole; Microbial Sensitivity Tests | 2021 |
Can Helicobacter pylori eradication affect long-term mortality?
Topics: Clarithromycin; Diabetes Mellitus, Type 2; Helicobacter Infections; Helicobacter pylori; Humans | 2021 |
Helicobacter pylori Antibiotic Resistance: Stewardship, Tailored Therapies, and Future Perspectives.
Topics: Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans | 2021 |
Impact of Vonoprazan Triple-Drug Blister Packs on H. pylori Eradication Rates in Japan: Interrupted Time Series Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Interrupted Time Series Analysis; Japan; Pharmaceutical Preparations; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2021 |
Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Republic of Korea | 2021 |
Genotyping Helicobacter pylori antibiotic resistance and virulence-associated genes in patients with gastric cancer in Wenzhou, China.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Stomach Neoplasms; Virulence | 2021 |
Unacceptable Antibiotic Resistance Rates for Helicobacter pylori in Turkey: Something Must Change.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Turkey; Urease | 2021 |
Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV-positive than HIV-negative individuals: A descriptive observational study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2021 |
Antimicrobial Resistance and the Successful Eradication of
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2021 |
Early genetic diagnosis of clarithromycin resistance in
Topics: Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Early Diagnosis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 23S | 2021 |
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2021 |
Benefits of a Molecular-Based Method for the Detection of Clarithromycin-Resistant
Topics: Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans | 2021 |
Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant
Topics: Anti-Bacterial Agents; Bacterial Load; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prognosis; Retrospective Studies | 2021 |
Helicobacter pylori eradication with a clarithromycin-based triple therapy in elderly patients.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Retrospective Studies | 2021 |
10-Day and 14-day high-dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Propensity Score; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2021 |
Screening for Helicobacter pylori infection and Clarithromycin resistance using Real-Time Polymerase Chain Reaction.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Real-Time Polymerase Chain Reaction | 2021 |
Favorable outcomes of rescue second- or third-line culture-based Helicobacter pylori eradication treatment in areas of high antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Low Adherence to Society Guidelines for the Management of Helicobacter Pylori Among Pediatric Gastroenterologists.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Gastroenterologists; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Retrospective Studies | 2021 |
Clarithromycin resistance in Helicobacter pylori and its molecular determinants in Northern Spain, 2013-2015.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Infant, Newborn; Intestinal Mucosa; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Spain; Young Adult | 2017 |
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyloric Antrum; Stomach | 2017 |
Smoking increases the likelihood of Helicobacter pylori treatment failure.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Case-Control Studies; Clarithromycin; Cross-Sectional Studies; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Sex Factors; Smoking; Social Class; Treatment Failure | 2017 |
Antibiotic susceptibility of Helicobacter pylori in Iceland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iceland; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Young Adult | 2017 |
Gastrointestinal: Idiopathic granulomatous gastritis observed by magnifying narrow-band imaging endoscopy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Narrow Band Imaging; Rabeprazole; Stomach Diseases | 2017 |
Clarithromycin-Induced Mania after Triple Therapy for the Eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Antipsychotic Agents; Bipolar Disorder; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans | 2016 |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Dog Diseases; Dogs; Gastric Mucosa; Gastritis; Gastrointestinal Hormones; Gene Expression; Helicobacter Infections; Peptide Hormones; Real-Time Polymerase Chain Reaction; Stomach | 2017 |
A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2017 |
The diagnosis and management of H. pylori infection in Singapore.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Singapore | 2017 |
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Young Adult | 2017 |
The "report card" to grade H. Pylori treatment regimens: is it achievable in real-world in areas with high clarithromycin resistance?
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Decision-Making; Drug Resistance, Bacterial; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Treatment Outcome | 2017 |
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Austria; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Genes, Bacterial; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Histocytochemistry; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Real-Time Polymerase Chain Reaction; Young Adult | 2018 |
Antibiotic susceptibility of Helicobacter pylori strains isolated from Iranian children: High frequency of A2143G point mutation associated with clarithromycin resistance.
Topics: Adolescent; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Prevalence; RNA, Ribosomal, 23S | 2017 |
Secondary antibiotic resistance of Helicobacter pylori isolates in Israeli children and adults.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline; Young Adult | 2017 |
Impact of health insurance coverage for
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Gastritis; Health Policy; Helicobacter Infections; Helicobacter pylori; Humans; Insurance Coverage; Insurance, Health; Japan; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies | 2017 |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2017 |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2017 |
Micromotor-enabled active drug delivery for in vivo treatment of stomach infection.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Delivery Systems; Drug Therapy, Combination; Gastric Dilatation; Helicobacter Infections; Helicobacter pylori; Magnesium; Mice; Nanotechnology; Proton Pump Inhibitors | 2017 |
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Failure; Treatment Outcome | 2017 |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Tetracycline | 2017 |
Clarithromycin-based therapy of Helicobacter pylori in Iran.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Iran | 2017 |
Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2017 |
Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.
Topics: Abdominal Pain; Adult; Aged; Clarithromycin; Colchicine; Drug Interactions; Familial Mediterranean Fever; Female; Helicobacter Infections; Humans; Middle Aged; Retrospective Studies; Rhabdomyolysis | 2018 |
Enrichment of Helicobacter pylori mutant strains after eradication therapy analyzed by gastric wash-based quantitative pyrosequencing.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Fluids; Clarithromycin; DNA, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Neoplasms; Therapeutic Irrigation | 2017 |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2018 |
Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Helicobacter Infections; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Stroke; Time Factors; United Kingdom | 2018 |
GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones.
Topics: Adult; Anti-Bacterial Agents; Bacteriological Techniques; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histocytochemistry; Humans; Male; Mass Screening; Molecular Diagnostic Techniques | 2017 |
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Consensus; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Proton Pump Inhibitors; Young Adult | 2018 |
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Laboratory Services; Drug Resistance, Bacterial; Gastroenterologists; Helicobacter Infections; Helicobacter pylori; Humans; Intersectoral Collaboration; Treatment Outcome; World Health Organization | 2017 |
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Databases, Factual; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Incidence; Male; Middle Aged; Proton Pump Inhibitors; Risk Assessment; Stomach Neoplasms | 2018 |
A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Neoplasms | 2018 |
Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Prospective Studies | 2017 |
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study.
Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Risk Factors | 2018 |
Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Hospitals; Humans; Macrolides; Male; Middle Aged; Retrospective Studies; Spain; Treatment Failure; Young Adult | 2018 |
Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction.
Topics: Antigens, Bacterial; Bacterial Proteins; Child; Clarithromycin; Drug Resistance, Bacterial; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Prevalence; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sensitivity and Specificity; Urease | 2018 |
Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medical Records, Problem-Oriented; Metronidazole; Middle Aged; Probiotics; Proton Pump Inhibitors; Republic of Korea; Retrospective Studies; Treatment Outcome | 2018 |
Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Failure; Young Adult | 2018 |
Helicobacter pylori resistance in the Netherlands: a growing problem?
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Netherlands; Tetracycline | 2017 |
Time to Make a Change in the Cutoff Value of Clarithromycin Resistance in the Treatment of Helicobacter pylori Infection.
Topics: Clarithromycin; Drug Resistance, Bacterial; Growth Hormone; Helicobacter Infections; Helicobacter pylori; Humans; Peptide Fragments | 2018 |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.
Topics: Adult; Aged; Aspirin; Chemoprevention; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Remission Induction; Risk Factors; Stomach Neoplasms | 2018 |
Helicobacter pylori eradication: poor medical compliance from East to West of the world.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2018 |
High frequency of metronidazole and clarithromycin-resistant Helicobacter pylori in formalin-fixed, paraffin-embedded gastric biopsies.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Formaldehyde; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Mutation; Nitroreductases; Paraffin Embedding; Stomach | 2018 |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2018 |
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Treatment Outcome | 2018 |
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Incidence; Levofloxacin; Male; Middle Aged; Protective Factors; Proton Pump Inhibitors; Registries; Retrospective Studies; Risk Factors; Stomach Neoplasms | 2018 |
Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, rRNA; Genotype; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Mutation; Phenotype; RNA, Ribosomal, 23S; Whole Genome Sequencing | 2018 |
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2018 |
Evaluation of Helicobacter pylori Infection and Clarithromycin Resistance in Strains From Symptomatic Colombian Children.
Topics: Adolescent; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Colombia; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Prevalence; Stomach | 2018 |
Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
Topics: Adult; Algeria; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Tetracycline | 2018 |
Helicobacter pylori in esplenectomized patients with immune primary trombocytopenia
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Platelet Count; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Treatment Outcome | 2017 |
Eradication of Helicobacter pylori infection was associated with complete cure of resistant bleeding per gums.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomatognathic Diseases | 2018 |
Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2018 |
Editorial: Helicobacter pylori resistance and sequential therapy.
Topics: Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans | 2018 |
[Phylogenetic study of drug resistance genes from clinical isolates of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Phylogeny; Tetracycline; Tibet | 2018 |
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell; Metronidazole; Middle Aged; Organometallic Compounds; Rabeprazole; Salicylates | 2018 |
Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Pharmacogenomic Variants; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure | 2019 |
Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chile; Clarithromycin; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mutation; Nitroreductases; Prevalence; Real-Time Polymerase Chain Reaction | 2018 |
Droplet Digital PCR-Based Detection of Clarithromycin Resistance in Helicobacter pylori Isolates Reveals Frequent Heteroresistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Feces; Female; Gastric Mucosa; Genetic Variation; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2018 |
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides | 2018 |
Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Clarithromycin; Cost-Benefit Analysis; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Precision Medicine; RNA, Ribosomal, 23S; Young Adult | 2019 |
An Economic Modeling Study of
Topics: Aged; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cost-Benefit Analysis; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multiplex Polymerase Chain Reaction; Oligonucleotides; Treatment Outcome | 2018 |
Peptide Nucleic Acid Probe-Based Analysis as a New Detection Method for Clarithromycin Resistance in
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptide Nucleic Acids; Point Mutation; Republic of Korea | 2018 |
Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2018 |
Helicobacter pylori antimicrobial resistance in a pediatric population.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Prospective Studies | 2018 |
Characterization of clarithromycin heteroresistance among Helicobacter pylori strains isolated from the antrum and corpus of the stomach.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach; Young Adult | 2019 |
Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication: A prospective, observational study.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Point Mutation; Prospective Studies; RNA, Bacterial; RNA, Ribosomal, 23S | 2018 |
[Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2018 |
Smoking and Drinking Did Not Increase the Failure of Therapeutic Helicobacter pylori Eradication by Vonoprazan, Clarithromycin, and Amoxicillin.
Topics: Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Smoking; Sulfonamides; Treatment Failure | 2019 |
Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Point Mutation; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Vietnam; Young Adult | 2019 |
Antibiotic Resistance Is the Key Element in Treatment of Helicobacter pylori Infection.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans | 2018 |
Efficacy of standard triple therapy versus Levofloxacin based alternate therapy against Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Comparative Effectiveness Research; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Pakistan; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2018 |
The Resistance Rate of Helicobacter Pylori to Clarithromycin and Main Mutations on Bacterial Genomic Responsible for Bacterial Resistance: A Comparative Study in Children and Adults, Tehran and Iran.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Genome, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; RNA, Ribosomal, 23S; Young Adult | 2019 |
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2018 |
Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.
Topics: Aged; Anti-Bacterial Agents; Blood Glucose; Clarithromycin; Cohort Studies; Diabetes Mellitus; Drug Therapy, Combination; Female; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Propensity Score; Proportional Hazards Models; Risk Factors; Stomach Neoplasms; Time Factors | 2019 |
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
Topics: Adult; Alcohol Drinking; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bismuth; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Proton Pump Inhibitors; Treatment Failure | 2018 |
Low-level primary clarithromycin resistance of Helicobacter pylori in Burkina Faso: A prospective molecular study.
Topics: Burkina Faso; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 23S | 2019 |
Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mutation; Peru; Prevalence; RNA, Ribosomal, 23S; Rural Population | 2018 |
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2019 |
Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Child; Child, Preschool; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Middle Aged; Molecular Diagnostic Techniques; Mutation; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sensitivity and Specificity; Stomach | 2019 |
How and when investigating and treating Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Incidental Findings; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Tinidazole | 2018 |
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Proton Pump Inhibitors; Registries | 2018 |
Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2019 |
Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Point Mutation; Polymorphism, Restriction Fragment Length; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Turkey; Young Adult | 2019 |
Gastric juice-based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bacterial Load; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity; Stomach; Treatment Failure | 2019 |
[Amoxicillin-Clarithromycin-Containing Bismuth Quadruple Therapy for Primary Eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome | 2019 |
[Eradication Rates of 10-day Sequential Therapy for
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Republic of Korea; Tertiary Care Centers; Treatment Outcome | 2019 |
Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real-time PCR.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastric Mucosa; Gene Amplification; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Real-Time Polymerase Chain Reaction | 2019 |
Effect of Helicobacter pylori Treatment on Unexplained Iron Deficiency Anemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; California; Causality; Clarithromycin; Cohort Studies; Comorbidity; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Young Adult | 2019 |
Helicobacter pylori resistance to clarithromycin and fluoroquinolones in a pediatric population in Turkey: A cross-sectional study.
Topics: Adolescent; Anti-Bacterial Agents; Biopsy; Child; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Stomach; Turkey | 2019 |
Digoxin toxicity precipitated by Helicobacter pylori eradication therapy.
Topics: Acute Kidney Injury; Aged, 80 and over; Amoxicillin; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Atrial Fibrillation; Bradycardia; Bundle-Branch Block; Clarithromycin; Digoxin; Drug Interactions; Electrocardiography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyperkalemia; Immunoglobulin Fab Fragments; Omeprazole; Tachycardia, Ventricular | 2019 |
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Registries; Treatment Outcome; Young Adult | 2020 |
Molecular diagnosis of Helicobacter pylori antibiotic resistance in the Taif region, Saudi Arabia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Cohort Studies; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Nitroreductases; Pathology, Molecular; Prevalence; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Saudi Arabia; Tetracycline; Young Adult | 2019 |
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Republic of Korea; Tetracycline; Young Adult | 2019 |
Refractory Helicobacter pylori gastritis: The hidden predictors of resistance.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymorphism, Restriction Fragment Length; Risk Factors; RNA, Ribosomal, 23S; Salvage Therapy | 2019 |
Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Quinolones; Tanzania; Tertiary Care Centers; Treatment Failure; Young Adult | 2019 |
Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
Topics: Anti-Bacterial Agents; Clarithromycin; Dysbiosis; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Time Factors | 2019 |
Endoscopic and Histological Findings among Israeli Populations Infected with Helicobacter pylori: Does Ethnicity Matter?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Arabs; Biopsy; Clarithromycin; Demography; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Jews; Male; Middle Aged; Risk Factors; Socioeconomic Factors | 2019 |
Population-level macrolide consumption is associated with clarithromycin resistance in Helicobacter pylori: An ecological analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides | 2019 |
Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Amoxicillin; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prevalence; Treatment Outcome | 2019 |
Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Risk Factors; Sex Factors; Tetracycline; Young Adult | 2020 |
Genotypic determination of resistance and heteroresistance to clarithromycin in Helicobacter pylori isolates from antrum and corpus of Colombian symptomatic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Clarithromycin; Colombia; Drug Resistance, Bacterial; Female; Genotype; Genotyping Techniques; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Prevalence; Pyloric Antrum; Stomach; Young Adult | 2019 |
Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Databases, Factual; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Risk Factors; Sensitivity and Specificity; Treatment Failure; Young Adult | 2019 |
A Triple-Drug Blister-Packaged Drug with Vonoprazan Improves First-Line Eradication of Helicobacter pylori in Elderly Patients: A Retrospective Propensity Score-Matched Cohort Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Packaging; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Propensity Score; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Young Adult | 2020 |
Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Infant; Infant, Newborn; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; Taiwan; Tertiary Care Centers | 2019 |
Diabetes Increases Risk of Gastric Cancer After
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Diabetes Mellitus, Type 2; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Risk Factors; Stomach Neoplasms | 2019 |
Detection of Helicobacter pylori with clarithromycin resistance-associated mutations using peptide nucleic acid probe-based melting point analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Oligonucleotide Probes; Peptide Nucleic Acids; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sensitivity and Specificity; Transition Temperature | 2019 |
Effect of Previous Nitroimidazole Treatment on Helicobacter pylori Eradication Success.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment.
Topics: Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans | 2019 |
Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study.
Topics: Age Factors; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Prevalence; Retrospective Studies; Sex Factors; Spain | 2019 |
Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quinolones; Tetracycline; Young Adult | 2019 |
Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in Helicobacter pylori Eradication Therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Omeprazole; Tinidazole | 2019 |
Novel high resolution melt curve assay for the analysis of predominance of Helicobacter pylori clarithromycin resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Genotyping Techniques; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sensitivity and Specificity; Transition Temperature; Young Adult | 2019 |
High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Brazil; Child; Child, Preschool; Clarithromycin; Developing Countries; Disease Eradication; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Young Adult | 2013 |
Prevalence of clarithromycin-resistant Helicobacter pylori in patients with chronic tonsillitis by allele-specific Scorpion real-time polymerase chain reaction assay.
Topics: Adolescent; Adult; Alleles; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Chronic Disease; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Iran; Prevalence; Real-Time Polymerase Chain Reaction; Tonsillitis; Young Adult | 2013 |
Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pakistan; Peptic Ulcer; Prevalence; Recurrence; Treatment Outcome; Young Adult | 2013 |
Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction.
Topics: Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Detemir; Insulin, Long-Acting; Male; Omeprazole | 2013 |
Education and imaging. Gastrointestinal: colonic mucosa-associated lymphoid tissue lymphoma regressed by levofloxacin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colonic Neoplasms; Colonoscopy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Endosonography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Multimodal Imaging; Occult Blood; Ofloxacin; Polymerase Chain Reaction; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Childhood headache and H. pylori--a possible association.
Topics: Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Recurrence | 2013 |
Case report: Helicobacter suis infection in a pig veterinarian.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Histocytochemistry; Humans; Male; Microscopy; Occupational Exposure; Pantoprazole; Polymerase Chain Reaction; Swine; Treatment Outcome; Veterinarians | 2013 |
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Developing Countries; Drug Therapy, Combination; Educational Status; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, University; Humans; Lost to Follow-Up; Male; Medication Adherence; Metronidazole; Middle Aged; Morocco; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Recurrence; Urea; Urease; Young Adult | 2013 |
Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection.
Topics: Adipokines; Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Chitinase-3-Like Protein 1; Clarithromycin; Drug Therapy, Combination; Female; Gene Expression; Helicobacter Infections; Humans; Lectins; Male; Middle Aged; Omeprazole; Plaque, Atherosclerotic; Rabbits; Up-Regulation | 2013 |
PCR detection of clarithromycin-susceptible and -resistant Helicobacter pylori from formalin-fixed, paraffin-embedded gastric biopsies.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Fixatives; Formaldehyde; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Microbial Sensitivity Tests; Paraffin Embedding; Point Mutation; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Retrospective Studies; RNA, Ribosomal, 23S; Stomach; Tissue Fixation | 2013 |
Living in Sofia is associated with a risk for antibiotic resistance in Helicobacter pylori: a Bulgarian study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bulgaria; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Assessment; Surveys and Questionnaires; Tetracycline; Topography, Medical; Young Adult | 2013 |
Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Oligonucleotide Probes; Peptide Nucleic Acids; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2013 |
Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2013 |
Helicobacter cinaedi and Helicobacter fennelliae transmission in a hospital from 2008 to 2012.
Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cluster Analysis; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Helicobacter; Helicobacter Infections; Hospitals; Humans; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing | 2013 |
Bismuth + metronidazole + tetracycline. Why risk adding bismuth?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2013 |
Survey in Iran of clarithromycin resistance in Helicobacter pylori isolates by PCR-RFLP.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteriological Techniques; Clarithromycin; Drug Resistance, Bacterial; Gastric Mucosa; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 2013 |
Delay of second-line eradication therapy for Helicobacter pylori can increase eradication failure.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2013 |
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Failure | 2014 |
[Clarithromycin-resistant Helicobacter pylori associated with 23S rRNA point mutations in Jeju Island].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Islands; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Proton Pump Inhibitors; Republic of Korea; RNA, Ribosomal, 23S; Young Adult | 2013 |
Concern about the efficacy of clarithromycin containing standard triple therapy in the eradication of Helicobacter pylori infection in Malaysia.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia | 2012 |
Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Tokyo; Young Adult | 2013 |
Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China.
Topics: Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S | 2013 |
What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach; Tetracycline; Treatment Outcome; Urea; Young Adult | 2013 |
Follow-up of Helicobacter pylori infection in children over two decades (1988-2007): persistence, relapse and acquisition rates.
Topics: Adolescent; Anti-Bacterial Agents; Belgium; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Multivariate Analysis; Recurrence; Stomach | 2014 |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chlorides; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Peptic Ulcer; Salicylates; Zinc Compounds | 2014 |
Might Helicobacter pylori infection be associated with distortion on taste perception?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Clarithromycin; Dysgeusia; Female; Gastritis; Gastroscopy; Ghana; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Metronidazole; Olfaction Disorders; Pantoprazole; Polymerase Chain Reaction; Saliva; Taste Perception; Urease; Young Adult | 2013 |
Macrolide and fluoroquinolone resistance in Helicobacter pylori isolates: an experience at a tertiary care centre in Pakistan.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Child; Clarithromycin; Codon; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pakistan; Polymerase Chain Reaction; Tertiary Healthcare | 2012 |
Granulomatous gastritis and Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Esomeprazole; Female; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Symptom Assessment; Treatment Outcome | 2013 |
Antibiotic resistance of Helicobacter pylori in Mashhad, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Chi-Square Distribution; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Sensitivity and Specificity; Tetracycline; Urease | 2013 |
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
Topics: Adamantane; Amoxicillin; Antitubercular Agents; Cell Membrane; Chloramphenicol; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Duodenal Ulcer; Duodenitis; Ethylenediamines; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Stomach Ulcer | 2013 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metaplasia; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms; Tetracycline | 2013 |
Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Colombia; DNA Mutational Analysis; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Middle Aged; Mutation; Phenotype; RNA, Ribosomal, 23S; Young Adult | 2013 |
[Fewer stomach cancers after Helicobacter pylori eradication].
Topics: Clarithromycin; Cross-Sectional Studies; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Mass Screening; Precancerous Conditions; Stomach Neoplasms; Stomach Ulcer | 2013 |
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori.
Topics: Alanine Transaminase; Amoxicillin; Anti-Bacterial Agents; Blood Glucose; Clarithromycin; Cytokines; Fatty Liver; Helicobacter Infections; Helicobacter pylori; Humans; Insulin; Insulin Resistance; Italy; Male; Metabolome; Middle Aged; Non-alcoholic Fatty Liver Disease | 2013 |
Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; RNA, Ribosomal, 23S | 2013 |
Prevalence of Helicobacter pylori cagA and vacA genes in Cypriot patients.
Topics: Adult; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Clarithromycin; Cyprus; DNA, Bacterial; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Phylogeography; Point Mutation; Prevalence; RNA, Ribosomal, 23S; Urease; Virulence Factors | 2013 |
Characterization of oral Helicobacter pylori strain by 4 methods.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Clarithromycin; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Mouth; Polymerase Chain Reaction; Virulence Factors | 2013 |
Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefixime; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2013 |
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Proton Pump Inhibitors; Risk Factors; Treatment Outcome; Vancomycin | 2013 |
Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Clarithromycin; DNA, Ribosomal; Drug Resistance, Bacterial; Dyspepsia; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Young Adult | 2013 |
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Ribosomal; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Microbial Sensitivity Tests; Phenotype; Point Mutation; Real-Time Polymerase Chain Reaction; RNA, Ribosomal | 2014 |
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Young Adult | 2013 |
Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates of Helicobacter pylori.
Topics: Antigens, Bacterial; Bacterial Proteins; Canada; Clarithromycin; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Helicobacter Infections; Helicobacter pylori; Humans; Immunoblotting; Lipopolysaccharides; Polysaccharides, Bacterial | 2014 |
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Disease Eradication; DNA Gyrase; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Prospective Studies; Proton Pump Inhibitors; RNA, Ribosomal, 23S; Treatment Failure | 2014 |
[Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk-do, Korea: multicenter study over 13 years].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Retrospective Studies; Treatment Outcome | 2014 |
Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy.
Topics: Adenine; Amoxicillin; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; HIV-1; Humans; Lansoprazole; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Tenofovir | 2014 |
Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Female; Genetic Predisposition to Disease; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Treatment Failure | 2014 |
Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism.
Topics: Amoxicillin; Child; Clarithromycin; Cytochrome P-450 CYP2C19; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Severity of Illness Index; Treatment Outcome | 2014 |
Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Neutrophil Infiltration | 2014 |
Successful treatment of primary immune thrombocytopenia in aged patients using clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunologic Factors; Purpura, Thrombocytopenic, Idiopathic | 2014 |
Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Endoscopy; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Time Factors; Treatment Outcome | 2014 |
[New approaches to therapy of Helicobacterpylori infection (by the materials of the Maastricht Consensus-IV, Florence, 2010)].
Topics: Anti-Bacterial Agents; Clarithromycin; Consensus Development Conferences as Topic; Drug Hypersensitivity; Drug Resistance, Bacterial; Drug Therapy, Combination; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Penicillins | 2013 |
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pronase; Stomach | 2014 |
Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2014 |
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Endoscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Microbiological Techniques; Mutation; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2014 |
Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2014 |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Base Sequence; China; Clarithromycin; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minority Groups; Molecular Sequence Data; Mutation; Peptic Ulcer; Phenotype; Polymerase Chain Reaction; Ribotyping; Treatment Outcome | 2014 |
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Cellulose; Chitosan; Clarithromycin; Concanavalin A; Diffusion; Drug Stability; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Membranes, Artificial; Microspheres; Mucins; Mucus; Powder Diffraction; Spectroscopy, Fourier Transform Infrared; Swine; X-Ray Diffraction | 2014 |
Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Cell Line, Tumor; Cellulose; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Nanocapsules; Stomach | 2014 |
Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; Base Sequence; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutation; Pakistan; Phylogeny; Sequence Analysis, DNA; Virulence; Young Adult | 2014 |
Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea?
Topics: Amoxicillin; Clarithromycin; Communicable Disease Control; Disease Eradication; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Republic of Korea; Tinidazole | 2014 |
PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2014 |
[State of mucosal barrier of the stomach after Helicobacter pylori eradication and ulcer healing in patients with duodenal ulcer disease].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome; Young Adult | 2013 |
GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genotyping Techniques; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Point Mutation; Republic of Korea; RNA, Ribosomal, 23S; Sensitivity and Specificity | 2014 |
[Determination of single nucleotide mutations in the 23S rRNA gene of Helicobacter pylori related to clarithromycin resistance in a population from Cauca, Colombia].
Topics: Adolescent; Adult; Aged; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Colombia; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gastritis; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mutation, Missense; Polymorphism, Single Nucleotide; Prospective Studies; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Alignment; Sequence Homology, Nucleic Acid; Young Adult | 2014 |
Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Genes, Bacterial; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Metronidazole; Microbial Sensitivity Tests; Mutation; Prevalence; RNA, Ribosomal, 23S | 2014 |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients.
Topics: Aged; Amoxicillin; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breath Tests; Chronic Disease; Clarithromycin; Diarrhea; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; HIV Infections; HIV-1; Humans; Male; Middle Aged; Omeprazole | 2014 |
Helicobacter pylori is not eradicated after triple therapy: a nested PCR based study.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Amoxicillin; Bacterial Proteins; Biopsy; Breath Tests; Chaperonin 60; Clarithromycin; DNA, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Phosphoglucomutase; Polymerase Chain Reaction; Sequence Analysis, DNA; Sigma Factor; Urease; Young Adult | 2014 |
[Rationale for improved treatment of ulcerative disease complicated by chronic pyelonephritis].
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Diet; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Kidney; Male; Middle Aged; Pyelonephritis; Rabeprazole; Risk Factors; Treatment Outcome; Ulcer | 2013 |
Diagnosis of helicobacter pylori infection.
Topics: Amoxicillin; Azithromycin; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2014 |
The Helicobacter pylori resistance rate to clarithromycin in Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutation, Missense; Peptic Ulcer; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 23S; Young Adult | 2015 |
[Antibiotic resistance of Helicobacter pylori: prevalence in one region in the southern Netherlands and implications for treatment].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Netherlands; Prevalence; Proton Pump Inhibitors; Retrospective Studies | 2014 |
Resistance testing for Helicobacter pylori infection: is it finally ready for prime time?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2014 |
Novel Helicobacter pylori sequencing test identifies high rate of clarithromycin resistance.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; DNA Mutational Analysis; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Polymerase Chain Reaction; Retreatment; RNA, Ribosomal, 23S; Sensitivity and Specificity; Treatment Failure; Young Adult | 2014 |
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rifabutin; Salvage Therapy; Spain; Tetracycline; Time Factors; Treatment Outcome | 2015 |
In vitro assessment of Helicobacter pylori ureases inhibition by honey fractions.
Topics: Amoxicillin; Anti-Bacterial Agents; Chemical Fractionation; Chloroform; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Honey; Urease | 2014 |
Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Republic of Korea; Retrospective Studies; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2014 |
[Progress in the treatment of Helicobacter pylori infection].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Chinese Herbal; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Metronidazole; Peptic Ulcer; Probiotics; Stomach Neoplasms | 2014 |
Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Logistic Models; Male; Middle Aged; Patient Compliance; Proton Pump Inhibitors; Recurrence; Treatment Outcome | 2015 |
Helicobacter pylori Infection in Children. Antimicrobial Resistance and Treatment Response.
Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Remission Induction; Retrospective Studies; Treatment Outcome; Urea | 2015 |
[Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Treatment Outcome | 2014 |
Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Prevalence; Retrospective Studies; Time Factors; Young Adult | 2015 |
Seminal Helicobacter pylori treatment improves sperm motility in infertile asthenozoospermic men.
Topics: Adult; Antibodies, Bacterial; Asthenozoospermia; Clarithromycin; Cohort Studies; Confidence Intervals; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A; Infertility, Male; Male; Omeprazole; Prospective Studies; Semen; Semen Analysis; Sperm Motility; Tinidazole; Treatment Outcome; Young Adult | 2014 |
Simultaneous determination of triple therapy for Helicobacter pylori in human plasma by reversed phase chromatography with online wavelength switching.
Topics: Administration, Oral; Anti-Bacterial Agents; Blood Chemical Analysis; Chromatography, Reverse-Phase; Clarithromycin; Drug Monitoring; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Liquid-Liquid Extraction; Omeprazole; Pharmaceutical Services, Online; Tinidazole | 2015 |
Low antibiotic resistance of Helicobacter pylori in The Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Netherlands; Prevalence; Young Adult | 2015 |
Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori.
Topics: Adhesiveness; Alginates; Anti-Bacterial Agents; Clarithromycin; Dosage Forms; Drug Delivery Systems; Gastric Mucosa; Glucuronic Acid; Helicobacter Infections; Helicobacter pylori; Hexuronic Acids; Mucins | 2015 |
High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Point Mutation; RNA, Ribosomal, 23S; Tertiary Care Centers; Vietnam; Young Adult | 2015 |
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
Topics: Amoxicillin; Chronic Disease; Clarithromycin; Disease Eradication; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Time Factors; Tokyo | 2014 |
[Helicobacter pylori infection in patients with functional dyspepsia, eradication rates in the Donetsk region].
Topics: Abdominal Pain; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Probiotics; Proton Pump Inhibitors; Treatment Outcome | 2014 |
The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece.
Topics: Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Gene Frequency; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Molecular Epidemiology; Mutation; Polymorphism, Single Nucleotide; Prevalence; Retrospective Studies; RNA, Ribosomal, 23S | 2014 |
Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Cross-Sectional Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Infant; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Poland; Prospective Studies; Tetracycline; Young Adult | 2014 |
Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Congo; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Real-Time Polymerase Chain Reaction; Tetracycline; Young Adult | 2015 |
Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Gyrase; DNA Primers; Drug Resistance, Bacterial; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Mutation, Missense; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sensitivity and Specificity | 2015 |
Not All Helicobacter Are pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Biopsy; Clarithromycin; Endoscopy, Digestive System; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Histocytochemistry; Humans; Male; Metronidazole; Microscopy; Pantoprazole; Proton Pump Inhibitors | 2015 |
Helicobacter pylori treatment in children: defining a dose for rabeprazole as a part of a triple therapy regimen.
Topics: Adolescent; Amoxicillin; Area Under Curve; Body Weight; Child; Child, Preschool; Clarithromycin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Proton Pump Inhibitors; Rabeprazole | 2015 |
Clarithromycin highly-loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Excipients; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Time Factors | 2015 |
Gastric inflammatory fibroid polyp morphologically changed by Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Endoscopy, Digestive System; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polyps; Proton Pump Inhibitors; Rabeprazole; Stomach Neoplasms | 2015 |
High-level primary clarithromycin resistance of Helicobacter pylori in Morocco: a prospective multicenter molecular study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Morocco; Prevalence; Prospective Studies; Young Adult | 2015 |
A 15-year-old boy with abdominal pain, growth retardation, and anemia secondary to Helicobacter pylori-associated peptic ulcer.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Growth Disorders; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2015 |
Pediatric Pharyngeal IgD-positive Monoclonal Plasmacytoid and Plasma Cell Neoplasm.
Topics: Adolescent; Amoxicillin; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunocompetence; Immunoglobulin D; Lansoprazole; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Paraproteins; Pharyngeal Neoplasms; Plasma Cells; Plasmablastic Lymphoma; Postoperative Complications; Prednisone; Remission Induction; Tonsillectomy; Vincristine | 2015 |
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Topics: Animals; Anti-Bacterial Agents; Chemokine CXCL10; Chemokine CXCL9; Clarithromycin; Gastric Mucosa; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice, Inbred C57BL; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 2015 |
Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Nitroimidazoles; Pantoprazole; Portugal; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Young Adult | 2015 |
Comparison of FISH, RFLP and agar dilution methods for testing clarithromycin resistance of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Young Adult | 2014 |
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Taiwan; Tetracycline; Virulence Factors | 2015 |
Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy.
Topics: Amoxicillin; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2015 |
Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies | 2016 |
In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Binding Sites; Clarithromycin; Computer-Aided Design; Curcumin; Drug Design; Helicobacter Infections; Helicobacter pylori; Metronidazole; Molecular Docking Simulation; Pantoprazole; Pattern Recognition, Automated; Protein Binding; Protein Conformation; Proton Pump Inhibitors; Structure-Activity Relationship | 2015 |
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moxifloxacin; Peptic Ulcer; Risk Factors; Young Adult | 2015 |
Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Disease-Free Survival; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Grading; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2015 |
Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Disease Eradication; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Spain; Young Adult | 2015 |
Letter: clarithromycin dose for H. pylori therapy remains unresolved.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Humans | 2015 |
Letter: clarithromycin dose for H. pylori therapy remains unresolved--authors' reply.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Humans | 2015 |
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Barrett Esophagus; Bismuth; Breath Tests; Clarithromycin; Disease Management; Drug Therapy, Combination; Dyspepsia; Feces; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Italy; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Urea | 2015 |
The best and worst treatments for Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2015 |
Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Carcinogenesis; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Goblet Cells; Helicobacter; Helicobacter Infections; Intestinal Neoplasms; Intestines; Male; Metronidazole; Mice, Inbred C57BL; Omeprazole; Verrucomicrobia | 2015 |
Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Chi-Square Distribution; Chronic Disease; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine Antagonists; Humans; Male; Middle Aged; Pantoprazole; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Urticaria | 2015 |
Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Sequence Data; Prevalence; Sicily; Virulence Factors | 2015 |
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Egypt; Female; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; RNA, Ribosomal, 23S; Young Adult | 2016 |
The Need for Resistance Surveillance and Antimicrobial Susceptibility Testing of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2015 |
Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Linezolid; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2015 |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Taiwan; Tetracycline; Time Factors | 2015 |
Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bulgaria; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2016 |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery?
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Obesity, Morbid; Portugal; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2016 |
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Utilization; Helicobacter Infections; Humans; Korea; Male; Middle Aged; Proton Pump Inhibitors; Spatio-Temporal Analysis; Surveys and Questionnaires; Treatment Failure; Young Adult | 2016 |
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Erythema Multiforme; Female; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2016 |
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Ascorbic Acid; Breath Tests; Clarithromycin; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Retrospective Studies; Treatment Outcome; Vitamin E; Vitamins; Young Adult | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Longitudinal Studies; Metronidazole; Omeprazole; Prospective Studies; Rifabutin; Tetracycline; Treatment Failure | 2015 |
Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Poland | 2015 |
Time to learn from the past and prepare for the future in Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2015 |
Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proton Pump Inhibitors; Republic of Korea; Retrospective Studies; Risk Factors; Sex Factors; Smoking; Time Factors; Treatment Failure; Young Adult | 2015 |
High-Level Primary Clarithromycin Resistance of Helicobacter pylori in Algiers, Algeria: A Prospective Multicenter Molecular Study.
Topics: Algeria; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Prospective Studies; RNA, Ribosomal, 23S; Stomach | 2016 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult | 2016 |
Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: a Novel Approach for Effective Treatment of H. pylori.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Delayed-Action Preparations; Drug Delivery Systems; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydroxamic Acids; Lactic Acid; Lectins; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Stomach | 2016 |
Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Carcinoma in Situ; Clarithromycin; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Proton Pump Inhibitors; Retrospective Studies; Stomach; Stomach Neoplasms | 2015 |
The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Mutation; Virulence Factors | 2016 |
Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Retrospective Studies; Tinidazole | 2015 |
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Autophagy; Case-Control Studies; Cathelicidins; Clarithromycin; Extracellular Traps; Female; Gastritis; Helicobacter Infections; Humans; Immunologic Factors; Male; Middle Aged; Neutrophils | 2016 |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Flowers; Helicobacter Infections; Helicobacter pylori; Hibiscus; Humans; Metronidazole; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts; Plants, Medicinal | 2016 |
High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Prognosis; RNA, Ribosomal, 23S; Stomach; Thailand; Young Adult | 2015 |
Cardiovascular outcomes associated with use of clarithromycin: population based study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Middle Aged; Propensity Score; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2016 |
Cardiovascular risks associated with clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Genetic Markers; Genotype; Genotyping Techniques; Helicobacter Infections; Helicobacter pylori; Humans; Male; Phylogeny; Proton Pump Inhibitors; Recurrence; Retrospective Studies | 2016 |
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015].
Topics: Clarithromycin; Drug Resistance, Microbial; Guinea; Helicobacter Infections; Hemorrhagic Fever, Ebola; Histoplasmosis; Hospitalization; Humans; Influenza, Human; Leprosy; Otorhinolaryngologic Neoplasms; Reunion; Severity of Illness Index; Tropical Medicine | 2016 |
Analysis of Helicobacter pylori genotypes in clinical gastric wash samples.
Topics: Aged; Aged, 80 and over; Base Sequence; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Female; Gastritis; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Analysis, RNA; Stomach; Therapeutic Irrigation | 2016 |
Antibiotic Resistant Pattern of Helicobacter Pylori Infection Based on Molecular Tests in Laos.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Laos; Male; Microbial Sensitivity Tests; Middle Aged; Mutation | 2016 |
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Outcome | 2016 |
Does the urea breath test predict eradication of Helicobacter pylori infection?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Radioisotopes; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea | 2016 |
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Teaching; Humans; Levofloxacin; Logistic Models; Macrolides; Male; Middle Aged; Multivariate Analysis; Republic of Korea; Retrospective Studies; Tertiary Care Centers | 2016 |
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Retrospective Studies | 2016 |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors | 2016 |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province].
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2016 |
The efficacy of blueberry and grape seed extract combination on triple therapy for Helicobacter pylori eradication: a randomised controlled trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bacterial Adhesion; Blueberry Plants; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Grape Seed Extract; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 2016 |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Proton Pump Inhibitors; Retrospective Studies; RNA, Ribosomal, 23S; Treatment Failure; United States; Young Adult | 2016 |
Impact of Helicobacter pylori Eradication Therapy on Platelet Counts in Patients With Chronic Idiopathic Thrombocytopenic Purpura.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Platelet Count; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2015 |
Study provides insufficient evidence of a link between clarithromycin and myocardial infarction.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Editorialists' reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Breath Tests; Clarithromycin; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulins, Intravenous; Iron; Lansoprazole; Purpura, Thrombocytopenic; Remission Induction | 2016 |
Author's reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Breath Tests; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Proportional Hazards Models; Proton Pump Inhibitors; Pyloric Antrum; Retrospective Studies; Risk Factors; Stomach; Stomach Neoplasms | 2016 |
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2016 |
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2016 |
Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Primers; DNA, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Molecular Diagnostic Techniques; Mucus; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Specimen Handling; Surgical Instruments | 2016 |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Spain; Stomach Ulcer | 2016 |
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cardiovascular Diseases; Case-Control Studies; Child; Child, Preschool; Clarithromycin; Cohort Studies; Databases, Factual; Female; Helicobacter Infections; Humans; Infant; Male; Middle Aged; Myocardial Infarction; Propensity Score; United Kingdom; Young Adult | 2016 |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prevalence; Retrospective Studies; Stomach Neoplasms | 2016 |
Primary resistance of Helicobacter pylori is still low in Southern Austria.
Topics: Adult; Aged; Anti-Bacterial Agents; Austria; Clarithromycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Virulence Factors | 2016 |
Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin.
Topics: Adult; Affect; Anti-Bacterial Agents; Anti-Infective Agents; Case-Control Studies; Clarithromycin; Delirium; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Outpatients; Proton Pump Inhibitors; Psychotic Disorders; Sleep Wake Disorders | 2016 |
Letter: global emergence of Helicobacter pylori antibiotic resistance - unanswered questions.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2016 |
Short term increase in neuropsychiatric events is seen with H pylori treatment containing clarithromycin.
Topics: Anti-Bacterial Agents; Behavior; Behavioral Symptoms; Clarithromycin; Dose-Response Relationship, Drug; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Mental Disorders; Risk Factors; Time Factors | 2016 |
[Quadruple therapy is more effective against H. pylori].
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors | 2016 |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitoring; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides; Treatment Outcome | 2016 |
Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Practice Patterns, Physicians'; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2017 |
Authors' reply.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors | 2016 |
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies | 2016 |
Emerging trends of antimicrobial resistance in Helicobacter pylori isolates obtained from Pakistani patients: The need for consideration of amoxicillin and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Pakistan | 2016 |
Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.
Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Chronic Disease; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mutation; RNA, Ribosomal, 23S; Virulence | 2016 |
High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Female; Genotyping Techniques; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; RNA, Ribosomal, 23S; Young Adult | 2016 |
[Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2016 |
Association of Hay Fever with the Failure of Helicobacter pylori Primary Eradication.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Rhinitis, Allergic, Seasonal | 2016 |
Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City.
Topics: Amoxicillin; Anti-Bacterial Agents; Argentina; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 23S | 2017 |
Helicobacter pylori resistance to clarithromycin in Reunion Island.
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Gastric Fundus; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Mutation; Proton Pump Inhibitors; Pyloric Antrum; Reunion; Stomach Neoplasms | 2016 |
Two Cases of Chronic Gastritis with non-Helicobacter pylori Helicobacter Infection.
Topics: Amoxicillin; Clarithromycin; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Humans; Male; Middle Aged; Rabeprazole | 2016 |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.
Topics: Alleles; Anti-Bacterial Agents; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Saliva | 2016 |
Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Feasibility Studies; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Young Adult | 2016 |
Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Proton Pump Inhibitors; Stomach Neoplasms; Time-to-Treatment; Treatment Outcome | 2016 |
Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2016 |
Helicobacter pylori Eradication?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 2016 |
[Not Available].
Topics: Adult; Aged; Bipolar Disorder; Clarithromycin; Cognition Disorders; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Middle Aged; Psychoses, Substance-Induced; Risk | 2016 |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; RNA, Ribosomal, 23S; Sulfonamides; Treatment Outcome; Urea | 2016 |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Brazil; Clarithromycin; Drug Resistance, Bacterial; Endoscopy; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Stomach; Young Adult | 2016 |
Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Real-Time Polymerase Chain Reaction; Young Adult | 2016 |
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Remission Induction; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome | 2016 |
Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia.
Topics: Adult; Aged; Amoxicillin; Brazil; Clarithromycin; Cytochrome P-450 CYP2C19; Dyspepsia; Endoscopy, Gastrointestinal; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Inactivation, Metabolic; Male; Middle Aged; Omeprazole; Polymorphism, Single Nucleotide | 2016 |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Early Detection of Cancer; Evidence-Based Medicine; Fluoroquinolones; Gastritis; Gastrointestinal Microbiome; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach; Stomach Neoplasms | 2017 |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Body Mass Index; Body Weight; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis, Atrophic; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leptin; Male; Middle Aged; Peptic Ulcer | 2016 |
Role of concomitant therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides | 2017 |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy; Female; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nepal; Nitroreductases; Point Mutation; Prevalence; Prokaryotic Initiation Factor-2; RNA, Ribosomal, 23S; Tetracycline; Young Adult | 2016 |
Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children.
Topics: Adolescent; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Genetic Variation; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Point Mutation | 2017 |
Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Failure | 2016 |
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Endoscopy; Female; Frameshift Mutation; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Mutation, Missense; Point Mutation; RNA, Ribosomal, 23S | 2016 |
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS.
Topics: Adult; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Egypt; Female; Gene Deletion; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 16S; Young Adult | 2016 |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2016 |
Acute psychotic episode secondary to Helicobacter pylori eradication treatment.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Psychoses, Substance-Induced | 2017 |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Salvage Therapy; Treatment Failure | 2017 |
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin | 2017 |
Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin | 2017 |
Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Male; Metronidazole; Middle Aged; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Urea | 2017 |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Failure | 2017 |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Portugal; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Young Adult | 2017 |
Comparative study: Vonoprazan and proton pump inhibitors in
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Safety; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2017 |
The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Guanosine Pentaphosphate; Guanosine Tetraphosphate; Helicobacter Infections; Helicobacter pylori; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Multifunctional Enzymes | 2017 |
Effect of biofilm formation by clinical isolates of
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biofilms; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tetracycline | 2017 |
Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children.
Topics: Adolescent; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Point Mutation; Polymerase Chain Reaction; Turkey | 2016 |
[National ranking exam. N63. What could fall at the exam?].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Education, Medical; Educational Measurement; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Urea | 2008 |
[Palpable purpura with severe pruritus].
Topics: Aged; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Prognosis; Pruritus; Purpura; Vasculitis, Leukocytoclastic, Cutaneous | 2008 |
Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Pilot Projects; Retrospective Studies; Stomach Neoplasms | 2008 |
A search for Helicobacter pyloriin localized vulvodynia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Metronidazole; Omeprazole; Vulvar Diseases; Young Adult | 2008 |
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
Topics: Amoxicillin; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Treatment Outcome | 2008 |
[Differences between European guideline and planned S3 guideline of DGVS. Need for Helicobacter pylori eradication to be decided on an individual basis].
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Practice Guidelines as Topic; Proton Pump Inhibitors; Stomach Diseases | 2008 |
Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects.
Topics: Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Finland; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Patient Compliance; Retrospective Studies; Risk Assessment; Treatment Failure; Treatment Outcome | 2008 |
Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Outcome | 2008 |
A rapid lateral flow stool antigen immunoassay and (14)C-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Child; Child, Preschool; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoassay; Male; Omeprazole; Sensitivity and Specificity | 2008 |
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tetracycline Resistance; Treatment Failure | 2008 |
Comparison of fluorescent in situ hybridization and histological method for the diagnosis of Helicobacter pylori in gastric biopsy samples.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histocytochemistry; Humans; In Situ Hybridization, Fluorescence; Sensitivity and Specificity | 2008 |
Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastroscopy; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Stomach Ulcer; Urea; Young Adult | 2008 |
Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients.
Topics: Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Ribosomes; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2008 |
Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2008 |
Drug utilization of clarithromycin for gastrointestinal disease treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clarithromycin; Clinical Audit; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug Utilization Review; Female; Gastrointestinal Diseases; Helicobacter Infections; Hospitals, General; Humans; Male; Middle Aged; Outpatients; Postprandial Period; Protein Synthesis Inhibitors; Retrospective Studies; Young Adult | 2008 |
A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alopecia; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colonic Polyps; Colonoscopy; Gastritis; Helicobacter Infections; Humans; Hyperpigmentation; Intestinal Polyposis; Lansoprazole; Male; Syndrome | 2008 |
Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Gliadin; Helicobacter Infections; Helicobacter pylori; Lectins; Male; Mice; Nanoparticles; Omeprazole; Time Factors | 2008 |
Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.
Topics: Acrylic Resins; Adhesives; Animals; Anti-Infective Agents; Cellulose; Chemistry, Pharmaceutical; Clarithromycin; DNA, Bacterial; Drug Compounding; Excipients; Gastric Juice; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Kinetics; Male; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyvinyls; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
[Eosinophilic gastritis after helicobacter pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endosonography; Eosinophilia; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Pantoprazole | 2008 |
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2008 |
The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; Polymerase Chain Reaction; Treatment Failure; Treatment Outcome | 2009 |
H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Helicobacter Infections; Helicobacter pylori; Hepatitis, Chronic; Humans; Liver Cirrhosis; Peptic Ulcer; Proton Pump Inhibitors; Research Design; Treatment Outcome | 2009 |
Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal; Turkey | 2008 |
[Topical issues of paediatric gastroenterology].
Topics: Child; Clarithromycin; Drug Therapy, Combination; Gastroenterology; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxybenzoates; Nitrofurans; Omeprazole; Pediatrics; Randomized Controlled Trials as Topic | 2008 |
[What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Multicenter Studies as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2009 |
[Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy: a case report].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Clarithromycin; Female; Helicobacter Infections; Humans; Lymphoma, B-Cell, Marginal Zone; Sulbactam; Urinary Bladder Neoplasms | 2008 |
Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens.
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Primers; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Middle Aged; Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2009 |
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.
Topics: Amoxicillin; Animals; Cells, Cultured; Chitosan; Clarithromycin; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Stability; Female; Glutamic Acid; Helicobacter Infections; Helicobacter pylori; Male; Mice; Nanoparticles; Omeprazole; Random Allocation | 2009 |
Evaluation of clarithromycin resistance in Helicobacter pylori obtained from culture isolates, gastric juice, and feces.
Topics: Adult; Aged; Clarithromycin; Drug Resistance, Bacterial; Feces; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 2009 |
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication.
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors | 2009 |
Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Fruit; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Magnetic Resonance Spectroscopy; Mallotus Plant; Metronidazole; Microbial Sensitivity Tests; Pakistan; Point Mutation | 2009 |
Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Peptic Ulcer; Polymerase Chain Reaction; Stomach; Tetracycline | 2009 |
On the efficacy of macrolide-based therapy for Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Roxithromycin; Treatment Outcome | 2009 |
Helicobacter pylori infection: approach of primary care physicians in a developing country.
Topics: Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Data Collection; Education, Medical, Continuing; Guideline Adherence; Health Knowledge, Attitudes, Practice; Helicobacter Infections; Helicobacter pylori; Humans; Pakistan; Physicians, Family; Stomach Ulcer | 2009 |
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure; Young Adult | 2009 |
Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.
Topics: Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Middle Aged; Mucous Membrane; Neoplasm Recurrence, Local; Neoplasm Staging; Omeprazole; Parotid Neoplasms; Radionuclide Imaging; Rare Diseases; Risk Assessment; Treatment Outcome | 2009 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.
Topics: Base Sequence; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
[Antibiotic resistance rates of Helicobacter pylori isolates and the comparison of E-test and fluorescent in situ hybridization methods for the detection of clarithromycin resistant strains].
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Middle Aged; Stomach; Young Adult | 2009 |
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Treatment Outcome | 2010 |
[Antihelicobacteric therapy for the patients with recurrent complicated postoperative gastroduodenal ulcer: indications, principles of conduction, efficacy].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Recurrence; Treatment Outcome | 2009 |
Helicobacter pylori: antibiotic resistance and treatment options.
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure | 2009 |
[Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitric Oxide; Omeprazole; Proton Pump Inhibitors | 2009 |
Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Minocycline | 2009 |
Drug resistance pattern and clonality in H. pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents, Local; beta-Lactamases; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline | 2009 |
Stomach-site specific drug delivery system of clarithromycin for eradication of Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Clarithromycin; Drug Carriers; Drug Compounding; Drug Stability; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Kinetics; Polysaccharides, Bacterial; Rabbits; Radiography; Stomach; Temperature | 2009 |
Pyrosequencing assay to rapidly detect clarithromycin resistance mutations in Canadian Helicobacter pylori isolates.
Topics: Anti-Bacterial Agents; Canada; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Increasing prevalence of primary clarithromycin resistance in Helicobacter pylori strains in Split, Croatia.
Topics: Anti-Bacterial Agents; Clarithromycin; Croatia; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Prevalence | 2009 |
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Tetracycline | 2009 |
[Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Point Mutation; Random Amplified Polymorphic DNA Technique; RNA, Ribosomal, 28S; Young Adult | 2009 |
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole | 2009 |
Stool polymerase chain reaction for Helicobacter pylori detection and clarithromycin susceptibility testing in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Child; Child, Preschool; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Polymerase Chain Reaction; Retrospective Studies; Sensitivity and Specificity; Urease | 2010 |
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits.
Topics: Adult; Anti-Bacterial Agents; Breath Tests; Clarithromycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Treatment Outcome; Urease | 2010 |
Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2009 |
Ten-day sequential therapy of Helicobacter pylori infection in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Patient Compliance; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Thailand; Time Factors; Treatment Outcome; Young Adult | 2010 |
[Rapid detection of clarithromycin resistant Helicobacter pylori from children's gastric biopsy specimens by polymerase chain reaction-restriction fragment length polymorphism].
Topics: Child; Clarithromycin; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 2009 |
Efficacy of standard triple therapy in the treatment of Helicobacter pylori infection: experience from Kuwait.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kuwait; Male; Middle Aged; Omeprazole; Treatment Outcome | 2010 |
Antibiotic resistance of Helicobacter pylori in Israeli children.
Topics: Adolescent; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Prospective Studies; Surveys and Questionnaires; Tetracycline; Treatment Failure | 2010 |
[Molecular-genetic typing of Helicobacter pylori: applied aspects of diagnosis and treatment of duodenal ulcer].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Duodenal Ulcer; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2009 |
[Epidemiological research of Helicobacter pylori resistance to clarithromycin at inhabitants of Sankt of Petersburg with a stomach ulcer].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Russia; Stomach Ulcer; Urban Population | 2009 |
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Immunoproliferative Small Intestinal Disease; Lansoprazole; Male; Omeprazole; Organometallic Compounds; Tinidazole; Young Adult | 2010 |
Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Ireland; Male; Metronidazole; Middle Aged; Prevalence | 2010 |
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.
Topics: Adolescent; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mutation; Retrospective Studies | 2010 |
Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Time Factors; Treatment Outcome; Urea | 2010 |
Clarithromycin resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Malaysia.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Middle Aged; Point Mutation; Polymorphism, Restriction Fragment Length; Prevalence; Retrospective Studies; RNA, Ribosomal, 23S; Stomach | 2010 |
Helicobacter pylori: prevalence and antibiotic susceptibility among Kenyans.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Black People; Child; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Kenya; Metronidazole; Microbial Sensitivity Tests; Prevalence | 2010 |
Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Chi-Square Distribution; Clarithromycin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Probability; Retrospective Studies; Sex Factors; Tetracycline; Young Adult | 2010 |
[Acute upper gastrointestinal bleeding after coronary intervention in acute myocardial infarction].
Topics: Aged; Amoxicillin; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Myocardial Infarction; Necrosis; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stomach Diseases; Stomach Ulcer | 2010 |
Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Polymorphism, Genetic; Rabeprazole | 2010 |
The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies | 2010 |
Characterization of 23S rRNA domain V mutations in gastric biopsy patients from the eastern Amazon.
Topics: Anti-Bacterial Agents; Biopsy; Brazil; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Diseases | 2010 |
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility.
Topics: Anti-Bacterial Agents; Clarithromycin; Culture Media; Enzyme-Linked Immunosorbent Assay; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Reproducibility of Results; Time Factors | 2010 |
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication?
Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tinidazole; Young Adult | 2010 |
Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection.
Topics: Alginates; Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Clarithromycin; Delayed-Action Preparations; Glucuronic Acid; Helicobacter Infections; Helicobacter pylori; Hexuronic Acids; Humans; Hypromellose Derivatives; Methylcellulose; Rabbits; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared | 2010 |
Clarithromycin use and risk of death in patients with ischemic heart disease.
Topics: Adult; Aged; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors | 2010 |
Risk factors associated with Helicobacter pylori infection treatment failure in a high prevalence area.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pakistan; Point Mutation; Prevalence; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Failure; Urea; Virulence Factors; Young Adult | 2011 |
Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Cytochrome P-450 Enzyme System; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Polymorphism, Genetic; Proton Pump Inhibitors | 2010 |
Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Cross-Sectional Studies; Esophagitis, Peptic; Female; Helicobacter Infections; Humans; Logistic Models; Los Angeles; Male; Middle Aged; Omeprazole; Patient Selection; Prevalence; Prospective Studies; Risk Factors; Surveys and Questionnaires; Treatment Outcome | 2010 |
Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori.
Topics: Aged; Bacterial Proteins; Clarithromycin; Dipeptides; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Membrane Transport Proteins; Microbial Sensitivity Tests; Middle Aged; Models, Molecular; Point Mutation; Protein Conformation; RNA, Bacterial; RNA, Ribosomal, 23S | 2010 |
[Acute psychosis induced by a Helicobacter pylori (H. pylori)-eradication treatment with amoxicillin, clarithromycin and pantoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Delusions; Drug Interactions; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Pantoprazole; Psychoses, Substance-Induced | 2010 |
Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions.
Topics: Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2010 |
Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Renal Dialysis; Treatment Outcome | 2010 |
Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome; Urea; Young Adult | 2010 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the UAE.
Topics: Anti-Bacterial Agents; Base Sequence; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA; United Arab Emirates | 2010 |
High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Prevalence; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Spain; Young Adult | 2010 |
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Point Mutation; Polymerase Chain Reaction; Prospective Studies; Tunisia; Young Adult | 2010 |
MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clarithromycin; Cyclophosphamide; Gastritis; Helicobacter Infections; Helicobacter pylori; Herpesvirus 8, Human; HIV Seronegativity; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Prednisone; Proton Pump Inhibitors; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms; Stomach Ulcer; Vinblastine; Vincristine | 2010 |
[A comparison analysis on the diagnosis of Helicobacter pylori infection and the detection of clarithromycin resistance according to biopsy sites].
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2010 |
Age-dependent eradication of Helicobacter pylori in Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Logistic Models; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2010 |
High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children.
Topics: Adhesins, Bacterial; Adolescent; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Brazil; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Prevalence; Severity of Illness Index; Virulence Factors | 2010 |
Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Proton Pump Inhibitors | 2010 |
Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery--fourteen days superior to seven days?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Obesity, Morbid; Proton Pump Inhibitors; Retrospective Studies | 2011 |
Long term changes in platelet counts after H. pylori eradication in non-ITP patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2010 |
Infection: Bismuth improves PPI-based triple therapy for H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; China; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Treatment Outcome | 2010 |
Sequential therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Young Adult | 2010 |
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Prognosis; Ranitidine; Smoking; Stomach; Time Factors | 2010 |
Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Image Enhancement; Lansoprazole; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index | 2011 |
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Retrospective Studies; Young Adult | 2010 |
[Helicobacter pylori eradication therapy for gastric ulcer in elderly].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Proton Pump Inhibitors; Stomach Ulcer | 2010 |
Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2010 |
Personalized treatment in the eradication therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Gastric Mucosa; Genetic Testing; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Precision Medicine; Treatment Outcome | 2011 |
The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Male; Metronidazole; Omeprazole; Stomach; Treatment Outcome | 2011 |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.
Topics: Adult; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Randomized Controlled Trials as Topic; RNA, Ribosomal, 23S; Treatment Outcome | 2011 |
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating.
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin | 2011 |
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin | 2011 |
Efficacy of clarithromycin plus metronidazole-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies | 2010 |
The effectiveness of systemic eradication therapy against oral Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Chronic Periodontitis; Clarithromycin; Dental Plaque; DNA, Bacterial; Drug Combinations; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth Mucosa; Proton Pump Inhibitors; Saliva; Stomach Diseases | 2011 |
Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Chi-Square Distribution; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitroimidazoles; Odds Ratio; Point Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Proton Pump Inhibitors; Ribotyping; Risk Assessment; Risk Factors; RNA, Ribosomal, 23S; Thailand; Time Factors; Treatment Outcome | 2011 |
Haematological side effect of Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Hematologic Diseases; Humans; Male; Metronidazole; Omeprazole | 2010 |
Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Mexico; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Sex Factors; Stomach | 2011 |
Quadruple or triple therapy to eradicate H pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tablets; Tetracycline | 2011 |
Activity of clarithromycin in mucosa-associated lymphoid tissue-type lymphomas: antiproliferative drug or simple antibiotic?
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Chlamydophila; Chlamydophila Infections; Clarithromycin; Helicobacter; Helicobacter Infections; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Treatment Outcome | 2011 |
Understanding and appreciating sequential therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome | 2011 |
Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 23S; Spain; Young Adult | 2011 |
The efficacy of a 1-week triple therapy for eradication of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Humans; Male; Omeprazole; Treatment Outcome | 2011 |
Efficacy, tolerability, and factors affecting the efficacy of the sequential therapy in curing Helicobacter pylori infection in clinical setting.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome | 2011 |
[Eradication therapy of antibiotic-resistant strains of Helicobacter pylori].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxybenzoates; Male; Metronidazole; Middle Aged; Nitrofurans; Proton Pump Inhibitors | 2010 |
[A case of Menetrier's disease showing mucus bridge observed during endoscopy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Hypertrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mucus; Pantoprazole; Proton Pump Inhibitors; Tomography, X-Ray Computed | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children.
Topics: Adolescent; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Decision Trees; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Infant, Newborn; North America; Peptic Ulcer; Proton Pump Inhibitors; Young Adult | 2011 |
High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies | 2011 |
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Pepsinogens; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2011 |
Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Pharmacogenetics; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2011 |
Does long-term aspirin use have any effect on Helicobacter pylori eradication?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome | 2011 |
Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2011 |
Helicobacter pylori eradication and weight gain: has it opened a Pandora's box?
Topics: Body Mass Index; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organometallic Compounds; Ranitidine | 2011 |
Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Breath Tests; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Patient Selection; Phenotype; Predictive Value of Tests; Quinolones; Ribotyping; Stomach; Treatment Failure | 2011 |
Sequential therapy in childhood Helicobacter pylori eradication: emphasis on drug compliance.
Topics: Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2011 |
Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture.
Topics: Adolescent; Austria; Biopsy; Child; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Dyspepsia; Feces; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Retrospective Studies | 2011 |
Helicobacter pylori infection-related pancytopenia in a young boy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anemia, Megaloblastic; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Pancytopenia; Vitamin B 12; Vitamin B 12 Deficiency | 2011 |
Application of real-time PCR stool assay for Helicobacter pylori detection and clarithromycin susceptibility testing in Brazilian children.
Topics: Adolescent; Anti-Bacterial Agents; Brazil; Child; Child, Preschool; Clarithromycin; Feces; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2011 |
Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Portugal; Prospective Studies; Tetracycline | 2011 |
Mass eradication of Helicobacter pylori: feasible and advisable?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Drugs, Generic; Feasibility Studies; Female; Health Policy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2011 |
Preliminary phytochemical screening and in vitro anti-helicobacter pylori activity of extracts of the stem bark of Bridelia micrantha (Hochst., Baill., Euphorbiaceae).
Topics: Acetates; Acetone; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Euphorbiaceae; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Phytotherapy; Plant Bark; Plant Extracts; Plant Stems; South Africa | 2011 |
Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
Topics: Adult; Aged; Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Republic of Korea; Tetracycline | 2012 |
Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; FMN Reductase; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Nitroreductases; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Young Adult | 2011 |
Helicobacter pylori associated with chronic urticaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Treatment Outcome; Urticaria | 2011 |
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Poland | 2011 |
Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies; Taiwan; Treatment Outcome; Urease | 2012 |
Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bulgaria; Clarithromycin; Coinfection; Drug Resistance, Multiple, Bacterial; Female; Health Personnel; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Respiratory Tract Infections; Risk Factors; Socioeconomic Factors; Surveys and Questionnaires; Urinary Tract Infections; Young Adult | 2012 |
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
Cure of alopecia areata after eradication of Helicobacter pylori: a new association?
Topics: Adult; Alopecia Areata; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole | 2011 |
[Characteristics of duodenogastric reflux in duodenal ulcer patients and its dynamics after Helicobacter pylori eradication].
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenogastric Reflux; Female; Follow-Up Studies; Gastric Acid; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Recurrence; Time Factors; Treatment Outcome | 2011 |
Regression of multiple duodenal hyperplastic polyps following Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Diseases; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyps; Metronidazole; Middle Aged; Rabeprazole | 2011 |
Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged | 2011 |
DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycin.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Multiplex Polymerase Chain Reaction; Oligonucleotides; Point Mutation; Real-Time Polymerase Chain Reaction; Stomach | 2011 |
Gastric wash-based molecular testing for antibiotic resistance in Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Lavage; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Rabeprazole; RNA, Ribosomal, 23S; Sequence Analysis, RNA; Statistics, Nonparametric; Urease | 2011 |
Monitoring of antibiotic resistance rates of Helicobacter pylori in Austrian children, 2002-2009.
Topics: Adolescent; Anti-Bacterial Agents; Austria; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Retrospective Studies | 2012 |
Role of gastritis pattern on Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2012 |
Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders.
Topics: Anti-Bacterial Agents; Bacterial Load; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Gastrointestinal Diseases; Gastrointestinal Tract; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2012 |
Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Microbiological Techniques; Middle Aged; RNA, Bacterial; RNA, Ribosomal, 23S; Temperature; Tissue Preservation; Urease | 2012 |
Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Biomarkers, Pharmacological; Clarithromycin; DNA Gyrase; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Treatment Failure | 2012 |
Is quadruple therapy the new triple therapy for H pylori?
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2012 |
Association of helicobacter pylori dupA with the failure of primary eradication.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Proton Pump Inhibitors; Retrospective Studies; Treatment Failure; Virulence Factors; Young Adult | 2012 |
Treatment of Helicobacter pylori in Latin America.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors | 2012 |
Treatment of Helicobacter pylori in Latin America.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors | 2012 |
Treatment of Helicobacter pylori in Latin America.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors | 2012 |
Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Microscopy, Confocal; Microscopy, Electron; Middle Aged; Omeprazole; Permeability; Statistics, Nonparametric | 2012 |
Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colorectal Neoplasms; Endoscopy, Digestive System; Female; Glucocorticoids; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyposis; Prednisolone; Rabeprazole; Recurrence; Remission Induction | 2012 |
H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroscopy; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Metaplasia; MicroRNAs; Middle Aged; Proto-Oncogene Proteins; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms | 2012 |
Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hospitals; Humans; Proton Pump Inhibitors; Spain; Treatment Outcome | 2012 |
Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Croatia; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2012 |
Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole | 2012 |
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Endoscopy; England; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Risk Factors; Wales | 2012 |
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Prebiotics; Probiotics; Proton Pump Inhibitors; Stomach Neoplasms | 2012 |
Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Cost-Benefit Analysis; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Retrospective Studies; Treatment Outcome | 2013 |
"Is it effective?" to "How to use it?": the era has changed in probiotics and functional food products against Helicobacter pylori infection.
Topics: Antibiosis; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Male | 2012 |
The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence | 2012 |
Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cluster Analysis; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Helicobacter; Helicobacter Infections; Hospitals; Humans; Japan; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Mutation; RNA, Ribosomal, 23S | 2012 |
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Spain; Surveys and Questionnaires; Time Factors; Treatment Failure | 2013 |
Anti-Helicobacter pylori potential of artemisinin and its derivatives.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antimalarials; Artemisia annua; Artemisinins; Cell Line, Tumor; Cell Survival; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Plant Components, Aerial | 2012 |
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.
Topics: Adult; Algorithms; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metaplasia; Middle Aged; Multiphasic Screening; Odds Ratio; Peptic Ulcer; Precancerous Conditions; Prevalence; Recurrence; Risk Factors; Stomach Neoplasms; Taiwan; Treatment Outcome | 2013 |
Time trends of primary antibiotic resistance of Helicobacter pylori isolates in Southern Croatia.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Croatia; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Time Factors | 2012 |
Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Diseases | 2012 |
Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA (+) status and clinical outcome.
Topics: Adult; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rural Population; Treatment Outcome; Turkey; Virulence Factors; Young Adult | 2013 |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Comorbidity; Disease Eradication; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Ulcer; Young Adult | 2012 |
Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Middle Aged | 2013 |
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult | 2013 |
Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Recurrence; Republic of Korea; Risk Factors; Socioeconomic Factors; Young Adult | 2013 |
Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lithuania; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Tetracycline | 2013 |
Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2012 |
Trends in the eradication rates of Helicobacter pylori infection for eleven years.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Comorbidity; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2012 |
Helicobacter pylori free-living and biofilm modes of growth: behavior in response to different culture media.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bacterial Proteins; Biofilms; Carbon-Sulfur Lyases; Clarithromycin; Colony Count, Microbial; Culture Media; Gene Expression Regulation, Bacterial; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Microbial Sensitivity Tests; Microbial Viability; Phenotype | 2013 |
Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Singapore; Treatment Outcome; Young Adult | 2013 |
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2012 |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; DNA Mutational Analysis; Drug Resistance, Bacterial; Erythromycin; Female; Gambia; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nitroreductases; RNA, Ribosomal, 16S; Tetracycline | 2013 |
Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rifabutin; Treatment Outcome; Urea | 2013 |
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; RNA, Ribosomal, 23S; Senegal; Tetracycline; Young Adult | 2013 |
[Eradication of helicobacter pylori: symptomatic treatment of reflux disease?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Esophagitis, Peptic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Randomized Controlled Trials as Topic | 2002 |
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Hematologic Tests; Humans; Lansoprazole; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Blood Platelets; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clarithromycin; Confidence Intervals; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Random Amplified Polymorphic DNA Technique; Reunion; Stomach Ulcer; Tetracycline; Treatment Failure | 2002 |
Risk factors for Helicobacter pylori resistance.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Risk Assessment; United States | 2002 |
Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Proton Pumps; Severity of Illness Index; Surveys and Questionnaires | 2002 |
Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Phospholipids; Stomach Ulcer; Treatment Outcome | 2002 |
Chronic urticaria induced by eradication therapy of Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Urticaria | 2002 |
One week regimen of esomeprazole based triple therapy is sufficient for duodenal ulcer healing and Helicobacter pylori eradication in patients with duodenal ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Prospective Studies; Treatment Outcome | 2002 |
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Reproducibility of Results | 2002 |
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Antibacterial effect of Kampo herbal formulation Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang) on Helicobacter pylori infection in mice.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Chinese Herbal; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Male; Medicine, Kampo; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbial Sensitivity Tests; Phytotherapy | 2002 |
Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.
Topics: Amoxicillin; Animals; Anti-Infective Agents, Local; Clarithromycin; Gastric Acid; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Male; Metronidazole; Mucus; Rats; Rats, Wistar | 2002 |
Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.
Topics: Anti-Bacterial Agents; Binding, Competitive; Clarithromycin; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Epithelial Cells; Gastric Mucosa; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Stomach; Treatment Outcome; Urease | 2002 |
Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm, Residual; Omeprazole | 2002 |
Factors associated with treatment failure of Helicobacter pylori infection in a developing country.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Developing Countries; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Risk Factors; Sex Factors; Sulfoxides; Treatment Failure | 2002 |
[Seven-day antihelicobacter therapy of duodenal ulcer associated with Helicobacter pylori and prospects for treating patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Stomach Ulcer | 2002 |
Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Molecular Sequence Data; Mutation; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Homology, Nucleic Acid | 2002 |
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Rabeprazole; Tinidazole | 2002 |
The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence | 2002 |
Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents.
Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; DNA, Ribosomal; Drug Resistance, Bacterial; Family; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Parents; Prevalence; Ribotyping; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2002 |
The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001).
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Ribosomal; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Metronidazole; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2002 |
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Methylprednisolone; Middle Aged; Omeprazole; Penicillins; Platelet Count; Purpura, Thrombocytopenic | 2002 |
A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunologic Tests; Male; Middle Aged; Omeprazole; Pepsinogen A; Peptic Ulcer; Rabeprazole; Reagent Kits, Diagnostic; ROC Curve; Sensitivity and Specificity | 2002 |
Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Mexico; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2002 |
Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Quinolones | 2002 |
[Microbiological factors that influence the eradication of Helicobacter pylori in adults and children].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Virulence | 2002 |
Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Biopsy; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Infant; Male; Microbial Sensitivity Tests; Prospective Studies; Pyloric Antrum; Sensitivity and Specificity | 2002 |
Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole | 2002 |
Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence | 2003 |
Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine | 2003 |
Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.
Topics: Adult; Alleles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Cytotoxins; DNA, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Omeprazole | 2003 |
[Patient with increased stomach cancer risk. Helicobacter can cause damage here].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Precancerous Conditions; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Sulfoxides | 2002 |
Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colony Count, Microbial; Helicobacter Infections; Helicobacter pylori; Mastic Resin; Metronidazole; Mice; Microbial Sensitivity Tests; Omeprazole; Resins, Plant; Stomach | 2003 |
Detection of Helicobacter pylori in paraffin-embedded and in shock-frozen gastric biopsy samples by fluorescent in situ hybridization.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Histological Techniques; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Paraffin Embedding; Sensitivity and Specificity; Stomach | 2003 |
[Association among anti-CagA antibody detection, antibiotic susceptibility, and peptic ulcer in patients with Helicobacter pylori infection].
Topics: Adult; Aged; Antibodies, Bacterial; Antibody Specificity; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Prognosis; Virulence | 2003 |
Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Diseases; Metronidazole; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Tetracycline | 2002 |
Helicobacter pylori hiccup.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esophagitis; Gastritis; Helicobacter Infections; Helicobacter pylori; Hiccup; Humans; Male; Omeprazole; Treatment Outcome | 2003 |
Clarithromycin resistance in Iranian H. pylori strains before introduction of clarithromycin.
Topics: Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; In Vitro Techniques; Iran; Microbial Sensitivity Tests | 2003 |
Helicobacter pylori and antimicrobial susceptibility in children.
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2003 |
Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests | 2003 |
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastric Mucosa; Gastrins; Gastritis, Atrophic; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Omeprazole; Ornithine Decarboxylase; Peroxidases; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 2003 |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 2003 |
[Antimicrobial susceptibility tests and resistant strain of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins | 2003 |
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole | 2003 |
[Detection of resistance to clarithromycin in clinical isolates of Helicobacter pylori from children and adults].
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2003 |
Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine | 2003 |
Antimicrobial activity of essential oils against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Buffers; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Lippia; Mice; Microbial Sensitivity Tests; Oils, Volatile; Phytotherapy; Plant Oils; Terpenes | 2003 |
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides | 2003 |
Reality and false premises of antimicrobial susceptibility testing for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2003 |
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophagus; Female; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Omeprazole; Penicillins | 2003 |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Treatment Outcome | 2003 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum | 2003 |
Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Esophagitis, Peptic; Female; Follow-Up Studies; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 2003 |
Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Interleukin-8; Lactobacillus; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Probiotics | 2003 |
Antimicrobial resistance in Helicobacter pylori isolates from children.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Child; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Pediatric; Humans; Male; Metronidazole; Tetracycline; Victoria | 2003 |
[Failure of Helicobacter pylori eradication--suggestions for further therapy].
Topics: Age Distribution; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; Metronidazole; Organometallic Compounds; Ranitidine; Rifabutin; Tinidazole; Treatment Failure | 2003 |
Detection of clarithromycin-resistant Helicobacter pylori in stool samples.
Topics: Anti-Bacterial Agents; Base Pairing; Base Sequence; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Feces; Gene Amplification; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; Restriction Mapping; Sensitivity and Specificity | 2003 |
Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Endoscopy, Gastrointestinal; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Netherlands; Retrospective Studies | 2003 |
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 2003 |
Prevalence of Helicobacter pylori resistance to clarithromycin and metronidazole determined by 23S ribosomal RNA and rdxA gene analyses in Hiroshima, Japan.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Mutation; Nitroreductases; Point Mutation; Prevalence; RNA, Ribosomal, 23S; RNA, Viral | 2003 |
Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole | 2003 |
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome | 2003 |
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enterococcus; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2003 |
Summaries for patients. Past antibiotic use affects resistance and outcomes of Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome | 2003 |
Summaries for patients. Effects of antibiotic treatment for Helicobacter pylori on normal bowel bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enterococcus; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2003 |
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Creatinine; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retrospective Studies | 2003 |
Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains.
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Pyloric Antrum; Stomach | 2003 |
Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Culture Media; DNA, Ribosomal; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach; Time Factors | 2003 |
Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Electric Impedance; Female; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Tomography; Treatment Outcome; Water | 2003 |
Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Sex Factors; Tinidazole; Urban Population | 2003 |
Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy.
Topics: Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Breath Tests; Clarithromycin; Cohort Studies; DNA, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peru; Poverty; Random Amplified Polymorphic DNA Technique; Recurrence; Urban Population | 2003 |
Lactoferrin: milking ulcers?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cattle; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Omeprazole; Rabeprazole; Tinidazole | 2003 |
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2003 |
[Definitive treatment of Helicobacter pylori infection in MALT low degree gastric lymphoma].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Remission Induction; Stomach Neoplasms | 2003 |
Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; India; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2003 |
[Influence of long-term macrolide therapy for chronic inflammation of respiratory tract on concurrent helicobacter pylori infection of stomach].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Respiratory Tract Diseases; Retrospective Studies; Time Factors | 2003 |
[Effect of clarithromycin on pathogenic factors in Helicobacter pylori].
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Antibody Formation; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Flagella; Gastric Mucosa; Gastritis; Heat-Shock Proteins; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Movement; Urease | 2003 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Duodenal Ulcer; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2003 |
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cell Transformation, Neoplastic; Clarithromycin; Female; Gastrectomy; Gastric Mucosa; Gastroenterostomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Stomach Neoplasms; Treatment Outcome | 2004 |
Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cost Savings; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Proton Pump Inhibitors; Proton Pumps | 2004 |
[Long-term course of reflux symptoms following Helicobacter pylori eradication].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Female; Follow-Up Studies; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Omeprazole; Peptic Ulcer; Prospective Studies; Time Factors | 2004 |
Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue.
Topics: Anti-Bacterial Agents; Carbocyanines; Clarithromycin; Drug Resistance, Bacterial; Fluorescein; Formaldehyde; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Macrolides; Reproducibility of Results; Stomach; Tissue Fixation | 2004 |
Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2004 |
Rapid combined characterization of microorganism and host genotypes using a single technology.
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Clarithromycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Gastric Mucosa; Genes, Bacterial; Genes, rRNA; Genomic Islands; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Mice; Mice, Transgenic; Point Mutation; Polymorphism, Single Nucleotide; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Virulence | 2004 |
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Blood Glucose; Breath Tests; Child; Child, Preschool; Clarithromycin; Diabetes Mellitus, Type 1; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Rabeprazole; Time Factors | 2004 |
Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Omeprazole; Physicians; Practice Guidelines as Topic; Primary Health Care; Surveys and Questionnaires | 2004 |
A national survey of primary care physicians' perceptions and practices related to Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Physicians, Family; Random Allocation; Surveys and Questionnaires; United States | 2004 |
The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura.
Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Chemokines; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prednisolone; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Culture Media; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptic Ulcer; Reference Standards | 2004 |
Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Finland; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Prospective Studies; Risk Factors | 2004 |
Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001.
Topics: Adult; Age Factors; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Sex Factors; Time Factors; Treatment Outcome; United Kingdom | 2004 |
Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria.
Topics: Achlorhydria; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2004 |
Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2004 |
In vitro exposure to macrolide antibiotics in Helicobacter pylori strains isolated from children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Gastrointestinal Diseases; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S | 2004 |
Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged | 2004 |
Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Biopsy; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Clarithromycin; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Protein Precursors; Sensitivity and Specificity; Urease | 2004 |
Effect of antibacterial therapy and salivary secretion on the efficacy of Helicobacter pylori eradication in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth; Omeprazole; Saliva; Sex Factors; Stomach; Tinidazole; Treatment Outcome | 2004 |
[Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole | 2004 |
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Platelet Count; Remission Induction; Thrombocytopenia | 2004 |
High level of resistance to metronidazole and clarithromycin in Helicobacter pylori isolated from pediatric patients in Poland (1997-2001).
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Poland; Stomach | 2004 |
Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis.
Topics: Adult; Amoxicillin; Breath Tests; Child; Clarithromycin; Disease Transmission, Infectious; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Urea | 2004 |
DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; DNA Fingerprinting; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction; Treatment Outcome | 2004 |
High prevalence rate of Helicobacter pylori resistance to clarithromycin during long-term multiple antibiotic therapy for chronic respiratory disease caused by non-tuberculous mycobacteria.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mutation; Mycobacterium Infections; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 2004 |
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Ulcer; Treatment Outcome | 2004 |
Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Jordan; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Risk Assessment; Severity of Illness Index; Sulfoxides; Treatment Outcome | 2004 |
T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Base Sequence; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 23S | 2004 |
Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cells, Cultured; Clarithromycin; Cyclooxygenase Inhibitors; Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Pyrazoles; Sulfonamides | 2004 |
Effects of Helicobacter pylori eradication among adults with intellectual disability.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Intellectual Disability; Male; Mental Disorders; Metronidazole; Omeprazole; Outcome Assessment, Health Care; Treatment Outcome | 2004 |
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Mutation; Nucleic Acid Conformation; Peptidyl Transferases; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Urban Population | 2004 |
An unusual case of hypoglycemia in a diabetic patient.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Diabetes Mellitus, Type 2; Drug Interactions; Duodenal Ulcer; Glyburide; Helicobacter Infections; Helicobacter pylori; Humans; Hypoglycemia; Hypoglycemic Agents; Male | 2004 |
Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Ribosomal; Drug Resistance, Bacterial; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sensitivity and Specificity; Transition Temperature | 2004 |
The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens; Biopsy; Breath Tests; Clarithromycin; Colony Count, Microbial; Cytological Techniques; Dyspepsia; Endoscopy, Gastrointestinal; Feces; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2004 |
Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori.
Topics: Amoxicillin; Anaerobiosis; Anti-Infective Agents; Bacterial Proteins; Chloramphenicol; Clarithromycin; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; FMN Reductase; Gene Deletion; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nitroreductases; Sequence Analysis, DNA; Tetracycline | 2004 |
[Resistance to antibiotics used in Helicobacter pylori infection in children].
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracyclines; Treatment Outcome | 2004 |
[Helicobacter pylori resistance to metronidazole and clarythromicin: descriptive analysis 1997-2000].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Spain | 2004 |
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.
Topics: Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nitroimidazoles; Ofloxacin; Proton Pump Inhibitors; Treatment Failure | 2004 |
Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin.
Topics: Anti-Bacterial Agents; Blueberry Plants; Cell Proliferation; Clarithromycin; Fragaria; Fruit; Helicobacter Infections; Helicobacter pylori; In Vitro Techniques; Plant Extracts; Sambucus; Time Factors; Vaccinium macrocarpon; Vaccinium myrtillus | 2004 |
Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Apoptosis; Cell Proliferation; Choristoma; Clarithromycin; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Intestines; Lansoprazole; Omeprazole; Stomach | 2004 |
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2004 |
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Chemistry, Pharmaceutical; Clarithromycin; Drug Combinations; Female; Gastritis; Half-Life; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Immunoglobulin G; Lansoprazole; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Omeprazole; Penicillins; Sucralfate; Viscosity | 2004 |
Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Treatment Outcome | 2004 |
Results of triple eradication therapy in Japanese children: a retrospective multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides | 2004 |
[The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Cisapride; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Reproducibility of Results; Sulfoxides; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2004 |
Growth competition of macrolide-resistant and -susceptible Helicobacter pylori strains.
Topics: Anti-Infective Agents; Base Sequence; Clarithromycin; Clone Cells; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2004 |
Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Prospective Studies; Recurrence; Yemen | 2004 |
Clarithromycin treatment selects for persistent macrolide-resistant bacteria in throat commensal flora.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Microbial Sensitivity Tests; Neisseria; Pharynx; Streptococcus | 2005 |
[Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children].
Topics: Anti-Bacterial Agents; Biopsy; Child; Clarithromycin; Drug Resistance, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Prevalence; Stomach | 2004 |
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2005 |
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.
Topics: Area Under Curve; Azathioprine; Clarithromycin; Drug Administration Schedule; Drug Interactions; Duodenitis; Half-Life; Heart Transplantation; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Tacrolimus | 2005 |
Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Rabeprazole; Tokyo | 2005 |
[Clarithromycin resistance of Helicobacter pylori strains isolated from antral biopsy specimens].
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Pyloric Antrum | 2004 |
Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Rifabutin; Tinidazole | 2005 |
Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Clarithromycin; Enterobacteriaceae; Enterococcus; Feces; Helicobacter Infections; Helicobacter pylori; Intestines; Lansoprazole; Macaca; Omeprazole; Proton Pump Inhibitors | 2005 |
Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area.
Topics: Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Disease Transmission, Infectious; Drug Therapy, Combination; Dyspepsia; Family; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Predictive Value of Tests; Prevalence; Risk Factors; Secondary Prevention; Social Class; Surveys and Questionnaires | 2005 |
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gene Rearrangement; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin Heavy Chains; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prognosis; Remission Induction; Stomach Neoplasms | 2005 |
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Male; Omeprazole; Specific Pathogen-Free Organisms | 2005 |
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Stomach; Time Factors | 2005 |
Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antioxidants; Ascorbic Acid; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Microbial Sensitivity Tests; Stilbenes; Time Factors; Urease; Vitamin E | 2005 |
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura.
Topics: Amoxicillin; Breath Tests; Clarithromycin; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome; Urea | 2005 |
Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Specimen Handling | 2005 |
Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy.
Topics: Adult; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Treatment Failure | 2005 |
Comparison of proton pump inhibitor-based triple therapy with losec and the generic drug, Omepradex, for efficacy of Helicobacter pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Generic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2005 |
Antibiotic resistance of Helicobacter pylori isolated in Split, Southern Croatia.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Croatia; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole | 2005 |
Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Rosacea | 2005 |
Macrolide-affected Toll-like receptor 4 expression from Helicobacter pylori-infected monocytes does not modify interleukin-8 production.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lipopolysaccharides; Macrolides; Membrane Glycoproteins; Monocytes; Receptors, Cell Surface; Toll-Like Receptor 4; Toll-Like Receptors | 2005 |
[Helicobacter pylori infection in patients with chronic hives and asthma].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Asthma; Chronic Disease; Clarithromycin; Enzyme Inhibitors; Feces; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin E; Male; Middle Aged; Omeprazole; Treatment Outcome; Urticaria | 2005 |
Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000.
Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Resistance; Dyspepsia; Emigration and Immigration; Female; Helicobacter Infections; Helicobacter pylori; Hospitals; Humans; London; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Polymorphism, Genetic; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 23S | 2005 |
Polymerase chain reaction--restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample.
Topics: Adolescent; Anti-Bacterial Agents; Antigens, Bacterial; Child; Child, Preschool; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 2005 |
Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2005 |
Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori.
Topics: Adhesives; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Compounding; Gastric Mucosa; Half-Life; Helicobacter Infections; Helicobacter pylori; Microscopy, Electron, Scanning; Microspheres; Mucous Membrane; Nephelometry and Turbidimetry; Particle Size; Penicillins; Solubility | 2005 |
[Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Polyps; Stomach Neoplasms | 2005 |
[Evaluation of gatifloxacin-based triple therapy for refractory H. pylori].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 2005 |
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies; Autoimmune Diseases; Bacterial Proteins; Breath Tests; Celiac Disease; Child; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female; Ferrous Compounds; Gastrins; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Prospective Studies; Urease; Vitamin B 12 Deficiency | 2005 |
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Biopsy; Clarithromycin; Colony Count, Microbial; Cytochrome P-450 CYP2C19; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Outcome | 2005 |
Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracycline | 2005 |
Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from human feces.
Topics: Clarithromycin; Drug Resistance, Microbial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Sensitivity and Specificity | 2005 |
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Microscopy, Electron, Transmission; Middle Aged; Omeprazole; Stomach; Treatment Outcome | 2005 |
Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Fluorescent Dyes; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Paraffin Embedding; Reagent Kits, Diagnostic; Sensitivity and Specificity; Stomach; Time Factors | 2005 |
Assessment of Helicobacter pylori clarithromycin resistance mutations in archival gastric biopsy samples.
Topics: Anti-Bacterial Agents; Base Sequence; Biopsy; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Switzerland | 2005 |
Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Biphenyl Compounds; Clarithromycin; Drug Resistance, Bacterial; Guanidine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Middle Aged; Urease | 2005 |
Eradication of Helicobacter spp. from a rat breeding colony.
Topics: Amoxicillin; Animal Feed; Animals; Animals, Laboratory; Clarithromycin; DNA Primers; Electrophoresis, Agar Gel; Feces; Helicobacter; Helicobacter Infections; Metronidazole; Omeprazole; Polymerase Chain Reaction; Rats; RNA, Ribosomal, 16S; Rodent Diseases | 2005 |
Alarming clarithromycin resistance of Helicobacter pylori in Turkish population.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Turkey | 2005 |
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; CD55 Antigens; CD59 Antigens; Clarithromycin; Complement C3c; Complement Inactivator Proteins; Complement System Proteins; Female; Gastric Mucosa; Gastritis; Glycosylphosphatidylinositols; Helicobacter Infections; Helicobacter pylori; Humans; Male; Membrane Cofactor Protein; Middle Aged; Omeprazole; Peptic Ulcer; Receptors, Complement | 2005 |
Determinants of non-response in Helicobacter pylori eradication trials.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure | 2005 |
Primary mucosa-associated lymphoid tissue lymphoma occurring in the rectum.
Topics: Amoxicillin; Biopsy, Needle; Clarithromycin; Colonoscopy; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Helicobacter Infections; Humans; Immunohistochemistry; Intestinal Mucosa; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Omeprazole; Rectal Neoplasms; Risk Assessment; Treatment Outcome | 2005 |
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Cyclin-Dependent Kinase Inhibitor p27; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-8; Lansoprazole; Male; Middle Aged; Omeprazole; Proteins; Proto-Oncogene Proteins c-myc; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Phase Kinase-Associated Proteins | 2006 |
Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Poland; Tetracycline | 2005 |
Helicobacter pylori infection rate in patients with nontuberculous mycobacteriosis who are on longterm combination chemotherapy of clarithromycin and rifampicin.
Topics: Aged; Aged, 80 and over; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Mycobacterium Infections; Rifampin | 2005 |
Heterogeneous susceptibility to metronidazole and clarithromycin of Helicobacter pylori isolates from a single biopsy in adults is confirmed in children.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Point Mutation; Polymorphism, Restriction Fragment Length; Prospective Studies; Random Amplified Polymorphic DNA Technique; Stomach | 2005 |
Diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance by fluorescence in situ hybridization from formalin-fixed, paraffin-embedded gastric biopsy specimens.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Formaldehyde; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Paraffin Embedding; Stomach; Tissue Fixation | 2005 |
CagA status and Helicobacter pylori eradication among dyspeptic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Biomarkers; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Eosinophils; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphocytes; Male; Middle Aged; Omeprazole; Peptic Ulcer | 2005 |
[The cause of failure of eradication treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2005 |
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Gastrointestinal Tract; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain Measurement; Quality of Life; Stomach Ulcer; Surveys and Questionnaires | 2005 |
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Male; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2005 |
Helicobacter pylori: factors affecting eradication and recurrence.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Sulfoxides | 2005 |
Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 23S; Time Factors | 2006 |
[The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Stomach Ulcer | 2005 |
Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2005 |
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Pilot Projects; Rabeprazole; Treatment Failure; Treatment Outcome | 2006 |
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Peptic Ulcer; Polymerase Chain Reaction; Prevalence | 2006 |
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Rifabutin; Sulfoxides; Treatment Outcome | 2006 |
Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline | 2006 |
"Best practice' for Helicobacter pylori eradication in the primary care setting.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ireland; Omeprazole; Primary Health Care; Rabeprazole | 2006 |
[Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenum; Esophagus; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Stomach | 2006 |
[Pseudomembranous colitis after Helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2006 |
Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Combinations; Drug Synergism; Ethanol; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medicine, Traditional; Microbial Sensitivity Tests; Plant Extracts; Propolis; Zingiber officinale | 2006 |
Primary clarithromycin resistance to Helicobacter pylori and therapy failure in children: the experience in West Virginia.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; West Virginia | 2006 |
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymerase Chain Reaction; Ranitidine; Treatment Outcome | 2005 |
Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Recurrence; Risk Factors; Tetracycline | 2006 |
Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.
Topics: Adolescent; Age Distribution; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Prospective Studies; Sex Distribution; Treatment Failure | 2006 |
Helicobacter pylori eradication in peptic dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2005 |
Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Teaching; Humans; Kenya; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2005 |
Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; China; Clarithromycin; Cohort Studies; Cost-Benefit Analysis; Diclofenac; Drug Administration Schedule; Female; Health Care Costs; Health Services; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk Factors | 2006 |
Helicobacter pylori antimicrobial resistance and risk factors in Denmark 1998-2004: no need for concern?
Topics: Anti-Bacterial Agents; Clarithromycin; Denmark; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Risk Factors | 2006 |
Primary cutaneous MALT-type lymphoma and Helicobacter pylori: a possible relationship.
Topics: Adult; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Skin Neoplasms | 2006 |
Helicobacter pylori isolated from patients who later failed H. pylori eradication triple therapy readily develop resistance to clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Duodenal Ulcer; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; In Vitro Techniques; Point Mutation; Proton Pump Inhibitors; RNA, Bacterial; RNA, Ribosomal, 23S; Stomach Ulcer; Treatment Failure | 2006 |
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Species Specificity; Tetracycline; Virulence | 2006 |
Is there a role for sequential in sequential anti-H. pylori therapy?
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2006 |
Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Common Variable Immunodeficiency; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Stomach Neoplasms | 2006 |
[Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Perforation; Randomized Controlled Trials as Topic; Recurrence; Tetracycline; Time Factors | 2006 |
Influence of smoking and CYP2C19 genotypes on H. pylori eradication success.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Smoking; Treatment Outcome | 2007 |
Management of the dyspeptic patient: anything goes?
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Surveys and Questionnaires; Treatment Outcome | 2006 |
Eradication of Helicobacter pylori and dosages of esomeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2006 |
[Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura].
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Platelet Count; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic | 2006 |
Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Rabeprazole; Statistics, Nonparametric | 2006 |
Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Mixed Function Oxygenases; Polymorphism, Genetic; Proton Pump Inhibitors | 2006 |
Contrast-enhanced ultrasonographic assessment of the response of Ménétrier disease to Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Contrast Media; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Polysaccharides; Ultrasonography | 2006 |
Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Patient Compliance; Prospective Studies; Treatment Outcome | 2006 |
Clarithromycin induced psychosis.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Humans; Male; Psychoses, Substance-Induced; Risk Factors | 2006 |
The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic; Turkey | 2006 |
Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication.
Topics: Acrylic Resins; Adult; Amoxicillin; Anti-Bacterial Agents; Biocompatible Materials; Chitosan; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogels; Male; Middle Aged | 2006 |
Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Remission Induction; Stomach Neoplasms | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Clarithromycin resistance prevalence and Icea gene status in Helicobacter Pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Clarithromycin; DNA, Ribosomal; Drug Resistance, Bacterial; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Turkey | 2006 |
Primary resistance and antibiotic minimum inhibitory concentrations for Helicobacter pylori strains, in Split, Croatia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Clarithromycin; Croatia; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests | 2006 |
Guidelines in the medical treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dyspepsia; Europe; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors | 2006 |
Analysis of resistance to clarithromycin and iceA status in Helicobacter pylori isolates from San Luis, Argentina.
Topics: Argentina; Bacterial Outer Membrane Proteins; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptic Ulcer; Point Mutation; RNA, Ribosomal, 23S; Stomach Neoplasms | 2006 |
[The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Tetracycline | 2006 |
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.
Topics: Adult; Aged; Alaska; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Population Groups; Sentinel Surveillance; Stomach; Tetracycline | 2006 |
Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure.
Topics: Amoxicillin; Anti-Bacterial Agents; Biomarkers; Biopsy; Body Weight; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Follow-Up Studies; Gastric Mucosa; Gastritis; Gene Expression; Ghrelin; Growth Hormone; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Middle Aged; Peptide Hormones; Prognosis; Proton Pump Inhibitors; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Some fibrocystic breast change may be caused by sexually transmitted H. pylori during oral nipple contact: supporting literature and case report of resolution after gut H. pylori eradication treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Female; Fibrocystic Breast Disease; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Models, Biological; Nipples; Serologic Tests; Time Factors; Treatment Outcome; Ultrasonography | 2007 |
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Retrospective Studies; Salicylates; Treatment Outcome | 2006 |
[Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sex Factors | 2006 |
Claritromycin resistance and Helicobacter pylori genotypes in Italy.
Topics: Adult; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged | 2006 |
Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Stomach Neoplasms | 2006 |
Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Halitosis; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Omeprazole; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2007 |
Adverse events reporting.
Topics: Abdominal Pain; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Fatigue; Femoral Fractures; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Paresthesia; Perceptual Disorders; Terminology as Topic; Vision, Low | 2007 |
Results from the pediatric European register for treatment of Helicobacter pylori (PERTH).
Topics: Adolescent; Antacids; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Microbial Sensitivity Tests; Omeprazole; Registries; Treatment Outcome | 2007 |
Clarithromycin resistance in Helicobacter pylori strains isolated from French children: prevalence of the different mutations and coexistence of clones harboring two different mutations in the same biopsy.
Topics: Biopsy; Child; Clarithromycin; Drug Resistance, Bacterial; Female; France; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Time Factors | 2007 |
Chest pain during triple therapy for duodenal ulcer.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Chest Pain; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Hiccup; Humans; Male; Mediastinal Emphysema; Metronidazole; Omeprazole; Radiography, Thoracic; Tomography, X-Ray Computed | 2007 |
Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Microbial Sensitivity Tests; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Sex Characteristics | 2007 |
Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pyloric Antrum; Sensitivity and Specificity; Treatment Outcome; Urease | 2007 |
[Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes].
Topics: Adolescent; Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prevalence; Sex Factors; Socioeconomic Factors; Time Factors | 2007 |
Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Stomach Ulcer | 2007 |
Is perforated marginal ulcer after the surgery of gastroduodenal ulcer associated with inadequate treatment for Helicobacter pylori eradication?
Topics: Adult; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Female; Gastrectomy; Gastric Outlet Obstruction; Helicobacter Infections; Helicobacter pylori; Humans; Jejunum; Male; Middle Aged; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Postoperative Complications; Reoperation; Retrospective Studies; Stomach Ulcer | 2007 |
Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children.
Topics: Adolescent; Anti-Bacterial Agents; Antigens, Bacterial; Child; Child, Preschool; Clarithromycin; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2007 |
Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Patient Selection; Taiwan; Tetracycline | 2007 |
Influence of H pylori on plasma ghrelin in patients without atrophic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Peptide Hormones; Turkey | 2007 |
A better cure rate with 800 mg than with 400 mg clarithromycin regimens in one-week triple therapy for Helicobacter pylori infection in cigarette-smoking peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Retrospective Studies; Smoking; Statistics, Nonparametric; Treatment Outcome | 2007 |
[Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients].
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Chile; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Tetracycline Resistance | 2007 |
Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
Topics: Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers, Tumor; Case-Control Studies; CDX2 Transcription Factor; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Hedgehog Proteins; Helicobacter Infections; Helicobacter pylori; Homeodomain Proteins; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Metaplasia; Middle Aged; Pepsinogen A; Precancerous Conditions; Stomach Neoplasms | 2007 |
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2007 |
Gastric inflammatory fibroid polyp treated with Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Polyps; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2007 |
Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Microbial Sensitivity Tests; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2007 |
[Antibiotic resistance of Helicobacter pylori].
Topics: Anti-Bacterial Agents; Clarithromycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique | 2007 |
[Reliable Helicobacter eradication. Combination package facilitates therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Packaging; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Patient Compliance; Stomach Diseases | 2006 |
Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenitis; Duodenoscopy; Duodenum; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index | 2007 |
[The epidemiology of clarithromycin resistance of Helicobacter pylori infection in Hungary].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Male; Middle Aged; Prevalence; Risk Factors | 2007 |
Helicobacter pylori primary resistant strains over 11 years in French children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; France; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Time Factors | 2007 |
Levofloxacin in first-line treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Treatment Outcome | 2007 |
Detection and clarithromycin susceptibility testing of Helicobacter pylori in stool specimens by real-time PCR: how to get accurate test results.
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests | 2007 |
[Side effects of Helicobacter pylori eradication therapy].
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 2007 |
Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Restriction Fragment Length; Treatment Outcome | 2007 |
High Helicobacter pylori resistance rate to clarithromycin in Turkey.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; RNA, Bacterial; Turkey | 2007 |
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteroides; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Feces; Female; Gram-Positive Cocci; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Nose; Omeprazole; Pharynx; Prospective Studies | 2007 |
Pyroderma gangrenosum: resolution after treatment for Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Pyoderma Gangrenosum | 2006 |
Efficacy of clarithromycin-based triple therapy for treating Helicobacter pylori in Thai non-ulcer dyspeptic patients with clarithromycin-resistant strains.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Thailand; Treatment Outcome | 2006 |
Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene.
Topics: Anti-Bacterial Agents; Chile; Clarithromycin; Drug Resistance, Bacterial; Genes, rRNA; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2007 |
Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Diterpenes; Drug Resistance, Bacterial; Drug Therapy, Combination; Fatty Alcohols; Genetic Variation; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Microbial Sensitivity Tests; Specific Pathogen-Free Organisms | 2007 |
Clarithromycin resistance, tumor necrosis factor alpha gene polymorphism and mucosal inflammation affect H. pylori eradication success.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Aryl Hydrocarbon Hydroxylases; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastric Mucosa; Gene Frequency; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-10; Male; Middle Aged; Mixed Function Oxygenases; Pharmacogenetics; Point Mutation; Polymorphism, Genetic; Treatment Outcome; Tumor Necrosis Factor-alpha; Virulence | 2007 |
Detection of clarithromycin-resistant Helicobacter pylori in frozen gastric biopsies from pediatric patients by a commercially available fluorescent in situ hybridization.
Topics: Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Freezing; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Stomach | 2007 |
Rapid screening of clarithromycin resistance in Helicobacter pylori by pyrosequencing.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 23S; Sensitivity and Specificity; Sequence Analysis, DNA | 2007 |
Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; DNA Primers; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Peptic Ulcer; Phenotype; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2007 |
Helicobacter pylori and antibiotic resistance.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans | 2007 |
Helicobacter pylori recurrence and infection rate in Israeli adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Middle Aged; Omeprazole; Prognosis; Prospective Studies; Recurrence; Surveys and Questionnaires | 2008 |
Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Sex Factors | 2007 |
A quintuple therapy for H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Omeprazole; Probiotics; Treatment Outcome | 2007 |
[Antimicrobial susceptibility of H pylori strains obtained from Paraguayan patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Paraguay | 2007 |
[Pathogen eradication prevents gastrointestinal complications].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Peptic Ulcer; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Premedication; Proton Pump Inhibitors; Risk Factors; Secondary Prevention | 2007 |
Failure of sequential therapy to eradicate Helicobacter pylori in previously treated subjects.
Topics: Adolescent; Adult; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tinidazole; Treatment Failure | 2007 |
Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Humans; Middle Aged; Psoriasis | 2008 |
Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Clarithromycin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Gastric Mucosa; Gels; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Male; Polysaccharides, Bacterial; Solubility; Stomach; Sucralfate; Viscosity | 2008 |
[Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Child; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2007 |
Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline | 2008 |
[Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Retrospective Studies | 2007 |
Detection of Helicobacter pylori and its sensitivity to antibiotics. A step forward in the use of molecular methods.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Viral; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach | 2007 |
Routine use of real-time PCR for detection of Helicobacter pylori and of clarithromycin resistance mutations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Clarithromycin; Culture Media; DNA, Viral; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; RNA, Ribosomal, 23S; Sensitivity and Specificity; Stomach | 2007 |
Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Genes, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Polymorphism, Single Nucleotide | 2008 |
Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Combinations; Excipients; Gastric Mucosa; Gastrointestinal Tract; Gliadin; Helicobacter Infections; Helicobacter pylori; Male; Microscopy, Electron, Transmission; Nanoparticles; Omeprazole; Particle Size; Rats; Rats, Sprague-Dawley; Tissue Adhesives | 2008 |
Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Platelet Count; Prospective Studies; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic | 2008 |
[Duodenal ulcer and helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Duodenoscopy; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2007 |
Effect of Helicobacter pylori eradication on gastric carcinogenesis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amoxicillin; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lansoprazole; Male; Specific Pathogen-Free Organisms; Stomach Neoplasms; Time Factors | 2008 |
Application of polymerase chain reaction-based assays for rapid identification and antibiotic resistance screening of Helicobacter pylori in gastric biopsies.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Stomach; Tetracycline | 2008 |
[Sequential therapy regimen for Helicobacter pylori infection in children].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Omeprazole; Prospective Studies; Time Factors | 2008 |
Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Antibodies; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Middle Aged; Phenotype; Prospective Studies; Stomach; Stomach Neoplasms; Tropomyosin; Tumor Suppressor Protein p53 | 2008 |
Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.
Topics: Adult; Aged; Alkylating Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Clarithromycin; Female; Helicobacter Infections; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Male; Middle Aged; Omeprazole; Retrospective Studies; Risk Factors; Tinidazole | 2008 |
Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Cameroon; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Pyloric Antrum; Sex Factors; Stomach; Tetracycline | 2008 |
[Effect of Helicobacter pylori eradication on iron deficiency anemia of unknown origin].
Topics: Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Absorption; Iron; Male; Middle Aged; Omeprazole; Prospective Studies; Remission Induction | 2008 |
Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Topics: Adult; Alanine Transaminase; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Hepatitis, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Topics: Animals; Anti-Infective Agents; Anti-Ulcer Agents; Carcinoma in Situ; Cell Proliferation; Clarithromycin; Disease Progression; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lithostathine; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Omeprazole; Precancerous Conditions; Stomach Neoplasms; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2008 |
The eradication of Helicobacter pylori is affected by body mass index (BMI).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Body Mass Index; Clarithromycin; Comorbidity; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Multivariate Analysis; Obesity, Morbid; Pantoprazole; Pilot Projects | 2008 |
Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Glucose; Carbamates; Clarithromycin; Diabetes Mellitus, Type 2; Drug Interactions; Helicobacter Infections; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Piperidines | 2008 |
Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori.
Topics: Alleles; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Fluorescence; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation, Missense; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 2008 |
Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Proton Pump Inhibitors; Treatment Outcome | 2008 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer; Tetracycline | 1995 |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1995 |
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori.
Topics: Amoxicillin; Circadian Rhythm; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole | 1995 |
Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels.
Topics: Adult; Carbamazepine; Clarithromycin; Drug Interactions; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tetracycline | 1995 |
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers.
Topics: Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1995 |
Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Topics: Aluminum Chloride; Aluminum Compounds; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chalcone; Chalcones; Chlorides; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Erythromycin; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Tetracycline; Zinc Compounds | 1994 |
Pseudomembranous colitis following clarithromycin therapy.
Topics: Aged; Clarithromycin; Duodenal Ulcer; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans | 1995 |
Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Tinidazole | 1995 |
Helicobacter pylori eradication and reinfection.
Topics: Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Omeprazole; Peptic Ulcer; Ranitidine | 1995 |
One-week low-dose triple therapy: new standards for Helicobacter pylori treatment.
Topics: Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tinidazole | 1995 |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline; Time Factors | 1994 |
[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?].
Topics: Adult; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Switzerland | 1994 |
Eradication of Helicobacter pylori with clarithromycin and omeprazole.
Topics: Adult; Aged; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1994 |
Clarithromycin for the eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Middle Aged | 1993 |
What is the meaning of ranitidine in successful triple-therapy against Helicobacter pylori infection?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ranitidine | 1995 |
Response to article by Forné et al.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Colloids; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Remission Induction | 1996 |
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Recurrence | 1995 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer | 1995 |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pilot Projects; Treatment Outcome | 1995 |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Patient Compliance; Penicillins; Recurrence; Tetracycline; Time Factors | 1996 |
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Carbamazepine; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1996 |
Clarithromycin and omeprazole for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1996 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer; Tetracycline | 1996 |
Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Clarithromycin; Clinical Enzyme Tests; Clinical Laboratory Techniques; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Urea; Urease | 1996 |
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins | 1996 |
Italian omeprazole triple therapy--a 1-week regimen.
Topics: Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Omeprazole; Time Factors; Tinidazole | 1996 |
Antimicrobial resistance and Helicobacter pylori.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles | 1996 |
H. pylori treatment recognized by FDA.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; United States; United States Food and Drug Administration | 1996 |
Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano He
Topics: Agar; Anti-Bacterial Agents; Clarithromycin; Color; Developing Countries; Drug Resistance, Microbial; Evaluation Studies as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Indicators and Reagents; Metronidazole; Microbial Sensitivity Tests; Peru; Reproducibility of Results | 1996 |
High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole | 1996 |
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies | 1996 |
In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning | 1996 |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole | 1996 |
Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Base Sequence; Clarithromycin; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Sequence Data; RNA, Bacterial; RNA, Ribosomal, 23S | 1996 |
Practice guidelines for treatment of peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine | 1996 |
Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyps; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1996 |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Stomach Ulcer | 1996 |
In-vitro activities of clarithromycin and other antimicrobial agents against Helicobacter pylori isolated from children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Microbial Sensitivity Tests | 1996 |
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Obstruction; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pyloric Stenosis | 1996 |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Electromyography; Female; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Myoelectric Complex, Migrating; Omeprazole | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Time Factors | 1996 |
Eradication of Helicobacter pylori followed by reinfection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Blotting, Southern; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Peptic Ulcer; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Recurrence | 1996 |
Atopic dermatitis successfully treated by eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Blotting, Western; Clarithromycin; Dermatitis, Atopic; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 1996 |
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Immunoproliferative Small Intestinal Disease; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Penicillins | 1997 |
Drugs for treatment of peptic ulcers.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Interactions; Drug Resistance, Microbial; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Misoprostol; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Salicylic Acid; Sucralfate; Tetracycline | 1997 |
Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Netherlands; Prevalence | 1996 |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Roxithromycin; Treatment Outcome | 1996 |
Life-threatening interaction between clarithromycin and disopyramide.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disopyramide; Drug Interactions; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Ventricular Fibrillation | 1997 |
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors | 1997 |
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Ceftibuten; Cephalosporins; Clarithromycin; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Omeprazole; Penicillins; Stomach | 1996 |
Effective 2-wk therapy for Helicobacter pylori disease in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Metronidazole; Omeprazole; Pyloric Antrum; Time Factors | 1997 |
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Buffers; Chromatography, High Pressure Liquid; Clarithromycin; Gastric Juice; Half-Life; Helicobacter; Helicobacter Infections; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Metronidazole; Omeprazole; Penicillins; Solutions | 1997 |
Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Regression Analysis; Sex Factors; Smoking; Tinidazole; Treatment Failure | 1997 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1996 |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole | 1997 |
[The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Time Factors | 1997 |
PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Clarithromycin; DNA Probes; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Reproducibility of Results; Serotyping; Stomach Diseases | 1997 |
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Female; Gastritis; Germany; Helicobacter Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1997 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Chronic Disease; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Juice; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lactoferrin; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum | 1997 |
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence | 1996 |
Clarithromycin-induced fever in a patient with Helicobacter pylori gastritis.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Fever; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male | 1997 |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Prospective Studies; Time Factors; Wound Healing | 1997 |
Evaluation of the dyspeptic patient: a cost-utility study.
Topics: Adult; Ambulatory Care; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Barium Sulfate; Clarithromycin; Contrast Media; Cost-Benefit Analysis; Decision Support Techniques; Dyspepsia; Endoscopy, Gastrointestinal; Evaluation Studies as Topic; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Probability; Quality of Life; Recurrence; Survival Rate; Treatment Outcome; Value of Life | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Superoxide Dismutase | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Spectrometry; Metronidazole; Middle Aged; Omeprazole; Sensitivity and Specificity; Tetracycline | 1997 |
Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole | 1997 |
Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins; Proctoscopy; Rectal Neoplasms; Remission Induction | 1997 |
Pharmacological therapy of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Tetracycline; Treatment Outcome; Vaccination | 1997 |
Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Risk Factors; Tetracyclines; Time Factors; Treatment Outcome; Wound Healing | 1997 |
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1997 |
[Two step therapy for education of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 1997 |
[Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1997 |
Regression of mucosa-associated lymphoid-tissue lymphoma after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins | 1997 |
H. pylori eradication by LAC.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Food-Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 1997 |
Low dose, short-term, triple therapy for helicobacter pylori associated peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Peptic Ulcer | 1997 |
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Time Factors; Treatment Failure | 1997 |
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Tetracycline | 1997 |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hypoproteinemia; Metronidazole; Omeprazole; Stomach | 1997 |
[Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, and pepsinogen II after eradication therapy of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Penicillins; Pepsinogens; Peptic Ulcer; Proton Pump Inhibitors | 1997 |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pilot Projects; Tetracycline; Treatment Outcome | 1996 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole | 1996 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Risk Factors; Salicylates; Sex Factors; Weight Gain | 1997 |
[Successful eradication of H. pylori in an elderly patient with gastric cancer after effective UFT-E therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Diterpenes; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Neoplasms; Tegafur; Uracil | 1997 |
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori.
Topics: Clarithromycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 23S | 1996 |
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins | 1997 |
Pragmatic eradication of H. pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1997 |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins; Polymerase Chain Reaction; Pyloric Antrum; Stomach Neoplasms; Stomach Ulcer | 1997 |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Stomach Ulcer; Time Factors; Tinidazole | 1997 |
Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; DNA Primers; Drug Therapy, Combination; Enzyme Inhibitors; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Ulcer | 1998 |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Male; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1998 |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
Topics: Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 1998 |
New, improved Helicobacter pylori eradication therapy in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1998 |
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Lansoprazole; Male; Metronidazole; Omeprazole; Peptic Ulcer; Time Factors | 1998 |
[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection].
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Risk Factors; Stomach Ulcer | 1998 |
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Omeprazole; Tinidazole; Treatment Failure | 1998 |
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillin Resistance; Penicillins; Peptic Ulcer | 1998 |
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1998 |
[Resistance of Helicobacter pylori to clarithomycin].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged | 1998 |
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Time Factors | 1998 |
Effectiveness of omeprazole-amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Humans; Japan; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Time Factors | 1998 |
[Topics on Helicobacter pylori (discussion)].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Stomach Neoplasms | 1998 |
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Duodenal Ulcer; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Polymerase Chain Reaction | 1998 |
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Stomach Ulcer; Sulfoxides; Tinidazole; Treatment Outcome | 1998 |
Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Phenotype; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 23S | 1998 |
[Is dental plaque a normal Helicobacter pylori reservoir?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Dental Plaque; Disease Reservoirs; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prevalence; Recurrence; Sulfoxides | 1998 |
Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; IgA Vasculitis; Male; Middle Aged; Omeprazole; Penicillins; Stomach Diseases | 1998 |
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Proton Pump Inhibitors; Sensitivity and Specificity; Spectrum Analysis; Urea | 1998 |
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Blotting, Western; Clarithromycin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; Liver Function Tests; Omeprazole; Treatment Outcome | 1998 |
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 1998 |
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Clarithromycin; DNA, Ribosomal; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyloric Antrum; RNA, Ribosomal, 23S | 1998 |
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 1998 |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection.
Topics: Adolescent; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole | 1998 |
[Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stomach Ulcer | 1998 |
Characterization of clinical isolates of Helicobacter pylori in Singapore.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Cytotoxins; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Prevalence; Random Amplified Polymorphic DNA Technique; Singapore; Stomach; Tetracycline Resistance | 1998 |
Helicobacter pylori eradication failure--'salvage' therapies needed.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Treatment Failure | 1998 |
Contact granulomas.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Clarithromycin; Granuloma, Laryngeal; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole | 1998 |
Treating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine | 1998 |
Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sites.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; New South Wales | 1998 |
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitroimidazoles; Omeprazole; Tinidazole; Treatment Failure | 1998 |
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitrofurantoin; Tetracycline | 1998 |
Healing of cimetidine-resistant Ménétrier's disease by eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Cimetidine; Clarithromycin; Diterpenes; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hypoproteinemia; Lansoprazole; Omeprazole; Time Factors | 1998 |
Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance.
Topics: Anti-Bacterial Agents; Base Sequence; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sensitivity and Specificity; Sequence Analysis, RNA | 1998 |
One-week low-dose triple therapy is effective in treating Helicobacter pylori-infected patients with bleeding peptic ulcers.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1998 |
Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Stomach Ulcer; Treatment Outcome; Wound Healing | 1998 |
[Treatment of Helicobacter pylori infection].
Topics: Antacids; Anti-Bacterial Agents; Clarithromycin; Dyspepsia; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Norway; Practice Patterns, Physicians'; Surveys and Questionnaires | 1998 |
[Eradication of Helicobacter pylori by triple therapy in ulcerous patients: the role of endoscopy and antibiotic sensitivity].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1998 |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 23S | 1999 |
Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Gastric Acid; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Omeprazole; Peroxidase; Stomach Ulcer | 1999 |
Treatment of Helicobacter heilmannii-associated gastritis in a 14-year-old boy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Granulocytes; Helicobacter; Helicobacter Infections; Humans; Male; Omeprazole; Penicillins | 1999 |
Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.
Topics: Aged; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Omeprazole | 1999 |
Helicobacter pylori resists arrest.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Failure | 1999 |
Understanding peptic ulcer disease pharmacotherapeutics.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1999 |
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tetracycline | 1999 |
Clarithromycin-based triple therapies.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans | 1999 |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Costs and Cost Analysis; Decision Support Techniques; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Models, Economic; Omeprazole | 1996 |
Clarithromycin-induced acute psychoses in peptic ulcer disease.
Topics: Acute Disease; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Psychoses, Substance-Induced | 1999 |
[Profile of the resistance to macrolides and imidazoles of Helicobacter pylori in a sample of the Portuguese population].
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Sensitivity and Specificity; Stomach | 1998 |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Toxins; Bacterial Vaccines; Bismuth; Clarithromycin; Drug Therapy, Combination; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli Proteins; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Metronidazole; Omeprazole; Organometallic Compounds; Recombinant Proteins; Salicylates; Saliva; Urease | 1999 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Utilization; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Netherlands; Tetracycline | 1999 |
Helicobacter pylori infection and persistent hyperemesis gravidarum.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hyperemesis Gravidarum; Omeprazole; Penicillins; Peptic Ulcer; Pregnancy; Pregnancy Complications, Infectious; Proton Pump Inhibitors; Ranitidine | 1999 |
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies | 1999 |
Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii.
Topics: Animals; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Azithromycin; Biopsy; Bismuth; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Cat Diseases; Cats; Clarithromycin; Female; Gas Chromatography-Mass Spectrometry; Helicobacter; Helicobacter Infections; Male; Metronidazole; Polymerase Chain Reaction; Prospective Studies; Random Allocation; Ranitidine; Stomach Diseases; Tinidazole; Urea | 1999 |
Treatment of Helicobacter pylori infection in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Randomized Controlled Trials as Topic; Reproducibility of Results | 1999 |
Effect of clarithromycin and omeprazole therapy on the diversity and stability of genotypes of Helicobacter pylori from duodenal ulcer patients.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Base Sequence; Clarithromycin; DNA Primers; Drug Therapy, Combination; Duodenal Ulcer; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Omeprazole; Point Mutation; RNA, Ribosomal, 23S | 1999 |
[Are 5 days of omeprazole plus 2 antibiotics enough for eradication of H. pylori? Comments on sample size].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Confidence Intervals; Data Interpretation, Statistical; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Sample Size; Time Factors | 1999 |
My approach to Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Proton Pump Inhibitors | 1999 |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Retreatment; Treatment Failure | 1999 |
Occurence of resistance mutation and clonal expansion in Helicobacter pylori multiple-strain infection: a potential risk in clarithromycin-based therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Risk; RNA, Ribosomal, 23S | 1999 |
Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States.
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Urban; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; United States | 1999 |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Remission, Spontaneous; Treatment Outcome | 1999 |
What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance?
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Tetracycline Resistance; Treatment Outcome | 1999 |
Re-treatment after Helicobacter pylori eradication failure.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Failure | 1999 |
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Base Sequence; Clarithromycin; DNA Primers; Drug Resistance, Microbial; Evaluation Studies as Topic; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; Polymerase Chain Reaction; Sensitivity and Specificity | 1999 |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastrointestinal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole | 1999 |
[A ration proposal for the eradicating treatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1999 |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Attitude of Health Personnel; Breath Tests; Carbon Isotopes; Carbon Radioisotopes; Clarithromycin; Drug Resistance, Microbial; Enzyme Inhibitors; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Practice Patterns, Physicians'; Proton Pump Inhibitors; Radiopharmaceuticals; Surveys and Questionnaires; Urea | 1999 |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Protein-Losing Enteropathies | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Treatment Outcome | 1999 |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.
Topics: Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic | 1999 |
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colonic Neoplasms; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Omeprazole | 2000 |
Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; DNA Primers; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sucralfate; Time Factors; Treatment Outcome | 1999 |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1999 |
Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay.
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nucleic Acid Hybridization; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Specimen Handling | 2000 |
Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients?
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Dyspepsia; Empiricism; Endoscopy, Digestive System; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Quality of Life | 1999 |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Proton Pump Inhibitors | 2000 |
Clarithromycin resistance in Helicobacter pylori: implications for therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors | 2000 |
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA Primers; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S | 2000 |
Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis.
Topics: Anti-Bacterial Agents; Biopsy; Cell Division; Clarithromycin; DNA Damage; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Nick-End Labeling; Ki-67 Antigen; Metronidazole | 1999 |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diverticulum; Drug Therapy, Combination; Duodenal Diseases; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage | 2000 |
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Risk Factors; Treatment Outcome | 2000 |
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute-Phase Reaction; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biomarkers; Breath Tests; Cholesterol, HDL; Cholesterol, LDL; Clarithromycin; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Triglycerides; Urea | 2000 |
Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Treatment Outcome; United States | 2000 |
[Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prognosis; Prospective Studies; Remission Induction; Spain | 2000 |
Costs and benefits of a test-and-treat strategy in Helicobacter pylori-infected subjects: a prospective intervention study in general practice.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Cost Savings; Costs and Cost Analysis; Drug Therapy, Combination; Family Practice; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Ranitidine | 2000 |
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Oligonucleotide Probes; Point Mutation; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S | 2000 |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis; Female; Gastroscopy; Heartburn; Helicobacter Infections; Helicobacter pylori; Hernia, Diaphragmatic; Humans; Male; Omeprazole; Penicillins; Primary Health Care; Retrospective Studies; Stomach Ulcer | 2000 |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Stomach; Tetracycline | 2000 |
[Usefulness of Helicobacter pylori antigen detection in stools in the diagnosis of infection and confirming eradication after treatment].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Clarithromycin; Data Interpretation, Statistical; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins; Sensitivity and Specificity | 2000 |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Creatinine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Ranitidine | 2000 |
Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 1999 |
High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; DNA Mutational Analysis; Drug Resistance, Multiple; Female; Gene Frequency; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Point Mutation; RNA, Ribosomal, 23S | 2000 |
Iron-deficiency anemia associated with Helicobacter pylori gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Endoscopy, Gastrointestinal; Feces; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iron; Lansoprazole; Male; Metronidazole; Omeprazole; Stomach; Urea | 2000 |
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged | 2000 |
Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage; Stomach Ulcer; Treatment Outcome | 2000 |
OAM for cure of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Penicillins | 2000 |
When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after helicobacter pylori eradication?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Proton Pump Inhibitors; Remission Induction; Stomach; Stomach Neoplasms; Time Factors | 2000 |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Primary Health Care; Tetracycline | 2000 |
Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Carnivora; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Endoscopy; Female; Helicobacter; Helicobacter Infections; Lansoprazole; Male; Omeprazole; Penicillins; Polymerase Chain Reaction; Stomach; Stomach Ulcer | 2000 |
Treatment of Helicobacter pylori infection: is less more?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Time Factors | 2000 |
Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Duodenal Ulcer; Family Health; Helicobacter Infections; Helicobacter pylori; Humans; Male; Penicillins; Recurrence; Ribotyping | 2000 |
[Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence; Stomach Ulcer; Time Factors | 2000 |
Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy.
Topics: Adolescent; Amoxicillin; Antibodies, Bacterial; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Feces; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin G; Omeprazole; Polymerase Chain Reaction; Time Factors; Urea | 2000 |
[Treatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Proton Pumps; Treatment Outcome | 2000 |
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome | 2000 |
Helicobacter pylori infection in recurrent abdominal pain.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Recurrence; Retrospective Studies; Stomach; Switzerland | 2000 |
Drug resistance in Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2000 |
Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Retreatment; Retrospective Studies; Time Factors; Treatment Failure | 2000 |
CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin G; Male; Omeprazole; Penicillins | 2000 |
Clarithromycin resistance in Helicobacter pylori infection: does it matter?
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mutation; Prevalence; Proton Pump Inhibitors; RNA, Bacterial; Time Factors | 2000 |
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Ranitidine; Salicylates | 2000 |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 2000 |
Helicobacter pylori infection in renal transplant recipients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Kidney Transplantation; Lansoprazole; Male; Middle Aged; Omeprazole; Postoperative Complications; Proton Pump Inhibitors; Time Factors | 2000 |
Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence | 2000 |
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens.
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Colony Count, Microbial; Culture Media; Dyspepsia; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests | 2001 |
High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Prospective Studies | 2001 |
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy].
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Failure | 2000 |
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Ranitidine | 2001 |
Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.
Topics: Anti-Bacterial Agents; Base Sequence; Clarithromycin; DNA, Ribosomal; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Sequence Data; Nucleic Acid Denaturation; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2001 |
Prevalence of Helicobacter pylori resistant strains in the southern part of Switzerland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Prevalence; Switzerland | 2000 |
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Flagellin; Genotype; Helicobacter Infections; Helicobacter pylori; Metronidazole; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Treatment Failure; Virulence | 2000 |
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Omeprazole; Penicillins; Prospective Studies; Remission Induction; Stomach Neoplasms | 2001 |
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus.
Topics: Adult; Aged; Amoxicillin; Antibodies, Bacterial; Blood Glucose; Clarithromycin; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Therapy, Combination; Female; Gastric Emptying; Gastritis; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Neurologic Examination; Omeprazole | 2001 |
Helicobacter pylori: changing patterns of ulcer disease and antibiotic resistance.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Australia; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 2000 |
Antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Stomach Diseases; Western Australia | 2000 |
[Acute delirium, probably precipitated by clarithromycin].
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Aged; Anti-Bacterial Agents; Clarithromycin; Delirium; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Netherlands | 2001 |
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Proton Pump Inhibitors; Remission Induction; Stomach Neoplasms | 2001 |
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Plasmacytoma; Stomach Neoplasms; Treatment Outcome | 2001 |
[Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Belgium; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prevalence; Prospective Studies; Treatment Outcome; Urban Population | 2001 |
Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
Topics: Adolescent; Adult; Age Distribution; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Middle Aged; Omeprazole; Penicillins; Population Surveillance; Recurrence; Singapore; Time Factors; Urban Health | 2000 |
Molecular resistance testing of Helicobacter pylori in gastric biopsies.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Primers; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Diseases; Urease | 2001 |
Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Biological Transport; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Duodenum; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Penicillins; Peptic Ulcer; Rats; Rats, Wistar | 2001 |
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Sex Characteristics; Tetracycline; Tetracycline Resistance | 2001 |
PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Stomach | 2001 |
[Principles of managing Helicobacter pylori infections. Guidelines of the European Society of Gastroenterology in Primary Health Care].
Topics: Amoxicillin; Biopsy; Clarithromycin; Drug Resistance, Microbial; Duodenoscopy; Enzyme-Linked Immunosorbent Assay; Europe; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Primary Health Care; Proton Pump Inhibitors; Serologic Tests; Societies, Medical | 2000 |
Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Clarithromycin; Digoxigenin; DNA Probes; DNA, Bacterial; Drug Resistance, Microbial; Genes, rRNA; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Ireland; RNA, Ribosomal, 23S; Stomach | 2001 |
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Patient Care Planning; Penicillins; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Treatment Outcome | 2001 |
Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Polymerase Chain Reaction; Proton Pump Inhibitors | 2001 |
Beneficial effect of Helicobacter pylori eradication in dermatologic diseases.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Blotting, Western; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Recurrence; Seroepidemiologic Studies; Skin Diseases | 2001 |
Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin.
Topics: Anti-Bacterial Agents; Cell Culture Techniques; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2001 |
Prevalence of gastric myoelectrical abnormalities in patients with nonulcer dyspepsia and H. pylori infection: resolution after H. pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Electromyography; Female; Follow-Up Studies; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence | 2001 |
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prevalence; Retrospective Studies; Sex Factors; United States | 2001 |
Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Female; Follow-Up Studies; Genetic Markers; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Microsatellite Repeats; Middle Aged; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins p21(ras); Stomach Neoplasms; Time Factors; Tumor Suppressor Protein p53 | 2001 |
4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Rabeprazole | 2001 |
[Eradication therapy of Helicobacter pylori in antibiotic resistance].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Stomach Ulcer | 2001 |
Clarithromycin resistance and eradication of Helicobacter pylori in children.
Topics: Adolescent; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2001 |
What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Drug Administration Schedule; Drug Costs; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome; Urea | 2001 |
Polycolonization of Helicobacter pylori among Chinese subjects.
Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Stomach | 2001 |
In search of the Holy Grail of Heliocobacter pylori remedies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Humans; Metronidazole; Pilot Projects; Ranitidine; Spain | 2001 |
Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cell Division; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Movement; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Sulfides; Treatment Failure | 2001 |
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence; Retrospective Studies; Treatment Failure | 2001 |
Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Culture Media; DNA, Ribosomal; Drug Resistance, Microbial; Endoscopy, Gastrointestinal; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Random Amplified Polymorphic DNA Technique; RNA, Ribosomal, 23S | 2001 |
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Ampulla of Vater; Biopsy; Clarithromycin; Common Bile Duct Neoplasms; Drug Therapy, Combination; Duodenal Neoplasms; Endosonography; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Lymphoma, Follicular; Male; Middle Aged; Omeprazole | 2001 |
A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Stomach Diseases | 2001 |
Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Severity of Illness Index | 2001 |
The effectiveness of one-week triple eradication therapy for perforated duodenal ulcer patients treated with simple closure.
Topics: Adult; Amoxicillin; Clarithromycin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer Perforation; Postoperative Care; Recurrence; Treatment Outcome | 2001 |
Clinical and endoscopic improvement of lymphocytic gastritis with eradication of Helicobacter pylori.
Topics: Aged; Anemia, Iron-Deficiency; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypoproteinemia; Lymphocytes; Male | 2001 |
Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Occult Blood; Omeprazole; Penicillins | 2001 |
A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children.
Topics: Anti-Bacterial Agents; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Confidence Intervals; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Spain | 2001 |
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.
Topics: Adult; Antiphospholipid Syndrome; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Immunoglobulin M; Metronidazole; Omeprazole; Time Factors | 2001 |
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Indoles; Male; Microbial Sensitivity Tests; Penicillins; Stomach Diseases; Tryptophan-tRNA Ligase | 2001 |
The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter; Chi-Square Distribution; Clarithromycin; Dental Calculus; Dental Plaque; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Oral Hygiene; Oral Hygiene Index; Penicillins; Recurrence; Statistics as Topic; Stomach Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 2001 |
Gastric leptin and Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biomarkers; Biopsy; Body Mass Index; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leptin; Male; Middle Aged; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Stomach Neoplasms | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Laparoscopy; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Postoperative Complications; Ranitidine; Recurrence; Stomach Ulcer; Tetracycline; Time Factors | 2001 |
Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Topics: Adult; Aged; Chi-Square Distribution; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Probability; Prospective Studies; Stomach Ulcer; Thailand; Treatment Outcome | 2001 |
Efficacy of Helicobacter pylori eradication therapies: a single centre observational study.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Ranitidine; Treatment Outcome | 2001 |
Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2001 |
Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome; Wound Healing | 2001 |
Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2001 |
Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Omeprazole; Penicillins; Polyps; Remission Induction; Stomach; Stomach Neoplasms | 2001 |
Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Breath Tests; Clarithromycin; Cohort Studies; Costs and Cost Analysis; Decision Support Techniques; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Predictive Value of Tests; Recurrence; Unnecessary Procedures | 2001 |
An attempt at Helicobacter pylori eradication with intravenous clarithromycin in perforated peptic ulcer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer Perforation; Stomach Ulcer | 2001 |
Antibiotic susceptibility of Helicobacter pylori in the Chinese population.
Topics: China; Clarithromycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results; Tetracycline | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori.
Topics: Biopsy; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2001 |
Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests; Time Factors | 2001 |
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Health Care Costs; Helicobacter Infections; Humans; Lansoprazole; Markov Chains; Omeprazole; Penicillins; Stomach Ulcer; Treatment Outcome | 2001 |
Guidelines in the management of Helicobacter pylori infection in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Penicillins; Practice Guidelines as Topic; Proton Pump Inhibitors | 2001 |
Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland.
Topics: Adolescent; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Point Mutation; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S | 2001 |
Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Rosacea; Sulfoxides | 2001 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2001 |
Duodenal mucosa-associated lymphoid tissue lymphoma treated by eradication of Helicobacter pylori: report of 2 cases including EUS findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Benzimidazoles; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Duodenoscopy; Endosonography; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Treatment Outcome | 2001 |
Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR.
Topics: Anti-Bacterial Agents; Base Pair Mismatch; China; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2002 |
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Confidence Intervals; Drug Resistance, Microbial; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Probability; Sensitivity and Specificity | 2001 |
Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Population Surveillance; Prevalence; Risk Factors; Stomach Ulcer; United States | 2002 |
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2002 |
Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; DNA Methylation; Drug Therapy, Combination; Female; Gene Expression; Genes, p16; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2002 |
Antibiotic resistance of Helicobacter pylori strains in Japanese children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Nitroreductases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2002 |
Pyloricidins, novel anti-helicobacterpylori antibiotics produced by Bacillus sp. I. Taxonomy, fermentation and biological activity.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacillus; Biological Assay; Clarithromycin; Fermentation; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides | 2001 |
[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Purpura, Thrombocytopenic, Idiopathic | 2001 |
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Occupational Diseases; Omeprazole; Prospective Studies; Treatment Outcome | 2002 |
Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study.
Topics: Amoxicillin; Antacids; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2001 |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults.
Topics: Adolescent; Adult; Amoxicillin; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2002 |
Resolution of collagenous colitis after treatment for Helicobacter pylori.
Topics: Aged; Biopsy, Needle; Clarithromycin; Colitis; Collagen; Diarrhea; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2002 |
[Clarithromycin in eradication therapy of helicobacter infections in children].
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans | 2001 |
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillin Resistance; Penicillins; Retrospective Studies | 2002 |
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antigens; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2002 |
[The prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in Beijing].
Topics: Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Point Mutation; Prevalence; RNA, Ribosomal, 23S | 2001 |
Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children.
Topics: Abdominal Pain; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Clarithromycin; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Humans; Male; Penicillins; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2002 |
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs.
Topics: Amoxicillin; Clarithromycin; Cost-Benefit Analysis; Databases, Factual; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Netherlands; Proton Pump Inhibitors | 2002 |
Clarithromycin increases the release of heat shock protein B from Helicobacter pylori.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Electrophoresis, Gel, Two-Dimensional; Heat-Shock Proteins; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Sequence Data; Treatment Failure | 2002 |
[Gastroduodenal ulcer in childhood].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Informed Consent; Japan; Lansoprazole; Male; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Treatment Failure | 2002 |
Failure of Helicobacter pylori eradication: is poor compliance the main cause?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Peptic Ulcer; Treatment Failure | 2002 |
[Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Spain; Tetracycline | 2002 |
Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Brazil; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Point Mutation | 2002 |
[Pharmacotherapeutic aspects of early postoperative period in patients with complicated gastroduodenal ulcer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Combined Modality Therapy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Postoperative Period; Proton Pumps; Tinidazole; Vagotomy | 2002 |
Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigen-Presenting Cells; CD28 Antigens; Cell Count; Clarithromycin; Drug Therapy, Combination; Fluorescent Antibody Technique, Indirect; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Immunoenzyme Techniques; Macrophages; Metronidazole; Omeprazole; Treatment Outcome | 2002 |
[Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Primary Health Care; Surveys and Questionnaires | 2002 |
Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Ribosomal; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Female; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S; Stomach | 2002 |
Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime.
Topics: Amoxicillin; Cefixime; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2002 |
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Family; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence | 2002 |
Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Clarithromycin; Coloring Agents; Dental Plaque; Drug Therapy, Combination; Female; Fluorescent Dyes; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Tongue | 2001 |
The genetic gymnastics of our indigenous microbes.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Ecosystem; Genetic Variation; Genetics, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Stomach | 2002 |
In vitro anti-Helicobacter pylori activity of BAS-118, a new benzamide derivative.
Topics: Anti-Bacterial Agents; Benzamides; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer | 2002 |
Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Diterpenes; Drug Synergism; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Stomach | 2002 |
Clarithromycin and omeprazole for Helicobacter pylori.
Topics: Clarithromycin; Erythromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1992 |